PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA
J	Dicks, AB; Elgendy, IY; Thondapu, V; Ghoshhajra, B; Waller, HD; Rubio, M; Abdurahman, K; Schainfield, RM; Weinberg, I				Dicks, Andrew B.; Elgendy, Islam Y.; Thondapu, Vikas; Ghoshhajra, Brian; Waller, Harold D.; Rubio, Manolo; Abdurahman, Khalil; Schainfield, Robert M.; Weinberg, Ido			Clinical characteristics, treatment, and outcomes of patients with renal artery dissections	VASCULAR MEDICINE			English	Meeting Abstract									[Dicks, Andrew B.; Thondapu, Vikas; Ghoshhajra, Brian; Waller, Harold D.; Rubio, Manolo; Abdurahman, Khalil; Schainfield, Robert M.; Weinberg, Ido] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Elgendy, Islam Y.] Weill Cornell Med Qatar, Doha, Qatar				Elgendy, Islam Y/C-3900-2017; Dicks, Andrew/AGI-3067-2022	Elgendy, Islam Y/0000-0001-9853-7591; 				0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1383	NP15	NP16					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100041					2022-04-28	
J	Patricio, JC; Beltran, J; Dy, T				Patricio, Joseph Christian; Beltran, Jenny; Dy, Timothy			Aortic tumor and a lower extremity undifferentiated pleomorphic sarcoma	VASCULAR MEDICINE			English	Meeting Abstract									[Patricio, Joseph Christian; Beltran, Jenny; Dy, Timothy] St Lukes Med Ctr Quezon City, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1325	NP28	NP29					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100064					2022-04-28	
J	Sindiong, MKR; Beltran, J; Supan, JV				Sindiong, Monica Kristine Reyes; Beltran, Jenny; Supan, Jael Victoria			The Deadly Quad - Polycythemia vera (PV) and Atherosclerosis in a 43-year-old Diabetic Smoker presenting with Chronic Limb Threatening Ischemia (CLTI)	VASCULAR MEDICINE			English	Meeting Abstract									[Sindiong, Monica Kristine Reyes; Beltran, Jenny; Supan, Jael Victoria] St Lukes Med Ctr Quezon City, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1274	NP25	NP25					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100057					2022-04-28	
J	Wheeler, J				Wheeler, Jason			Antiphospholipid antibody induction after infliximab treatment for inflammatory bowel disease	VASCULAR MEDICINE			English	Meeting Abstract									[Wheeler, Jason] Cleveland Clin, Cleveland, OH 44106 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1411	NP32	NP33					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100072					2022-04-28	
J	Al-Otaibi, M; Shah, NB; Iftikhar, O; Sharma, P; Rao, K; Bashir, R; Lakhter, V				Al-Otaibi, Mohamad; Shah, Neal B.; Iftikhar, Omer; Sharma, Prateek; Rao, Koneti; Bashir, Riyaz; Lakhter, Vladimir			First-in-human experience of the Bashir Endovascular Catheter in the treatment of iliocaval deep vein thrombosis	VASCULAR MEDICINE			English	Article						deep vein thrombosis (DVT); endovascular therapy; intravascular ultrasound; post-thrombotic syndrome; thrombolytic therapy; venous thromboembolism (VTE)	DIRECTED THROMBOLYSIS	Deep vein thrombosis (DVT) is a common disorder affecting approximately 900,000 new patients in the United States each year. Although the mainstay of treatment of DVT patients is therapeutic anticoagulation, some patients remain significantly symptomatic and therefore require more advanced interventions such as catheter-directed thrombolysis (CDT). We describe a case series of 13 patients with acute symptomatic inferior vena cava (IVC) and iliofemoral DVT that were treated with CDT using the Bashir Endovascular Catheter (BEC). We report the first-in-human use of BEC, which is a novel pharmacomechanical thrombolysis device. All the treated patients had complete and rapid resolution of their symptoms with excellent venous outflow. Despite initial promising results, larger studies using this catheter design will be needed to assess the role of BEC-directed therapy on rates of post-thrombotic syndrome and bleeding complications.	[Al-Otaibi, Mohamad; Shah, Neal B.] Temple Univ Hosp & Med Sch, Dept Internal Med, Philadelphia, PA USA; [Iftikhar, Omer; Sharma, Prateek; Bashir, Riyaz; Lakhter, Vladimir] Temple Univ Hosp & Med Sch, Dept Cardiovasc Dis, 3401 N Broad St 9PP, Philadelphia, PA 19140 USA; [Rao, Koneti] Temple Univ Hosp & Med Sch, Dept Hematol, Sol Sherry Thrombosis Ctr, Philadelphia, PA USA		Lakhter, V (通讯作者)，Temple Univ Hosp & Med Sch, Dept Cardiovasc Dis, 3401 N Broad St 9PP, Philadelphia, PA 19140 USA.	Vladimir.Lakhter@tuhs.temple.edu		lakhter, vladimir/0000-0002-2813-8437			Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017; Comerota AJ, 2019, CIRCULATION, V139, P1162, DOI 10.1161/CIRCULATIONAHA.118.037425; Engelberger RP, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002027; Francis CW, 2001, VASC MED, V6, P181, DOI 10.1177/1358836X0100600309; Gurewich V, 2016, J AM COLL CARDIOL, V68, P2099, DOI 10.1016/j.jacc.2016.07.780; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2020, J VASC SURG-VENOUS L, V8, P8, DOI 10.1016/j.jvsv.2019.03.023; Kim HS, 2006, J VASC INTERV RADIOL, V17, P1099, DOI 10.1097/01.RVI.0000228334.47073.C4; Notten P, 2020, THROMB HAEMOSTASIS, V120, P1188, DOI 10.1055/s-0040-1713171; Notten P, 2020, LANCET HAEMATOL, V7, pE40, DOI 10.1016/S2352-3026(19)30209-1; Okafor ON, 2015, J AM COLL CARDIOL, V65, P1683, DOI 10.1016/j.jacc.2015.02.040; Owens Charles A, 2008, Semin Intervent Radiol, V25, P37, DOI 10.1055/s-2008-1052304; US Food Drug Administration, 2019, BASH PLUS END CATH P; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066	14	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					648	653	1358863X211028287	10.1177/1358863X211028287		AUG 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000685782900001	34392749				2022-04-28	
J	Sharma, AM; Kim, ESH; Kadian-Dodov, D; Armstrong, E				Sharma, Aditya M.; Kim, Esther S. H.; Kadian-Dodov, Daniella; Armstrong, Ehrin			The 2020 SVM/SVU Consensus Statement for the Interpretation of Peripheral Arterial and Venous Doppler Waveforms: An interview with SVM members of the Writing Committee	VASCULAR MEDICINE			English	Editorial Material									[Sharma, Aditya M.] Univ Virginia, Cardiovasc Med, Charlottesville, VA USA; [Kim, Esther S. H.] Vanderbilt Univ, Sch Med, Vasc Med, Nashville, TN 37212 USA; [Kadian-Dodov, Daniella] Icahn Sch Med Mt Sinai, Vasc Med, New York, NY 10029 USA; [Armstrong, Ehrin] Univ Colorado, Cardiol, Denver, CO 80202 USA		Sharma, AM (通讯作者)，Univ Virginia, Div Cardiovasc Med, 200 Jeanette Lancaster Way, Charlottesville, VA 22903 USA.	as8ah@hscmail.mcc.virginia.edu					Kim ES, 2020, J VASC ULTRASOUND, V44, P118; Kim ESH, 2020, VASC MED, V25, P484, DOI 10.1177/1358863X20937665; Nicolaides AN, 1981, INVESTIGATION VASCUL; Scissons RP, 2015, J VASC ULTRASOUND, V39, P151	4	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					117	118	1358863X20980055	10.1177/1358863X20980055		DEC 2020	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000618419100001	33375915	Bronze			2022-04-28	
J	Solano, MSJ; Obrado-Nabablit, M; Heidari, M; Balcos, K; Gotohio, M				Solano, Maria Shinilli Jean; Obrado-Nabablit, Marjorie; Heidari, Marjan; Balcos, Katrina; Gotohio, Michelle			Effectiveness and safety of combined direct oral anticoagulant and antiplatelet therapy among high-risk peripheral artery disease patients-a meta-analysis	VASCULAR MEDICINE			English	Meeting Abstract									[Solano, Maria Shinilli Jean; Obrado-Nabablit, Marjorie; Heidari, Marjan; Balcos, Katrina; Gotohio, Michelle] Manila Doctors Hosp, Manila, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1408	NP19	NP19					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100045					2022-04-28	
J	Bunte, MC; Monteleone, PP				Bunte, Matthew C.; Monteleone, Peter P.			Adapting vascular care amidst a pandemic: Considering COVID-19 and looking forward	VASCULAR MEDICINE			English	Editorial Material						coronavirus disease 2019 (COVID-19); peripheral artery disease (PAD); revascularization; Vascular Quality Initiative (VQI)			[Bunte, Matthew C.] St Lukes Hlth Syst, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Bunte, Matthew C.] Univ Missouri, Sch Med, Kansas City, MO 64110 USA; [Monteleone, Peter P.] Univ Texas Austin, Dell Sch Med, Ascens Texas Cardiovasc, Austin, TX 78712 USA		Bunte, MC (通讯作者)，Univ Missouri, St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	mbunte@saintlukeskc.org		Bunte, Matthew/0000-0002-8768-1376			Lin JC, 2021, J VASC SURG, V73, P392, DOI 10.1016/j.jvs.2020.06.051; Lou JY, 2021, VASC MED, V26, P613, DOI 10.1177/1358863X211021918; Society for Vascular Surgery, 2021, VASC QUAL IN VASC ME	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					624	625	1358863X211035175	10.1177/1358863X211035175		AUG 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000684647900001	34380346	Bronze			2022-04-28	
J	Osipova, O; Cheban, A; Ignatenko, P; Ruzankin, P; Prokopenko, E; Karpenko, A				Osipova, Olesia; Cheban, Alexey; Ignatenko, Pavel; Ruzankin, Pavel; Prokopenko, Evgeny; Karpenko, Andrey			The effect of the stented iliac lesions TASC-II C, D on the femoropopliteal bypass patency: Propensity score-matched observational study	VASCULAR MEDICINE			English	Article; Early Access						femoropopliteal bypass; hybrid surgery; iliac artery stenting; non-inferiority trial; propensity score methods	HYBRID PROCEDURES; REVASCULARIZATION; ISCHEMIA; DISEASE; VEIN	Introduction Concurrent stenting of complex iliac lesions during infrainguinal bypasses can increase the complexity of a case and impact outcomes. Objective Our aim was to evaluate the effect of inflow stenting of TASC-II C, D iliac lesions on femoropopliteal bypass patency. Methods A retrospective observational cohort study of patients who underwent femoropopliteal bypass with TASC-II C, D iliac artery stenting (hybrid group) or without inflow lesions (non-hybrid group) was conducted. After propensity score matching, 120 patients were included in the non-hybrid group and 60 patients in the hybrid one. The median follow-up was 432 (193; 1313) days in the hybrid group and 472 (196; 1376) days in the non-hybrid group (p = 0.94). Results No significant differences were found between the groups in 30-day morbidity and serious adverse events. At 3 years, primary and secondary bypass patency for the hybrid group and non-hybrid group were 62.2% versus 59.9% (p = 0.36) and 63.7% versus 64.3% (p = 0.077), respectively. The primary patency of the iliac stents in patients of the hybrid group was 95% at 3 years. The estimated hazard ratio for primary patency for hybrid versus non-hybrid was 0.77, with 90% CI: 0.50-1.21; the noninferiority upper bound being 1.31, which corresponds to a 10% additive noninferiority margin for probabilities. The 3 years of freedom from amputation in patients with chronic limb-threatening ischemia was 94.1% and 75.0% in the hybrid and non-hybrid groups, respectively (p = 0.09). Conclusion The outcomes of the femoropopliteal bypass in hybrid surgery supplemented with stenting of TASC-II C, D iliac lesions was similar to femoropopliteal bypass with intact inflow arteries.	[Osipova, Olesia; Cheban, Alexey; Ignatenko, Pavel; Karpenko, Andrey] Meshalkin Natl Med Res Ctr, Ctr Vasc & Hybrid Surg, Novosibirsk 630055, Russia; [Ruzankin, Pavel; Prokopenko, Evgeny] Sobolev Inst Math, Novosibirsk, Russia; [Ruzankin, Pavel; Prokopenko, Evgeny] Novosibirsk State Univ, Dept Probabil Theory & Math Stat, Novosibirsk, Russia		Osipova, O (通讯作者)，Meshalkin Natl Med Res Ctr, Ctr Vasc & Hybrid Surg, Novosibirsk 630055, Russia.	Osipova_o@meshalkin.ru	Ruzankin, Pavel S./I-8485-2014; Prokopenko, Evgeny/J-6778-2018	Ruzankin, Pavel S./0000-0002-5262-3037; Prokopenko, Evgeny/0000-0003-2913-4195; Osipova, Olesia/0000-0002-7418-3298	Ministry of Science and Higher Education of the Russian Federation [075-15-2019-1675]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work of Pavel Ruzankin and Evgeny Prokopenko was supported by the Mathematical Center in Akademgorodok under agreement No. 075-15-2019-1675 with the Ministry of Science and Higher Education of the Russian Federation.	Ahn S, 2017, ASIAN J SURG, V40, P215, DOI 10.1016/j.asjsur.2015.11.006; Antoniou GA, 2009, EUR J VASC ENDOVASC, V38, P616, DOI 10.1016/j.ejvs.2009.06.016; Balaz P, 2012, SCAND J SURG, V101, P232, DOI 10.1177/145749691210100402; Benetis R, 2016, ARCH MED SCI, V12, P353, DOI 10.5114/aoms.2016.59261; Cotroneo AR, 2007, CARDIOVASC INTER RAD, V30, P355, DOI 10.1007/s00270-005-0296-5; da Silva GT, 2009, BIOL BLOOD MARROW TR, V15, P120, DOI 10.1016/j.bbmt.2008.10.004; Davies M G, 1991, Ann Vasc Surg, V5, P519, DOI 10.1007/BF02015275; de Donato G, 2015, ANN VASC SURG, V29, P738, DOI 10.1016/j.avsg.2014.12.027; Dosluoglu HH, 2010, J VASC SURG, V51, P1425, DOI 10.1016/j.jvs.2010.01.092; Eagleton MJ, 1997, J VASC SURG, V26, P928, DOI 10.1016/S0741-5214(97)70004-1; Joh JH, 2014, EXP THER MED, V7, P804, DOI 10.3892/etm.2014.1513; Lee SC, 2018, VASA, V47, P235, DOI 10.1024/0301-1526/a000694; Liu Changwei, 2001, Chinese Medical Sciences Journal, V16, P165; Matsagkas M, 2011, ANN VASC SURG, V25, P1063, DOI 10.1016/j.avsg.2011.07.010; Piazza M, 2017, ANN VASC SURG, V44, P282, DOI 10.1016/j.avsg.2017.04.018; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Ruzankin PS, 2020, METHODOL COMPUT APPL, V22, P477, DOI 10.1007/s11009-019-09718-4; Sayers RD, 1998, BRIT J SURG, V85, P934; Taurino M, 2014, VASC ENDOVASC SURG, V48, P123, DOI 10.1177/1538574413512381; TAYLOR LM, 1990, J VASC SURG, V11, P193, DOI 10.1067/mva.1990.17235; Ye W, 2011, J VASC SURG, V53, P1728, DOI 10.1016/j.jvs.2011.02.005; Zhou Min, 2013, Zhonghua Wai Ke Za Zhi, V51, P240	22	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.											1358863X211021165	10.1177/1358863X211021165		JUL 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TM6NW	WOS:000675668100001	34269143				2022-04-28	
J	Zilinyi, RS; Sethi, SS				Zilinyi, Robert S.; Sethi, Sanjum S.			Improving risk stratification in acute pulmonary embolism: How do we target our therapies more effectively?	VASCULAR MEDICINE			English	Editorial Material						biomarkers; pulmonary embolism (PE); risk stratification	SEVERITY INDEX; PROSPECTIVE VALIDATION		[Zilinyi, Robert S.] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA; [Sethi, Sanjum S.] Columbia Univ, Irving Med Ctr, Div Cardiol, Dept Med,Ctr Intervent Vasc Therapy, 161 Ft Washington Ave Fl 6, New York, NY 10032 USA		Sethi, SS (通讯作者)，Columbia Univ, Irving Med Ctr, Div Cardiol, Dept Med,Ctr Intervent Vasc Therapy, 161 Ft Washington Ave Fl 6, New York, NY 10032 USA.	sss2270@cumc.columbia.edu	Sethi, Sanjum S./AAO-2601-2020	Sethi, Sanjum S./0000-0002-3438-7034	American Heart AssociationAmerican Heart Association	Dr Sethi reports research funding from the American Heart Association. Dr. Zilinyi has no financial disclosures.	Barnes GD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10779; Bova C, 2014, EUR RESPIR J, V44, P694, DOI 10.1183/09031936.00006114; Donze J, 2008, THROMB HAEMOSTASIS, V100, P943, DOI 10.1160/TH08-05-0285; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Lankeit M, 2014, EUR RESPIR J, V43, P1669, DOI 10.1183/09031936.00211613; Lankeit M, 2011, CIRCULATION, V124, P2716, DOI 10.1161/CIRCULATIONAHA.111.051177; Newman J, 2021, VASC MED, V26, P556, DOI 10.1177/1358863X211002276; Pruszczyk P, 2014, JACC-CARDIOVASC IMAG, V7, P553, DOI 10.1016/j.jcmg.2013.11.004; Secemsky E, 2018, AM J MED, V131, P1506, DOI 10.1016/j.amjmed.2018.07.035	11	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					561	562	1358863X211021917	10.1177/1358863X211021917		JUN 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000666605300001	34159862	Bronze			2022-04-28	
J	Romero, JR; Himali, JJ; Beiser, A; Pase, MP; Davis-Plourde, KL; Parva, P; Seshadri, S; Mitchell, GF				Romero, Jose R.; Himali, Jayandra J.; Beiser, Alexa; Pase, Matthew P.; Davis-Plourde, Kendra L.; Parva, Pedram; Seshadri, Sudha; Mitchell, Gary F.			Aortic stiffness and cerebral microbleeds: The Framingham Heart Study	VASCULAR MEDICINE			English	Letter						arterial stiffness; cerebral microbleeds; cerebrovascular disease	SMALL-VESSEL DISEASE; ARTERIAL STIFFNESS; RISK		[Romero, Jose R.; Himali, Jayandra J.; Beiser, Alexa; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, 715 Albany St,B-608, Boston, MA 02118 USA; [Romero, Jose R.; Himali, Jayandra J.; Beiser, Alexa; Pase, Matthew P.; Davis-Plourde, Kendra L.; Seshadri, Sudha; Mitchell, Gary F.] NHLBI Framingham Heart Study, Framingham, MA USA; [Himali, Jayandra J.; Beiser, Alexa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Himali, Jayandra J.; Seshadri, Sudha] UT Hlth San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX USA; [Himali, Jayandra J.; Seshadri, Sudha] UT Hlth San Antonio, Long Sch Med, Dept Populat Hlth Sci, San Antonio, TX USA; [Pase, Matthew P.] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Clayton, Vic, Australia; [Pase, Matthew P.] Harvard TH Chan Sch Publ Hlth, Cambridge, MA USA; [Parva, Pedram] Harvard Med Sch, Boston VA Hlth Care Syst, Dept Radiol, Boston, MA 02115 USA; [Parva, Pedram] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA		Romero, JR (通讯作者)，Boston Univ, Sch Med, Dept Neurol, 715 Albany St,B-608, Boston, MA 02118 USA.	joromero@bu.edu		Pase, Matthew/0000-0002-4143-8485; /0000-0003-1391-9481; Romero, Jose/0000-0002-1101-2950; Davis-Plourde, Kendra/0000-0001-6654-0710	National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart StudyUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HC-25195, HHSN268201500001I]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS17950]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG008122, K23AG038444, R03 AG048180-01A1, AG033193, AG049607, R01 AG059725-02]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1 HL64753, R01 HL076784, 1 R01 AG028321, P30 AG010129]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL67288, 2K24HL04334]; National Heart Foundation of Australia Future Leader FellowshipNational Heart Foundation of Australia [102052]	The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study (contracts N01-HC-25195 and HHSN268201500001I), grants from the National Institute of Neurological Disorders and Stroke (NS17950), the National Institute of Aging (R01 AG008122, K23AG038444; R03 AG048180-01A1; R01 AG008122, AG033193, AG049607; R01 AG059725-02), NIH grants (1RO1 HL64753; R01 HL076784; 1 R01 AG028321, P30 AG010129), and NHLBI grants (HL67288, and 2K24HL04334). Dr Pase is funded by a National Heart Foundation of Australia Future Leader Fellowship (ID 102052).	Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Romero JR, 2017, NEUROBIOL AGING, V54, P94, DOI 10.1016/j.neurobiolaging.2017.02.018; Romero JR, 2014, STROKE, V45, P1492, DOI 10.1161/STROKEAHA.114.004130; Saji N, 2015, PULSE, V3, P182, DOI 10.1159/000443614; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Seo WK, 2008, CEREBROVASC DIS, V26, P618, DOI 10.1159/000166837; Shoamanesh A, 2015, NEUROLOGY, V84, P825, DOI 10.1212/WNL.0000000000001279; Tomiyama H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005729	12	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					312	314	1358863X20979740	10.1177/1358863X20979740		JAN 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000618439300001	33393444				2022-04-28	
J	Raja, A; Spertus, J; Yeh, RW; Secemsky, EA				Raja, Aishwarya; Spertus, John; Yeh, Robert W.; Secemsky, Eric A.			Assessing Health-Related Quality of Life among Patients with Peripheral Artery Disease: A Review of the Literature and Focus on Patient-Reported Outcome Measures	VASCULAR MEDICINE			English	Review						claudication; critical limb ischemia (CLI); outcomes; peripheral artery disease (PAD); quality of life		Peripheral artery disease (PAD) is a progressive atherosclerotic disease associated with high rates of morbidity and mortality. Symptomatic PAD typically presents with claudication, and symptom severity strongly associates with reduced health-related quality of life (HRQoL). Existing treatment strategies for PAD are aimed at reducing symptom severity and improving functional outcomes. However, there is a need to incorporate patient-reported outcome measures (PROMs) into PAD treatment and research in order to provide more patient-centered care. This review will discuss the impact of PAD on HRQoL, existing PROMs available to assess PAD-related HRQoL, utilization of PROMs in research studies and registries, and challenges and solutions related to the integration of PROMs into research and clinical settings.	[Raja, Aishwarya; Yeh, Robert W.; Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, 375 Longwood Ave,4th Floor, Boston, MA 02215 USA; [Raja, Aishwarya; Yeh, Robert W.; Secemsky, Eric A.] Harvard Med Sch, Boston, MA 02115 USA; [Spertus, John] St Lukes Mid Amer Heart Inst, Dept Cardiovasc Med, Kansas City, MO USA; [Yeh, Robert W.; Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA		Secemsky, EA (通讯作者)，Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, 375 Longwood Ave,4th Floor, Boston, MA 02215 USA.	esecemsk@bidmc.harvard.edu	Spertus, John/ABD-3075-2021	Secemsky, Eric/0000-0003-3861-3163	NIH/NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL150290]	Eric Secemsky is funded by the NIH/NHLBI K23HL150290.	Abernethy AP, 2008, HEALTH SERV RES, V43, P1975, DOI 10.1111/j.1475-6773.2008.00887.x; Aquarius AE, 2006, ARCH SURG-CHICAGO, V141, P161, DOI 10.1001/archsurg.141.2.161; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Beaton DE, 2002, CURR OPIN RHEUMATOL, V14, P109, DOI 10.1097/00002281-200203000-00006; Bhardwaj B, 2019, JACC-CARDIOVASC INTE, V12, P1140, DOI 10.1016/j.jcin.2019.03.012; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Blumenthal DM, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004794; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Bredart A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-15; Chan PS, 2014, CIRC-CARDIOVASC QUAL, V7, P640, DOI 10.1161/CIRCOUTCOMES.114.000967; Cheung YB, 2006, J CLIN EPIDEMIOL, V59, P185, DOI 10.1016/j.jclinepi.2005.06.011; Chong PFS, 2002, J VASC SURG, V36, P764, DOI 10.1067/mva.2002.127338; Criqui M H, 1996, Vasc Med, V1, P65; Derksen FAWM, 2016, BRIT J GEN PRACT, V66, pE887, DOI 10.3399/bjgp16X687565; Desai SS, 2018, JAMA SURG, V153, P957, DOI 10.1001/jamasurg.2018.0498; Devine EB, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.2024; Dreyer MA., 2020, STATPEARLS INTERNET; Duff S, 2019, VASC HEALTH RISK MAN, V15, P187, DOI 10.2147/VHRM.S209241; Feveile H, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-27; Forbes JF, 2010, J VASC SURG, V51, p43S, DOI 10.1016/j.jvs.2010.01.076; Gardner AW, 2018, VASC MED, V23, P349, DOI 10.1177/1358863X18762599; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471; Gray WA, 2015, J VASC INTERV RADIOL, V26, P21, DOI 10.1016/j.jvir.2014.09.018; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Gundy CM, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-35; Nguyen H, 2021, J MED RADIAT SCI, V68, P186, DOI 10.1002/jmrs.421; Harwood AE, 2017, GEFASSCHIRURGIE, V22, P159, DOI 10.1007/s00772-017-0269-4; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hoeks SE, 2009, J VASC SURG, V49, P371, DOI 10.1016/j.jvs.2008.08.089; Huo T, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0858-2; Irvine EJ, 1996, J CLIN EPIDEMIOL, V49, P1177, DOI 10.1016/0895-4356(96)00136-9; Karimi M, 2016, PHARMACOECONOMICS, V34, P645, DOI 10.1007/s40273-016-0389-9; Larsen ASF, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0760-3; Maron DJ, 2018, AM HEART J, V201, P124, DOI 10.1016/j.ahj.2018.04.011; Mays RJ, 2011, J VASC SURG, V53, P1410, DOI 10.1016/j.jvs.2010.11.092; McDermott MM, 2018, JAMA-J AM MED ASSOC, V319, P1665, DOI 10.1001/jama.2018.3275; McDermott MM, 2018, J CARDIOPULM REHABIL, V38, P63, DOI 10.1097/HCR.0000000000000343; Mehta T, 2006, EUR J VASC ENDOVASC, V31, P46, DOI 10.1016/j.ejvs.2005.08.028; Morgan MBF, 2001, J VASC SURG, V33, P679, DOI 10.1067/mva.2001.112326; Murphy TP, 2015, J AM COLL CARDIOL, V65, P999, DOI 10.1016/j.jacc.2014.12.043; Mustapha J, 2019, J ENDOVASC THER, V26, P143, DOI 10.1177/1526602819827295; Nagy KV, 2018, EUROPACE, V20, P1506, DOI 10.1093/europace/eux342; Nassif ME, 2019, CIRCULATION, V140, P1463, DOI 10.1161/CIRCULATIONAHA.119.042929; Nehler MR, 2003, VASC MED, V8, P115, DOI 10.1191/1358863x03vm483ra; Niebauer K, 2006, ANN ALLERG ASTHMA IM, V96, P316, DOI 10.1016/S1081-1206(10)61242-2; Nordanstig J, 2014, J VASC SURG, V59, P700, DOI 10.1016/j.jvs.2013.08.099; Nordin A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0167-6; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Olin JW, 2016, J AM COLL CARDIOL, V67, P1338, DOI 10.1016/j.jacc.2015.12.049; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Patel MR, 2015, J AM COLL CARDIOL, V65, P931, DOI 10.1016/j.jacc.2014.12.036; Poku E, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0563-y; Prcic Alden, 2013, Acta Inform Med, V21, P160, DOI 10.5455/aim.2013.21.160-165; Puhan MA, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-30; Qintar M, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003665; Raja A, 2020, VASC MED, V25, pNP4; Regensteiner JG, 1996, J VASC SURG, V23, P104, DOI 10.1016/S0741-5214(05)80040-0; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rolstad S, 2011, VALUE HEALTH, V14, P1101, DOI 10.1016/j.jval.2011.06.003; Rotenstein LS, 2017, NEW ENGL J MED, V377, P1309, DOI 10.1056/NEJMp1707537; Rutter LA, 2017, J PSYCHOPATHOL BEHAV, V39, P140, DOI 10.1007/s10862-016-9571-9; Shu J, 2018, ATHEROSCLEROSIS, V275, P379, DOI 10.1016/j.atherosclerosis.2018.05.033; Sloan J, 2003, DRUG INF J, V37, P23, DOI 10.1177/009286150303700105; Smolderen KG, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003860; Spertus J, 2004, AM HEART J, V147, P301, DOI 10.1016/j.ahj.2003.08.001; Spertus JA, 2015, CIRC-CARDIOVASC QUAL, V8, P469, DOI 10.1161/CIRCOUTCOMES.115.001958; Treat-Jacobson D, 2019, CIRCULATION, V140, pE700, DOI 10.1161/CIR.0000000000000727; Treat-Jacobson D, 2012, VASC MED, V17, P405, DOI 10.1177/1358863X12466708; Wagle NW, 2017, IMPLEMENTING PATIENT, DOI DOI 10.1056/CAT.17.0373; Wann-Hansson Christine, 2004, Health Qual Life Outcomes, V2, P9, DOI 10.1186/1477-7525-2-9; Weinberger M, 1996, J CLIN EPIDEMIOL, V49, P135, DOI 10.1016/0895-4356(95)00556-0; Wu AZ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004519; Wu AW, 1997, QUAL LIFE RES, V6, P3, DOI 10.1023/A:1026471020698	75	5	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					317	325	1358863X20977016	10.1177/1358863X20977016		DEC 2020	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000608807300001	33295253	Green Accepted			2022-04-28	
J	Beyer, SE; Shanafelt, C; Pinto, DS; Weinstein, JL; Giri, J; Sista, AK; Yeh, RW; Secemsky, EA; Carroll, BJ				Beyer, Sebastian E.; Shanafelt, Colby; Pinto, Duane S.; Weinstein, Jeffrey L.; Giri, Jay; Sista, Akhilesh K.; Yeh, Robert W.; Secemsky, Eric A.; Carroll, Brett J.			National trends in utilization of thrombolytic therapy for acute pulmonary embolism	VASCULAR MEDICINE			English	Letter						pulmonary embolism (PE); catheter-directed treatment; thrombolysis			[Beyer, Sebastian E.; Shanafelt, Colby] New York Presbyterian Hosp, Weill Cornell Med Coll, Weill Cornell Med Ctr New York City, Div Cardiol, New York, NY USA; [Pinto, Duane S.; Yeh, Robert W.; Secemsky, Eric A.; Carroll, Brett J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, 185 Pilgrim Rd,Palmer 4, Boston, MA 02115 USA; [Weinstein, Jeffrey L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Intervent Radiol, Boston, MA USA; [Giri, Jay] Univ Penn, Dept Med, Penns Cardiovasc Outcomes Qual & Evaluat Res CAVO, Cardiovasc Med Div, Philadelphia, PA 19104 USA; [Sista, Akhilesh K.] NYU, Dept Radiol, Sch Med, 560 1St Ave, New York, NY 10016 USA; [Yeh, Robert W.; Secemsky, Eric A.; Carroll, Brett J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02115 USA		Carroll, BJ (通讯作者)，Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, 185 Pilgrim Rd,Palmer 4, Boston, MA 02115 USA.	Bcarrol2@bidmc.harvard.edu		Secemsky, Eric/0000-0003-3861-3163			Beyer SE, 2020, CHEST, V157, P645, DOI 10.1016/j.chest.2019.10.049; Chatterjee S, 2014, JAMA-J AM MED ASSOC, V311, P2414, DOI 10.1001/jama.2014.5990; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; HCUP, NIS OVERVIEW; Piazza G, 2015, JACC-CARDIOVASC INTE, V8, P1382, DOI 10.1016/j.jcin.2015.04.020	5	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					75	76	1358863X211048544	10.1177/1358863X211048544		OCT 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000712013000001	34696648				2022-04-28	
J	Huizing, E; Kum, S; Ipema, J; Varcoe, RL; Shah, AP; de Vries, JPPM; Unlu, C				Huizing, Eline; Kum, Steven; Ipema, Jetty; Varcoe, Ramon L.; Shah, Atman P.; de Vries, Jean-Paul P. M.; Unlu, Cagdas			Mid-term outcomes of an everolimus-eluting bioresorbable vascular scaffold in patients with below-the-knee arterial disease: A pooled analysis of individual patient data	VASCULAR MEDICINE			English	Article						below-the-knee disease; bioresorbable vascular scaffold; chronic limb-threatening ischemia (CLTI); infrapopliteal artery; patency; peripheral artery disease (PAD)		Previous studies on everolimus-eluting bioresorbable vascular scaffolds (BVS) have shown promising 1-year primary patency rates in infrapopliteal arteries. Literature from large cohorts on long-term outcomes with the infrapopliteal Absorb BVS (Abbott Vascular) is lacking. The aim of this study is to pool published and unpublished data to provide a more precise estimate of the 24-month outcomes of Absorb BVS for the treatment of infrapopliteal disease. For the pooled analysis, updated original and newly collected data from three cohorts on treatment with the Absorb BVS for de novo infrapopliteal lesions were combined. The primary endpoint was freedom from restenosis. Secondary endpoints were freedom from clinically driven target lesion revascularization (CD-TLR), major amputation and survival. The pooled analysis included a total of 121 patients with 161 lesions, treated with 189 Absorb BVS in 126 limbs. The mean age of the patients was 73 years, 57% had diabetes mellitus, and 75% were classified as Rutherford-Becker class 5 or 6. Of the 161 lesions, 101 (63%) were calcified and 36 (22%) were occlusions. Successful deployment was achieved with all scaffolds. Freedom from restenosis was 91.7% and 86.6% at 12 and 24 months, respectively, and freedom from CD-TLR was 97.2% and 96.6%. Major amputation occurred in 1.6% of the limbs. Overall survival was 85% at 24 months. In conclusion, this pooled analysis represents the largest reported analysis of mid-term results of the Absorb BVS for the management of chronic limb-threatening ischemia. At 24 months, the Absorb BVS was safe with promising clinical outcomes for the treatment of infrapopliteal disease.	[Huizing, Eline; Ipema, Jetty; Unlu, Cagdas] Northwest Clin, Dept Surg, Alkmaar, Netherlands; [Kum, Steven] Changi Gen Hosp, Dept Surg, Vasc Serv, Singapore, Singapore; [Varcoe, Ramon L.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Varcoe, Ramon L.] Prince Wales Hosp, Dept Surg, Sydney, NSW, Australia; [Shah, Atman P.] Univ Chicago, Cardiol Sect, Chicago, IL 60637 USA; [de Vries, Jean-Paul P. M.] Univ Med Ctr Groningen, Div Vasc Surg, Dept Surg, Groningen, Netherlands		Huizing, E (通讯作者)，Northwest Clin Alkmaar, Dept Surg, Wilhelminalaan 12, NL-1815 JD Alkmaar, Netherlands.	e.huizing@nwz.nl		Huizing, Eline/0000-0002-5297-2640			Almasri J, 2018, J VASC SURG, V68, P624, DOI 10.1016/j.jvs.2018.01.066; [Anonymous], 2016, ABSORB GT1 BIORESORB; Bosiers M, 2012, J VASC SURG, V55, P390, DOI 10.1016/j.jvs.2011.07.099; Conte MS, 2019, J VASC SURG, V69, p3S, DOI 10.1016/j.jvs.2019.02.016; Dia A, 2021, VASCULAR, V29, P355, DOI 10.1177/1708538120954947; Dia A, 2019, CATHETER CARDIO INTE, V94, P1028, DOI 10.1002/ccd.28546; Duda SH, 2003, J VASC INTERV RADIOL, V14, P291, DOI 10.1097/01.RVI.0000058423.01661.57; Frank U, 2019, VASA, V48, P7, DOI 10.1024/0301-1526/a000834; Geraghty Patrick J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P295, DOI 10.1177/1531003506297195; Giaquinta A, 2017, VASC ENDOVASC SURG, V51, P60, DOI 10.1177/1538574416689429; Karnabatidis D, 2011, J ENDOVASC THER, V18, P1, DOI 10.1583/10-3242.1; Katsanos K, 2016, J ENDOVASC THER, V23, P851, DOI 10.1177/1526602816671740; Kum S, 2020, J ENDOVASC THER, V27, P616, DOI 10.1177/1526602820922524; Liu XC, 2017, INT J SURG, V44, P166, DOI 10.1016/j.ijsu.2017.06.075; Mosquera Arochena NJ, 2016, J CARDIOVASC SURG, V57, P677; Mustapha JA, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003468; Rastan A, 2012, J AM COLL CARDIOL, V60, P587, DOI 10.1016/j.jacc.2012.04.035; Siablis D, 2009, J VASC INTERV RADIOL, V20, P1141, DOI 10.1016/j.jvir.2009.05.031; Soule B, 2003, EUR J VASC ENDOVASC, V25, P139, DOI 10.1053/ejvs.2002.1801; Varcoe RL, 2019, INT ANGIOL, V38, P121, DOI 10.23736/S0392-9590.19.04049-5; Varcoe RL, 2018, J ENDOVASC THER, V25, P694, DOI 10.1177/1526602818799736; Varcoe RL, 2016, JACC-CARDIOVASC INTE, V9, P1721, DOI 10.1016/j.jcin.2016.06.005	22	2	2	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		195	199	1358863X20977907	10.1177/1358863X20977907		JAN 2021	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000621127600001	33507844	Green Published			2022-04-28	
J	Kobayashi, T; Young, MN; Giri, J				Kobayashi, Taisei; Young, Michael N.; Giri, Jay			Volume, outcomes, and 'Centers of Excellence' for pulmonary embolism care	VASCULAR MEDICINE			English	Editorial Material						Centers of Excellence; pulmonary embolism (PE); quality improvement			[Kobayashi, Taisei; Giri, Jay] Hosp Univ Penn, Div Cardiovasc Med, 3400 Civ Ctr Blvd,Smilow South Tower,11th Floor, Philadelphia, PA 19146 USA; [Kobayashi, Taisei; Giri, Jay] Cardiovasc Outcomes Qual & Evaluat Res Ctr, Philadelphia, PA USA; [Young, Michael N.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Div Cardiovasc Med, Lebanon, NH 03766 USA		Giri, J (通讯作者)，Hosp Univ Penn, Div Cardiovasc Med, 3400 Civ Ctr Blvd,Smilow South Tower,11th Floor, Philadelphia, PA 19146 USA.	Jay.Giri@pennmedicine.upenn.edu					Barnes Geoffrey, 2017, Hosp Pract (1995), V45, P76, DOI 10.1080/21548331.2017.1309954; Barnes GD, 2016, CHEST, V150, P1414, DOI 10.1016/j.chest.2016.09.034; Chaudhury P, 2019, AM J CARDIOL, V124, P1465, DOI 10.1016/j.amjcard.2019.07.043; Elrod JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2340-y; Finkelstein M, 2021, VASC MED, V26, P38, DOI 10.1177/1358863X20970263; Jimenez D, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4416; Khatana SAM, 2019, JAMA INTERN MED, V179, P1138, DOI 10.1001/jamainternmed.2019.0567; Saposnik G, 2007, NEUROLOGY, V69, P1142, DOI 10.1212/01.wnl.0000268485.93349.58; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Wright C, 2019, J THROMB THROMBOLYS, V48, P331, DOI 10.1007/s11239-019-01875-0; Xenos ES, 2019, J VASC SURG-VENOUS L, V7, P493, DOI 10.1016/j.jvsv.2018.11.014	11	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					47	49		10.1177/1358863X20980523		JAN 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000618410300001	33448907				2022-04-28	
J	Cueto-Robledo, G; Graniel-Palafox, LE; Garcia-Cesar, M; Cueto-Romero, HD; Roldan-Valadez, E				Cueto-Robledo, Guillermo; Graniel-Palafox, Luis-Eugenio; Garcia-Cesar, Marisol; Cueto-Romero, Hector-Daniel; Roldan-Valadez, Ernesto			Images in Vascular Medicine: Multiple Rasmussen aneurysms in noncavitary, multidrug-resistant tuberculosis	VASCULAR MEDICINE			English	Editorial Material; Early Access									[Cueto-Robledo, Guillermo; Cueto-Romero, Hector-Daniel] Hosp Gen Mexico Dr Eduardo Liceaga, Cardioresp Emergencies, Mexico City, DF, Mexico; [Cueto-Robledo, Guillermo; Garcia-Cesar, Marisol] Hosp Gen Mexico Dr Eduardo Liceaga, Pulm Circulat Clin, Mexico City, DF, Mexico; [Cueto-Robledo, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico; [Graniel-Palafox, Luis-Eugenio] Hosp Gen Mexico Dr Eduardo Liceaga, Intervent Radiol Serv, Mexico City, DF, Mexico; [Roldan-Valadez, Ernesto] Hosp Gen Mexico Dr Eduardo Liceaga, Directorate Res, Mexico City, DF, Mexico; [Roldan-Valadez, Ernesto] IM Sechenov First Moscow State Med Univ, Dept Radiol, Sechenov Univ, Moscow, Russia		Roldan-Valadez, E (通讯作者)，Hosp Gen Mexico Dr Eduardo Liceaga, Dr Balmis 148, Mexico City 06720, DF, Mexico.	Ernest.roldan@usa.net					Garcia-Reina S, 2018, ANN THORAC SURG, V106, pE205, DOI 10.1016/j.athoracsur.2018.03.032; Jaspard M, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101732; Giraldo-Montoya AM, 2018, INT J INFECT DIS, V69, P8, DOI 10.1016/j.ijid.2018.01.023; Syed Madiha, 2015, BMC Res Notes, V8, P346, DOI 10.1186/s13104-015-1313-7	4	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.											1358863X211056681	10.1177/1358863X211056681		NOV 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XH8QP	WOS:000725692700001	34802310	Bronze			2022-04-28	
J	Adham, S; Armengol, G; Cailleux-Talbot, N; Levesque, H; Benhamou, Y; Miranda, S				Adham, Salma; Armengol, Guillaume; Cailleux-Talbot, Nicole; Levesque, Herve; Benhamou, Ygal; Miranda, Sebastien			Bilateral deep vein thrombosis: Time to screen for occult cancer?	VASCULAR MEDICINE			English	Letter						occult cancer; screening strategy; venous thromboembolism (VTE); deep vein thrombosis (DVT)			[Adham, Salma] Hop Europeen Georges Pompidou, AP HP, Ctr Reference Malad Vasc Rares, Dept Genet, Paris, France; [Adham, Salma] Univ Paris Ctr, Fac Med Paris Descartes, Paris, France; [Armengol, Guillaume; Cailleux-Talbot, Nicole; Levesque, Herve; Benhamou, Ygal; Miranda, Sebastien] Rouen Univ Hosp, Dept Internal Med, Rouen, France; [Levesque, Herve; Benhamou, Ygal; Miranda, Sebastien] Normandie Univ, UNIROUEN, INSERM, U1096,EnVI, Rouen, France		Miranda, S (通讯作者)，CHU Rouen, INSERM, Dept Med Interne, U1096, 1 Rue Germont, F-76031 Rouen, France.	sebastien.miranda@chu-rouen.fr					Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Delluc A, 2017, J THROMB HAEMOST, V15, P2076, DOI 10.1111/jth.13791; Ihaddadene R, 2016, BLOOD, V127, P2035, DOI 10.1182/blood-2015-11-682963; Imberti D, 2008, HAEMATOLOGICA, V93, P273, DOI 10.3324/haematol.11458; Le Gal G, 2015, J THROMB HAEMOST, V13, P563, DOI 10.1111/jth.12851; Robin P, 2016, LANCET ONCOL, V17, P193, DOI 10.1016/S1470-2045(15)00480-5; Seinturier C, 2005, J THROMB HAEMOST, V3, P1362, DOI 10.1111/j.1538-7836.2005.01393.x	7	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					660	661	1358863X211034919	10.1177/1358863X211034919		SEP 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000697017100001	34533078				2022-04-28	
J	Lee, DO; Kim, JH; Kang, HW; Kim, DY; Lee, WI; Cho, TJ; Lee, DY				Lee, Dong-Oh; Kim, Ji Hye; Kang, Ho Won; Kim, Dae Yoo; Lee, Wonik; Cho, Tae-Joon; Lee, Dong Yeon			Calcifying characteristics of peripheral vascular smooth muscle cells of chronic kidney disease patients with critical limb ischemia	VASCULAR MEDICINE			English	Article						chronic kidney disease; peripheral artery disease (PAD); vascular calcification; vascular smooth muscle cell		The role of vascular smooth muscle cells (VSMCs) in vascular calcification, which is related to chronic kidney disease (CKD), has been studied in greater detail in the major arteries relative to the peripheral arteries. We compared the calcifying characteristics of peripheral VSMCs relative to non-pathologic major VSMCs in patients with severe peripheral artery disease (PAD). We isolated peripheral VSMCs from the posterior tibial artery of 10 patients with CKD who underwent below-knee amputation for critical limb ischemia (CLI). Using normal human aortic VSMCs as a control group, we cultured the cells in normal and high phosphate media for 10 days, and subsequently tested by immunofluorescence staining. We compared the calcification levels between the two groups using various assays, tests for cell viability, and scanning electron microscopy. As a result, calcification of pathologic peripheral VSMCs increased significantly with time (p = 0.028) and was significantly higher than that in human aortic VSMCs in calcium assays (p = 0.043). Dead cells in the pathologic VSMC group were more distinct in high phosphate media than in human aortic VSMCs. In conclusion, VSMCs from the peripheral artery of patients with severe CKD and CLI who underwent amputation surgery showed marked calcifying characteristics compared to normal human aortic VSMCs.	[Lee, Dong-Oh; Kim, Ji Hye; Kang, Ho Won; Kim, Dae Yoo; Lee, Wonik; Cho, Tae-Joon; Lee, Dong Yeon] Seoul Natl Univ Hosp, Dept Orthoped Surg, 101 Daehak No, Seoul 110744, South Korea		Lee, DY (通讯作者)，Seoul Natl Univ Hosp, Dept Orthoped Surg, 101 Daehak No, Seoul 110744, South Korea.	leedy@snu.ac.kr		Kang, Ho Won/0000-0002-0792-9045	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2018R1D1A1B07046823]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A1B07046823).	Chen NC, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9035193; Chen NX, 2015, CURR OSTEOPOROS REP, V13, P372, DOI 10.1007/s11914-015-0293-9; Chen YX, 2019, KAOHSIUNG J MED SCI, V35, P393, DOI 10.1002/kjm2.12072; Ciceri P, 2015, MOL CELL BIOCHEM, V410, P197, DOI 10.1007/s11010-015-2552-6; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Drawz P, 2015, ANN INTERN MED, V162, DOI 10.7326/AITC201506020; Faries PL, 2002, J SURG RES, V104, P22, DOI 10.1006/jsre.2002.6399; Garimella PS, 2014, ADV CHRONIC KIDNEY D, V21, P460, DOI 10.1053/j.ackd.2014.07.005; Goikuria H, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030023; Grootaert MOJ, 2018, CARDIOVASC RES, V114, P622, DOI 10.1093/cvr/cvy007; Guzman RJ, 2013, DIABETES RES CLIN PR, V99, P281, DOI 10.1016/j.diabres.2012.12.022; Haitjema S, 2016, ATHEROSCLEROSIS, V255, P66, DOI 10.1016/j.atherosclerosis.2016.10.039; Ho CY, 2016, ARTERIOSCL THROM VAS, V36, P1475, DOI 10.1161/ATVBAHA.116.306717; Hortells L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141751; Hunter LW, 2014, INT J NANOMED, V9, P2689, DOI 10.2147/IJN.S63189; Ichihashi S, 2019, J ENDOVASC THER, V26, P613, DOI 10.1177/1526602819860124; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Li JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102276; Manzoor S, 2018, KIDNEY INT REP, V3, P1328, DOI 10.1016/j.ekir.2018.07.011; Martin-Pardillos A, 2013, TOXICOL SCI, V131, P641, DOI 10.1093/toxsci/kfs313; Mika J, 2011, AM J SPORT MED, V39, P624, DOI 10.1177/0363546510388876; Montorsi P, 2005, AM J CARDIOL, V96, p19M; Moss SC, 2007, OCHSNER J, V7, P133; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; O'Neill WC, 2015, ARTERIOSCL THROM VAS, V35, P439, DOI 10.1161/ATVBAHA.114.304764; Petsophonsakul P, 2019, ARTERIOSCL THROM VAS, V39, P1351, DOI 10.1161/ATVBAHA.119.312787; Randhawa MS, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004605; Rocha-Singh KJ, 2014, CATHETER CARDIO INTE, V83, pE212, DOI 10.1002/ccd.25387; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Torii S, 2019, JACC-CARDIOVASC IMAG, V12, P1501, DOI 10.1016/j.jcmg.2018.08.039; Vervloet M, 2017, KIDNEY INT, V91, P808, DOI 10.1016/j.kint.2016.09.024; Villa-Bellosta R, 2015, METHODS MOL BIOL, V1339, P119, DOI 10.1007/978-1-4939-2929-0_8; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Voelkl J, 2019, CELL MOL LIFE SCI, V76, P2077, DOI 10.1007/s00018-019-03054-z; Vriens B, 2018, DIABETIC MED, V35, P895, DOI 10.1111/dme.13634; Wei JY, 2015, J PINEAL RES, V58, P429, DOI 10.1111/jpi.12226; Yan L, 2015, DRUG DES DEV THER, V9, P6497, DOI 10.2147/DDDT.S96207; Yang W, 2020, J PHARMACOL EXP THER, V372, P277, DOI 10.1124/jpet.119.263160; Yoo JH, 2020, CLIN ORTHOP SURG, V12, P171, DOI 10.4055/cios19125; Zettervall SL, 2018, J VASC SURG, V67, P507, DOI 10.1016/j.jvs.2017.06.086; Zhang DH, 2017, KIDNEY BLOOD PRESS R, V42, P1205, DOI 10.1159/000485874; Zhong Y, 2018, STEM CELL RES, V30, P100, DOI 10.1016/j.scr.2018.05.008; Zhu WQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20763-w	44	1	1	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		139	146	1358863X20984525	10.1177/1358863X20984525		FEB 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000621156300001	33591894				2022-04-28	
J	Armstrong, EJ; Armstrong, DG				Armstrong, Ehrin J.; Armstrong, David G.			Vascular Disease Patient Information Page: Critical limb ischemia	VASCULAR MEDICINE			English	Article						amputation; chronic limb-threatening ischemia (CLTI); critical limb ischemia (CLI); diabetic foot ulcer; peripheral artery disease (PAD)			[Armstrong, Ehrin J.] Univ Colorado, Dept Med, 1700 N Wheeling St, Aurora, CO 80045 USA; [Armstrong, David G.] Univ Southern Calif, Dept Surg, Keck Sch Med, Los Angeles, CA 90007 USA		Armstrong, EJ (通讯作者)，Univ Colorado, Dept Med, 1700 N Wheeling St, Aurora, CO 80045 USA.	Ehrin.armstrong@gmail.com			NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK124789] Funding Source: Medline		Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Armstrong DG, 2020, J FOOT ANKLE RES, V13, DOI 10.1186/s13047-020-00383-2; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Armstrong EJ, 2019, J ENDOVASC THER, V26, P199, DOI 10.1177/1526602819826593; Armstrong EJ, 2014, J VASC SURG, V60, P1565, DOI 10.1016/j.jvs.2014.08.064; Menard MT, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003219; Ratchford EV, 2017, VASC MED, V22, P442, DOI 10.1177/1358863X17722212; Ratchford EV, 2016, VASC MED, V21, P477, DOI 10.1177/1358863X16661767; Ratchford EV, 2014, VASC MED, V19, P218, DOI 10.1177/1358863X14534803; Singh S, 2014, VASC MED, V19, P307, DOI 10.1177/1358863X14538330	10	0	0	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		228	231	1358863X20987611	10.1177/1358863X20987611		FEB 2021	4	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000620762800001	33587691	Bronze			2022-04-28	
J	Creager, MA; Hamburg, NM; Calligaro, KD; Casanegra, AI; Freeman, R; Gordon, PA; Gornik, HL; Kim, ESH; Leeper, NJ; Merli, GJ; Niazi, K; Olin, JW; Quiroz, R; Kaso, ER; Wasan, S; Waxler, AR; White, CJ; Solaru, KW; Williams, MS; Arrighi, JA; Mendes, LA; Day, J; Dec, GW; Denktas, A; Drajpuch, D; Fernandes, S; Francis, SA; Hahn, RT; Housholder-Hughes, SD; Khan, SS; Klarich, K; Kondapaneni, MD; Lee, KS; Lin, CH; Marine, JE; McConnaughey, S; Ryan, T; Silvestry, FE; Solomon, MA; Spicer, RL; Wang, A; Weissman, G; Weitz, HH				Creager, Mark A.; Hamburg, Naomi M.; Calligaro, Keith D.; Casanegra, Ana, I; Freeman, Rosario; Gordon, Phyllis A.; Gornik, Heather L.; Kim, Esther S. H.; Leeper, Nicholas J.; Merli, Geno J.; Niazi, Khusrow; Olin, Jeffrey W.; Quiroz, Rene; Kaso, Elona Rrapo; Wasan, Suman; Waxler, Andrew R.; White, Christopher J.; Solaru, Khendi White; Williams, Marlene S.; Arrighi, James A.; Mendes, Lisa A.; Day, Jennifer; Dec, G. William, Jr.; Denktas, Ali; Drajpuch, David; Fernandes, Susan; Francis, Sanjeev A.; Hahn, Rebecca T.; Housholder-Hughes, Susan D.; Khan, Sadiya S.; Klarich, Kyle; Kondapaneni, Meera Devi; Lee, Kwan S.; Lin, C. Huie; Marine, Joseph E.; McConnaughey, Shannon; Ryan, Thomas; Silvestry, Frank E.; Solomon, Michael A.; Spicer, Robert L.; Wang, Andrew; Weissman, Gaby; Weitz, Howard H.		ACC Competency Management Comm; Assoc Black Cardiologists; Soc Cardiovasc Angiography Interve; Soc Vasc Nursing; Soc Vasc Surg	2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)	VASCULAR MEDICINE			English	Article						ACC; AHA; SVM; ACP Training Statement; aortic diseases; cerebrovascular disease; clinical competence; fellowship training; lymphedema; peripheral artery disease; Raynaud phenomenon; vascular medicine; venous insufficiency; venous thromboembolism			[Creager, Mark A.] Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, Lebanon, NH 03766 USA; [Hamburg, Naomi M.] Boston Univ, Sch Med, Med, Cardiovasc Med Sect, Boston, MA 02215 USA; [Calligaro, Keith D.] Penn Hosp, Vasc Surg, Philadelphia, PA 19107 USA; [Calligaro, Keith D.] Penn Hosp, Vasc Surg Fellowship, Philadelphia, PA 19107 USA; [Calligaro, Keith D.] Penn Hosp, Surg, Philadelphia, PA 19107 USA; [Casanegra, Ana, I] Mayo Clin, Gonda Vasc Ctr, Thrombosis & Thrombophilia Clin, Rochester, MN USA; [Casanegra, Ana, I] Mayo Clin, Cardiovasc Dept, Vasc Med Div, Med, Rochester, MN USA; [Freeman, Rosario] Univ Washington, Med, Seattle, WA 98195 USA; [Freeman, Rosario] Univ Washington, Cardiol Fellowship, Seattle, WA 98195 USA; [Gordon, Phyllis A.] Univ Texas Hlth Sci Ctr San Antonio, Vasc Surg Div, San Antonio, TX 78229 USA; [Gornik, Heather L.] Univ Hosp Harrington Heart & Vasc Inst, Vasc Ctr, Cleveland, OH USA; [Gornik, Heather L.] Case Western Reserve Univ, Sch Med, Med, Cleveland, OH 44106 USA; [Kim, Esther S. H.] Vanderbilt Heart & Vasc Inst, Med Cardiovasc Med, Sect Vasc Med, Nashville, TN USA; [Leeper, Nicholas J.] Stanford Univ, Sch Med, Vasc Med, Stanford, CA 94305 USA; [Leeper, Nicholas J.] Stanford Univ, Sch Med, Surg & Med, Stanford, CA 94305 USA; [Merli, Geno J.] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Merli, Geno J.] Jefferson Vasc Ctr, Philadelphia, PA USA; [Merli, Geno J.] Sidney Med Coll, Med & Surg, Div Vasc Med, Philadelphia, PA USA; [Niazi, Khusrow] Emory Univ, Peripheral Vasc Intervent, Atlanta, GA 30322 USA; [Olin, Jeffrey W.] Icahn Sch Med Mt Sinai, Zena & Michael Wiener Cardiovasc Inst, New York, NY 10029 USA; [Olin, Jeffrey W.] Icahn Sch Med Mt Sinai, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, Med Cardiol, New York, NY 10029 USA; [Olin, Jeffrey W.] Icahn Sch Med Mt Sinai, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, Vasc Med & Vasc Diagnost Lab, New York, NY 10029 USA; [Quiroz, Rene] Cardiol Clin San Antonio, San Antonio, TX USA; [Kaso, Elona Rrapo] Univ Virginia Hlth Syst, Adv Cardiovasc Imaging, Div Cardiovasc Med, Charlottesville, VA USA; [Wasan, Suman] Univ N Carolina, Rex Healthcare Vasc Specialists, Raleigh, NC USA; [Waxler, Andrew R.] Penn State Coll Med, Med, Hershey, PA USA; [Waxler, Andrew R.] Philadelphia Coll Osteopath Med, Med, Philadelphia, PA USA; [White, Christopher J.] Ochsner Med Ctr, Med & Cardiol, Jefferson, AR USA; [White, Christopher J.] Value Based Care Syst Chair Cardiovasc Dis, Jefferson, AR USA; [Solaru, Khendi White] Univ Hosp Harrington Heart & Vasc Inst, Dept Med, Cleveland, OH USA; [Solaru, Khendi White] Case Western Reserve Univ, Sch Med, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Williams, Marlene S.] Johns Hopkins Univ, Med, Baltimore, MD 21218 USA; [Williams, Marlene S.] Johns Hopkins Bayview Med Ctr, Cardiac Intens Care Unit, Baltimore, MD 21224 USA; [Francis, Sanjeev A.] Maine Med Ctr, MaineHlth Cardiol, Educ, Portland, ME USA; [Francis, Sanjeev A.] Maine Med Ctr, MaineHlth Cardiol, Cardiovasc Inst, Portland, ME USA; [Francis, Sanjeev A.] Maine Med Ctr, MaineHlth Cardiol, Cardiovasc Med Fellowship Program, Portland, ME USA; [Francis, Sanjeev A.] Tufts Univ, Sch Med, Medford, MA 02155 USA; [Dec, G. William, Jr.] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA; [Housholder-Hughes, Susan D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Housholder-Hughes, Susan D.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA		Creager, MA (通讯作者)，Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, Lebanon, NH 03766 USA.						Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Alpert, J AM COLL CARDIOL, V25, P1; Arrighi, J AM COLL CARDIOL, V67; Bates ER., J AM COLL CARDIOL, V65; Budoff MJ., J AM COLL CARDIOL, V65; Fuster V., J AM COLL CARDIOL, V65; Gerhard-Herman MD., J AM COLL CARDIOL, V69, pE71; Gray BH., J AM COLL CARDIOL, V65; Intersocietal Accreditation Commission, IAC STANDARDS GUIDEL; Kwong RY., J AM COLL CARDIOL, V65	10	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					91	112	1358863X20987551	10.1177/1358863X20987551		JAN 2021	22	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000618412700001					2022-04-28	
J	Losurdo, F; Ferraresi, R; Ucci, A; Zanetti, A; Clerici, G; Zambon, A				Losurdo, Fabrizio; Ferraresi, Roberto; Ucci, Alessandro; Zanetti, Anna; Clerici, Giacomo; Zambon, Antonella			Association of infrapopliteal medial arterial calcification with lower-limb amputations in high-risk patients: A systematic review and meta-analysis	VASCULAR MEDICINE			English	Review						amputation; calcification; meta-analysis; peripheral artery disease (PAD)		Medial arterial calcification (MAC) is a known risk factor for cardiovascular morbidity. The association between vascular calcifications and poor outcome in several vascular districts suggest that infrapopliteal MAC could be a risk factor for lower-limb amputation (LLA). This study's objective is to review the available literature focusing on the association between infrapopliteal MAC and LLA in high-risk patients. The PubMed and Embase databases were systematically searched. We selected original studies reporting the association between infrapopliteal MAC and LLAs in patients with diabetes and/or peripheral artery disease (PAD). Estimates were pooled using either a fixed-effects or a random-effects model meta-analysis. Heterogeneity was evaluated using the Q and I-2 statistics. Publication bias was investigated with a funnel plot and Egger test. The trim-and-fill method was designed to estimate the possibly missing studies. Influence analysis was conducted to search studies influencing the final result. Test of moderators was used to compare estimates in good versus non-good-quality studies. Fifteen articles satisfied the selection criteria (n = 6489; median follow-up: 36 months). MAC was significantly associated with LLAs (pooled adjusted risk ratio (RR): 2.27; 95% CI: 1.89-2.74; I-2 = 25.3%, Q-test: p = 0.17). This association was kept in the subgroup of patients with diabetes (RR: 2.37; 95% CI: 1.76-3.20) and patients with PAD (RR: 2.48; 95% CI: 1.72-3.58). The association was maintained if considering as outcome only major amputations (RR: 2.11; 95% CI: 1.46-3.06). Our results show that infrapopliteal MAC is associated with LLAs, thus suggesting MAC as a possible new marker of the at-risk limb.	[Losurdo, Fabrizio; Zanetti, Anna; Zambon, Antonella] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy; [Losurdo, Fabrizio] ASST Bergamo Est POT FM Passi, Diabet Foot Outpatient Clin, Calcinate, BG, Italy; [Ferraresi, Roberto; Clerici, Giacomo] Ctr Cura Piede Diabetico, Clin San Carlo, Paderno Dugnano, MI, Italy; [Ucci, Alessandro] Univ Hosp Parma, Vasc Surg, Parma, Italy; [Zambon, Antonella] IRCCS Biostat Unit, Ist Auxol Italiano, Milan, Italy		Losurdo, F (通讯作者)，ASST Bergamo Est, Amb Piede Diabet POT FM, Piazza Osped 3, I-24050 Calcinate, BG, Italy.	f.losurdo@campus.unimib.it	ferraresi, roberto/ABD-9467-2021		'Master in Epidemiologia e Biostatistica per la Ricerca Clinica' program held at the University of Milan-Bicocca, Milan, Italy	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the `Master in Epidemiologia e Biostatistica per la Ricerca Clinica' program held at the University of Milan-Bicocca, Milan, Italy.	An WS, 2010, INT UROL NEPHROL, V42, P773, DOI 10.1007/s11255-009-9697-8; Aragon-Sanchez J, 2013, INT J LOW EXTR WOUND, V12, P252, DOI 10.1177/1534734613511636; Boyko EJ, 2018, DIABETES CARE, V41, P891, DOI 10.2337/dc17-2210; Brechow A, 2013, THER ADV ENDOCRINOL, V4, P83, DOI 10.1177/2042018813489719; Carrington AL, 2001, CLIN SCI, V101, P261, DOI 10.1042/CS20010018; Chantelau E, 1997, EXP CLIN ENDOCR DIAB, V105, P11, DOI 10.1055/s-0029-1211786; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; Ferrier T M, 1967, Med J Aust, V1, P5; Guzman RJ, 2008, J AM COLL CARDIOL, V51, P1967, DOI 10.1016/j.jacc.2007.12.058; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinchliffe RJ, 2016, DIABETES-METAB RES, V32, P37, DOI 10.1002/dmrr.2698; Huang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090201; Jablonski KL, 2013, HEMODIAL INT, V17, pS17, DOI 10.1111/hdi.12084; Kang IS, 2016, J VASC SURG, V64, P1335, DOI 10.1016/j.jvs.2016.04.047; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lau WL, 2013, SEMIN NEPHROL, V33, P93, DOI 10.1016/j.semnephrol.2012.12.011; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; Liberati A., 2009, ANN INTERN MED, V6, DOI [10.1371/journal.pmed.1000100, DOI 10.7326/0003-4819-151-4-200908180-00135]; Likis FE, 2012, COMP EFFECTIVENESS R; London G M, 1999, Am Heart J, V138, P220; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; McDermott MM, 2017, JACC-CARDIOVASC IMAG, V10, P1003, DOI 10.1016/j.jcmg.2016.08.012; Morbach S, 2012, DIABETES CARE, V35, P2021, DOI 10.2337/dc12-0200; Moualla, 2016, J VASC MED SURG, V4, P262; Mustapha JA, 2017, J CARDIOVASC SURG, V58, P383, DOI 10.23736/S0021-9509.17.09878-0; Narula N, 2018, J AM COLL CARDIOL, V72, P2152, DOI 10.1016/j.jacc.2018.08.002; NISKANEN L, 1994, DIABETES CARE, V17, P1252, DOI 10.2337/diacare.17.11.1252; O'Connell D, 2008, NEWCASTLE OTTAWA SCA; O'Neill WC, 2015, ARTERIOSCL THROM VAS, V35, P439, DOI 10.1161/ATVBAHA.114.304764; Pacha HM, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5547; R Core Team, 2018, R LANG ENV STAT COMP; Resnick HE, 2004, DIABETES CARE, V27, P1885, DOI 10.2337/diacare.27.8.1885; Rocha-Singh KJ, 2014, CATHETER CARDIO INTE, V83, pE212, DOI 10.1002/ccd.25387; Schantl AE, 2019, ADV THER-GERMANY, V2, DOI 10.1002/adtp.201800094; Silvestro A, 2006, VASC MED, V11, P69, DOI 10.1191/1358863x06vm678oa; Singh GD, 2017, VASC MED, V22, P210, DOI 10.1177/1358863X16689831; Spreen MI, 2018, J VASC SURG, V67, P1864, DOI 10.1016/j.jvs.2017.10.061; Tani T, 2020, J PATHOL, V250, P30, DOI 10.1002/path.5346; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; von Hippel PT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0024-z; Wickstrom JE, 2017, EUR J VASC ENDOVASC, V53, P696, DOI 10.1016/j.ejvs.2017.02.012; Yang WL, 2019, CLIN CHIM ACTA, V499, P118, DOI 10.1016/j.cca.2019.09.002	45	4	4	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		164	173	1358863X20979738	10.1177/1358863X20979738		DEC 2020	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000618412300001	33375914				2022-04-28	
J	Waddell, A; Seed, S; Broom, DR; McGregor, G; Birkett, ST; Harwood, AE				Waddell, Alexander; Seed, Sally; Broom, David R.; McGregor, Gordon; Birkett, Stefan T.; Harwood, Amy E.			Safety of home-based exercise for people with intermittent claudication: A systematic review	VASCULAR MEDICINE			English	Review						claudication; complication rate; exercise therapy; home-based exercise; peripheral artery disease (PAD); safety	PERIPHERAL ARTERIAL-DISEASE; QUALITY-OF-LIFE; ANKLE-BRACHIAL INDEX; TEST IN-TRAIN; WALKING EXERCISE; PHYSICAL-ACTIVITY; PROGRAM; REHABILITATION; PAIN; IMPACT	Intermittent claudication (IC) is a classic symptom of peripheral artery disease, with first line treatment being supervised exercise therapy (SET). Despite this, SET is frequently underutilised, and adherence is often poor. An alternative option are home-based exercise programmes (HBEP). Although HBEPs are well tolerated, to the authors' knowledge, no research has assessed their safety. The aim of this review was to assess the safety of HBEPs in people living with IC. We performed an electronic search of the MEDLINE, CINAHL, and Cochrane Library databases. The main parameter of interest was complication rate, calculated as the number of related adverse events per patient-hours. Subanalysis was undertaken to determine differences in safety for studies that did and did not include pre-exercise cardiac screening, and for studies with exercise at low, moderate, and high levels of claudication pain. Our search strategy identified 8693 results, of which 27 studies were included for full review. Studies included 1642 participants completing 147,810 patient-hours of home-based exercise. Four related adverse events were reported, three of which were cardiac in origin, giving an all-cause complication rate of one event per 36,953 patient-hours. Three of these events occurred following exercise to high levels of claudication pain, and one occurred with pain-free exercise. All four events occurred in studies without cardiac screening. Based on the low number of related adverse events, HBEPs appear to be a safe method of exercise prescription for people with IC. Our results strengthen the rationale for providing alternative exercise options for this population. PROSPERO Registration No.: CRD42021254581	[Waddell, Alexander; Broom, David R.; McGregor, Gordon; Harwood, Amy E.] Coventry Univ, Inst Hlth & Wellbeing, Ctr Sport Exercise & Life Sci, 20 Whitefriars St,Alison Gingell Bldg, Coventry CV1 2DS, W Midlands, England; [Seed, Sally; Birkett, Stefan T.] Univ Cent Lancashire, Sch Sport & Hlth Sci, Preston, Lancs, England; [McGregor, Gordon] Univ Hosp Coventry & Warwickshire NHS Trust, Ctr Exercise & Hlth, Dept Cardiopulm Rehabil, Coventry, W Midlands, England; [McGregor, Gordon] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry, W Midlands, England		Waddell, A (通讯作者)，Coventry Univ, Inst Hlth & Wellbeing, Ctr Sport Exercise & Life Sci, 20 Whitefriars St,Alison Gingell Bldg, Coventry CV1 2DS, W Midlands, England.	alexanderjrwaddell@gmail.com	McGregor, Gordon/AAP-1917-2020	McGregor, Gordon/0000-0001-8963-9107; Waddell, Alex/0000-0002-9880-655X; Birkett, Stefan/0000-0003-0422-6843; Harwood, Amy Elizabeth/0000-0002-5745-2564			Abaraogu U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201095; Bronas UG., 2019, J CLIN EXERC PHYSIOL, V8, P102; Collins TC, 2011, DIABETES CARE, V34, P2174, DOI 10.2337/dc10-2399; Cornelis Nils, 2021, JMIR Rehabil Assist Technol, V8, pe18739, DOI 10.2196/18739; Cucato GG, 2013, CLINICS, V68, P974, DOI 10.6061/clinics/2013(07)14; Degischer S, 2002, VASC MED, V7, P109, DOI 10.1191/1358863x02vm432oa; Divakaran S, 2021, CIRC-CARDIOVASC QUAL, V14, DOI 10.1161/CIRCOUTCOMES.121.007953; Dopheide JF, 2017, EUR J PREV CARDIOL, V24, P178, DOI 10.1177/2047487316665231; Dopheide JF, 2015, CLIN RES CARDIOL, V104, P751, DOI 10.1007/s00392-015-0840-5; Dua A, 2020, J VASC SURG, V71, P1702, DOI 10.1016/j.jvs.2019.08.238; Fakhry F, 2011, ARCH PHYS MED REHAB, V92, P1066, DOI 10.1016/j.apmr.2011.02.007; Gardner AW, 2006, ANGIOLOGY, V57, P539, DOI 10.1177/0003319706293114; Gardner AW, 2021, MED SCI SPORT EXER, V53, P732, DOI 10.1249/MSS.0000000000002526; Gardner AW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001107; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Gommans LNM, 2015, J VASC SURG, V61, P512, DOI 10.1016/j.jvs.2014.08.070; Gyldenlove T, 2019, INT J ANGIOL, V28, P161, DOI 10.1055/s-0039-1692661; Harwood AE., 2017, B ROY COLL SURG ENGL, V99, P207; Harwood AE, 2021, VASCULAR, DOI 10.1177/17085381211035259; Harwood AE, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000897; Harwood AE, 2017, J VASC NURS, V35, P131, DOI 10.1016/j.jvn.2017.03.001; Imfeld S, 2006, VASA-J VASCULAR DIS, V35, P178, DOI 10.1024/0301-1526.35.3.178; Lamberti N, 2021, INTERN EMERG MED, V16, P1307, DOI 10.1007/s11739-020-02598-4; Lamberti N, 2016, ANGIOLOGY, V67, P772, DOI 10.1177/0003319715618481; Lane R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub4; Malagoni AM, 2011, CIRC J, V75, P2128, DOI 10.1253/circj.CJ-10-1311; Manfredini F, 2004, INT ANGIOL, V23, P379; Manfredini F, 2008, CIRC J, V72, P946, DOI 10.1253/circj.72.946; Mays RJ, 2015, VASC MED, V20, P339, DOI 10.1177/1358863X15572725; McDermott MM, 2021, JAMA-J AM MED ASSOC, V325, P1266, DOI 10.1001/jama.2021.2536; McDermott MM, 2013, JAMA-J AM MED ASSOC, V310, P57, DOI 10.1001/jama.2013.7231; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mika P, 2005, AM J PHYS MED REHAB, V84, P756, DOI 10.1097/01.phm.0000176346.94747.49; Mouser MJ, 2009, VASC MED, V14, P103, DOI 10.1177/1358863X08098596; National Institute for Health and Care Excellence, 2020, PER ART DIS DIAGN MA; Page MJ, 2021, PLOS MED, V18, DOI [10.1371/journal.pmed.1003583, 10.1016/j.ijsu.2021.105906]; Parmenter BJ, 2015, SPORTS MED, V45, P231, DOI 10.1007/s40279-014-0261-z; Prevost A, 2015, EUR J PREV CARDIOL, V22, P373, DOI 10.1177/2047487313512217; Pymer S, 2021, J VASC SURG, V74, P2076, DOI 10.1016/j.jvs.2021.03.063; Regensteiner JG, 1997, ANGIOLOGY, V48, P291, DOI 10.1177/000331979704800402; Regensteiner JG, 2008, VASC MED, V13, P15, DOI 10.1177/1358863X07084911; Roberts AJ, 2008, EUR J VASC ENDOVASC, V36, P319, DOI 10.1016/j.ejvs.2008.04.008; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sandercock GRH, 2007, J SPORT SCI MED, V6, P471; Savage P, 2001, J Cardiopulm Rehabil, V21, P152, DOI 10.1097/00008483-200105000-00006; Saxon JT, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.012541; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Spafford C, 2014, BRIT J SURG, V101, P760, DOI 10.1002/bjs.9519; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Treat-Jacobson D, 2019, CIRCULATION, V140, pE700, DOI 10.1161/CIR.0000000000000727; van Schaardenburgh M, 2017, J VASC SURG, V65, P1473, DOI 10.1016/j.jvs.2016.12.106	54	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2022	27	2			SI		186	192	1358863X211060388	10.1177/1358863X211060388		DEC 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	0I8MI	WOS:000739455700001	34930062	Green Published, Green Accepted, hybrid			2022-04-28	
J	Lanzi, S; Nussbaumer, P; Calanca, L; Mazzolai, L; Malatesta, D				Lanzi, Stefano; Nussbaumer, Paula; Calanca, Luca; Mazzolai, Lucia; Malatesta, Davide			Descending stair walking in patients with symptomatic lower extremity peripheral artery disease: A pilot study	VASCULAR MEDICINE			English	Editorial Material						claudication; exercise therapy; peripheral artery disease (PAD); physical actvity	EXERCISE		[Lanzi, Stefano; Calanca, Luca; Mazzolai, Lucia] Lausanne Univ Hosp, Heart & Vessel Dept, Div Angiol, Lausanne, Vaud, Switzerland; [Nussbaumer, Paula; Malatesta, Davide] Univ Lausanne, Inst Sport Sci, Lausanne, Vaud, Switzerland		Lanzi, S (通讯作者)，Lausanne Univ Hosp CHUV, Heart & Vessel Dept, Div Angiol, Ch Mt Paisible 18, CH-1011 Lausanne, Vaud, Switzerland.	stefano.lanzi@chuv.ch		Lanzi, Stefano/0000-0003-1089-6309			Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Chen TC, 2017, MED SCI SPORT EXER, V49, P1614, DOI 10.1249/MSS.0000000000001267; Gault ML, 2013, AGING DIS, V4, P351, DOI 10.14336/AD.2013.0400351; Harwood AE, 2016, ANN VASC SURG, V34, P280, DOI 10.1016/j.avsg.2016.02.009; Hernandez H, 2017, J VASC SURG, V66, pE21, DOI 10.1016/j.jvs.2017.06.011; Hody S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00536; Hyldahl RD, 2014, MUSCLE NERVE, V49, P155, DOI 10.1002/mus.24077; Luck JC, 2017, J APPL PHYSIOL, V123, P2, DOI 10.1152/japplphysiol.01110.2016; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Parmenter BJ, 2020, BRIT J SPORT MED, V54, P452, DOI 10.1136/bjsports-2018-100205; Pipinos Iraklis I, 2007, Vasc Endovascular Surg, V41, P481, DOI 10.1177/1538574407311106; Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995; Pizzimenti M, 2020, J CACHEXIA SARCOPENI, V11, P866, DOI 10.1002/jcsm.12587; Regnersgaard S, 2022, EUR J SPORT SCI, V22, P279, DOI 10.1080/17461391.2020.1856936; Theodorou Anastasios A, 2013, BMC Res Notes, V6, P87, DOI 10.1186/1756-0500-6-87; Treat-Jacobson D, 2019, CIRCULATION, V139, pE10, DOI 10.1161/CIR.0000000000000623	16	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2022	27	2			SI		171	173	1358863X211058784	10.1177/1358863X211058784		DEC 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	0I8MI	WOS:000727828800001	34865584	hybrid, Green Published			2022-04-28	
J	D'Oria, M; Ziani, B; Pipitone, MD; Lepidi, S				D'Oria, Mario; Ziani, Barbara; Pipitone, Marco Damiano; Lepidi, Sandro			Prognostic interaction between age and sex on early and late outcomes following carotid endarterectomy for asymptomatic and symptomatic de-novo carotid stenosis	VASCULAR MEDICINE			English	Meeting Abstract									[D'Oria, Mario; Ziani, Barbara; Pipitone, Marco Damiano; Lepidi, Sandro] Univ Hosp Trieste, Trieste, Italy									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1335	NP12	NP12					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100034					2022-04-28	
J	Kinlay, S; Ostrowski, S; Sherrod, R; Sobieszczyk, P; Eisenhauer, A; Todoran, T				Kinlay, Scott; Ostrowski, Simon; Sherrod, Rebecca; Sobieszczyk, Piotr; Eisenhauer, Andrew; Todoran, Thomas			Long-term outcomes after superficial femoral artery revascularization in the elderly	VASCULAR MEDICINE			English	Meeting Abstract									[Kinlay, Scott; Sherrod, Rebecca] VA Boston Healthcare Syst, West Roxbury, MA USA; [Ostrowski, Simon] Univ Pittsburgh, Pittsburgh, PA USA; [Sobieszczyk, Piotr] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Eisenhauer, Andrew] Cent Maine Med Ctr, Lewiston, ME USA; [Todoran, Thomas] Med Univ South Carolina, Charleston, SC 29425 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1358	NP14	NP14					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100038					2022-04-28	
J	Sahai, A; Bhandari, R; Godwin, M; McIntyre, T; Chung, MK; Iskandar, JP; Kamran, H; Hariri, E; Aggarwal, A; Burton, R; Kalra, A; Bartholomew, JR; McCrae, KR; Elbadawi, A; Bena, J; Svensson, LG; Kapadia, S; Cameron, SJ				Sahai, Aditya; Bhandari, Rohan; Godwin, Matthew; McIntyre, Thomas; Chung, Mina K.; Iskandar, Jean-Pierre; Kamran, Hayaan; Hariri, Essa; Aggarwal, Anu; Burton, Robert; Kalra, Ankur; Bartholomew, John R.; McCrae, Keith R.; Elbadawi, Ayman; Bena, James; Svensson, Lars G.; Kapadia, Samir; Cameron, Scott J.			Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19	VASCULAR MEDICINE			English	Article						ACE2; COVID-19; platelets; SARS-CoV-2; thrombosis; TMPRSS2	RECEPTOR; ACE2; PROTEIN	Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral pandemic marked by increased risk of thrombotic events. However, the role of platelets in the elevated observed thrombotic risk in COVID-19 and utility of antiplatelet agents in attenuating thrombosis is unknown. We aimed to determine if the antiplatelet effect of aspirin may mitigate risk of myocardial infarction, cerebrovascular accident, and venous thromboembolism in COVID-19. We evaluated 22,072 symptomatic patients tested for COVID-19. Propensity-matched analyses were performed to determine if treatment with aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) affected thrombotic outcomes in COVID-19. Neither aspirin nor NSAIDs affected mortality in COVID-19. Thus, aspirin does not appear to prevent thrombosis and death in COVID-19. The mechanisms of thrombosis in COVID-19, therefore, appear distinct and the role of platelets as direct mediators of SARS-CoV-2-mediated thrombosis warrants further investigation.	[Sahai, Aditya; Bhandari, Rohan; Kamran, Hayaan; Kalra, Ankur; Bartholomew, John R.; Svensson, Lars G.; Kapadia, Samir; Cameron, Scott J.] Cleveland Clin, Sect Vasc Med, Dept Cardiovasc Med, Desk J3-5,9500 Euclid Ave, Cleveland, OH 44195 USA; [Sahai, Aditya; Bhandari, Rohan; Chung, Mina K.; Kamran, Hayaan; Kalra, Ankur; Bartholomew, John R.; McCrae, Keith R.; Svensson, Lars G.; Kapadia, Samir; Cameron, Scott J.] Cleveland Clin, Heart Vasc & Thorac Inst, Cleveland, OH 44106 USA; [Bhandari, Rohan; Godwin, Matthew; McIntyre, Thomas; Chung, Mina K.; Aggarwal, Anu; Cameron, Scott J.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Chung, Mina K.; McCrae, Keith R.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Iskandar, Jean-Pierre; Hariri, Essa; Burton, Robert] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [McCrae, Keith R.; Cameron, Scott J.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Elbadawi, Ayman] Univ Texas Med Branch, Div Cardiovasc Med, Galveston, TX 77555 USA; [Bena, James] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA		Cameron, SJ (通讯作者)，Cleveland Clin, Sect Vasc Med, Dept Cardiovasc Med, Desk J3-5,9500 Euclid Ave, Cleveland, OH 44195 USA.	cameros3@ccf.org	Hariri, Essa/K-8487-2017; Cameron, Scott/AAW-8429-2021	Hariri, Essa/0000-0002-5056-2517; Cameron, Scott/0000-0002-9616-1540; Bhandari, Rohan/0000-0003-1063-6291	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL128856, LRP HL120200, R01 HL143402]	This work was supported by the National Heart, Lung, and Blood Institute (grant nos. K08HL128856 and LRP HL120200 to Scott J. Cameron and R01 HL143402 to Keith R. McCrae).	Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652; Barrett TJ, 2020, CIRC RES, V127, P945, DOI 10.1161/CIRCRESAHA.120.317803; Bekelis K, 2020, STROKE, V51, P3570, DOI 10.1161/STROKEAHA.120.031217; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Cameron SJ, 2015, CIRCULATION, V132, P47, DOI 10.1161/CIRCULATIONAHA.115.015656; Chow JH, 2021, ANESTH ANALG, V132, P930, DOI 10.1213/ANE.0000000000005292; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Elbadawi A, 2021, ARTERIOSCL THROM VAS, V41, P545, DOI 10.1161/ATVBAHA.120.315304; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891; Giollo A, 2021, ANN RHEUM DIS, V80, DOI [10.1136/annrheumdis-2020-217598, 10.1136/annrheumdis-2020-218845, 10.1136/annrheumdis-2020-218830]; Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; HAYNES DR, 1993, AGENTS ACTIONS, V39, P49, DOI 10.1007/BF01975714; He L., 2020, BIORXIV; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hikmet F, 2020, MOL SYST BIOL, V16, P9610, DOI DOI 10.15252/msb.20209610; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hottz ED, 2020, BLOOD, V136, P1330, DOI 10.1182/blood.2020007252; Hu L, 2017, CIRCULATION, V136, P817, DOI 10.1161/CIRCULATIONAHA.116.026995; Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013; Kor DJ, 2016, JAMA-J AM MED ASSOC, V315, P2406, DOI 10.1001/jama.2016.6330; Koupenova M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09607-x; Li F, 2019, AM J EPIDEMIOL, V188, P250, DOI 10.1093/aje/kwy201; Liang WC, 2020, GUT, V69, P1141, DOI 10.1136/gutjnl-2020-320832; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; Nassa G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18985-5; Nicolai L, 2020, CIRCULATION, V142, P1176, DOI 10.1161/CIRCULATIONAHA.120.048488; Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044; Rovas A, 2021, ANGIOGENESIS, V24, P145, DOI 10.1007/s10456-020-09753-7; Schmidt RA, 2018, TRANSL RES, V195, P1, DOI 10.1016/j.trsl.2017.11.006; Shahjouei S, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102939; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Sharif-Askari NS, 2020, MOL THER-METH CLIN D, V18, P1, DOI 10.1016/j.omtm.2020.05.013; Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035; Veras FP, 2020, J EXP MED, V217, DOI 10.1084/jem.20201129; von der Thusen JH, 2021, J HEMATOP, V14, P79, DOI 10.1007/s12308-020-00423-7; Wang J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02063; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674; Zaid Y, 2020, CIRC RES, V127, P1404, DOI 10.1161/CIRCRESAHA.120.317703; Zhang S, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00954-7; Zhao Y, 2020, AM J RESP CRIT CARE, V202, P756, DOI 10.1164/rccm.202001-0179LE; Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999	49	4	5	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					626	632	1358863X211012754	10.1177/1358863X211012754		MAY 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000652853900001	34010070	hybrid, Green Published			2022-04-28	
J	Hishikari, K; Hikita, H; Abe, F; Ito, N; Kanno, Y; Iiya, M; Murai, T; Takahashi, A; Yonetsu, T; Sasano, T				Hishikari, Keiichi; Hikita, Hiroyuki; Abe, Fumichika; Ito, Naruhiko; Kanno, Yoshinori; Iiya, Munehiro; Murai, Tadashi; Takahashi, Atsushi; Yonetsu, Taishi; Sasano, Tetsuo			Risk factors and prognostic impact of post-discharge bleeding after endovascular therapy for peripheral artery disease	VASCULAR MEDICINE			English	Article						dual antiplatelet therapy; endovascular therapy; hemodialysis; major bleeding	DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; BLOOD-TRANSFUSION; FOCUSED UPDATE; PREDICTORS; ASPIRIN; BIVALIRUDIN; ANGIOPLASTY; MONOTHERAPY; PREVENTION	This study evaluated the incidence, predictors, and impact of bleeding requiring hospitalization following successful endovascular therapy (EVT) for peripheral artery disease. Platelet inhibition after EVT reduces the risk of major adverse limb events but increases the risk of bleeding. The incidence of post-discharge bleeding after EVT, its independent predictors, and its prognostic importance in clinical practice have not been fully addressed. We evaluated 779 consecutive patients who underwent EVT. We found that 77 patients (9.9%) were hospitalized for major bleeding during follow-up after EVT (median 39 months, range 22-66 months), with almost half (48.1%) of the bleeding categorized as gastrointestinal bleeding. Significant predictors of post-discharge bleeding were hemodialysis (hazard ratio (HR), 3.12; 95% CI: 1.93 to 5.05; p < 0.001) and dual antiplatelet therapy (DAPT) use (HR, 1.87; 95% CI: 1.03 to 3.41; p = 0.041). During follow-up, the all-cause mortality-free survival rate was significantly worse in patients who had experienced major bleeding than in those who had not (log-rank test chi(2) = 54.6; p < 0.001). Cox proportional hazards analysis showed that major bleeding (HR, 2.78; 95% CI: 1.90 to 4.06; p < 0.001) was an independent predictor of all-cause death after EVT. Hospitalization for post-discharge bleeding after EVT is associated with a substantially increased risk of death, even after successful EVT. We concluded that patients' predicted bleeding risk should be considered when selecting patients likely to benefit from EVT, and that the risk should be considered especially thoroughly in hemodialysis patients.	[Hishikari, Keiichi; Hikita, Hiroyuki; Abe, Fumichika; Ito, Naruhiko; Kanno, Yoshinori; Iiya, Munehiro; Murai, Tadashi; Takahashi, Atsushi; Yonetsu, Taishi] Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa, Japan; [Hishikari, Keiichi; Yonetsu, Taishi; Sasano, Tetsuo] Tokyo Med & Dent Univ, Cardiovasc Med, Tokyo, Japan		Hishikari, K (通讯作者)，Yokosuka Kyosai Hosp, Dept Cardiovasc Ctr, 1-16 Yonegahama Dori, Yokosuka, Kanagawa 2388558, Japan.	hishikari_86@yahoo.co.jp					Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Beiswenger AC, 2018, J VASC SURG, V67, P1922, DOI 10.1016/j.jvs.2018.02.047; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP., 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cacoub PP, 2009, EUR HEART J, V30, P192, DOI 10.1093/eurheartj/ehn534; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Feit F, 2008, J AM COLL CARDIOL, V51, P1645, DOI 10.1016/j.jacc.2007.11.081; Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jacc.2007.01.003; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Keough-Ryan TM, 2005, AM J KIDNEY DIS, V46, P845, DOI 10.1053/j.ajkd.2005.07.043; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Ko DT, 2010, CIRC-CARDIOVASC INTE, V3, P140, DOI 10.1161/CIRCINTERVENTIONS.109.928721; Ko DT, 2009, AM HEART J, V158, P592, DOI 10.1016/j.ahj.2009.06.030; Kolte D, 2017, CIRCULATION, V136, P167, DOI 10.1161/CIRCULATIONAHA.117.027625; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Newby LK, 2003, J THROMB THROMBOLYS, V16, P119, DOI 10.1023/B:THRO.0000024050.78728.35; Nikolsky E, 2005, AM J CARDIOL, V96, P474, DOI 10.1016/j.amjcard.2005.04.005; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P547, DOI 10.1016/j.jacc.2004.03.080; Nikolsky E, 2009, J AM COLL CARDIOL, V54, P1293, DOI 10.1016/j.jacc.2009.07.019; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Soden PA, 2016, J VASC SURG, V64, P1633, DOI 10.1016/j.jvs.2016.05.098; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Yeh RW, 2015, J AM COLL CARDIOL, V65, P787, DOI 10.1016/j.jacc.2015.01.004	32	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					281	287	1358863X21992863	10.1177/1358863X21992863		MAR 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000625499400001	33645340				2022-04-28	
J	Da Porto, A; Cavarape, A; Catena, C; Colussi, G; Casarsa, V; Sechi, LA				Da Porto, Andrea; Cavarape, Alessandro; Catena, Cristiana; Colussi, Gianluca; Casarsa, Viviana; Sechi, Leonardo Alberto			Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease	VASCULAR MEDICINE			English	Letter						atherothrombosis; peripheral artery disease; vitamin D; biomarkers	D DEFICIENCY; PREVALENCE; HEALTH		[Da Porto, Andrea; Cavarape, Alessandro; Catena, Cristiana; Colussi, Gianluca; Casarsa, Viviana; Sechi, Leonardo Alberto] Univ Udine, Dept Internal Med, Udine, Italy		Da Porto, A (通讯作者)，ASUFC, I-331000 Udine, Italy.	daporto.andrea@gmail.com	Colussi, GianLuca/I-2061-2012; DA PORTO, ANDREA/AAB-9752-2019	Colussi, GianLuca/0000-0003-1673-540X; DA PORTO, ANDREA/0000-0001-9995-0169			Bauersachs R, 2020, ANGIOLOGY, V71, P303, DOI 10.1177/0003319719896477; Carbone F, 2014, WORLD J CARDIOL, V6, P260, DOI 10.4330/wjc.v6.i5.260; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Iannuzzo G, 2018, J CLIN ENDOCR METAB, V103, P2107, DOI 10.1210/jc.2018-00136; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; McDermott MM, 2014, VASC MED, V19, P18, DOI 10.1177/1358863X13518364; Nsengiyumva V, 2015, ATHEROSCLEROSIS, V243, P645, DOI 10.1016/j.atherosclerosis.2015.10.011; Szymczak-Pajor I, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040794; van de Luijtgaarden KM, 2012, EUR J VASC ENDOVASC, V44, P301, DOI 10.1016/j.ejvs.2012.06.017	11	0	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					315	316	1358863X20979360	10.1177/1358863X20979360		JAN 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000618402900001	33448908				2022-04-28	
J	Nalugo, M; Harroun, N; Li, CL; Belaygorod, L; Semenkovich, CF; Zayed, MA				Nalugo, Margaret; Harroun, Nikolai; Li, Chenglong; Belaygorod, Larisa; Semenkovich, Clay F.; Zayed, Mohamed A.			Canagliflozin impedes ischemic hind-limb recovery in the setting of diabetes	VASCULAR MEDICINE			English	Article						amputation; angiogenesis; canagliflozin; hind-limb ischemia; limb perfusion	GLUCOSE COTRANSPORTER 2; FOOD-INTAKE; INHIBITORS; PATHOPHYSIOLOGY; RATIONALE; MORTALITY; DISEASE; DESIGN; MOUSE; MODEL	There is a reported increased incidence of lower extremity amputations in individuals with diabetes who are treated with canagliflozin (an SGLT2 receptor inhibitor). It is unclear whether this is an unintended consequence of therapy, or whether canagliflozin can affect peripheral limb perfusion in the setting of underling arterial malperfusion. To evaluate this we explored the effect of canagliflozin on tissue recovery following unilateral hind-limb ischemia (HLI). Adult wildtype (+/+) and diabetic (db/db) mice were maintained on 8 weeks of a regular chow diet, or a chow diet containing canagliflozin (200 mg/kg). Following HLI, hind-limb appearance, function, and Doppler perfusion were serially evaluated. Gastrocnemius muscle fiber size and microvessel density were also evaluated 21 days following HLI. We observed that db/db that received a diet containing canagliflozin had significantly worse hind-limb function and appearance scores compared to both db/db mice that received a regular diet and +/+ mice that received a canagliflozin diet. At post-HLI day 21, db/db mice that received a canagliflozin diet also had decreased Doppler perfusion, gastrocnemius muscle fiber size, and microvessel density compared to +/+ mice that received a canagliflozin diet. These findings indicate that canagliflozin appears to impede ischemic peripheral tissue recovery and warrant further clinical investigation in individuals with diabetes and a history of peripheral artery disease.	[Nalugo, Margaret; Harroun, Nikolai; Li, Chenglong; Belaygorod, Larisa; Zayed, Mohamed A.] Washington Univ, Sch Med, Dept Surg, Vasc Surg Sect, Campus Box 8109 Surg,660 South Euclid Ave, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Zayed, Mohamed A.] Washington Univ, Sch Med, Mol Cell Biol Div, St Louis, MO USA; [Zayed, Mohamed A.] Washington Univ, Dept Biomed Engn, McKelvey Sch Engn, St Louis, MO 63110 USA; [Zayed, Mohamed A.] Vet Affairs St Louis Hlth Care Syst, St Louis, MO USA		Zayed, MA (通讯作者)，Washington Univ, Sch Med, Dept Surg, Vasc Surg Sect, Campus Box 8109 Surg,660 South Euclid Ave, St Louis, MO 63110 USA.	zayedm@wustl.edu			Vascular Cures Foundation Wylie Scholar Award; American Surgical Association Research Fellowship Award; Society for Vascular Surgery Foundation Research Investigator Award; Washington University School of Medicine Diabetes Research Center: NIH/NIDDK [P30 DK020589, R01 DK101392]; Washington University School of Medicine Diabetes Research Center: NIH/NHLBI [K08 HL132060]	This work was supported by grants from the Vascular Cures Foundation Wylie Scholar Award (MAZ), American Surgical Association Research Fellowship Award (MAZ), Society for Vascular Surgery Foundation Research Investigator Award (MAZ), Washington University School of Medicine Diabetes Research Center: NIH/NIDDK P30 DK020589 (MAZ), NIH/NHLBI K08 HL132060 (MAZ), and NIH/NIDDK R01 DK101392 (CFS).	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Behnammanesh G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00362; Birkeland KI, 2017, LANCET DIABETES ENDO, V5, P709, DOI 10.1016/S2213-8587(17)30258-9; Brown E, 2019, DIABETES OBES METAB, V21, P9, DOI 10.1111/dom.13650; Carr CL, 2011, ARTERIOSCL THROM VAS, V31, P2526, DOI 10.1161/ATVBAHA.111.230177; Chatterjee S, 2019, CURR PROB CARDIOLOGY, V44, P207, DOI 10.1016/j.cpcardiol.2018.06.004; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen K, 2019, MOL IMMUNOL, V114, P289, DOI 10.1016/j.molimm.2019.07.026; Christensen J, 2016, TELEMED E-HEALTH, V22, P789, DOI 10.1089/tmj.2015.0165; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dai XZ, 2018, J CELL MOL MED, V22, P89, DOI 10.1111/jcmm.13296; Dai XZ, 2017, CIRC RES, V120, pE7, DOI 10.1161/CIRCRESAHA.117.310619; Devineni D, 2015, INT J CLIN PHARM TH, V53, P438, DOI 10.5414/CP202324; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Fadini GP, 2017, LANCET DIABETES ENDO, V5, P680, DOI 10.1016/S2213-8587(17)30257-7; Humphries MD, 2016, J VASC SURG, V64, P1747, DOI 10.1016/j.jvs.2016.06.096; Jardine MJ, 2017, AM J NEPHROL, V46, P462, DOI 10.1159/000484633; Kaji K, 2018, INT J CANCER, V142, P1712, DOI 10.1002/ijc.31193; Kalra S, 2014, DIABETES THER, V5, P355, DOI 10.1007/s13300-014-0089-4; Kobayashi K, 2000, METABOLISM, V49, P22, DOI 10.1016/S0026-0495(00)90588-2; Lopez-de-Andres A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101597; Mancini SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23420-4; Matthews DR, 2019, DIABETOLOGIA, V62, P926, DOI 10.1007/s00125-019-4839-8; Nasiri-Ansari N, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0749-1; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Neal B, 2013, AM HEART J, V166, P217, DOI 10.1016/j.ahj.2013.05.007; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; RAMIREZ I, 1978, PHYSIOL PSYCHOL, V6, P187; Sherman SE, 2018, JACC-BASIC TRANSL SC, V3, P327, DOI 10.1016/j.jacbts.2018.01.010; US Food and Drug Administration, 2013, HIGHL PRESCR INF INV; Vallianou NG, 2017, DIABETES METAB SYND, V11, P311, DOI 10.1016/j.dsx.2016.12.003; Verma S, 2018, CIRCULATION, V137, P405, DOI 10.1161/CIRCULATIONAHA.117.032031; Villani LA, 2016, MOL METAB, V5, P1048, DOI 10.1016/j.molmet.2016.08.014; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2017, FASEB J, V31, P2686, DOI 10.1096/fj.201601348R; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	40	3	3	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		131	138	1358863X20961153	10.1177/1358863X20961153		OCT 2020	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000582540900001	33095685	Green Accepted			2022-04-28	
J	Kolluri, R; Lugli, M; Villalba, L; Varcoe, R; Maleti, O; Gallardo, F; Black, S; Forgues, F; Lichtenberg, M; Hinahara, J; Ramakrishnan, S; Beckman, J				Kolluri, Raghu; Lugli, Marzia; Villalba, Laurencia; Varcoe, Ramon; Maleti, Oscar; Gallardo, Fernando; Black, Stephen; Forgues, Fannie; Lichtenberg, Michael; Hinahara, Jordan; Ramakrishnan, Saranya; Beckman, Josh			An estimate of the economic burden of venous leg ulcers associated with deep venous obstruction	VASCULAR MEDICINE			English	Article						burden of illness; healthcare costs; venous insufficiency; venous leg ulcers (VLU); wound care	CLINICAL-PRACTICE GUIDELINES; MANAGEMENT; COST; PREVALENCE; SOCIETY; DISEASE; DISORDERS; VEIN	Introduction: Venous leg ulcers (VLU) embody the most severe stage of the broad spectrum of chronic venous disease. Approximately 40% of patients with VLU present with the underlying deep venous disease (DVD). Although the data are scarce, these deep venous disease-related VLU (DRV) are thought to have higher recurrence rates and a substantial economic burden. The objective of this study was to assess the economic burden of DRV across Australia, France, Germany, Italy, Spain, the UK, and the USA. Methods: A comprehensive literature review was undertaken to identify publications documenting the incidence and prevalence of VLU and DRV, medical resource utilization, and associated costs of DRV. Findings from this literature review were used to estimate the economic burden of illness, including direct medical costs over a 12-month interval following initial presentation of a newly formed DRV. Results: Total annual incidence of new or recurrent DRV in Australia, France, Germany, Italy, Spain, UK, and the US are estimated at 122,000, 263,000, 345,000, 253,000, 85,000, 230,000, and 643,000 events, respectively, in 2019. Incidence ranges from 0.73 to 3.12 per 1000 persons per year. The estimated annual direct medical costs for patients managed conservatively in these geographies total similar to $10.73 billion (USD) or $5527 per person per year. Conclusion: The availability of published data on the costs of VLU care varies widely across countries considered in this analysis. Although country-specific VLU practice patterns vary, there is a uniform pattern of high-cost care.	[Kolluri, Raghu] Riverside Methodist Hosp, Dept Internal Med, OhioHlth, 3705 Olentangy River Rd, Columbus, OH 43214 USA; [Lugli, Marzia; Maleti, Oscar] Hesperia Hosp, Dept Cardiovasc Surg, Modena, Italy; [Villalba, Laurencia] Vasc Care Ctr, Dept Vasc Surg, Wollongong, NSW, Australia; [Varcoe, Ramon] Univ New South Wales, Dept Surg, Sydney, NSW, Australia; [Gallardo, Fernando] Hosp Quironsalud, Dept Vasc Surg, Marbella, Spain; [Black, Stephen] Guys & St Thomas NHS Fdn Trust, Dept Vasc Surg, London, England; [Forgues, Fannie] Ctr Phlebol Intervent, Clin Pasteur, Region Toulouse, Toulouse, France; [Lichtenberg, Michael] Arnsberg Vasc Ctr, Angiol Dept, Arnsberg, Germany; [Hinahara, Jordan; Ramakrishnan, Saranya] Boston Healthcare Associates Inc, Boston, MA USA; [Beckman, Josh] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN USA		Kolluri, R (通讯作者)，Riverside Methodist Hosp, Dept Internal Med, OhioHlth, 3705 Olentangy River Rd, Columbus, OH 43214 USA.	kolluri.raghu@gmail.com		Kolluri, Raghu/0000-0002-4374-7513	Philips Image Guided Therapy; Philips	The authors disclosed receipt of the following financial support for research, authorship, and/or publication of this article: This research was supported by funding from Philips Image Guided Therapy. Philips funded Boston Healthcare Associates for the data analysis and synthesis. All authors were involved in all aspects of the manuscript preparation and were uncompensated for the work.	Agale SV, 2013, ULCERS, V2013, P1, DOI [DOI 10.1155/2013/413604, 10.1155/2013/413604]; Alhalbouni S, 2012, ANN VASC SURG, V26, P185, DOI 10.1016/j.avsg.2011.05.033; [Anonymous], 2017, GUID CLIN PRACT CONS; [Anonymous], 2006, MAN VEN LEG ULC EXCL; Barnsbee L, 2019, INT WOUND J, V16, P112, DOI 10.1111/iwj.13000; Carter MJ, 2014, VALUE HEALTH, V17, P801, DOI 10.1016/j.jval.2014.08.001; Cheng QL, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3234-3; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Dominguez-Gil, 2005, REV ESP EC SALUD, P487; Edwards H, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-86; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; Epstein DM, 2019, BRIT J SURG, V106, P555, DOI 10.1002/bjs.11082; Fife CE, 2018, ADV WOUND CARE, V7, P77, DOI 10.1089/wound.2017.0743; Fife CE, 2012, WOUNDS, V24, P10; Finlayson KJ, 2018, INT WOUND J, V15, P686, DOI 10.1111/iwj.12911; George R, 2014, EUR J VASC ENDOVASC, V48, P330, DOI 10.1016/j.ejvs.2014.04.031; Gohel MS, 2018, NEW ENGL J MED, V378, P2105, DOI 10.1056/NEJMoa1801214; GRAHAM I, 2003, CAN FAM PHYSICIAN, V49; Ito T, 2016, J DERMATOL, V43, P853, DOI 10.1111/1346-8138.13286; Jarbrink K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0400-8; Kolluri R, 2020, J VASC SURG-VENOUS L, V8, P775, DOI 10.1016/j.jvsv.2019.12.071; Lawrence PF, 2020, J VASC SURG-VENOUS L, V8, P601, DOI 10.1016/j.jvsv.2019.09.016; Levy E, 2001, J MAL VASCUL, V26, P39; Ma H, 2014, J VASC SURG-VENOUS L, V2, P355, DOI 10.1016/j.jvsv.2014.04.006; Management of chronic venous leg ulcers, 2010, MAN CHRON VEN LEG UL; Rumbo-Prieto JM, 2018, ENFERM CLIN, V28, P49, DOI 10.1016/j.enfcli.2017.10.003; Marston W, 2016, WOUND REPAIR REGEN, V24, P136, DOI 10.1111/wrr.12394; Marston W, 2011, J VASC SURG, V53, P1303, DOI 10.1016/j.jvs.2010.10.120; McDaniel HB, 2002, J VASC SURG, V35, P723, DOI 10.1067/mva.2002.121128; Melikian R, 2019, J VASC SURG-VENOUS L, V7, P98, DOI 10.1016/j.jvsv.2018.07.014; Mosti G, 2018, CHRONIC WOUND CARE M, V5, P23, DOI 10.2147/CWCMR.S172060; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; National Institute for Health and Care Excellence (NICE), 2007, LOW LIMB DEEP VEIN V; National Institute for Health and Care Excellence (NICE), 2013, VAR VEINS DIAGN MAN; Neglen P, 2007, J VASC SURG, V46, P979, DOI 10.1016/j.jvs.2007.06.046; Neumann HAM, 2016, J EUR ACAD DERMATOL, V30, P1843, DOI 10.1111/jdv.13848; O'Donnell TF, 2014, J VASC SURG, V60, p3S, DOI 10.1016/j.jvs.2014.04.049; Olin JW, 1999, VASC MED, V4, P1; Purwins S, 2010, INT WOUND J, V7, P97, DOI 10.1111/j.1742-481X.2010.00660.x; Quesada Ramos C., 2015, ANALISIS COSTE EFECT; Rabe E, 2003, PHLEBOLOGIE, V32, P1; Raju S, 2006, J VASC SURG, V44, P136, DOI 10.1016/j.jvs.2006.02.065; Rice J Bradford, 2014, J Med Econ, V17, P347, DOI 10.3111/13696998.2014.903258; Rognoni C, 2020, J COMP EFFECT RES, V9, P705, DOI 10.2217/cer-2020-0030; Sen CK, 2019, ADV WOUND CARE, V8, P39, DOI 10.1089/wound.2019.0946; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Thomson M., 2011, MECH VASCULAR DIS RE; Vedantham, 2019, ENDOVASCULAR TODAY; Venous leg ulcer, 2019, VEN LEG ULC; Wang WD, 2016, PHLEBOLOGY, V31, P376, DOI 10.1177/0268355515596474; Youn YJ, 2019, KOREAN J INTERN MED, V34, P269, DOI 10.3904/kjim.2018.230	51	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					63	72	1358863X211028298	10.1177/1358863X211028298		AUG 2021	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000685794200001	34392750	hybrid, Green Published			2022-04-28	
J	Ratchford, EV; Evans, NS				Ratchford, Elizabeth, V; Evans, Natalie S.			Vascular Disease Patient Information Page: Pernio (chilblains)	VASCULAR MEDICINE			English	Editorial Material						chilblains; microangiopathy; pernio; perniosis; vasospasm			[Ratchford, Elizabeth, V] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21287 USA; [Evans, Natalie S.] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Harrington Heart & Vasc Inst,Med Ctr, Cleveland, OH 44106 USA		Ratchford, EV (通讯作者)，Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21287 USA.	evr@jhmi.edu					Choi E, 2021, VASC MED, V26, P56, DOI 10.1177/1358863X20983455; Herman A, 2020, JAMA DERMATOL, V156, P998, DOI 10.1001/jamadermatol.2020.2368; Houghton DE, 2017, VASC MED, V22, P545, DOI 10.1177/1358863X17737374; Ratchford EV, 2015, VASC MED, V20, P269, DOI 10.1177/1358863X15579122; Schmaier AA, 2020, VASC MED, V25, P604, DOI 10.1177/1358863X20963804; WINNER AL, 1946, LANCET, V251, P663	6	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					576	578	1358863X211023560	10.1177/1358863X211023560		AUG 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000681431600001	34344232	Bronze			2022-04-28	
J	Giannopoulos, S; Armstrong, EJ				Giannopoulos, Stefanos; Armstrong, Ehrin J.			Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia	VASCULAR MEDICINE			English	Review						anti-hypertensive therapy; anti-platelet therapy; cardioprotective medication; critical limb ischemia (CLI); medical therapy; smoking cessation		Critical limb ischemia (CLI) constitutes the most advanced form of peripheral artery disease (PAD) and is characterized by ischemic rest pain, tissue loss and/or gangrene. Optimized medical care and risk factor modification in addition to revascularization could reduce the incidence of cardiovascular events and major adverse limb events, improving patients' quality of life and promising higher survival rates. Adequate adherence to cardioprotective medications, including antithrombotic therapy (e.g. antiplatelets, anticoagulants), cholesterol-lowering agents (e.g. statins, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors), angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), and smoking cessation should be strongly encouraged for patients with CLI. This review examines these guideline-recommended therapies in terms of cardiovascular and limb-related risk reduction in patients with CLI.	[Giannopoulos, Stefanos; Armstrong, Ehrin J.] Univ Colorado, Div Cardiol, Rocky Mt Reg VA Med Ctr, Denver, CO 80202 USA		Armstrong, EJ (通讯作者)，Univ Colorado, Div Cardiol, Rocky Mt Reg VA Med Ctr, 1700 N Wheeling St, Aurora, CO 80045 USA.	Ehrin.armstrong@gmail.com		Giannopoulos, Stefanos/0000-0002-1942-911X			Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Aiello FA, 2012, J VASC SURG, V55, P371, DOI 10.1016/j.jvs.2011.08.044; Aiyappa, 2015, INDIAN J VASC ENDOVA, V2, P55; Anand S, 2007, NEW ENGL J MED, V357, P217; Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; ANDERSON L, 2016, COCHRANE DB SYST REV, V2016; Antoniou GA, 2015, J VASC SURG, V61, P519, DOI 10.1016/j.jvs.2014.10.021; Armstrong EJ, 2019, J ENDOVASC THER, V26, P199, DOI 10.1177/1526602819826593; Armstrong EJ, 2015, J VASC SURG, V62, P156, DOI 10.1016/j.jvs.2015.01.051; Armstrong EJ, 2015, VASC MED, V20, P237, DOI 10.1177/1358863X15574321; Armstrong EJ, 2014, J VASC SURG, V60, P1565, DOI 10.1016/j.jvs.2014.08.064; Armstrong EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000697; Aung PP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000123.pub2; Azarbal A, 2015, J CARDIOVASC PHARM T, V20, P144, DOI 10.1177/1074248414545126; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bhupathiraju SN, 2011, CLIN CHIM ACTA, V412, P1493, DOI 10.1016/j.cca.2011.04.038; Bodewes TCF, 2018, J VASC SURG, V67, P800, DOI 10.1016/j.jvs.2017.07.130; Bonaca MP, 2020, NEW ENGL J MED, V382, P1994, DOI 10.1056/NEJMoa2000052; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Bonaca MP, 2016, J AM COLL CARDIOL, V67, P2719, DOI 10.1016/j.jacc.2016.03.524; Cacoub PP, 2009, EUR HEART J, V30, P192, DOI 10.1093/eurheartj/ehn534; Capell WH, 2018, AM HEART J, V199, P83, DOI 10.1016/j.ahj.2018.01.011; Chen DC, 2015, VASC HEALTH RISK MAN, V11, P185, DOI 10.2147/VHRM.S76651; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; ClinicalTrials, 2020, ACP 01 PATIENTS CRIT; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Connolly SJ, 2018, LANCET, V391, P205, DOI 10.1016/S0140-6736(17)32458-3; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Conte MS, 2015, J VASC SURG, V61, p1S, DOI 10.1016/j.jvs.2014.12.006; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/S0140-6736(17)32252-3, 10.1016/s0140-6736(17)32252-3]; Dosluoglu HH, 2014, VASC MED, V19, P86, DOI 10.1177/1358863X14528271; Dosluoglu HH, 2012, J VASC SURG, V56, P361, DOI 10.1016/j.jvs.2012.01.054; Dosluoglu HH, 2010, J VASC SURG, V51, P1178, DOI 10.1016/j.jvs.2009.11.077; Faglia E, 2014, DIABETES RES CLIN PR, V103, P292, DOI 10.1016/j.diabres.2013.12.060; Feringa HHH, 2006, J AM COLL CARDIOL, V47, P1182, DOI 10.1016/j.jacc.2005.09.074; Fernandez N, 2010, J VASC SURG, V52, P834, DOI 10.1016/j.jvs.2010.04.070; Ferreira V, 2019, ANN VASC SURG, V55, P78, DOI 10.1016/j.avsg.2018.06.008; Gebauer K, 2018, VASA, V47, P165, DOI 10.1024/0301-1526/a000689; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Golledge J, 2019, CURR OPIN LIPIDOL, V30, P470, DOI 10.1097/MOL.0000000000000638; Gresele P, 2011, BRIT J CLIN PHARMACO, V72, P634, DOI 10.1111/j.1365-2125.2011.04034.x; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Gurbel PA, 2014, JACC-HEART FAIL, V2, P1, DOI 10.1016/j.jchf.2013.07.007; Helander EM, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0607-y; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hess CN, 2017, CIRCULATION, V135, P2534, DOI 10.1161/CIRCULATIONAHA.117.024469; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Iftikhar O, 2016, ANGIOLOGY, V67, P549, DOI 10.1177/0003319715604768; Iida O, 2015, JACC-CARDIOVASC INTE, V8, P1493, DOI 10.1016/j.jcin.2015.07.005; Iida O, 2013, CIRCULATION, V127, P2307, DOI 10.1161/CIRCULATIONAHA.112.000711; JONASON T, 1987, ACTA MED SCAND, V221, P253; Jones WS, 2014, EUR HEART J, V35, P242, DOI 10.1093/eurheartj/eht492; Khan SZ, 2020, ANN VASC SURG, V63, P275, DOI 10.1016/j.avsg.2019.08.093; Kokkinidis DG, 2020, VASC MED, V25, P427, DOI 10.1177/1358863X20916526; Kokkinidis DG, 2020, VASC MED, V25, P106, DOI 10.1177/1358863X19894055; Kray JE, 2017, VASC HEALTH RISK MAN, V13, P269, DOI 10.2147/VHRM.S137698; Kumbhani DJ, 2014, EUR HEART J, V35, P2864, DOI 10.1093/eurheartj/ehu080; Landmesser U, 2017, EUR HEART J, V38, P2245, DOI 10.1093/eurheartj/ehw480; Lane R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub3; Lee FS, 2008, BLOOD REV, V22, P321, DOI 10.1016/j.blre.2008.04.003; Lee HF, 2021, EUR HEART J-CARD PHA, V7, P50, DOI 10.1093/ehjcvp/pvz072; Li P, 2008, HYPERTENSION, V51, P252, DOI 10.1161/HYPERTENSIONAHA.107.097394; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lonn EM, 2001, CIRCULATION, V103, P919; Lu DB, 2011, DIABETES RES CLIN PR, V92, P26, DOI 10.1016/j.diabres.2010.12.010; Marston WA, 2006, J VASC SURG, V44, P108, DOI 10.1016/j.jvs.2006.03.026; Matsubara Y, 2017, J VASC SURG, V65, P1390, DOI 10.1016/j.jvs.2016.09.030; McDermott MM, 2011, J AM COLL CARDIOL, V57, P2356, DOI 10.1016/j.jacc.2010.12.038; Mehaffey JH, 2017, J VASC SURG, V66, P1109, DOI 10.1016/j.jvs.2017.04.036; Mehta SR, 2018, J AM COLL CARDIOL, V71, P303, DOI [10.1016/j.jacc.2018.03.008, 10.1016/j.jacc.2017.12.001]; Miyashita Y, 2011, ANGIOLOGY, V62, P15, DOI 10.1177/0003319710371619; Moll F, 2018, J ENDOVASC THER, V25, P158, DOI 10.1177/1526602818760488; Nguyen TA, 2005, J AM COLL CARDIOL, V45, P1157, DOI 10.1016/j.jacc.2005.01.034; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Norgren L, 2018, EUR J VASC ENDOVASC, V55, P109, DOI 10.1016/j.ejvs.2017.11.006; Ostergren J, 2004, EUR HEART J, V25, P17, DOI 10.1016/j.ehj.2003.10.033; Patel MR, 2015, EUR J PREV CARDIOL, V22, P734, DOI 10.1177/2047487314533215; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Piller LB, 2014, J GEN INTERN MED, V29, P1475, DOI 10.1007/s11606-014-2947-1; Randon C, 2010, J VASC SURG, V51, P869, DOI 10.1016/j.jvs.2009.11.062; Robless P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003748.pub2; Rogers KC, 2015, DRUGS, V75, P377, DOI 10.1007/s40265-015-0364-3; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Rossi M, 2014, MICROVASC RES, V93, P46, DOI 10.1016/j.mvr.2014.03.001; Roth EM, 2018, REV CARDIOVASC MED, V19, pS31, DOI 10.3909/ricm19S1S0002; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Sandfort V, 2017, J ADDICT MED, V11, P126, DOI 10.1097/ADM.0000000000000282; Saqib NU, 2013, J VASC SURG, V57, P692, DOI 10.1016/j.jvs.2012.08.115; Saraidaridis JT, 2015, J VASC SURG, V62, P392, DOI 10.1016/j.jvs.2015.03.043; Scali ST, 2011, J VASC SURG, V54, P1006, DOI 10.1016/j.jvs.2011.04.021; Schanzer A, 2008, J VASC SURG, V47, P774, DOI 10.1016/j.jvs.2007.11.056; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Sigrid, LINC 2017; Sobieszczyk P, 2013, CIRCULATION, V128, P749, DOI 10.1161/CIRCULATIONAHA.113.001560; Soga Y, 2012, EUR J VASC ENDOVASC, V44, P577, DOI 10.1016/j.ejvs.2012.09.020; Soga Y, 2011, J VASC SURG, V54, P1659, DOI 10.1016/j.jvs.2011.06.024; Spiliopoulos S, 2015, J VASC INTERV RADIOL, V26, P1423, DOI 10.1016/j.jvir.2015.06.034; Squizzato A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005158.pub4; Stavroulakis K, 2017, J VASC SURG, V66, P1534, DOI 10.1016/j.jvs.2017.05.115; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Suckow BD, 2015, J VASC SURG, V61, P126, DOI 10.1016/j.jvs.2014.05.093; Talukdar A, 2017, J VASC SURG, V66, P1143, DOI 10.1016/j.jvs.2017.02.052; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Tepe G, 2012, EUR RADIOL, V22, P1998, DOI 10.1007/s00330-012-2441-2; Teruya T, 2010, J VASC SURG, V51, P1188; Tomoi Y, 2013, CARDIOVASC INTERV TH, V28, P374, DOI 10.1007/s12928-013-0188-6; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Vogel TR, 2013, CIRC-CARDIOVASC INTE, V6, P694, DOI 10.1161/CIRCINTERVENTIONS.113.000274; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Westin GG, 2014, J AM COLL CARDIOL, V63, P682, DOI 10.1016/j.jacc.2013.09.073; Xie BC, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7528464; Yang Mei, 2013, Biomed Res Int, V2013, P462179, DOI 10.1155/2013/462179; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zanchetti A, 2006, J HYPERTENS, V24, P2163, DOI 10.1097/01.hjh.0000249692.96488.46	119	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		210	224	1358863X20987612	10.1177/1358863X20987612		FEB 2021	15	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000621135500001	33587692	Bronze			2022-04-28	
J	Hurst, JE; Tehan, PE; Hussey, K; Woodburn, J				Hurst, Joanne E.; Tehan, Peta Ellen; Hussey, Keith; Woodburn, James			Association of peripheral artery disease and chronic limb-threatening ischemia with socioeconomic deprivation in people with diabetes: A population data-linkage and geospatial analysis	VASCULAR MEDICINE			English	Article						chronic limb-threatening ischemia (CLTI); diabetes; geospatial mapping; health disparities; peripheral artery disease (PAD); spatial clustering		The association between the prevalence and geographical distribution of peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) in patients with diabetes in the context of socioeconomic deprivation is not well understood. We undertook a retrospective cohort study of 76,307 people with diabetes admitted as a hospital inpatient in a large Scottish health administrative area. Utilising linked health records, we identified diagnoses of PAD and/or CLTI and their distribution using small area cartography techniques according to multiple deprivation maps. Spatial autocorrelation techniques were applied to examine PAD and CLTI patterning. Association between crude inpatient prevalence-adjusted outcome rates and exposure to social deprivation were determined. We found crude prevalence-adjusted rates of 8.05% for PAD and 1.10% for CLTI with a five- to sevenfold difference from the least to most deprived regions. Statistically significant hot spots were found for PAD (p < 0.001) and CLTI (p < 0.001) in the most deprived areas, and cold spots for PAD (p < 0.001) but not CLTI (p = 0.72) in the least deprived areas. Major health disparities in PAD/CLTI diagnoses in people with diabetes is driven by socioeconomic deprivation.	[Hurst, Joanne E.; Woodburn, James] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland; [Tehan, Peta Ellen] Univ Newcastle, Fac Hlth & Med, Sch Hlth Sci, Ourimbah, NSW, Australia; [Hussey, Keith] Queen Elizabeth Univ Hosp, Dept Vasc Surg, Glasgow, Lanark, Scotland		Hurst, JE (通讯作者)，Glasgow Caledonian Univ, Sch Hlth & Life Sci, Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.	joanne.hurst@gcu.ac.uk	Tehan, Peta/H-7080-2019	Tehan, Peta/0000-0002-0014-3023; Hurst, Joanne/0000-0003-1175-1216; Woodburn, James/0000-0002-5497-8739			Aboyans V, 2006, CIRCULATION, V113, P2623, DOI 10.1161/CIRCULATIONAHA.105.608679; Aerden D, 2011, ANN VASC SURG, V25, P770, DOI 10.1016/j.avsg.2010.12.025; Ahmad N, 2014, J ROY SOC MED, V107, P483, DOI 10.1177/0141076814557301; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; CIAVARELLA A, 1993, DIABETES METAB, V19, P586; Conte MS, 2019, J VASC SURG, V69, p3S, DOI 10.1016/j.jvs.2019.02.016; Diehm N, 2006, EUR J VASC ENDOVASC, V31, P59, DOI 10.1016/j.ejvs.2005.09.006; Ellis DA, 2017, LANCET PUBLIC HEALTH, V2, pE551, DOI 10.1016/S2468-2667(17)30217-7; Ferguson HJM, 2010, EUR J VASC ENDOVASC, V40, P76, DOI 10.1016/j.ejvs.2010.03.008; Fitridge R, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3242; Foster HME, 2018, LANCET PUBLIC HEALTH, V3, pE576, DOI 10.1016/S2468-2667(18)30200-7; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gray L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-245; Hazlehurst MF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030472; HSocial Disadvantage Research Centre  Department of Social Policy and Social Work University of Oxford, 2016, SCOTT IND DEP 2016; Hurst JE, 2020, DIABETOLOGIA, V63, P659, DOI 10.1007/s00125-019-05056-9; Hussey K, 2015, EUR J VASC ENDOVASC, V49, P277, DOI 10.1016/j.ejvs.2014.12.015; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; Mukherjee D, 2009, J NATL MED ASSOC, V101, P999, DOI 10.1016/S0027-9684(15)31066-X; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nickinson ATO, 2020, J VASC SURG, V71, P669, DOI 10.1016/j.jvs.2019.08.229; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Read SH, 2016, DIABETOLOGIA, V59, P2106, DOI 10.1007/s00125-016-4054-9; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Scottish Government, 2016, SCOTT IND MULT DEPR, P1; Vart P, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004995; Walker J, 2016, J EPIDEMIOL COMMUN H, V70, P596, DOI 10.1136/jech-2015-206702; Walsh D, 2017, PUBLIC HEALTH, V151, P1, DOI 10.1016/j.puhe.2017.05.016; Walsh D, 2017, CHANGING ETHNIC PROF; Wilkinson R., 2003, Social determinants of health: the solid facts	31	3	3	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		147	154	1358863X20981132	10.1177/1358863X20981132		JAN 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cardiovascular System & Cardiology	RK4JL	WOS:000618496500001	33492205	hybrid, Green Published			2022-04-28	
J	Elbadawi, A; Elgendy, IY; Megaly, M; Elzeneini, M; Mentias, A; Omer, M; Ogunbayo, G; Rai, D; Drachman, DE; Shishehbor, MH				Elbadawi, Ayman; Elgendy, Islam Y.; Megaly, Michael; Elzeneini, Mohammed; Mentias, Amgad; Omer, Mohamed; Ogunbayo, Gbolahan; Rai, Devesh; Drachman, Douglas E.; Shishehbor, Mehdi H.			Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease	VASCULAR MEDICINE			English	Article						chronic kidney disease (CKD); critical limb ischemia (CLI); endovascular; revascularization; surgical	PERIPHERAL ARTERY-DISEASE; AMPUTATION-FREE SURVIVAL; ADMINISTRATIVE DATA; NATIONAL TRENDS; BYPASS; REVASCULARIZATION; MANAGEMENT; MORTALITY; THERAPY; QUALITY	There is a paucity of data on the outcomes and revascularization strategies for critical limb ischemia (CLI) among patients with chronic kidney disease (CKD). Hence, we conducted a nationwide analysis to evaluate the trends and outcomes of hospitalizations for CLI with CKD. The National Inpatient Sample database (2002-2015) was queried for hospitalizations for CLI. The trends of hospitalizations for CLI with CKD were reported, and endovascular versus surgical revascularization strategies for CLI with CKD were compared. The main study outcome was in-hospital mortality. The analysis included 2,139,640 hospitalizations for CLI, of which 484,224 (22.6%) had CKD. There was an increase in hospitalizations for CLI with CKD (P-trend= 0.01), but a reduction in hospitalizations for CLI without CKD (P-trend= 0.01). Patients with CLI and CKD were less likely to undergo revascularization compared with patients without CKD. CLI with CKD had higher rates of in-hospital mortality (4.8% vs 2.5%, adjusted odds ratio (OR) 2.01; 95% CI 1.93-2.11) and major amputation compared with no CKD. Revascularization for CLI with CKD was associated with lower rates of mortality (3.7% vs 5.3%, adjusted-OR 0.78; 95% CI 0.72-0.84) and major amputation compared with no revascularization. Compared with endovascular revascularization, surgical revascularization for CLI with CKD was associated with higher rates of in-hospital mortality (4.7% vs 2.7%, adjusted-OR 1.67; 95% CI 1.43-1.94). In conclusion, this contemporary observational analysis showed an increase in hospitalizations for CLI among patients with CKD. CLI with CKD was associated with higher in-hospital mortality compared with no CKD. Compared with endovascular therapy, surgical revascularization for CLI with CKD was associated with higher in-hospital mortality.	[Elbadawi, Ayman] Univ Texas Med Branch, Dept Cardiovasc Med, Galveston, TX 77555 USA; [Elgendy, Islam Y.] Weill Cornell Med Qatar, Doha, Qatar; [Megaly, Michael; Omer, Mohamed] Abbott NW Hosp, Minneapolis Heart Inst, Minneapolis, MN USA; [Elzeneini, Mohammed] Univ Florida, Div Internal Med, Gainesville, FL USA; [Mentias, Amgad] Univ Iowa, Div Cardiol, Iowa City, IA USA; [Ogunbayo, Gbolahan] Univ Kentucky, Div Cardiol, Lexington, KY USA; [Rai, Devesh] Rochester Gen Hosp, Div Internal Med, Rochester, NY 14621 USA; [Drachman, Douglas E.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Drachman, Douglas E.] Harvard Med Sch, Boston, MA 02115 USA; [Shishehbor, Mehdi H.] Univ Hosp, Harrington Heart & Vasc Inst, 11100 Euclid Ave,Lakeside Third Floor, Cleveland, OH 44106 USA; [Shishehbor, Mehdi H.] Case Western Reserve Univ, Sch Med, 11100 Euclid Ave,Lakeside Third Floor, Cleveland, OH 44106 USA		Shishehbor, MH (通讯作者)，Univ Hosp, Harrington Heart & Vasc Inst, 11100 Euclid Ave,Lakeside Third Floor, Cleveland, OH 44106 USA.; Shishehbor, MH (通讯作者)，Case Western Reserve Univ, Sch Med, 11100 Euclid Ave,Lakeside Third Floor, Cleveland, OH 44106 USA.	shishem@gmail.com	Elgendy, Islam Y/C-3900-2017; Rai, Devesh/AAW-4510-2021; Mentias, Amgad/L-6104-2017	Elgendy, Islam Y/0000-0001-9853-7591; Mentias, Amgad/0000-0001-6555-2517; Ogunbayo, Gbolahan/0000-0002-4140-8067; Elzeneini, Mohammed/0000-0003-0668-0994; Megaly, Michael/0000-0003-3176-6677			Agarwal S, 2016, J AM COLL CARDIOL, V67, P1901, DOI 10.1016/j.jacc.2016.02.040; Agency for Healthcare Research and Quality, 2015, 2014 NAT HEALTHC QUA; Agency for Healthcare Research and Quality, AHRQ PUB, V16-0015; Ambur V, 2019, J VASC SURG, V69, P491, DOI 10.1016/j.jvs.2018.05.229; Bekwelem W, 2014, VASC MED, V19, P483, DOI 10.1177/1358863X14559589; Benoit E, 2012, J VASC SURG, V55, P781, DOI 10.1016/j.jvs.2011.10.089; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Egorova NN, 2010, J VASC SURG, V51, P878, DOI 10.1016/j.jvs.2009.10.102; Elbadawi A, 2020, JACC-CARDIOVASC INTE, V13, P1729, DOI 10.1016/j.jcin.2020.04.038; Elbadawi A, 2019, AM J CARDIOL, V123, P25, DOI 10.1016/j.amjcard.2018.09.030; Elgendy IY, 2020, J AM COLL CARDIOL, V75, P113, DOI 10.1016/j.jacc.2019.11.009; Farber A, 2014, TECH VASC INTERV RAD, V17, P221, DOI 10.1053/j.tvir.2014.08.012; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Goodney PP, 2009, J VASC SURG, V50, P54, DOI 10.1016/j.jvs.2009.01.035; HCUP Databases, 2019, HEALTHC COST UT PROJ; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hioki H, 2016, VASC MED, V21, P137, DOI 10.1177/1358863X15619241; Hong MS, 2011, ANN VASC SURG, V25, P44, DOI 10.1016/j.avsg.2010.08.006; Kolte D, 2017, CIRCULATION, V136, P167, DOI 10.1161/CIRCULATIONAHA.117.027625; Liew YP, 2008, CLIN J AM SOC NEPHRO, V3, P1084, DOI 10.2215/CJN.04411007; Lin JH, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005273; Luders F, 2016, CLIN J AM SOC NEPHRO, V11, P216, DOI 10.2215/CJN.05600515; McCoach CE, 2013, VASC MED, V18, P19, DOI 10.1177/1358863X13475836; Meyerson SL, 2001, J VASC SURG, V34, P27, DOI 10.1067/mva.2001.116350; Ogunbayo G, 2019, AM J CARDIOL, V124, P321, DOI 10.1016/j.amjcard.2019.04.036; Pasqualini L, 2007, J INTERN MED, V262, P668, DOI 10.1111/j.1365-2796.2007.01863.x; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Shishehbor MH, 2016, J AM COLL CARDIOL, V68, P2002, DOI 10.1016/j.jacc.2016.04.071; Shishehbor MH, 2016, VASC MED, V21, P144, DOI 10.1177/1358863X16630118; Slovut DP, 2008, VASC MED, V13, P281, DOI 10.1177/1358863X08091485; Teraa M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002938	32	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		155	163	1358863X20951270	10.1177/1358863X20951270		OCT 2020	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000575513300001	33002372				2022-04-28	
J	Luo, LF; Zhang, YS; Hsu, C; Korshunov, V; Long, XC; Knight, P; Berk, B; Yan, C				Luo, Lingfeng; Zhang, Yishuai; Hsu, Chia; Korshunov, Vyacheslav; Long, Xiaochun; Knight, Peter; Berk, Bradford; Yan, Chen			Efficient suppression of vascular smooth muscle cell proliferation and intimal hyperplasia by targeting phosphodiesterase 10A	VASCULAR MEDICINE			English	Meeting Abstract									[Luo, Lingfeng] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Luo, Lingfeng; Zhang, Yishuai; Hsu, Chia; Korshunov, Vyacheslav; Knight, Peter; Berk, Bradford; Yan, Chen] Univ Rochester, Aab Cardiovasc Res Inst, Rochester, NY USA; [Long, Xiaochun] Augusta Univ, Vasc Biol Ctr, Augusta, GA USA				Zhang, Yishuai/AAE-6676-2022					0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				YIA 1374	NP4	NP5					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100022					2022-04-28	
J	Salces, NW; Sy, FF				Salces, Neil Wayne; Sy, Florge Francis			Incidental finding of a painless Stanford b aortic dissection in a 60-year-old female admitted for ischemic stroke	VASCULAR MEDICINE			English	Meeting Abstract									[Salces, Neil Wayne] Philippine Heart Ctr, Quezon City, Philippines; [Sy, Florge Francis] Chong Hua Hosp, Cebu, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1324	NP28	NP28					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100063					2022-04-28	
J	Kolluri, R; Lugli, M; Villalba, L				Kolluri, R.; Lugli, M.; Villalba, L.			An estimate of the economic burden of venous leg ulcers associated with deep venous disease (pg 1, 2021)	VASCULAR MEDICINE			English	Correction																	Kolluri R, 2022, VASC MED, V27, P63, DOI 10.1177/1358863X211028298	1	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					NP1	NP1	1358863X211048020	10.1177/1358863X211048020		SEP 2021	1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000700412600001		Bronze			2022-04-28	
J	Gao, JP; Guo, W				Gao, Jiang-Ping; Guo, Wei			Mechanisms of abdominal aortic aneurysm progression: A review	VASCULAR MEDICINE			English	Review						abdominal aortic aneurysm (AAA); fibroblasts; hemodynamics; intraluminal thrombus; macrophages; perivascular adipose tissue; vasa vasorum	PERIVASCULAR ADIPOSE-TISSUE; THROMBUS-COVERED WALL; REGULATORY T-CELLS; INTRALUMINAL THROMBUS; ADVENTITIAL INFLAMMATION; VASA VASORUM; GROWTH; ASSOCIATION; ADIPOCYTES; RECEPTORS	Abdominal aortic aneurysm (AAA) is a common disease associated with significant cardiovascular morbidity and mortality. Up to now, there is still controversy on the choice of treatment method of AAA. Even so, the mechanisms of AAA progression are poorly defined, making targeting new therapies problematic. Current evidence favors an interaction of the hemodynamic microenvironment with local and systemic immune responses. In this review, we aim to provide an update of mechanisms in AAA progression, involving hemodynamics, perivascular adipose tissue, adventitial fibroblasts, vasa vasorum remodeling, intraluminal thrombus, and distribution of macrophage subtypes.	[Gao, Jiang-Ping] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Vasc Surg, Beijing, Peoples R China; [Guo, Wei] Chinese Peoples Liberat Army Gen Hosp, Dept Vasc Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China		Guo, W (通讯作者)，Chinese Peoples Liberat Army Gen Hosp, Dept Vasc Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	guoweiplagh@sina.com		Gao, Jiang-Ping/0000-0003-0371-9072			Ahmadieh S, 2020, CLIN SCI, V134, P3, DOI 10.1042/CS20190577; Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P2374, DOI 10.1161/ATVBAHA.113.301280; Akoumianakis I, 2017, CARDIOVASC RES, V113, P999, DOI 10.1093/cvr/cvx111; ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Antoniou GA, 2020, EUR J VASC ENDOVASC, V59, P385, DOI 10.1016/j.ejvs.2019.11.030; Apoloni RC, 2019, ANN VASC SURG, V54, P176, DOI 10.1016/j.avsg.2018.06.016; Baltieri N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00229; BECKMAN EN, 1986, AM J CLIN PATHOL, V85, P21, DOI 10.1093/ajcp/85.1.21; Bi Y, 2013, EUR J VASC ENDOVASC, V45, P145, DOI 10.1016/j.ejvs.2012.11.015; Boytard L, 2013, ARTERIOSCL THROM VAS, V33, P431, DOI 10.1161/ATVBAHA.112.300663; Busch A, 2016, J VASC RES, V53, P49, DOI 10.1159/000447263; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Chen SS, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117207; Chiou AC, 2001, J SURG RES, V99, P371, DOI 10.1006/jsre.2001.6207; Chistiakov DA, 2017, ACTA PHYSIOL, V219, P382, DOI 10.1111/apha.12725; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cronin O, 2013, ATHEROSCLEROSIS, V226, P321, DOI 10.1016/j.atherosclerosis.2012.10.041; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Dale MA, 2016, J IMMUNOL, V196, P4536, DOI 10.4049/jimmunol.1502454; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Ding Y, 2021, VASC PHARMACOL, V136, DOI 10.1016/j.vph.2020.106818; Ding Y, 2020, ANN VASC SURG, V67, P254, DOI 10.1016/j.avsg.2020.02.011; DOBRIN PB, 1984, ARCH SURG-CHICAGO, V119, P405; Dutertre CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089983; Elbadawi A., 2019, CIRCULATION, V140, P12690; Feldmann K, 2019, ATHEROSCLEROSIS, V287, P81, DOI 10.1016/j.atherosclerosis.2019.06.897; Folkesson M, 2011, ATHEROSCLEROSIS, V218, P294, DOI 10.1016/j.atherosclerosis.2011.05.002; Freestone T, 1997, ARTERIOSCL THROM VAS, V17, P10, DOI 10.1161/01.ATV.17.1.10; Gabel G, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006798; Golledge J, 2009, BRIT J SURG, V96, P628, DOI 10.1002/bjs.6633; Haurani MJ, 2007, CARDIOVASC RES, V75, P679, DOI 10.1016/j.cardiores.2007.06.016; Hendy K, 2014, ATHEROSCLEROSIS, V235, P182, DOI 10.1016/j.atherosclerosis.2014.04.021; Hirose H, 2001, ANN NY ACAD SCI, V947, P416; Horimatsu T, 2018, CARDIOVASC DRUG THER, V32, P503, DOI 10.1007/s10557-018-6821-y; Hosseini V, 2020, ADV SCI, V7, DOI 10.1002/advs.202000173; Jalalzadeh H, 2016, EUR J VASC ENDOVASC, V52, P333, DOI 10.1016/j.ejvs.2016.05.002; Joly F, 2020, ANN BIOMED ENG, V48, P606, DOI 10.1007/s10439-019-02375-1; Kasashima S, 2008, AM J SURG PATHOL, V32, P197, DOI 10.1097/PAS.0b013e3181342f0d; Kazi M, 2005, ARTERIOSCL THROM VAS, V25, P1341, DOI 10.1161/01.ATV.0000166601.49954.21; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Kim HW, 2020, ARTERIOSCL THROM VAS, V40, P2569, DOI 10.1161/ATVBAHA.120.312470; Kugo H, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10020149; Kugo H, 2019, ADIPOCYTE, V8, P229, DOI 10.1080/21623945.2019.1636625; Kwon HM, 1998, J AM COLL CARDIOL, V32, P2072, DOI 10.1016/S0735-1097(98)00482-3; Lareyre F, 2017, ARTERIOSCL THROM VAS, V37, P2171, DOI 10.1161/ATVBAHA.117.309999; Lasheras JC, 2007, ANNU REV FLUID MECH, V39, P293, DOI 10.1146/annurev.fluid.39.050905.110128; Lindeman JHN, 2015, EXPERT REV CARDIOVAS, V13, P839, DOI 10.1586/14779072.2015.1052408; Lindholt JS, 2008, VASC ENDOVASC SURG, V42, P329, DOI 10.1177/1538574408315205; Liu CL, 2020, EUR HEART J, V41, P2456, DOI 10.1093/eurheartj/ehz856; Liu ZY, 2012, CIRC RES, V111, P1261, DOI [10.1161/CIRCRESAHA.112.270520, 10.1161/circresaha.112.270520]; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Lu S, 2014, J IMMUNOL, V192, P4897, DOI 10.4049/jimmunol.1301009; Mata KM, 2011, INT J EXP PATHOL, V92, P26, DOI 10.1111/j.1365-2613.2010.00746.x; McFadden EP, 2004, INVEST RADIOL, V39, P585, DOI 10.1097/01.rli.0000138089.98165.88; Menges AL, 2019, J VASC SURG, V70, P1318, DOI 10.1016/j.jvs.2018.10.091; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Monux G, 2017, BRIT J CLIN PHARMACO, V83, P2661, DOI 10.1111/bcp.13383; Piacentini L, 2019, ARTERIOSCL THROM VAS, V39, P237, DOI 10.1161/ATVBAHA.118.311803; Raffort J, 2017, NAT REV CARDIOL, V14, P457, DOI 10.1038/nrcardio.2017.52; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Reimerink JJ, 2013, BRIT J SURG, V100, P1405, DOI 10.1002/bjs.9235; Ren WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28149; Sakaue T, 2017, HYPERTENSION, V70, P780, DOI 10.1161/HYPERTENSIONAHA.117.09512; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655; Speelman L, 2010, J VASC SURG, V51, P19, DOI 10.1016/j.jvs.2009.08.075; Stather PW, 2013, BRIT J SURG, V100, P863, DOI 10.1002/bjs.9101; Suh MK, 2020, J VASC SURG, V72, P1087, DOI 10.1016/j.jvs.2019.08.285; Tanaka H, 2017, JOVE-J VIS EXP, DOI 10.3791/55763; Tanaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134386; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057398; Terada K, 2018, BIOCHEM BIOPH RES CO, V501, P145, DOI 10.1016/j.bbrc.2018.04.196; Tilson M D, 2000, Int J Surg Investig, V1, P453; Tilson MD, 2016, J VASC SURG, V64, P1523, DOI 10.1016/j.jvs.2016.06.119; Vaaramaki S, 2019, EUR J VASC ENDOVASC, V58, P182, DOI 10.1016/j.ejvs.2019.03.006; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Wanhainen A, 2020, CARDIOVASC RES, V116, P450, DOI 10.1093/cvr/cvz133; White JV, 1996, ANN NY ACAD SCI, V800, P97, DOI 10.1111/j.1749-6632.1996.tb33302.x; Wiernicki I, 2015, EUR J RADIOL, V84, P662, DOI 10.1016/j.ejrad.2014.12.022; Wiernicki I, 2010, ATHEROSCLEROSIS, V212, P161, DOI 10.1016/j.atherosclerosis.2010.04.033; Wynn Thomas A, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1422s93; Xu JY, 2015, INT J MOL SCI, V16, P11574, DOI 10.3390/ijms160511574; Yang H, 2021, ARTERIOSCL THROM VAS, V41, P1158, DOI 10.1161/ATVBAHA.120.315607	88	0	0	6	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					88	96	1358863X211021170	10.1177/1358863X211021170		JUL 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000675683100001	34278882				2022-04-28	
J	Raju, S; Walker, W; Noel, C; Kuykendall, R; Powell, T; Jayaraj, A				Raju, Seshadri; Walker, William; Noel, Chandler; Kuykendall, Riley; Powell, Thomas; Jayaraj, Arjun			Dimensional disparity between duplex and intravascular ultrasound in the assessment of iliac vein stenosis	VASCULAR MEDICINE			English	Article						duplex; iliac compression syndrome; iliac vein stenosis; May&#8211; Thurner syndrome		Minimum iliac vein caliber necessary to maintain normal peripheral venous pressure can be derived by the Poiseuille equation. Duplex was compared to intravascular ultrasound (IVUS) in the assessment of iliac vein stenosis in this single center retrospective study. Parallel IVUS and duplex caliber data for common iliac vein (CIV) and external iliac vein (EIV) in 382 limbs were separately compared. One or both segments were stenotic by IVUS criteria in 213 limbs. Neither segment was stenotic by IVUS in 22 limbs. Bland-Altman analyses and Passing-Bablok linear regressions were used. Duplex calibers were dimensionally smaller than corresponding IVUS images of CIV and EIV segments in Bland-Altman comparison by a mean of 54 mm(2) and 34 mm(2), respectively. Passing-Bablok regression suggested the difference was due to a systematic bias and not proportional. Duplex yields a smaller cross-sectional image of CIV and EIV compared to IVUS. Duplex is not a reliable diagnostic test for iliac vein stenosis.	[Raju, Seshadri; Walker, William; Noel, Chandler; Kuykendall, Riley; Powell, Thomas; Jayaraj, Arjun] RANE Ctr, Jackson, MS USA		Raju, S (通讯作者)，St Dominics Mem Hosp, RANE Ctr, 971 Lakeland Dr,Suite 401, Jackson, MS 39216 USA.	rajumd@earthlink.net					Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; Bredahl K, 2013, EUR J VASC ENDOVASC, V46, P525, DOI 10.1016/j.ejvs.2013.09.012; Calogero E, 2018, J CARDIOVASC ECHOGR, V28, P218, DOI 10.4103/jcecho.jcecho_57_18; DAgostino R. B., 1986, GOODNESS OF FIT TECH; Danielsson Gudmundur, 2002, Vasc Endovascular Surg, V36, P271, DOI 10.1177/153857440203600404; de Simone G, 1999, HYPERTENSION, V33, P800, DOI 10.1161/01.HYP.33.3.800; Gagne PJ, 2018, J VASC SURG-VENOUS L, V6, P48, DOI 10.1016/j.jvsv.2017.07.009; Gagne PJ, 2017, J VASC SURG-VENOUS L, V5, P678, DOI 10.1016/j.jvsv.2017.04.007; Hall JE., GUYTON HALL TXB MED, P1145; Jayaraj A., 2019, RUTHERFORDS VASCULAR, V2, P2116; Jayaraj A, 2021, J VASC SURG-VENOUS L, V9, P73, DOI 10.1016/j.jvsv.2020.07.012; Jayaraj A, 2019, J VASC SURG-VENOUS L, V7, P195, DOI 10.1016/j.jvsv.2018.10.001; Kassab G, 2019, J VASC SURG-VENOUS L, V7, P151, DOI 10.1016/j.jvsv.2018.07.020; Kayilioglu SI, 2016, J VASC SURG-VENOUS L, V4, P2, DOI 10.1016/j.jvsv.2015.08.002; Labropoulos N, 2007, J VASC SURG, V46, P101, DOI 10.1016/j.jvs.2007.02.062; LI S, 1993, PHYSIOL MEAS, V14, P291, DOI 10.1088/0967-3334/14/3/007; Metzger PB, 2016, J VASC SURG-VENOUS L, V4, P18, DOI 10.1016/j.jvsv.2015.07.002; Montminy ML, 2019, J VASC SURG-VENOUS L, V7, P801, DOI 10.1016/j.jvsv.2019.03.015; Neglen P, 2007, J VASC SURG, V46, P979, DOI 10.1016/j.jvs.2007.06.046; Padberg F, 2003, J VASC SURG, V37, P79, DOI 10.1067/mva.2003.61; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Raju S, 2008, EUR J VASC ENDOVASC, V36, P606, DOI 10.1016/j.ejvs.2008.03.015; Raju S, 2006, J VASC SURG, V44, P136, DOI 10.1016/j.jvs.2006.02.065; Raju S, 2020, J VASC SURG-VENOUS L, V8, P970, DOI 10.1016/j.jvsv.2020.02.021; Raju S, 2019, J VASC SURG-VENOUS L, V7, P428, DOI 10.1016/j.jvsv.2018.08.009; Raju S, 2019, J VASC SURG-VENOUS L, V7, P184, DOI 10.1016/j.jvsv.2018.06.015; Raju S, 2018, PHLEBOLOGY, V33, P451, DOI 10.1177/0268355517718763; Raju S, 2017, J VASC SURG-VENOUS L, V5, P864, DOI 10.1016/j.jvsv.2017.05.024; Raju S, 2014, J VASC SURG-VENOUS L, V2, P260, DOI 10.1016/j.jvsv.2013.12.004; Raju S, 2015, J VASC SURG-VENOUS L, V3, P58, DOI 10.1016/j.jvsv.2014.08.001; Raju S, 2014, J VASC SURG-VENOUS L, V2, P52, DOI 10.1016/j.jvsv.2013.01.005; Raju S, 2015, SEMIN VASC SURG, V28, P47, DOI 10.1053/j.semvascsurg.2015.07.001; Raju S, 2013, J VASC SURG-VENOUS L, V1, P165, DOI 10.1016/j.jvsv.2012.09.006; Raju S, 2011, J VASC SURG, V53, P123, DOI 10.1016/j.jvs.2010.07.068; Raju S, 2010, J VASC SURG, V51, P401, DOI 10.1016/j.jvs.2009.08.032; Raju S, 2009, J VASC SURG, V50, P1114, DOI 10.1016/j.jvs.2009.06.055; Saleem T, 2020, J VASC SURG-VENOUS L, V8, P634, DOI 10.1016/j.jvsv.2019.10.021; You SH, 2017, ULTRASONOGRAPHY, V36, P17, DOI 10.14366/usg.16022; Zander D, 2020, ULTRASOUND INT OPEN, V06, pE14, DOI 10.1055/a-1223-1134	39	0	0	1	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					549	555	1358863X211003663	10.1177/1358863X211003663		APR 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000641114900001	33840321				2022-04-28	
J	Cameron, SJ; Engel, R				Cameron, Scott J.; Engel, Robert			Keeping an eye on vascular disease	VASCULAR MEDICINE			English	Editorial Material						ocular ischaemia; orbital ultrasound; peripheral vascular disease; microvascular			[Cameron, Scott J.] Cleveland Clin Fdn, Sect Vasc Med, Heart Vasc & Thorac Inst, Dept Cardiovasc Med, J3-5,9500 Euclid Ave, Cleveland, OH 44195 USA; [Engel, Robert] Cleveland Clin Fdn, Cole Eye Inst, Dept Optometry, 9500 Euclid Ave, Cleveland, OH 44195 USA		Cameron, SJ (通讯作者)，Cleveland Clin Fdn, Sect Vasc Med, Heart Vasc & Thorac Inst, Dept Cardiovasc Med, J3-5,9500 Euclid Ave, Cleveland, OH 44195 USA.	cameros3@ccf.org	Cameron, Scott/AAW-8429-2021	Cameron, Scott/0000-0002-9616-1540			Allon R, 2021, AM J MED, V134, P36, DOI 10.1016/j.amjmed.2020.07.013; Avery MB, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010509; Cameron SJ, 2015, J AM COLL CARDIOL, V65, P2760, DOI 10.1016/j.jacc.2015.05.014; HOLLENHORST RW, 1954, AMA ARCH OPHTHALMOL, V52, P819; HOLLENHORST RW, 1966, AM J OPHTHALMOL, V61, P1159, DOI 10.1016/0002-9394(66)90238-8; Liew G, 2011, REV ESP CARDIOL, V64, P515, DOI [10.1016/j.recesp.2011.02.014, 10.1016/j.rec.2011.02.017]; Ponto KA, 2015, J THROMB HAEMOST, V13, P1254, DOI 10.1111/jth.12982; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Ruiz-Ares G, 2021, VASC MED, V26, P302, DOI 10.1177/1358863X21993214; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Wang L, 2008, HYPERTENSION, V51, P119, DOI 10.1161/HYPERTENSIONAHA.107.098343; Yang C, 2020, ATHEROSCLEROSIS, V294, P62, DOI 10.1016/j.atherosclerosis.2019.10.012	12	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					310	311	1358863X211008528	10.1177/1358863X211008528		APR 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000638760600001	33823703	Bronze			2022-04-28	
J	Maga, M; Laczak, P; Kaczmarczyk, P; Wandzilak, M; Maga, P				Maga, Mikolaj; Laczak, Patrycja; Kaczmarczyk, Pawel; Wandzilak, Maciej; Maga, Pawel			Images in Vascular Medicine: Successful endovascular treatment of psoriasis-induced critical limb ischemia	VASCULAR MEDICINE			English	Editorial Material							DISEASES		[Maga, Mikolaj; Laczak, Patrycja; Kaczmarczyk, Pawel; Maga, Pawel] Jagiellonian Univ, Med Coll, Fac Med, Dept Angiol, Krakow, Poland; [Maga, Mikolaj] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Dept Rehabil Internal Med,Inst Physiotherapy, Krakow, Poland; [Maga, Mikolaj; Kaczmarczyk, Pawel; Wandzilak, Maciej; Maga, Pawel] Univ Hosp Krakow, Clin Dept Angiol, Krakow, Poland		Maga, M (通讯作者)，Jagiellonian Univ, Med Coll, Dept Angiol, Jakubowskiego 2 St, PL-30688 Krakow, Poland.	mikolaj.maga@gmail.com		Maga, Mikolaj/0000-0003-3701-3692; Laczak, Patrycja/0000-0003-2437-2880			Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Sajja AP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01234; Takeshita J, 2017, J AM ACAD DERMATOL, V76, P377, DOI 10.1016/j.jaad.2016.07.064	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					350	351	1358863X21994663	10.1177/1358863X21994663		FEB 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000624230700001	33629648	Bronze			2022-04-28	
J	Muller, AM; Rapple, V; Bradaric, C; Koppara, T; Kehl, V; Fusaro, M; Cassese, S; Ott, I; Kastrati, A; Laugwitz, KL; Ibrahim, T				Muller, Arne M.; Rapple, Veronika; Bradaric, Christian; Koppara, Tobias; Kehl, Victoria; Fusaro, Massimiliano; Cassese, Salvatore; Ott, Ilka; Kastrati, Adnan; Laugwitz, Karl-Ludwig; Ibrahim, Tareq			Outcomes of endovascular treatment for infrapopliteal peripheral artery disease based on the updated TASC II classification	VASCULAR MEDICINE			English	Article						angioplasty; atherosclerosis; endovascular procedures; infrapopliteal arteries; peripheral artery disease (PAD)	CRITICAL LIMB ISCHEMIA; BARE-METAL STENTS; SIROLIMUS-ELUTING STENTS; INTER-SOCIETY CONSENSUS; BALLOON ANGIOPLASTY; RISK-FACTORS; PREVALENCE; MULTICENTER; MANAGEMENT; REVASCULARIZATION	We retrospectively analyzed all endovascular procedures of infrapopliteal arterial lesions (n = 383) performed in 270 patients at our institution between December 2008 and January 2018. The overall technical success rate was 97% and yielded 98% for stenoses (n = 214) and 95% for occlusions (n = 169). Trans-Atlantic Inter-Society Consensus (TASC II) classification had no impact on success rates (TASC A + B vs C + D; 96.5% vs 96.9%, p = 0.837). Freedom from clinically driven target lesion revascularization (TLR) after 6 and 12 months was 88.3% and 77.2%. TLR was comparable for TASC A to C lesions and no difference was observed comparing groups of moderately complex TASC A/B lesions and more complex TASC C/D lesions (TASC A + B vs C + D; 78.5% vs 74.2%, p = 0.457). Freedom from TLR was significantly lower in very complex TASC D lesions (TASC A + B + C vs D; 79.7% vs 42.5%, p < 0.001). Multivariate analysis identified TASC D lesions (hazard ratio D/A: 1.5; overall p = 0.002), Fontaine class III and IV (hazard ratio III or IV/IIa or IIb: 2.4; p = 0.041), and occlusive lesions (hazard ratio occlusion/stenosis: 2.4; p = 0.026) as predictors for TLR. In conclusion, endovascular therapy for infrapopliteal artery disease was safe and accompanied with a promising long-term outcome.	[Muller, Arne M.; Rapple, Veronika; Bradaric, Christian; Koppara, Tobias; Laugwitz, Karl-Ludwig; Ibrahim, Tareq] Tech Univ Munich, Klin & Poliklin Innere Med 1, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany; [Kehl, Victoria] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Informat Stat & Epidemiol, Munich, Germany; [Fusaro, Massimiliano; Cassese, Salvatore; Kastrati, Adnan] Tech Univ Munich, Abt Herz & Kreislauferkrankungen, Deutsch Herzzentrum Munchen, Munich, Germany; [Ott, Ilka] Helios Klinikum Pforzheim, Abt Kardiol Angiol & Intens Med, Pforzheim, Germany; [Kastrati, Adnan; Laugwitz, Karl-Ludwig] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site, Munich, Germany		Muller, AM (通讯作者)，Tech Univ Munich, Klin & Poliklin Innere Med 1, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany.	arne.mueller@tum.de					Aboyans V, 2017, KARDIOL POL, V75, P1065, DOI 10.5603/KP.2017.0216; Bosiers M, 2012, J VASC SURG, V55, P390, DOI 10.1016/j.jvs.2011.07.099; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Davies MG, 2008, ANN VASC SURG, V22, P790, DOI 10.1016/j.avsg.2008.04.007; Diehm C, 2004, ATHEROSCLEROSIS, V172, P95, DOI 10.1016/S0021-9150(03)00204-1; Dorweiler B, 2002, EUR J VASC ENDOVASC, V24, P309, DOI 10.1053/ejvs.2002.1735; Feiring AJ, 2010, J AM COLL CARDIOL, V55, P1580, DOI 10.1016/j.jacc.2009.11.072; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; IYER SS, 1990, CATHETER CARDIO DIAG, V20, P251, DOI 10.1002/ccd.1810200408; Jaff MR, 2015, VASC MED, V20, P465, DOI 10.1177/1358863X15597877; Kashyap Vikram S, 2002, Vasc Endovascular Surg, V36, P255; Katsanos K, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.011245; Kok HK, 2017, DIAGN INTERV RADIOL, V23, P360, DOI 10.5152/dir.2017.17040; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Park UJ, 2018, VASC ENDOVASC SURG, V52, P498, DOI 10.1177/1538574418779466; Rand T, 2011, RADIOLOGY, V261, P634, DOI 10.1148/radiol.11101357; Randon C, 2010, CARDIOVASC INTER RAD, V33, P260, DOI 10.1007/s00270-009-9765-6; Rastan A, 2012, J AM COLL CARDIOL, V60, P587, DOI 10.1016/j.jacc.2012.04.035; Rastan A, 2011, EUR HEART J, V32, P2274, DOI 10.1093/eurheartj/ehr144; Scheinert D, 2012, J AM COLL CARDIOL, V60, P2290, DOI 10.1016/j.jacc.2012.08.989; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shu J, 2018, ATHEROSCLEROSIS, V275, P379, DOI 10.1016/j.atherosclerosis.2018.05.033; Siablis D, 2014, JACC-CARDIOVASC INTE, V7, P1048, DOI 10.1016/j.jcin.2014.04.015; Singh GD, 2017, J ENDOVASC THER, V24, P321, DOI 10.1177/1526602817704643; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Zeller T, 2014, J AM COLL CARDIOL, V64, P1568, DOI 10.1016/j.jacc.2014.06.1198	30	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					18	25	1358863X20967091	10.1177/1358863X20967091		DEC 2020	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000608822100001	33256573				2022-04-28	
J	Horiuchi, M; Stoner, L				Horiuchi, Masahiro; Stoner, Lee			Macrovascular and microvascular responses to prolonged sitting with and without bodyweight exercise interruptions: A randomized cross-over trial	VASCULAR MEDICINE			English	Article						arterial stiffness index; near infrared spectroscopy; pulse wave velocity; sitting breaks	PULSE-WAVE VELOCITY; ENDOTHELIAL DYSFUNCTION; STRATEGIES; TIME	Exposure to uninterrupted prolonged sitting leads to macro- and microvascular complications, which can contribute to increased cardiovascular disease risk. This study investigated the macrovascular and microvascular responses to 3 h of sitting that was: (i) uninterrupted (CON); and (ii) interrupted every 20 min with 1 min light intensity half squats plus calf raises (EX). Twenty healthy participants (21 [SD: 2] years; 21.5 [SD: 1.6] kg/m(2)) were recruited to participate in this randomized cross-over trial. Macrovascular function was quantified using brachial-ankle pulse wave velocity (baPWV) and the lower- and upper-limb arterial stiffness index (ASI). Microvascular function was quantified as the medial gastrocnemius tissue oxygen saturation (StO(2)) area under the curve (AUC) during reactive hyperemia. The baPWV did not significantly change with time (p = 0.594) or by condition (p = 0.772). The arm ASI increased by 3.6 (95% CI: 0.7 to 6.6, effect size [ES] = 0.27) with a nonsignificant condition effect (p = 0.219). There was a significant interaction effect for leg ASI (p = < 0.001), with ASI increasing (impairment) by 18.7 (95% CI: 12.1 to 25.3, ES = 0.63) for CON and decreasing (improvement) by -11.9 (95% CI: -18.5 to -5.3, ES = 0.40) for EX compared to presitting. Similarly, the AUC decreased (detrimental) by 18% (Delta = -321, 95% CI: -543 to -100, ES = 0.32) for CON and increased by 32% (Delta = 588, 95% CI: 366 to 809, ES = 0.59) for EX. The leg ASI was inversely associated with StO(2) AUC (interclass correlation coefficient: -0.66, 95% CI: -0.51 to -0.77). These preliminary findings suggest that regularly interrupting prolonged sitting with simple bodyweight exercises may help to preserve lower-limb vascular function.	[Horiuchi, Masahiro] Mt Fuji Res Inst, Div Human Environm Sci, Kami Yohida 5597-1, Fuji Yoshida City, Yamanashi 4030005, Japan; [Stoner, Lee] Univ N Carolina, Dept Exercise & Sports Sci, Chapel Hill, NC 27515 USA		Horiuchi, M (通讯作者)，Mt Fuji Res Inst, Div Human Environm Sci, Kami Yohida 5597-1, Fuji Yoshida City, Yamanashi 4030005, Japan.	mhoriuchi@mfri.pref.yamanashi.jp			Japan Society for the Promotion of Science (JSPS, KAKENHI)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP18K11012]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by the Japan Society for the Promotion of Science (JSPS, KAKENHI, grant no. JP18K11012 to Dr Horiuchi).	Altunkan Sekip, 2005, Eur J Intern Med, V16, P580, DOI 10.1016/j.ejim.2005.06.011; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Cheng YB, 2015, PULSE, V3, P253, DOI 10.1159/000444645; Credeur DP, 2019, AM J CARDIOL, V123, P260, DOI 10.1016/j.amjcard.2018.10.014; de Oliveira GV, 2019, MICROVASC RES, V126, DOI 10.1016/j.mvr.2019.103911; de Oliveira GV, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12556; Dempsey PC, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-01044-0; Evans WS, 2019, J APPL PHYSIOL, V127, P781, DOI 10.1152/japplphysiol.00318.2019; Fisher JP, 2010, EXP PHYSIOL, V95, P572, DOI 10.1113/expphysiol.2009.047332; Gibbons TD, 2019, EXP PHYSIOL, V104, P1790, DOI 10.1113/EP088077; Gibbs BB, 2017, J HYPERTENS, V35, P2411, DOI [10.1097/HJH.0000000000001463, 10.1097/hjh.0000000000001463]; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Horiuchi M, 2021, VASC MED, V26, P386, DOI 10.1177/1358863X20988899; Horiuchi M, 2020, MICROVASC RES, V129, DOI 10.1016/j.mvr.2019.103972; Katzmarzyk PT, 2019, MED SCI SPORT EXER, V51, P1227, DOI 10.1249/MSS.0000000000001935; Kenward MG, 2010, BIOSTATISTICS, V11, P1, DOI 10.1093/biostatistics/kxp046; Kowalsky RJ, 2019, APPL PHYSIOL NUTR ME, V44, P1025, DOI 10.1139/apnm-2018-0633; Kucharska-Newton AM, 2019, CLIN CHEM, V65, P108, DOI 10.1373/clinchem.2018.287623; Morishima T, 2017, CLIN SCI, V131, P1045, DOI 10.1042/CS20170031; Morishima T, 2016, AM J PHYSIOL-HEART C, V311, pH177, DOI 10.1152/ajpheart.00297.2016; Overholser BR, 2008, NUTR CLIN PRACT, V23, P76, DOI 10.1177/011542650802300176; Restaino RM, 2016, AM J PHYSIOL-HEART C, V310, pH648, DOI 10.1152/ajpheart.00943.2015; Restaino RM, 2015, EXP PHYSIOL, V100, P829, DOI 10.1113/EP085238; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Stewart AD, 2003, HYPERTENSION, V42, P915, DOI 10.1161/01.HYP.0000092882.65699.19; Stoner L, 2020, VASC MED, V25, P419, DOI 10.1177/1358863X20926588; Sugawara J, 2010, AM J CARDIOL, V106, P856, DOI 10.1016/j.amjcard.2010.05.011; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Thosar SS, 2015, MED SCI SPORT EXER, V47, P843, DOI 10.1249/MSS.0000000000000479; Thosar SS, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-50; Vranish JR, 2017, AM J PHYSIOL-HEART C, V312, pH800, DOI 10.1152/ajpheart.00823.2016; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	33	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2022	27	2			SI		127	135	1358863X211053381	10.1177/1358863X211053381		NOV 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	0I8MI	WOS:000726514800001	34809506				2022-04-28	
J	Kinlay, S; Ostrowski, S; Sherrod, R; Todoran, T; Eisenhauer, A; Sobieszczyk, P				Kinlay, Scott; Ostrowski, Simon; Sherrod, Rebecca; Todoran, Thomas; Eisenhauer, Andrew; Sobieszczyk, Piotr			Critical limb ischemia and long-term outcomes after superficial femoral artery revascularization	VASCULAR MEDICINE			English	Meeting Abstract									[Kinlay, Scott; Sherrod, Rebecca] VA Boston Healthcare Syst, West Roxbury, MA USA; [Kinlay, Scott] Harvard Med Sch, Boston, MA 02115 USA; [Kinlay, Scott; Sobieszczyk, Piotr] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Ostrowski, Simon] Univ Pittsburgh, Pittsburgh, PA USA; [Todoran, Thomas] Med Univ South Carolina, Charleston, SC 29425 USA; [Eisenhauer, Andrew] Cent Maine Med Ctr, Lewiston, ME USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1359	NP14	NP14					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100039					2022-04-28	
J	Norgren, L; North, R; Baumgartner, I; Berger, JS; Blomster, JI; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Mulder, H; Patel, MR; Rockhold, FW; Fowkes, FGR				Norgren, Lars; North, Rebecca; Baumgartner, Iris; Berger, Jeffrey S.; Blomster, Juuso, I; Hiatt, William R.; Jones, W. Schuyler; Katona, Brian G.; Mahaffey, Kenneth W.; Mulder, Hillary; Patel, Manesh R.; Rockhold, Frank W.; Fowkes, F. Gerry R.			World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial	VASCULAR MEDICINE			English	Article						epidemiology; geographical variation; outcome; peripheral artery disease (PAD); prevention; risk factors	ISCHEMIC EVENTS; RISK-FACTORS; CLOPIDOGREL	Regional variations exist in the epidemiology of peripheral artery disease (PAD), in comorbidities, use of secondary prevention, and outcomes. Large studies of these variations in worldwide populations are rare. The EUCLID (Examining Use of tiCagreLor In peripheral artery Disease) trial included 13,885 patients with PAD from four geographical regions (Central/South America, Europe, Asia, North America) and compared monotherapy with ticagrelor and clopidogrel. Inclusion criteria were either an ankle-brachial index < 0.80 or a prior revascularization. The primary efficacy endpoint was time to first occurrence of any event in the composite of cardiovascular death, myocardial infarction, or ischemic stroke and did not differ between the study arms. This post hoc analysis of EUCLID confirmed that regional differences occurred in the inclusion criteria with more prior revascularization in North America (73.9%) and Asia (72.5%) compared with Central/South America (34.0%) and Europe (51.6%). The characteristics of patients also differed. Prior amputation at baseline was most frequent in Central/South America (6.3%) compared with other regions (1.6-2.8%). A history of stroke was most common in Asia, coronary heart disease in North America, and diabetes in Central/South America compared with other regions. The incidence of outcomes in patients with PAD varied by region. North America had the highest rate of the primary combined endpoint (5.97 events/100 patient-years). Corresponding rates were 4.80, 3.95, and 3.87 for Asia, Europe, and Central/South America, respectively. Hospitalization for acute limb ischemia (events/100 patient-years) was most frequent in Europe (0.75) and North America (0.74) compared with Asia (0.60) and Central/South America (0.33). Adjustment for inclusion criteria and relevant PAD characteristics did not have a major impact on these regional differences. Further adjustment for concomitant disease, risk factors, and preventive medication modified the regional differences only marginally. In conclusion, substantial regional differences were found in cardiovascular and limb outcomes in patients with PAD and were not explained by variation in the category of included patients, concomitant disease, risk factors, and prevention. Such differences, which may be due to variation in other factors such as background population rates or clinical care, need to be considered when designing and interpreting large international studies (ClinicalTrials.gov Identifier: NCT01732822).	[Norgren, Lars] Orebro Univ, Fac Med & Hlth, S-70185 Orebro, Sweden; [North, Rebecca] North Carolina State Univ, Dept Stat, Raleigh, NC USA; [Baumgartner, Iris] Univ Bern, Bern Univ Hosp, Inselspital, Div Angiol,Swiss Cardiovasc Ctr, Bern, Switzerland; [Berger, Jeffrey S.] NYU, Sch Med, Dept Med, New York, NY USA; [Berger, Jeffrey S.] NYU, Dept Surg, Sch Med, New York, NY 10016 USA; [Blomster, Juuso, I] Univ Turku, Turku Univ Hosp, Turku, Finland; [Hiatt, William R.] Univ Colorado, Sch Med, Dept Med, Div Cardiol, Aurora, CO USA; [Jones, W. Schuyler; Mulder, Hillary; Patel, Manesh R.; Rockhold, Frank W.] Duke Clin Res Inst, Durham, NC USA; [Jones, W. Schuyler; Patel, Manesh R.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Katona, Brian G.] AstraZeneca Gaithersburg, Gaithersburg, MD USA; [Mahaffey, Kenneth W.] Stanford Univ, Sch Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA; [Fowkes, F. Gerry R.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland		Norgren, L (通讯作者)，Orebro Univ, Fac Med & Hlth, S-70185 Orebro, Sweden.; Norgren, L (通讯作者)，Orebro Univ, Univ Hosp, Dept Surg, S-70185 Orebro, Sweden.	Lars.Norgren@regionorebrolan.se	Patel, Manesh/AAC-5385-2019	Norgren, Lars/0000-0003-2071-7132; Berger, Jeffrey/0000-0001-8216-4647	AstraZenecaAstraZeneca	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: AstraZeneca sponsored the EUCLID trial. Dr Blomster was and Dr Katona is a paid employee of AstraZeneca who worked independently on the manuscript outside of their employment. Therefore, the authors received no financial support for the research, authorship, and publication of this article.	Abtan J, 2017, CLIN CARDIOL, V40, P710, DOI 10.1002/clc.22721; Barnes JA, 2020, ARTERIOSCL THROM VAS, V40, P1808, DOI 10.1161/ATVBAHA.120.314595; Berger JS, 2016, AM HEART J, V175, P86, DOI 10.1016/j.ahj.2016.01.018; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Ducrocq G, 2014, EUR J PREV CARDIOL, V21, P1509, DOI 10.1177/2047487313501278; European Medicines Agency, 2013, EMA985712013; Fowkes FG, 2017, INT ANGIOL, V36, P203, DOI 10.23736/S0392-9590.16.03716-0; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; Fudim M, 2020, CIRC-CARDIOVASC QUAL, V13, P639, DOI 10.1161/CIRCOUTCOMES.120.006512; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hess CN, 2019, CIRCULATION, V140, P556, DOI 10.1161/CIRCULATIONAHA.119.039773; Hess CN, 2017, CIRCULATION, V135, P2534, DOI 10.1161/CIRCULATIONAHA.117.024469; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Kansal A, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.119.008069; Katsanos K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135692; Makin A, 2002, INT J CLIN PRACT, V56, P605; Norgren L., 2007, EUR J VASC ENDOVASC, V33, pS1; Norgren L, 2018, EUR J VASC ENDOVASC, V55, P109, DOI 10.1016/j.ejvs.2017.11.006; Olivier CB, 2019, JAMA CARDIOL, V4, P7, DOI 10.1001/jamacardio.2018.4171; Ward R, 2020, AM HEART J, V220, P51, DOI 10.1016/j.ahj.2019.11.007	21	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					21	29	1358863X211038620	10.1177/1358863X211038620		SEP 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000695252900001	34516308	Green Published, hybrid			2022-04-28	
J	Tehan, PE; Rounsley, R; Sebastian, M; Chuter, VH				Tehan, Peta Ellen; Rounsley, Richard; Sebastian, Mathew; Chuter, Vivienne Helaine			Diagnostic accuracy of postexercise toe-brachial index for identifying peripheral artery disease (PAD): A pilot study	VASCULAR MEDICINE			English	Letter						critical limb ischemia (CLI); exercise testing; peripheral artery disease (PAD); toe-brachial index (TBI); vascular diagnostics	EXERCISE; SPECIFICITY; SENSITIVITY; FOOT		[Tehan, Peta Ellen; Chuter, Vivienne Helaine] Univ Newcastle, Sch Hlth Sci, Coll Hlth Med & Wellbeing, POB 127, Ourimbah, NSW, Australia; [Rounsley, Richard] Vasc Hlth Care, Lake Macquarie, NSW, Australia; [Sebastian, Mathew] John Hunter Hosp, Dept Surg, Newcastle, NSW, Australia		Tehan, PE (通讯作者)，Univ Newcastle, Sch Hlth Sci, Coll Hlth Med & Wellbeing, POB 127, Ourimbah, NSW, Australia.	Peta.Tehan@newcastle.edu.au	Tehan, Peta/H-7080-2019	Tehan, Peta/0000-0002-0014-3023			Geyman J., 2000, EVIDENCE BASED CLIN; Hammad TA, 2017, VASC MED, V22, P204, DOI 10.1177/1358863X16676902; Hinchliffe RJ, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3276; Koelemay MJW, 1996, BRIT J SURG, V83, P404, DOI 10.1002/bjs.1800830336; Kovacs D, 2018, ATHEROSCLEROSIS, V269, P151, DOI 10.1016/j.atherosclerosis.2018.01.023; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Tehan P, 2015, J ULTRAS MED, V34, P1737, DOI 10.7863/ultra.15.14.09071; Tehan PE, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-018-0309-7; Tehan PE, 2018, VASC MED, V23, P116, DOI 10.1177/1358863X17751259; Tehan PE, 2017, J FOOT ANKLE RES, V10, DOI 10.1186/s13047-017-0236-z; Tehan PE, 2016, J DIABETES COMPLICAT, V30, P155, DOI 10.1016/j.jdiacomp.2015.07.019; Williams DT, 2007, DIABETIC MED, V24, P1105, DOI 10.1111/j.1464-5491.2007.02218.x	12	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					657	659	1358863X211039548	10.1177/1358863X211039548		SEP 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000695325500001	34488499				2022-04-28	
J	Choi, E; Henkin, S				Choi, Eunjung; Henkin, Stanislav			Raynaud's phenomenon and related vasospastic disorders	VASCULAR MEDICINE			English	Article						acrocyanosis; livedo reticularis; pernio; Raynaud&#8217; s; vasospasm		Raynaud's phenomenon, which is characterized by episodic digital pallor, cyanosis and rubor upon exposure to cold environment or to stress, is relatively common, although the prevalence depends on the climate. Still, it is under-diagnosed, under-treated, and often confused with other conditions. Primary Raynaud's phenomenon (i.e., Raynaud disease) must be distinguished from secondary Raynaud's phenomenon (i.e., Raynaud syndrome) as long-term morbidity and outcomes differ vastly between the two conditions. Additionally, the practitioner must differentiate between Raynaud's phenomenon and related vascular disorders, such as acrocyanosis, pernio, and livedo reticularis. In this article, we review differences between the conditions and suggest an approach to diagnosis and treatment strategy for these disorders.	[Choi, Eunjung; Henkin, Stanislav] Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA		Henkin, S (通讯作者)，Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	stanislav.henkin@hitchcock.org		Henkin, Stanislav/0000-0001-5968-1216			Al-Sudany NK, 2016, DERMATOL THER, V29, P263, DOI 10.1111/dth.12350; Allen EV, 1932, AM J MED SCI, V183, P187, DOI 10.1097/00000441-193202000-00004; Almahameed Amjad, 2008, Curr Treat Options Cardiovasc Med, V10, P128, DOI 10.1007/s11936-008-0014-0; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; Battesti G, 2020, J AM ACAD DERMATOL, V83, P1219, DOI 10.1016/j.jaad.2020.06.1018; Belch J, 2017, VASA, V46, P413, DOI 10.1024/0301-1526/a000661; Bentea GP, 2020, VASC MED, V25, P559, DOI 10.1177/1358863X20953901; Block JA, 2001, LANCET, V357, P2042, DOI 10.1016/S0140-6736(00)05118-7; Boada A, 2010, AM J DERMATOPATH, V32, P19, DOI 10.1097/DAD.0b013e3181af1d24; Boas EP, 1922, J AMER MED ASSOC, V79, P1404, DOI 10.1001/jama.1922.02640170030009; BOLLINGER A, 1985, J CARDIOVASC PHARM, V7, pS147, DOI 10.1097/00005344-198500073-00017; Bollinger A, 1977, Bibl Anat, P142; Bose N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0558-9; Brand F N, 1997, Vasc Med, V2, P296; Cappel JA, 2014, MAYO CLIN PROC, V89, P207, DOI 10.1016/j.mayocp.2013.09.020; CARDELLI MB, 1989, MED CLIN N AM, V73, P1127, DOI 10.1016/S0025-7125(16)30623-X; Carpentier P H, 1998, Rev Prat, V48, P1641; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Chotani MA, 2004, AM J PHYSIOL-HEART C, V286, pH59, DOI 10.1152/ajpheart.00268.2003; COFFMAN JD, 1984, CLIN PHARMACOL THER, V36, P369, DOI 10.1038/clpt.1984.189; COFFMAN JD, 1988, EUR J CLIN INVEST, V18, P309, DOI 10.1111/j.1365-2362.1988.tb01264.x; COFFMAN JD, 1975, PROG CARDIOVASC DIS, V18, P123, DOI 10.1016/0033-0620(75)90002-X; COFFMAN JD, 1971, NEW ENGL J MED, V285, P259, DOI 10.1056/NEJM197107292850505; COFFMAN JD, 1989, AM J MED, V87, P264; COFFMAN JD, 1990, CARDIOVASC DRUG THER, V4, P45, DOI 10.1007/BF00053426; Cohen R., 1989, J VASC MED BIOL, V1, P21; COHEN RA, 1981, CIRC RES, V49, P1196, DOI 10.1161/01.RES.49.5.1196; Coleiro B, 2001, RHEUMATOLOGY, V40, P1038, DOI 10.1093/rheumatology/40.9.1038; Cribier B, 2001, J AM ACAD DERMATOL, V45, P924, DOI 10.1067/mjd.2001.117861; Crowson AN, 1997, HUM PATHOL, V28, P478, DOI 10.1016/S0046-8177(97)90038-1; Curtiss P, 2018, J AM ACAD DERMATOL, V78, P1110, DOI 10.1016/j.jaad.2018.01.043; Cutolo M, 2014, J RHEUMATOL, V41, P881, DOI 10.3899/jrheum.131284; DAVIS E, 1982, ADV MICROCIRCULAT, V10, P101; Dean Steven M, 2011, Curr Treat Options Cardiovasc Med, V13, P179, DOI 10.1007/s11936-011-0115-z; DOWD PM, 1986, BRIT MED J, V293, P923, DOI 10.1136/bmj.293.6552.923-a; DuVall J, 2019, P UCLA HLTH, V23, P1; Eberhardt R., 2013, VASCULAR MED COMPANI, V3rd, P640; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGEL RR, 1994, EPIDEMIOL REV, V16, P184, DOI 10.1093/oxfordjournals.epirev.a036150; FLAVAHAN NA, 1987, J PHARMACOL EXP THER, V241, P361; Flavahan NA, 2015, NAT REV RHEUMATOL, V11, P146, DOI 10.1038/nrrheum.2014.195; FLEISCHER AB, 1990, DERMATOL CLIN, V8, P347; Flombaum CD, 1999, AM J KIDNEY DIS, V33, P555, DOI 10.1016/S0272-6386(99)70194-0; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002/art.21041; Freedman RR, 1996, ARTHRITIS RHEUM, V39, P1189, DOI 10.1002/art.1780390717; FREEDMAN RR, 1989, CIRCULATION, V80, P859, DOI 10.1161/01.CIR.80.4.859; FREEDMAN RR, 1995, CIRCULATION, V92, P1448, DOI 10.1161/01.CIR.92.6.1448; FREEMAN R, 1992, SEMIN NEUROL, V12, P385, DOI 10.1055/s-2008-1041195; GANOR S, 1983, J AM ACAD DERMATOL, V8, P136, DOI 10.1016/S0190-9622(83)80309-0; Garner R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006389; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016/j.jaad.2004.11.051; Godoy A, 2019, VASC MED, V24, P361, DOI 10.1177/1358863X19849627; GROSS AS, 1993, INT J DERMATOL, V32, P276, DOI 10.1111/j.1365-4362.1993.tb04267.x; Hachulla E, 2016, ANN RHEUM DIS, V75, P1009, DOI 10.1136/annrheumdis-2014-207001; Hallam R, 1930, MED PRESS CIRC, V129, P408; Heidrich H, 2010, VASA, V39, P33, DOI 10.1024/0301-1526/a000003; Henkin S., VASCULAR MED COMPANI, V2020, P625; HERMAN EW, 1981, ARCH DERMATOL, V117, P26, DOI 10.1001/archderm.117.1.26; Hirschl M, 2006, ARTHRITIS RHEUM-US, V54, P1974, DOI 10.1002/art.21912; HOLTI G, 1978, ANGIOLOGY, V29, P89, DOI 10.1177/000331977802900113; Hughes M, 2017, MICROVASC RES, V111, P32, DOI 10.1016/j.mvr.2016.12.008; Iwata H, 1987, Sangyo Igaku, V29, P500; JACOB JR, 1986, ARCH INTERN MED, V146, P1589, DOI 10.1001/archinte.146.8.1589; JOBE JB, 1985, J RHEUMATOL, V12, P953; Jones GT, 2003, ARTHRITIS RHEUM-US, V48, P3518, DOI 10.1002/art.11340; Kakimura M, 1973, J Nutr Sci Vitaminol (Tokyo), V19, P375; Khanna D, 2016, JAMA-J AM MED ASSOC, V315, P1975, DOI 10.1001/jama.2016.5258; Khouri C, 2019, LANCET RHEUMATOL, V1, pE237, DOI 10.1016/S2665-9913(19)30079-7; Koenig M, 2008, ARTHRITIS RHEUM-US, V58, P3902, DOI 10.1002/art.24038; KONTOS HA, 1969, CIRCULATION, V39, P259, DOI 10.1161/01.CIR.39.2.259; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007/s00415-005-0967-9; Kurklinsky AK, 2011, VASC MED, V16, P288, DOI 10.1177/1358863X11398519; Landry GJ, 2013, J VASC SURG, V57, P1710, DOI 10.1016/j.jvs.2013.03.012; Lata K, 2015, AM J MED, V128, pE45, DOI 10.1016/j.amjmed.2015.04.031; Lewis T, 1930, HEART-J STUD CIRC, V15, P229; Lewis T, 1941, BRIT MED J, V1941, P837; Lewis T, 1929, HEART-J STUD CIRC, V15, P7; Mak O T, 1988, Adv Exp Med Biol, V242, P119; Manappallil RG, 2017, J CLIN DIAGN RES, V11, DOI 10.7860/JCDR/2017/25300.9784; Mangiafico RA, 1996, ANGIOLOGY, V47, P1033, DOI 10.1177/000331979604701102; Mannava S, 2011, J HAND SURG-AM, V36A, P1708, DOI 10.1016/j.jhsa.2011.07.011; Maricq HR, 1997, J RHEUMATOL, V24, P879; Masuda H, 2016, INTERNAL MED, V55, P319, DOI 10.2169/internalmedicine.55.6251; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; Maverakis E, 2014, J AUTOIMMUN, V48-49, P60, DOI 10.1016/j.jaut.2014.01.020; Mohokum M, 2012, ANGIOLOGY, V63, P535, DOI 10.1177/0003319711432861; Monticone G, 2000, J AM ACAD DERMATOL, V42, P787, DOI 10.1067/mjd.2000.103046; MORRISH DW, 1976, LANCET, V2, P851; Neumeister MW, 2015, HAND CLIN, V31, P23, DOI 10.1016/j.hcl.2014.09.003; Nguyen VA, 2010, RHEUMATOLOGY, V49, P583, DOI 10.1093/rheumatology/kep413; Olin J., 1996, PERIPHERAL VASCULAR, V2nd, P607; Olin JW., VASCULAR MED COMPANI, V2013, P613; Pavlov-Dolijanovic SR, 2013, RHEUMATOL INT, V33, P2967, DOI 10.1007/s00296-013-2844-7; PEACOCK JH, 1959, CIRC RES, V7, P821, DOI 10.1161/01.RES.7.6.821; Plissonneau Duquene P, 2015, Int Angiol, V34, P467; Polidoro L, 2012, INTERN MED J, V42, P531, DOI 10.1111/j.1445-5994.2010.02399.x; Pope J, 2000, COCHRANE DB SYST REV, V1998; Pope J., 2000, COCHRANE DB SYST REV, V1998; Purdue G F, 1986, J Burn Care Rehabil, V7, P331, DOI 10.1097/00004630-198607000-00007; REINERTSEN JL, 1981, ARTHRITIS RHEUM, V24, P1215, DOI 10.1002/art.1780240921; Rirash F, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000467.pub2; Roustit M, 2013, ANN RHEUM DIS, V72, P1696, DOI 10.1136/annrheumdis-2012-202836; RUSTIN MHA, 1990, J ROY SOC MED, V83, P495, DOI 10.1177/014107689008300807; RUSTIN MHA, 1989, BRIT J DERMATOL, V120, P267; Ryan T, 2004, MICRON, V35, P161, DOI 10.1016/j.micron.2003.11.010; Shulman LM, 1999, NEUROLOGY, V53, P1862, DOI 10.1212/WNL.53.8.1862; Simon TD, 2005, PEDIATRICS, V116, pE472, DOI 10.1542/peds.2004-2681; SIVULA A, 1966, ANGIOLOGY, V17, P269, DOI 10.1177/000331976601700501; Smyth AE, 1999, RHEUMATOLOGY, V38, P1094, DOI 10.1093/rheumatology/38.11.1094; Thompson AE, 2005, RHEUMATOLOGY, V44, P145, DOI 10.1093/rheumatology/keh390; THULESIUS O, 1976, ACTA CHIR SCAND, P53; Thune TH, 2006, EUR J VASC ENDOVASC, V32, P198, DOI 10.1016/j.ejvs.2006.01.017; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; VANHOUTTE PM, 1985, CLIN SCI, V68, pS121, DOI 10.1042/cs068s121; Verma Prashant, 2015, Skinmed, V13, P176; Weinberg I, 2012, AM J MED, V125, pE1, DOI 10.1016/j.amjmed.2011.05.007; WHITE KP, 1994, PEDIATR DERMATOL, V11, P1, DOI 10.1111/j.1525-1470.1994.tb00063.x; Whitman PA., 2020, PERNIO; Wigley FM, 1998, ARTHRITIS RHEUM-US, V41, P670, DOI 10.1002/1529-0131(199804)41:4<670::AID-ART14>3.3.CO;2-9; Wigley FM, 2002, NEW ENGL J MED, V347, P1001, DOI 10.1056/NEJMcp013013; WINNER AL, 1946, LANCET, V251, P663; WOLLERSHEIM H, 1986, CLIN PHARMACOL THER, V40, P219, DOI 10.1038/clpt.1986.166; Yang XA, 2010, J DRUGS DERMATOL, V9, P1242; Yie Kilsoo, 2019, Vasc Specialist Int, V35, P251, DOI 10.5758/vsi.2019.35.4.251; Zhang XC, 2016, INDIAN J PHARMACOL, V48, P321, DOI 10.4103/0253-7613.182889	126	2	2	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					56	70		10.1177/1358863X20983455			15	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000616964800010	33566754	Bronze			2022-04-28	
J	Krishan, S; Akhtar, K; Palacios, FS				Krishan, Satyam; Akhtar, Khawaja; Palacios, Federico Silva			The x factor-using chromogenic factor x to monitor oral anticoagulation therapy in patients with thrombotic anti-phospholipid syndrome	VASCULAR MEDICINE			English	Meeting Abstract									[Krishan, Satyam; Akhtar, Khawaja; Palacios, Federico Silva] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1436	NP36	NP37					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100080					2022-04-28	
J	Pasha, AK; Ullah, W; Thalambedu, N; Siddiqui, M; Houghton, D; Wysokinski, W; McBane, R				Pasha, Ahmed K.; Ullah, Waqas; Thalambedu, Nishanth; Siddiqui, Muhammad; Houghton, Damon; Wysokinski, Waldemar; McBane, Robert			Embolic propensity and in-hospital mortality following venous thrombosis among major cancer types	VASCULAR MEDICINE			English	Meeting Abstract									[Pasha, Ahmed K.; Houghton, Damon; Wysokinski, Waldemar; McBane, Robert] Mayo Clin, Rochester, MN USA; [Ullah, Waqas; Thalambedu, Nishanth] Abington Jefferson Hlth, Philadelphia, PA USA; [Siddiqui, Muhammad] Thomas Jefferson Hosp, Philadelphia, PA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1387	NP17	NP18					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100043					2022-04-28	
J	Benedetto, F; Spinelli, D; Pipito, N; Barilla, D; Stilo, F; De Caridi, G; Barilla, C; Spinelli, F				Benedetto, Filippo; Spinelli, Domenico; Pipito, Narayana; Barilla, David; Stilo, Francesco; De Caridi, Giovanni; Barilla, Chiara; Spinelli, Francesco			Inframalleolar bypass for chronic limb-threatening ischemia	VASCULAR MEDICINE			English	Article						below-the-ankle bypass; chronic limb-threatening ischemia (CLTI); infrainguinal bypass; inframalleolar bypass; lower limb revascularization; pedal artery		The aims of this study were to analyze the results of inframalleolar bypass for chronic limb-threatening ischemia (CLTI) and to identify outcome-predicting factors. All consecutive patients undergoing inframalleolar bypass for CLTI between 2015 and 2018 were included in this retrospective, single-center study. Outflow artery was the most proximal patent vessel segment in continuity with inframalleolar arteries. Bypasses originating from the popliteal artery were defined as 'short bypasses'. Sixty patients underwent inframalleolar bypass, with four patients undergoing bilateral procedures, making a total of 64 limbs included. The mean age was 73 +/- 14 and 52 (81%) were male. The great saphenous vein was the preferred conduit (n = 58, 91%), in a devalvulated fashion (n = 56, 88%). Superficial femoral artery was the most common inflow artery for 'long' grafts (n = 22, 34%), while popliteal artery was the inflow artery for all 'short' grafts (n = 25, 39%). Dorsalis pedis artery was chosen as an outflow artery in 41 patients (63%). Median follow-up was 21 months. Two-year primary and secondary patency, limb salvage, amputation-free survival, and overall survival rates were 67 +/- 6%, 88 +/- 4%, 84 +/- 4%, 72 +/- 6%, and 85 +/- 4%, respectively. At multivariate analysis, dialysis was an independent predictor for poor primary patency (HR, 4.6; 95% CI, 1.62-13.05; p = 0.004), whereas a short bypass was independently associated with an increased primary patency (HR, 0.3; 95% CI, 0.10-0.89; p = 0.03). In conclusion, bypass grafting to the inframalleolar arteries resulted in good patency rates, limb salvage and overall survival. Dialysis patients had lower primary patency but still had good limb salvage and survival. Short bypass was a predictor of improved primary patency.	[Benedetto, Filippo; Spinelli, Domenico; Pipito, Narayana; Barilla, David; De Caridi, Giovanni; Barilla, Chiara] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Unit Vasc Surg, Policlin G Martino, Messina, Italy; [Stilo, Francesco; Spinelli, Francesco] Campus Biomed Rome Univ, Vasc Surg Unit, Rome, Italy		Spinelli, D (通讯作者)，Policlin G Martino, Unit Vasc Surg, Dept Biomed & Dent Sci & Morphofunct Imaging, Via Consolare Valeria 1, I-98125 Messina, Italy.	dr.spinelli@me.com		Spinelli, Domenico/0000-0002-5002-0435; BARILLA', David/0000-0002-4675-7901; Stilo, Francesco/0000-0001-8259-8090			Albers M, 2005, J VASC SURG, V42, P449, DOI 10.1016/j.jvs.2005.05.031; ASCER E, 1988, J VASC SURG, V8, P434, DOI 10.1067/mva.1988.avs0080434; Barilla D, 2020, ANN VASC SURG, V63, P443, DOI 10.1016/j.avsg.2019.10.032; Benedetto F, 2020, ANN VASC SURG, V68, P426, DOI 10.1016/j.avsg.2020.04.056; Berceli SA, 1999, J VASC SURG, V30, P499, DOI 10.1016/S0741-5214(99)70077-7; Neto FCB, 2010, EUR J VASC ENDOVASC, V40, P747, DOI 10.1016/j.ejvs.2010.08.008; Calligaro KD, 1997, J VASC SURG, V26, P919, DOI 10.1016/S0741-5214(97)70003-X; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279; Flu HC, 2010, J VASC SURG, V51, P360, DOI 10.1016/j.jvs.2009.08.051; Furuyama T, 2019, VASCULAR, V27, P38, DOI 10.1177/1708538118798886; Fusaro Massimiliano, 2007, J Invasive Cardiol, V19, pE34; Hossain S, 2019, EUR J VASC ENDOVASC, V57, P382, DOI 10.1016/j.ejvs.2018.09.025; Huizing E, 2019, J VASC INTERV RADIOL, V30, P1361, DOI 10.1016/j.jvir.2019.05.001; Jaff MR, 2015, CATHETER CARDIO INTE, V86, P611, DOI 10.1002/ccd.26122; JOHNSON BL, 1995, J VASC SURG, V22, P280, DOI 10.1016/S0741-5214(95)70142-7; Kalra M, 2001, J VASC SURG, V33, P6, DOI 10.1067/mva.2001.112300; Leers SA, 1998, J VASC SURG, V28, P976, DOI 10.1016/S0741-5214(98)70023-0; Manzi M, 2009, J CARDIOVASC SURG, V50, P331; Manzi M, 2014, SEMIN INTERVENT RAD, V31, P313, DOI 10.1055/s-0034-1393967; Mazzariol F, 2000, EUR J VASC ENDOVASC, V19, P509, DOI 10.1053/ejvs.1999.1019; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Mohapatra A, 2018, J VASC SURG, V68, P168, DOI 10.1016/j.jvs.2017.10.076; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Panayiotopoulos YP, 1997, EUR J VASC ENDOVASC, V13, P477, DOI 10.1016/S1078-5884(97)80176-1; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Saarinen E, 2016, EUR J VASC ENDOVASC, V52, P815, DOI 10.1016/j.ejvs.2016.08.051; SHAH DM, 1995, ANN SURG, V222, P438; Spinelli F, 2011, INT ANGIOL, V30, P156; Spinelli F, 2015, ANN VASC SURG, V29, P272, DOI 10.1016/j.avsg.2014.09.032; Spinelli F, 2008, J VASC SURG, V48, P1641, DOI 10.1016/j.jvs.2008.07.086; Van Damme H, 2003, EUR J VASC ENDOVASC, V26, P635, DOI 10.1016/S1078-5884(03)00345-9	32	1	2	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		187	194	1358863X20978468	10.1177/1358863X20978468		JAN 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000618404400001	33407009				2022-04-28	
J	Kolluri, R				Kolluri, Raghu			Presidential Address: Action is better than inaction	VASCULAR MEDICINE			English	Editorial Material									[Kolluri, Raghu] OhioHlth Heart & Vasc, Vasc Med & Vasc Labs, 3705 Olentangy River Rd, Columbus, OH 43214 USA		Kolluri, R (通讯作者)，OhioHlth Heart & Vasc, Vasc Med & Vasc Labs, 3705 Olentangy River Rd, Columbus, OH 43214 USA.	Kolluri.raghu@gmail.com		Kolluri, Raghu/0000-0002-4374-7513				0	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					678	679	1358863X211051778	10.1177/1358863X211051778		OCT 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000710440000001	34665972				2022-04-28	
J	Narayanan, MA; Sheikh, A; Llanos, F; Mena, C				Narayanan, Mahesh Anantha; Sheikh, Azfar; Llanos, Fiorella; Mena, Carlos			Palliative subclavian stenting in a patient with a highly vascular metastatic histiocytic sarcoma with arterial invasion	VASCULAR MEDICINE			English	Meeting Abstract									[Narayanan, Mahesh Anantha] Univ Arizona, Banner Hlth, Phoenix, AZ USA; [Sheikh, Azfar] Univ Texas Houston, Houston, TX USA; [Llanos, Fiorella; Mena, Carlos] Yale Univ, New Haven, CT USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1328	NP29	NP29					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100065					2022-04-28	
J	Fassora, M; Calanca, L; Jaques, C; Mazzolai, L; Kayser, B; Lanzi, S				Fassora, Mattia; Calanca, Luca; Jaques, Cecile; Mazzolai, Lucia; Kayser, Bengt; Lanzi, Stefano			Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: A systematic review and meta-analysis	VASCULAR MEDICINE			English	Review						exercise therapy; high-intensity interval training; intermittent claudication; vascular rehabilitation; peripheral artery disease (PAD)	QUALITY-OF-LIFE; HEART-RATE; INTERMITTENT CLAUDICATION; CARDIOVASCULAR FUNCTION; POSITION STATEMENT; 6-MINUTE WALK; TREADMILL; REHABILITATION; MANAGEMENT; PRESCRIPTION	We investigated how nonpain-based exercise therapy intensity (light-to-moderate or vigorous) affects improvements in walking performance and cardiorespiratory fitness of patients with symptomatic lower-extremity peripheral artery disease (PAD). We searched the Embase, MEDLINE, Cochrane, Web of Science, and Google Scholar databases up to April 2021 and included randomized controlled trials reporting training therapies targeting exercise intensity (heart rate, oxygen consumption, or perceived exertion). The main outcomes were walking performance (pain-free [PFWD] and maximal [MWD] walking distance) and cardiorespiratory fitness (V?O-2peak). Secondary subanalyses examined the training modality (walking or other modalities) and the approach (high-intensity interval or moderate-intensity training). A total of 1132 patients were included. Light-to-moderate was superior to vigorous exercise intensity in improving MWD (223 m [95% CI 174 to 271], p < 0.00001; 153 m [95% CI 113 to 193], p < 0.00001; respectively) and PFWD (130 m [95% CI 87 to 173], p < 0.00001; 83 m [95% CI 61 to 104], p < 0.00001; respectively). When training modalities were considered, walking at a vigorous intensity (272 m [95% CI 207 to 337], p < 0.00001) showed the largest improvement in MWD compared to other exercise modalities. A larger increase in V?O-2peak was observed following vigorous (3.0 mL O-2 center dot kg(-1)center dot min(-1) [95% CI 2.4 to 3.6], p < 0.00001) compared to light-to-moderate (1.1 mL O-2 center dot kg(-1)center dot min(-1) [95% CI 0.4 to 1.7], p = 0.001) exercise intensity. These results indicate that vigorous was less effective than light-to-moderate intensity in improving walking performance, whereas it was more effective in improving V?O-2peak. When the training modalities were considered, walking at a vigorous intensity showed the greatest improvement in MWD. (PROSPERO Registration No.: CRD42020199469)	[Fassora, Mattia; Kayser, Bengt] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland; [Calanca, Luca; Mazzolai, Lucia; Lanzi, Stefano] Lausanne Univ Hosp, Div Angiol, Heart & Vessel Dept, Ch Mont Paisible 18, CH-1011 Lausanne, Switzerland; [Jaques, Cecile] Lausanne Univ Hosp, Med Lib, Lausanne, Switzerland; [Jaques, Cecile] Univ Lausanne, Lausanne, Switzerland		Lanzi, S (通讯作者)，Lausanne Univ Hosp, Div Angiol, Heart & Vessel Dept, Ch Mont Paisible 18, CH-1011 Lausanne, Switzerland.	stefano.lanzi@chuv.ch		Lanzi, Stefano/0000-0003-1089-6309; Jaques, Cecile/0000-0002-5571-5762			Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Ahmed HS, 2019, BIOSCI RES, V16, P629; Au TB, 2013, AUST FAM PHYSICIAN, V42, P397; Bartelink ML, 2004, BRIT J GEN PRACT, V54, P196; Brenner IKM, 2020, BIOL RES NURS, V22, P24, DOI 10.1177/1099800419884642; Bronas UG, 2011, J VASC SURG, V53, P1557, DOI 10.1016/j.jvs.2011.01.077; Camara LC, 2012, ANN VASC SURG, V26, P1114, DOI 10.1016/j.avsg.2012.03.012; Centers for Disease Control and Prevention Division of Nutrition Physical Activity and Obesity, 2020, PERC EX BORG RAT PER; Chehuen M, 2017, J SCI MED SPORT, V20, P886, DOI 10.1016/j.jsams.2017.02.011; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Collins EG, 2003, MED SCI SPORT EXER, V35, P384, DOI 10.1249/01.MSS.0000053658.82687.FF; Collins Eileen G, 2005, J Cardiovasc Nurs, V20, P177; Costa EC, 2018, SPORTS MED, V48, P2127, DOI 10.1007/s40279-018-0944-y; Coyne KS, 2003, J VASC SURG, V38, P296, DOI 10.1016/S0741-5214(03)00312-4; Cucato GG, 2013, CLINICS, V68, P974, DOI 10.6061/clinics/2013(07)14; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Drahota A., 2020, COCHRANE TRAINING; Fakhry F, 2012, J VASC SURG, V56, P1132, DOI 10.1016/j.jvs.2012.04.046; Frank U, 2019, VASA, V48, P7, DOI 10.1024/0301-1526/a000834; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gardner AW, 2012, J VASC SURG, V55, P1346, DOI 10.1016/j.jvs.2011.11.123; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; Gardner AW, 2008, J CARDIOPULM REHABIL, V28, P349, DOI 10.1097/HCR.0b013e31818c3b96; Gardner AW, 2005, J VASC SURG, V42, P702, DOI 10.1016/j.jvs.2005.05.049; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; Giallauria Francesco, 2016, Monaldi Arch Chest Dis, V86, P754, DOI 10.4081/monaldi.2016.754; Gommans LNM, 2017, J VASC SURG, V66, P515, DOI 10.1016/j.jvs.2017.02.033; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hannan AL, 2018, OPEN ACCESS J SPORTS, V9, P1, DOI 10.2147/OAJSM.S150596; Hansen D, 2019, EUR J PREV CARDIOL, V26, P1921, DOI 10.1177/2047487319859450; Harwood AE, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000897; Hiatt WR, 2014, CIRCULATION, V130, P69, DOI 10.1161/CIRCULATIONAHA.113.007003; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jansen SCP, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd009638.pub3, 10.1002/14651858.CD009638.pub3]; Karlsen T, 2017, PROG CARDIOVASC DIS, V60, P67, DOI 10.1016/j.pcad.2017.03.006; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Koutakis P, 2010, J VASC SURG, V52, P340, DOI 10.1016/j.jvs.2010.03.005; Kullo IJ, 2016, NEW ENGL J MED, V374, P861, DOI 10.1056/NEJMcp1507631; Lane Risha, 2017, Cochrane Database Syst Rev, V12, pCD000990, DOI 10.1002/14651858.CD000990.pub4; Lanzi S, 2021, VASC MED, V26, P259, DOI 10.1177/1358863X20984831; Leeper NJ, 2013, J VASC SURG, V57, P728, DOI 10.1016/j.jvs.2012.07.051; Liles DR, 2006, J SURG RES, V136, P294, DOI 10.1016/j.jss.2006.06.008; Lin E, 2019, EUR J PREV CARDIOL, V26, P1625, DOI 10.1177/2047487319846997; Lyu XF, 2016, J DIABETES, V8, P363, DOI 10.1111/1753-0407.12304; McDermott MM, 2021, JAMA-J AM MED ASSOC, V325, P1266, DOI 10.1001/jama.2021.2536; McDermott MM, 2014, CIRCULATION, V130, P61, DOI 10.1161/CIRCULATIONAHA.114.007002; McDermott MM, 2011, J AM COLL CARDIOL, V57, P2356, DOI 10.1016/j.jacc.2010.12.038; McDermott MM, 2010, J AM GERIATR SOC, V58, P1256, DOI 10.1111/j.1532-5415.2010.02941.x; McDermott MM, 2000, ANGIOLOGY, V51, P91, DOI 10.1177/000331970005100201; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mezzani A, 2013, EUR J PREV CARDIOL, V20, P442, DOI 10.1177/2047487312460484; Myers SA, 2015, REHABIL RES PRACT, V2015, DOI 10.1155/2015/124023; Nes BM, 2013, SCAND J MED SCI SPOR, V23, P697, DOI 10.1111/j.1600-0838.2012.01445.x; NICE, 2012, PER ART DIS DIAGN MA, V147; Nicolai SPA, 2010, J VASC SURG, V52, P348, DOI 10.1016/j.jvs.2010.02.022; Nicolai SPA, 2009, J VASC SURG, V50, P322, DOI 10.1016/j.jvs.2009.01.042; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Novakovic M, 2019, J VASC SURG, V70, P148, DOI 10.1016/j.jvs.2018.10.109; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Page MJ, 2021, PLOS MED, V18, DOI [10.1371/journal.pmed.1003583, 10.1016/j.ijsu.2021.105906]; Park SY, 2019, J APPL PHYSIOL, V127, P940, DOI 10.1152/japplphysiol.00209.2019; Parmenter BJ, 2020, BRIT J SPORT MED, V54, P452, DOI 10.1136/bjsports-2018-100205; Parmenter BJ, 2015, VASC MED, V20, P30, DOI 10.1177/1358863X14559092; Parmenter BJ, 2015, SPORTS MED, V45, P231, DOI 10.1007/s40279-014-0261-z; Parmenter BJ, 2011, ATHEROSCLEROSIS, V218, P1, DOI 10.1016/j.atherosclerosis.2011.04.024; Pipinos Iraklis I, 2007, Vasc Endovascular Surg, V41, P481, DOI 10.1177/1538574407311106; Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995; Pymer S, 2021, J CARDIOPULM REHABIL, V41, P188, DOI 10.1097/HCR.0000000000000551; Pymer Sean, 2020, BMJ Open, V10, pe038825, DOI 10.1136/bmjopen-2020-038825; Pymer S, 2019, J VASC SURG, V70, P2076, DOI 10.1016/j.jvs.2019.03.050; Regensteiner JG, 2008, VASC MED, V13, P15, DOI 10.1177/1358863X07084911; Sandercock GRH, 2007, J SPORT SCI MED, V6, P471; Sanderson B, 2006, J VASC SURG, V44, P119, DOI 10.1016/j.jvs.2006.03.037; Schieber MN, 2017, J VASC SURG, V66, P178, DOI 10.1016/j.jvs.2017.01.051; Slordahl SA, 2005, SCAND CARDIOVASC J, V39, P244, DOI 10.1080/14017430510035844; Tew G, 2009, CLIN SCI, V117, P405, DOI 10.1042/CS20080688; Treat-Jacobson D, 2019, CIRCULATION, V140, pE700, DOI 10.1161/CIR.0000000000000727; Treat-Jacobson D, 2019, CIRCULATION, V139, pE10, DOI 10.1161/CIR.0000000000000623; Treat-Jacobson D, 2009, VASC MED, V14, P203, DOI 10.1177/1358863X08101858; Viana AA, 2019, APPL PHYSIOL NUTR ME, V44, P348, DOI 10.1139/apnm-2018-0371; Walker RD, 2000, J VASC SURG, V31, P662, DOI 10.1067/mva.2000.104104; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wang E, 2008, EUR J APPL PHYSIOL, V104, P749, DOI 10.1007/s00421-008-0826-3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Wewege MA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009305; Wood RE, 2006, CLIN SCI, V111, P401, DOI 10.1042/CS20060151; Zwierska I, 2005, J VASC SURG, V42, P1122, DOI 10.1016/j.jvs.2005.08.021	90	0	0	3	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2022	27	2			SI		158	170	1358863X211034577	10.1177/1358863X211034577		SEP 2021	13	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	0I8MI	WOS:000704017700001	34579581	Green Published, hybrid			2022-04-28	
J	Gabrielli, D; Pagano, P; Boni, MV; Marinucci, C; Rossi, B; Santi, I; D'Emidio, F				Gabrielli, Daniela; Pagano, Paolo; Boni, Maria Virginia; Marinucci, Carlo; Rossi, Brunella; Santi, Ivan; D'Emidio, Fabio			Images in Vascular Medicine: Rare vascular infection in spondylodiscitis	VASCULAR MEDICINE			English	Editorial Material									[Gabrielli, Daniela; Pagano, Paolo; D'Emidio, Fabio] AV5 ASUR Marche, C&G Mazzoni Hosp, Unit Intervent Radiol, Via Iris, I-63100 Ascoli Piceno, Italy; [Boni, Maria Virginia] AV5 ASUR Marche, C&G Mazzoni Hosp, Vasc Med Unit, Ascoli Piceno, Italy; [Marinucci, Carlo] AV5 ASUR Marche, C&G Mazzoni Hosp, Radiol Unit, Ascoli Piceno, Italy; [Rossi, Brunella; Santi, Ivan] AV5 ASUR Marche, C&G Mazzoni Hosp, Nucl Med Unit, Ascoli Piceno, Italy		Gabrielli, D (通讯作者)，AV5 ASUR Marche, C&G Mazzoni Hosp, Unit Intervent Radiol, Via Iris, I-63100 Ascoli Piceno, Italy.	daniela-gabrielli@virgilio.it					Bossone E, 2018, EUR HEART J, V39, P739, DOI 10.1093/eurheartj/ehx319; Cina CS, 2001, J VASC SURG, V33, P861, DOI 10.1067/mva.2001.111977; Posacioglu H, 2009, TEX HEART I J, V36, P65	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					348	349	1358863X20988349	10.1177/1358863X20988349		FEB 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000621153600001	33600295	Bronze			2022-04-28	
J	Skeik, N; Nowariak, ME; Smith, JE; Alexander, JQ; Manunga, JM; Mirza, AK; Sullivan, TM				Skeik, Nedaa; Nowariak, Meagan E.; Smith, Jenna E.; Alexander, Jason Q.; Manunga, Jesse M.; Mirza, Aleem K.; Sullivan, Timothy M.			Lipid-lowering therapies in peripheral artery disease: A review	VASCULAR MEDICINE			English	Review						lipid-lowering; PCSK9; peripheral artery disease (PAD); statin; statin therapy	STATIN THERAPY; INTERMITTENT CLAUDICATION; CARDIOVASCULAR EVENTS; INFRAINGUINAL BYPASS; OUTCOMES; RISK; ATORVASTATIN; SYMPTOMS; SIMVASTATIN; MEDICATIONS	Peripheral artery disease (PAD) is estimated to affect approximately 8.5 million individuals in the US above the age of 40, and is associated with significant morbidity, mortality, and impairment. Despite the significant adverse limb and cardiovascular (CV) outcomes seen in patients with PAD, there is typically less attention paid to risk factor modification relative to other atherosclerotic diseases such as coronary artery disease (CAD) or stroke. In the current literature, statins have been shown to reduce mortality, major adverse CV events, major adverse limb events, and improve symptomatic outcomes in patients with PAD. In addition, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are emerging as an additional lipid-lowering therapy for patients with PAD. However, despite current guideline recommendations based on growing evidence, PAD patients are consistently undertreated with lipid-lowering therapies. We provide an extensive literature review and evidence-based recommendations for the use of statins and PCSK9 inhibitors in patients with PAD.	[Skeik, Nedaa; Nowariak, Meagan E.; Smith, Jenna E.; Alexander, Jason Q.; Manunga, Jesse M.; Mirza, Aleem K.; Sullivan, Timothy M.] Minneapolis Heart Inst & Fdn, 920 E 28th St,Suite 300, Minneapolis, MN 55407 USA		Skeik, N (通讯作者)，Minneapolis Heart Inst & Fdn, 920 E 28th St,Suite 300, Minneapolis, MN 55407 USA.	Nedaa.Skeik@allina.com		Skeik, Nedaa/0000-0003-2284-1938; Nowariak, Meagan/0000-0002-9406-1642	Minneapolis Heart Institute Foundation	The authors would like to thank the Minneapolis Heart Institute Foundation for their support.	Abbruzzese TA, 2004, J VASC SURG, V39, P1178, DOI 10.1016/j.jvs.2003.12.027; Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Aiello FA, 2012, J VASC SURG, V55, P371, DOI 10.1016/j.jvs.2011.08.044; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Arao K, 2017, HEART VESSELS, V32, P1186, DOI 10.1007/s00380-017-0988-1; Armstrong EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000697; Aronow WS, 2002, AM J CARDIOL, V90, P789, DOI 10.1016/S0002-9149(02)02616-4; Aronow WS, 2003, AM J CARDIOL, V92, P711, DOI 10.1016/S0002-9149(03)00833-6; Arya S, 2018, CIRCULATION, V137, P1435, DOI 10.1161/CIRCULATIONAHA.117.032361; Baril DT, 2013, J VASC SURG, V58, P949, DOI 10.1016/j.jvs.2013.04.036; Berger JS, 2017, J AM COLL CARDIOL, V69, P2293, DOI 10.1016/j.jacc.2017.02.064; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bonaca MP, 2018, LANCET DIABETES ENDO, V6, P934, DOI 10.1016/S2213-8587(18)30290-0; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Brunner G, 2013, ATHEROSCLEROSIS, V231, P371, DOI 10.1016/j.atherosclerosis.2013.09.034; Caro Jaime, 2005, BMC Cardiovasc Disord, V5, P14, DOI 10.1186/1471-2261-5-14; Criqui MH, 2001, VASC MED, V6, P3, DOI 10.1177/1358836X0100600i102; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Dopheide JF, 2018, J CLIN LIPIDOL, V12, P711, DOI 10.1016/j.jacl.2018.02.013; Dougherty M, 2007, J VASC SURG, V45, P653; Feringa HHH, 2007, J VASC SURG, V45, P936, DOI 10.1016/j.jvs.2007.01.024; Feringa HHH, 2006, J AM COLL CARDIOL, V47, P1182, DOI 10.1016/j.jacc.2005.09.074; Foley TR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005699; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Giri J, 2006, J AM COLL CARDIOL, V47, P998, DOI 10.1016/j.jacc.2005.10.052; Henke PK, 2004, J VASC SURG, V39, P357, DOI 10.1016/j.jvs.2003.08.030; Hiatt WR, 2010, VASC MED, V15, P171, DOI 10.1177/1358863X09360579; Hsu CY, 2017, J CLIN ENDOCR METAB, V102, P2373, DOI 10.1210/jc.2016-3717; Kumbhani DJ, 2014, EUR HEART J, V35, P2864, DOI 10.1093/eurheartj/ehu080; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1093/eurheartj/ehz455, 10.1016/j.atherosclerosis.2019.08.014]; McDermott MM, 2003, CIRCULATION, V107, P757, DOI 10.1161/01.CIR.0000050380.64025.07; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; Mondillo S, 2003, AM J MED, V114, P359, DOI 10.1016/S0002-9343(03)00010-X; Murphy SA, 2016, J AM COLL CARDIOL, V67, P353, DOI 10.1016/j.jacc.2015.10.077; Nastasi DR, 2018, STROKE, V49, P2953, DOI 10.1161/STROKEAHA.118.022922; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Parmar GM, 2019, J VASC SURG, V70, P539, DOI 10.1016/j.jvs.2018.07.089; PEDERSEN TR, 1994, LANCET, V344, P1383; Ramos R, 2016, J AM COLL CARDIOL, V67, P630, DOI 10.1016/j.jacc.2015.11.052; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; Reynolds K, 2020, VASC MED, V25, P3, DOI 10.1177/1358863X19871100; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schillinger M, 2004, EUR HEART J, V25, P742, DOI 10.1016/j.ehj.2004.02.012; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Schwartz GG, 2020, CIRCULATION, V141, P1608, DOI 10.1161/CIRCULATIONAHA.120.046524; Shapiro MD, 2018, CIRC RES, V122, P1420, DOI 10.1161/CIRCRESAHA.118.311227; Sigvant B, 2016, J VASC SURG, V64, P1009, DOI 10.1016/j.jvs.2016.03.429; Siracuse JJ, 2012, J VASC SURG, V55, P1001, DOI 10.1016/j.jvs.2011.10.128; Spring S, 2008, THROMB HAEMOSTASIS, V99, P182, DOI 10.1160/TH07-04-0265; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stossel TP, 2008, CELL, V134, P903, DOI 10.1016/j.cell.2008.09.008; Thiney M, 2018, ANN VASC SURG, V52, P138, DOI 10.1016/j.avsg.2018.03.021; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Westin GG, 2014, J AM COLL CARDIOL, V63, P682, DOI 10.1016/j.jacc.2013.09.073; Zhang KW, 2017, PAK J PHARM SCI, V30, P325	55	1	1	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					71	80	1358863X20957091	10.1177/1358863X20957091		OCT 2020	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000582540200001	33074778				2022-04-28	
J	Aronow, HD				Aronow, Herbert D.		Sci Sessions Program Comm	SVM Communications: Highlights from the 32nd SVM Scientific Sessions	VASCULAR MEDICINE			English	Editorial Material									[Aronow, Herbert D.] Lifespan Cardiovasc Inst, 593 Eddy St,RIH APC 730, Providence, RI 02903 USA		Aronow, HD (通讯作者)，Lifespan Cardiovasc Inst, 593 Eddy St,RIH APC 730, Providence, RI 02903 USA.	herbert.aronow@lifespan.org		Aronow, Herbert/0000-0002-9061-7893			Creager MA, 2021, VASC MED, V26, P469, DOI 10.1177/1358863X211012052; Kolluri R, 2021, VASC MED, V26, P678, DOI 10.1177/1358863X211051778	2	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					680	682	1358863X211054878	10.1177/1358863X211054878		NOV 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000716519400001	34747278	Bronze			2022-04-28	
J	Ng, JP; Bernardo, JM				Ng, Jan Patrick; Bernardo, Jasmin Melissa			Knowledge, attitude, and practices of physicians on anticoagulation among patients admitted with COVID-19 in the Philippines	VASCULAR MEDICINE			English	Meeting Abstract									[Ng, Jan Patrick; Bernardo, Jasmin Melissa] Makati Med Ctr, Makati, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1322	NP10	NP11					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100032					2022-04-28	
J	Report, C				Report, Case			Roadcut complete internal carotid artery occlusion presenting as stroke in the young: a case report	VASCULAR MEDICINE			English	Meeting Abstract									[Report, Case] Manila Doctors Hosp, Manila, Philippines				Hosseinzadeh, Dariush/AAE-8533-2022					0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1224	NP23	NP23					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100054					2022-04-28	
J	Horiuchi, M; Stoner, L				Horiuchi, Masahiro; Stoner, Lee			Effects of compression stockings on lower-limb venous and arterial system responses to prolonged sitting: A randomized cross-over trial	VASCULAR MEDICINE			English	Article						blood pooling; blood volume; compression therapy; heart rate; stroke volume; venous return	NEAR-INFRARED SPECTROSCOPY; FLOW-MEDIATED DILATION; NONINVASIVE ASSESSMENT; EXERCISE; TIME; OXYGENATION; THROMBOSIS; OUTPUT; RISK; DEEP	Exposure to prolonged sitting increases blood pooling and the risk of lower-extremity vascular arterial and venous complications, including deep vein thrombosis. Compression garment stockings (CGS) may prevent pooling, thereby mitigating the associated vascular complications. Three aims were addressed: (i) does use of CGS help to prevent blood pooling; (ii) does blood pooling correlate with decreased stroke volume; and (iii) does use of CGS preserve leg arterial flow-mediated dilation and reactive hyperemia response. Twenty inactive participants (22 +/- 4 years, 30% female, 22.1 +/- 2.0 kg/m(2)) were randomized to sit for 3 hours with (CGS) and without use of CGS. Blood pooling was determined using medial gastrocnemius total hemoglobin. Stroke volume was estimated using finger photoplethysmography, respectively. Macrovascular and microvascular function were measured using popliteal artery flow-mediated dilation and reactive hyperemia, respectively. In response to 3 hours of sitting: (i) there was an interaction effect for total hemoglobin (p < 0.001); the condition without use of CGS increased 10.5% (95% CI: 6.7 to 14.3) and CGS increased 4.3% (95% CI: 0.1 to 7.7); (ii) blood pooling was negatively associated with stroke volume (r = -0.58, 95% CI: -0.68 to -0.45); (iii) reactive hyperemia and flow-mediated arterial dilation was impaired after prolonged sitting, and use of CGS was not associated with attenuation of this impairment. Use of CGS decreases blood pooling but does not preserve arterial macrovascular and microvascular responses to prolonged sitting. Further study is warranted to determine whether CGS has additive benefits when combined with sitting interruption strategies.	[Horiuchi, Masahiro] Mt Fuji Res Inst, Div Human Environm Sci, Kami Yohida 5597-1, Fuji Yoshida City, Yamanashi 4030005, Japan; [Stoner, Lee] Univ N Carolina, Dept Exercise & Sports Sci, Chapel Hill, NC 27515 USA		Horiuchi, M (通讯作者)，Mt Fuji Res Inst, Div Human Environm Sci, Kami Yohida 5597-1, Fuji Yoshida City, Yamanashi 4030005, Japan.	mhoriuchi@mfri.pref.yamanashi.jp	Stoner, Lee/C-8504-2011	Stoner, Lee/0000-0002-0682-2270	Japan Society for the Promotion of Science (JSPS; KAKENHI)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP18K11012]	This work was supported in part by Japan Society for the Promotion of Science (JSPS; KAKENHI, Grant No. JP18K11012 to MH).	Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; Atkinson G, 2013, J HYPERTENS, V31, P287, DOI 10.1097/HJH.0b013e32835b8164; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bell EJ, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.014; Bringard A, 2006, J SPORT MED PHYS FIT, V46, P548; Cirovic S, 2006, AVIAT SPACE ENVIR MD, V77, P1009; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, pXXI; Credeur DP, 2019, AM J CARDIOL, V123, P260, DOI 10.1016/j.amjcard.2018.10.014; Downie SP, 2008, AM J PHYSIOL-HEART C, V294, pH2112, DOI 10.1152/ajpheart.01302.2007; Engbers MJ, 2017, J AM GERIATR SOC, V65, P2003, DOI 10.1111/jgs.14964; Evans WS, 2019, J APPL PHYSIOL, V127, P781, DOI 10.1152/japplphysiol.00318.2019; Grassi B, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091313; Healy B, 2010, J ROY SOC MED, V103, P447, DOI 10.1258/jrsm.2010.100155; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Horiuchi M, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13475; Horiuchi M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12304; Horiuchi M, 2014, EXP PHYSIOL, V99, P348, DOI 10.1113/expphysiol.2013.075846; Jones S, 2016, ARTERY RES, V16, P25, DOI 10.1016/j.artres.2016.09.001; Kenward MG, 2010, BIOSTATISTICS, V11, P1, DOI 10.1093/biostatistics/kxp046; MANGANO DT, 1980, CIRCULATION, V62, P535, DOI 10.1161/01.CIR.62.3.535; Merli GJ, 2006, CLIN GERIATR MED, V22, P75, DOI 10.1016/j.cger.2005.09.012; Ogoh S, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13046; Padilla J, 2017, AM J PHYSIOL-HEART C, V313, pH722, DOI 10.1152/ajpheart.00326.2017; Paterson C, 2020, SPORTS MED, V50, P1929, DOI 10.1007/s40279-020-01325-5; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Restaino RM, 2016, AM J PHYSIOL-HEART C, V310, pH648, DOI 10.1152/ajpheart.00943.2015; Restaino RM, 2015, EXP PHYSIOL, V100, P829, DOI 10.1113/EP085238; Scheres LJJ, 2017, J THROMB HAEMOST, V15, P1344, DOI 10.1111/jth.13712; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Stone KJ, 2016, ATHEROSCLEROSIS, V251, P234, DOI 10.1016/j.atherosclerosis.2016.06.030; Stoner L, 2013, J HYPERTENS, V31, P1057, DOI 10.1097/HJH.0b013e32836030dd; Stoner L, 2013, CLIN PHYSIOL FUNCT I, V33, P75, DOI 10.1111/j.1475-097X.2012.01154.x; Stoner L, 2012, J ATHEROSCLER THROMB, V19, P407; Sugawara J, 2003, ACTA PHYSIOL SCAND, V179, P361, DOI 10.1046/j.0001-6772.2003.01211.x; Thosar SS, 2015, MED SCI SPORT EXER, V47, P843, DOI 10.1249/MSS.0000000000000479; Vranish JR, 2017, AM J PHYSIOL-HEART C, V312, pH800, DOI 10.1152/ajpheart.00823.2016; Walsh LK, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13478; Watanuki Shigeki, 1994, Annals of Physiological Anthropology, V13, P121; Yang L, 2019, JAMA-J AM MED ASSOC, V321, P1587, DOI 10.1001/jama.2019.3636	39	5	5	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					386	393	1358863X20988899	10.1177/1358863X20988899		FEB 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000620751000001	33606965				2022-04-28	
J	Bishop, GJ; Lyden, SP; Ratchford, EV				Bishop, G. Jay; Lyden, Sean P.; Ratchford, Elizabeth, V			Vascular Disease Patient Information Page: Mesenteric artery stenosis	VASCULAR MEDICINE			English	Editorial Material						acute mesenteric ischemia; chronic mesenteric ischemia; mesenteric artery stenosis			[Bishop, G. Jay] Cleveland Clin, Sect Vasc Med, Cleveland, OH 44106 USA; [Lyden, Sean P.] Cleveland Clin, Dept Vasc Surg, Cleveland, OH 44106 USA; [Ratchford, Elizabeth, V] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21287 USA		Ratchford, EV (通讯作者)，Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21287 USA.	evr@jhmi.edu	Ratchford, Elizabeth/AAO-2722-2021	Ratchford, Elizabeth/0000-0002-2244-5604			Clair DG, 2016, NEW ENGL J MED, V374, P959, DOI 10.1056/NEJMra1503884; Hansen KJ, 2004, J VASC SURG, V40, P45, DOI 10.1016/j.jvs.2004.03.022; Ratchford EV, 2017, VASC MED, V22, P442, DOI 10.1177/1358863X17722212; Ratchford EV, 2016, VASC MED, V21, P477, DOI 10.1177/1358863X16661767; Thomas JH, 1998, J VASC SURG, V27, P840, DOI 10.1016/S0741-5214(98)70263-0; van Dijk LJD, 2019, UNITED EUR GASTROENT, V7, P179, DOI 10.1177/2050640618817698; Zeller T, 2010, VASC MED, V15, P333, DOI 10.1177/1358863X10372437	7	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					113	116	1358863X20979734	10.1177/1358863X20979734		DEC 2020	4	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000618403100001	33357138	Bronze			2022-04-28	
J	Chou, TH; Tram, NK; Eisert, SN; Bobbey, AJ; Atway, SA; Go, MR; Stacy, MR				Chou, Ting-Heng; Tram, Nguyen K.; Eisert, Susan Natalie; Bobbey, Adam J.; Atway, Said A.; Go, Michael R.; Stacy, Mitchel R.			Images in Vascular Medicine: Dual assessment of abnormal microvascular foot perfusion and lower extremity calcium burden in a patient with critical limb ischemia using hybrid SPECT/CT imaging	VASCULAR MEDICINE			English	Article									[Chou, Ting-Heng; Tram, Nguyen K.; Eisert, Susan Natalie; Stacy, Mitchel R.] Nationwide Childrens Hosp, Ctr Regenerat Med, Res Inst, Columbus, OH USA; [Eisert, Susan Natalie; Go, Michael R.; Stacy, Mitchel R.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43215 USA; [Bobbey, Adam J.] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Atway, Said A.] Ohio State Univ, Coll Med, Dept Orthopaed, Columbus, OH 43215 USA		Stacy, MR (通讯作者)，Ohio State Univ, Coll Med, Div Vasc Dis & Surg, Ctr Regenerat Med,Res Inst,Nationwide Childrens H, 575 Childrens Crossrd,WB4131, Columbus, OH 43215 USA.	mitchel.stacy@nationwidechildrens.org	Stacy, Mitchel/AFV-9752-2022; Tram, Nguyen K/AFW-5418-2022	Stacy, Mitchel/0000-0002-8423-1011; Tram, Nguyen K/0000-0003-4374-1485; Chou, Ting-Heng/0000-0003-1835-4184	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL135103]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this work was supported by the National Institutes of Health [R01 HL135103].	Alvelo JL, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.006932; Chou TH, 2020, ADV WOUND CARE, V9, P103, DOI 10.1089/wound.2018.0924; Yoon HC, 1997, ACAD RADIOL, V4, P666, DOI 10.1016/S1076-6332(97)80137-7	3	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		225	227	1358863X20964563	10.1177/1358863X20964563		OCT 2020	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000609136500001	33126838	Green Accepted, Bronze			2022-04-28	
J	Kontopodis, N; Charalambous, S; Vourakis, G; Galanakis, N; Mitsias, P; Tsetis, D; Ioannou, CV				Kontopodis, Nikolaos; Charalambous, Stavros; Vourakis, George; Galanakis, Nikolaos; Mitsias, Panayiotis; Tsetis, Dimitrios; Ioannou, Christos, V			Images in Vascular Medicine: Bright light amaurosis - When external carotid artery stenosis matters	VASCULAR MEDICINE			English	Editorial Material									[Kontopodis, Nikolaos; Ioannou, Christos, V] Univ Hosp Heraklion, Vasc Surg Unit, Dept Cardiothorac & Vasc Surg, POB 1352, Iraklion 71110, Greece; [Charalambous, Stavros; Galanakis, Nikolaos; Tsetis, Dimitrios] Univ Hosp Heraklion, Intervent Radiol Unit, Dept Med Imaging, Iraklion, Greece; [Vourakis, George; Mitsias, Panayiotis] Univ Hosp Heraklion, Dept Neurol, Iraklion, Greece; [Mitsias, Panayiotis] Univ Crete, Sch Med, Iraklion, Greece; [Mitsias, Panayiotis] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Kontopodis, N (通讯作者)，Univ Hosp Heraklion, Vasc Surg Unit, Dept Cardiothorac & Vasc Surg, POB 1352, Iraklion 71110, Greece.	kontopodisn@yahoo.gr		Kontopodis, Nikolaos/0000-0002-6792-5003			FURLAN AJ, 1979, ARCH NEUROL-CHICAGO, V36, P675, DOI 10.1001/archneur.1979.00500470045007; HILGERTNER L, 1994, INT ANGIOL, V13, P5; Knoflach M, 2011, CEREBROVASC DIS, V32, P35, DOI 10.1159/000326076; Quintas-Neves M, 2020, J CLIN NEUROSCI, V78, P397, DOI 10.1016/j.jocn.2020.05.023	4	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2022	27	2			SI		203	204	1358863X211048542	10.1177/1358863X211048542		OCT 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	0I8MI	WOS:000711530500001	34693850				2022-04-28	
J	D'Oria, M; Wanhainen, A; Lindstrom, D; Tegler, G; Mani, K				D'Oria, Mario; Wanhainen, Anders; Lindstrom, David; Tegler, Gustaf; Mani, Kevin			Pre-operative chronic kidney disease is associated with worse short-term and midterm outcomes in patients undergoing fenestrated-branched endovascular repair for pararenal and thoracoabdominal aortic aneurysms	VASCULAR MEDICINE			English	Meeting Abstract									[D'Oria, Mario; Wanhainen, Anders; Lindstrom, David; Tegler, Gustaf; Mani, Kevin] Uppsala Univ, Uppsala, Sweden									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1336	NP12	NP12					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100035					2022-04-28	
J	Dong, ZL; Zhao, YF; Zhao, XY; Xu, X; Li, LM; Zhao, JF; Liu, LW; Chi, YW				Dong, Zilong; Zhao, Yongfeng; Zhao, Xiaoyu; Xu, Xiao; Li, Lamei; Zhao, Junfeng; Liu, Liwen; Chi, Yung-Wei			Hemodynamic changes according to the clinical stages of chronic venous disease	VASCULAR MEDICINE			English	Meeting Abstract									[Dong, Zilong; Zhao, Yongfeng; Zhao, Xiaoyu; Xu, Xiao; Li, Lamei; Zhao, Junfeng; Liu, Liwen] Xijing Hosp, Dept Ultrasound, Xian, Peoples R China; [Chi, Yung-Wei] Univ Calif Davis, Vasc Ctr, Sacramento, CA 95817 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1302	NP8	NP8					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100028					2022-04-28	
J	Mintz, D; Shah, J; Parikh, R; Saleh, A; Dani, S; Levy, M				Mintz, David; Shah, Jay; Parikh, Rohan; Saleh, Ahmed; Dani, Saurabh; Levy, Michael			Using multi-modality with 3d imaging to guide right atrial thrombus extraction via Flowtriever	VASCULAR MEDICINE			English	Meeting Abstract									[Mintz, David; Shah, Jay; Parikh, Rohan; Saleh, Ahmed; Dani, Saurabh; Levy, Michael] Lahey Hosp & Med Ctr, Burlington, MA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1308	NP26	NP27					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100061					2022-04-28	
J	Ong, RJ; Geotina, JM; Perez-Santiago, C; Katigbak, G; Bernardo, JM				Ong, Renato Jr.; Geotina, Jose Manuel; Perez-Santiago, Cymbeline; Katigbak, Genevieve; Bernardo, Jasmine Melissa			A young Filipino male with clinical catastrophic antiphospholipid syndrome, hereditary thrombophilia and hyperthyroidism presenting as cortical vein thrombosis: a case report	VASCULAR MEDICINE			English	Meeting Abstract									[Ong, Renato Jr.; Geotina, Jose Manuel; Perez-Santiago, Cymbeline; Katigbak, Genevieve; Bernardo, Jasmine Melissa] Makati Med Ctr, Makati, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1183	NP22	NP22					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100051					2022-04-28	
J	Srivastava, A				Srivastava, Anshul			One HIT After Another: A Case of PE with HIT	VASCULAR MEDICINE			English	Meeting Abstract									[Srivastava, Anshul] Boston Med Ctr, Boston, MA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1184	NP22	NP23					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100052					2022-04-28	
J	Whipple, MO; Masters, KS; Huebschmann, AG; Scalzo, RL; Reusch, JEB; Bergouignan, A; Regensteiner, JG				Whipple, Mary O.; Masters, Kevin S.; Huebschmann, Amy G.; Scalzo, Rebecca L.; Reusch, Jane E. B.; Bergouignan, Audrey; Regensteiner, Judith G.			Acute effects of sedentary breaks on vascular health in adults at risk for type 2 diabetes: A systematic review	VASCULAR MEDICINE			English	Review						blood pressure; diabetes mellitus; obesity; physical activity; sedentary behavior; vascular health	ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; SITTING TIME; PHYSICAL-ACTIVITY; BEHAVIOR; ASSOCIATION; METAANALYSIS; GLUCOSE; INSULIN	The aim of this systematic review was to evaluate the available evidence regarding the acute effects of interrupting/breaking up prolonged sedentary behavior (SB) on vascular health among individuals at elevated risk for type 2 diabetes (T2D). Searches of MEDLINE, Embase, Web of Science, and Cochrane Library databases were conducted on April 7, 2020. Included studies: (1) examined the effect of breaking up prolonged SB in adults with or at elevated risk for T2D and (2) assessed a vascular health outcome, such as blood pressure (BP), flow-mediated dilation (FMD), pulse-wave velocity, or endothelin-1. A total of 20 articles (17 unique studies) were included. Only three studies reported adequate statistical power for the specified vascular outcome. The available evidence suggests that light and moderate intensity activity breaks are effective in acutely lowering BP when compared to prolonged sitting. The small number of studies that included FMD or other vascular outcomes prohibits conclusions regarding the impact of SB breaks on these outcomes. Few studies evaluating the impact of breaking up SB among adults at risk for T2D have included and been adequately powered to examine vascular outcomes, but our preliminary finding, that certain SB breaks improve BP, provides proof-of-concept for this line of inquiry. Future studies should examine both the acute and chronic vascular effects of breaking up SB among individuals most vulnerable to the effects of SB (e.g. older adults, those with T2D), as these individuals are both highly sedentary and at greatest risk of poor health outcomes. PROSPERO ID: CRD42020183423.	[Whipple, Mary O.; Huebschmann, Amy G.; Regensteiner, Judith G.] Univ Colorado, Dept Med, Div Gen Internal Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Whipple, Mary O.] Univ Colorado, Div Geriatr Med, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Whipple, Mary O.; Huebschmann, Amy G.; Scalzo, Rebecca L.; Reusch, Jane E. B.; Regensteiner, Judith G.] Univ Colorado, Ctr Womens Hlth Res, Anschutz Med Campus, Aurora, CO 80045 USA; [Masters, Kevin S.] Univ Colorado, Clin Hlth Psychol, Dept Psychol, Denver, CO 80202 USA; [Masters, Kevin S.] Univ Colorado, Anschutz Hlth & Wellness Ctr, Anschutz Med Campus, Aurora, CO 80045 USA; [Scalzo, Rebecca L.; Reusch, Jane E. B.; Bergouignan, Audrey] Univ Colorado, Div Endocrinol Metab & Diabet, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Scalzo, Rebecca L.; Reusch, Jane E. B.] Rocky Mt Reg VA, Aurora, CO USA; [Bergouignan, Audrey] Univ Strasbourg, French Natl Ctr Sci Res, Inst Pluridisciplinaire Hubert Curien, UMR 7178, Strasbourg, France		Whipple, MO (通讯作者)，Univ Colorado, Sch Med, Div Gen Internal Med, 12631 E 17th Ave,Box B-180, Aurora, CO 80045 USA.	Mary.Whipple@cuanschutz.edu		Reusch, Jane/0000-0001-8620-1003; Whipple, Mary/0000-0001-7073-3224; Huebschmann, Amy/0000-0002-9329-3142	National Institute of Aging (NIA), NIH [T32AG000279]; Center for Women's Health Research; Colorado National Obesity Research Center [P30DK048520]; Veterans Administration (VA) Career Development Award [BX004533]; VAUS Department of Veterans Affairs [BX002046, CX001532]; National Cancer Institute (NCI), NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA244688]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R00DK100465]	This publication was made possible by funding to Dr Whipple from the National Institute of Aging (NIA), NIH (T32AG000279, PI Schwartz), and the Center for Women's Health Research; to Dr Masters from the Colorado National Obesity Research Center (P30DK048520); to Dr Huebschmann from the National Cancer Institute (NCI), NIH (P50CA244688, PI Glasgow); to Dr Scalzo from a Veterans Administration (VA) Career Development Award (BX004533); to Dr Reusch from VA BX002046, VA CX001532, NIH P30DK116073 (PI Reusch), NIH UL1TR000154 (PI Sokol), and the Center for Women's Health Research; to Dr Bergouignan from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH (R00DK100465, PI Bergouignan), and the Colorado National Obesity Research Center (P30DK048520); and to Dr Regensteiner from the Center for Women's Health Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bailey DP, 2015, J SCI MED SPORT, V18, P294, DOI 10.1016/j.jsams.2014.03.008; Bellettiere J, 2019, CIRCULATION, V139, P1036, DOI 10.1161/CIRCULATIONAHA.118.035312; Bellettiere J, 2019, J GERONTOL A-BIOL, V74, P387, DOI 10.1093/gerona/gly101; Bellettiere J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180119; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Bhammar DM, 2017, MED SCI SPORT EXER, V49, P2119, DOI 10.1249/MSS.0000000000001315; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Carter SE, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14190; Carter SE, 2018, J APPL PHYSIOL, V125, P790, DOI 10.1152/japplphysiol.00310.2018; Champion RB, 2018, J SPORT SCI, V36, P2484, DOI 10.1080/02640414.2018.1464744; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Climie RE, 2018, J APPL PHYSIOL, V125, P1787, DOI 10.1152/japplphysiol.00544.2018; Dempsey PC, 2018, HYPERTENSION, V72, P1037, DOI 10.1161/HYPERTENSIONAHA.118.11190; Dempsey PC, 2016, J HYPERTENS, V34, P2376, DOI 10.1097/HJH.0000000000001101; Dempsey PC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0797-4; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunstan DW., 2017, SEDENTARY BEHAV HLTH, P31; Einarson TR, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0728-6; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Falconer CL, 2015, MED SCI SPORT EXER, V47, P2070, DOI 10.1249/MSS.0000000000000651; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Freire YA, 2019, J PHYS ACT HEALTH, V16, P727, DOI 10.1123/jpah.2018-0492; Gennuso KP, 2016, AGING CLIN EXP RES, V28, P943, DOI 10.1007/s40520-015-0386-4; Gibbs BB, 2017, J HYPERTENS, V35, P2411, DOI [10.1097/HJH.0000000000001463, 10.1097/hjh.0000000000001463]; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Halter JB, 2014, DIABETES, V63, P2578, DOI 10.2337/db14-0020; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Higgins JPT., 2011, COCHRANE HDB SYSTEMA; Kerr J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188544; Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001; Kowalsky RJ, 2019, APPL PHYSIOL NUTR ME, V44, P1025, DOI 10.1139/apnm-2018-0633; Kruse NT, 2018, MED SCI SPORT EXER, V50, P801, DOI 10.1249/MSS.0000000000001484; Larsen RN, 2014, NUTR METAB CARDIOVAS, V24, P976, DOI 10.1016/j.numecd.2014.04.011; Larsen RN, 2015, CLIN SCI, V129, P117, DOI 10.1042/CS20140790; Lee JH, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0316-7; Loh R, 2020, SPORTS MED, V50, P295, DOI 10.1007/s40279-019-01183-w; Moher D., 2009, PLOS MED, V6, pe1000097; Moldovanova I, 2008, HYPERTENSION, V51, P1203, DOI 10.1161/HYPERTENSIONAHA.107.107433; Paterson C, 2020, SPORTS MED, V50, P1929, DOI 10.1007/s40279-020-01325-5; Perdomo SJ, 2019, SPORT SCI HLTH, V15, P375, DOI 10.1007/s11332-019-00526-4; Puig-Ribera A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122474; Saunders TJ, 2018, SPORTS MED, V48, P2347, DOI 10.1007/s40279-018-0963-8; Schnurr TM, 2020, DIABETOLOGIA, V63, P1324, DOI 10.1007/s00125-020-05140-5; Smith JR, 2019, MED SCI SPORT EXER, V51, P874, DOI 10.1249/MSS.0000000000001877; Son Y, 2017, INT J VASC MED, V2017, DOI 10.1155/2017/7532702; Stamatakis E, 2019, J AM COLL CARDIOL, V73, P2062, DOI 10.1016/j.jacc.2019.02.031; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; US Department of Health and Human Services, 2018, PHYS ACT GUID AM, V2nd; van der Berg JD, 2016, DIABETOLOGIA, V59, P709, DOI 10.1007/s00125-015-3861-8; Vranish JR, 2017, AM J PHYSIOL-HEART C, V312, pH800, DOI 10.1152/ajpheart.00823.2016; Wennberg P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009630; West S, 2002, Evid Rep Technol Assess (Summ), P1; Wheeler MJ, 2019, HYPERTENSION, V73, P859, DOI 10.1161/HYPERTENSIONAHA.118.12373; Wheeler MJ, 2019, J APPL PHYSIOL, V126, P1049, DOI 10.1152/japplphysiol.00001.2019; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Yates T, 2020, J GERONTOL A-BIOL, V75, P139, DOI 10.1093/gerona/gly252; Zeigler ZS, 2016, MED SCI SPORT EXER, V48, P175, DOI 10.1249/MSS.0000000000000754	60	1	1	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					448	458	1358863X211009307	10.1177/1358863X211009307		MAY 2021	11	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000650020000001	33977799	Green Submitted			2022-04-28	
J	Pagliariccio, G; Mattioli, M; Gasparrini, S; Carbonari, L				Pagliariccio, Gabriele; Mattioli, Massimo; Gasparrini, Silvia; Carbonari, Luciano			Images in Vascular Medicine: Mid-aortic syndrome caused by subocclusive angiosarcoma	VASCULAR MEDICINE			English	Editorial Material; Early Access									[Pagliariccio, Gabriele] ASL 4 Teramo, Dept Vasc Surg, Teramo, Abruzzo, Italy; [Mattioli, Massimo] Azienda Osped Osped Riuniti Marche Nord, Dept Emergency Med, Piazzale Cinelli 4, I-61121 Pesaro, Marche, Italy; [Gasparrini, Silvia] Azienda Osped Univ Osped Riuniti, Dept Pathol Anat, Ancona, Marche, Italy; [Carbonari, Luciano] Azienda Osped Univ Osped Riuniti, Dept Vasc Surg, Ancona, Marche, Italy		Mattioli, M (通讯作者)，Azienda Osped Osped Riuniti Marche Nord, Dept Emergency Med, Piazzale Cinelli 4, I-61121 Pesaro, Marche, Italy.	mattio87@libero.it					Fatima J, 2013, J VASC SURG, V57, P756, DOI 10.1016/j.jvs.2012.09.023; Rajakaruna R, 2021, ANESTHESIOLOGY, V134, P938, DOI 10.1097/ALN.0000000000003760; Squizzato F, 2021, CIRC-CARDIOVASC IMAG, V14, DOI 10.1161/CIRCIMAGING.120.010854	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.											1358863X211057157	10.1177/1358863X211057157		NOV 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XH8QN	WOS:000725692500001	34809516	Bronze			2022-04-28	
J	Ong, R; Geotina, JM; Perez-Santiago, C; Katigbak, G; Bernardo, JM				Ong, Renato; Geotina, Jose Manuel; Perez-Santiago, Cymbeline; Katigbak, Genevieve; Bernardo, Jasmine Melissa			A young Filipino male with clinical catastrophic antiphospholipid syndrome and probable systemic lupus erythematosus presenting as cerebral venous thrombosis: a case report	VASCULAR MEDICINE			English	Meeting Abstract									[Ong, Renato; Geotina, Jose Manuel; Perez-Santiago, Cymbeline; Katigbak, Genevieve; Bernardo, Jasmine Melissa] Makati Med Ctr, Makati, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1180	NP21	NP22					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100050					2022-04-28	
J	Chen, NX; O'Neill, KD; Dominguez, JM; Moe, SM				Chen, Neal X.; O'Neill, Kalisha D.; Dominguez, James M., II; Moe, Sharon M.			Regulation of reactive oxygen species in the pathogenesis of matrix vesicles induced calcification of recipient vascular smooth muscle cells	VASCULAR MEDICINE			English	Article						calcification; cell signaling; matrix vesicle; mitochondria; oxidative stress; vascular smooth muscle cells	RAT MODEL; CALCIUM; PATHOPHYSIOLOGY; AUTOPHAGY; MINERALIZATION; TRAFFICKING; ACTIVATION; GENERATION; ROLES; NOX4	Introduction: Increased oxidative stress is associated with vascular calcification in patients with chronic kidney disease (CKD). We have previously demonstrated that cellular-derived matrix vesicles (MV), but not media-derived MV, are endocytosed in the presence of phosphorus by recipient normal rat vascular smooth muscle cells (VSMC) and induce calcification through ERK1/2 and [Ca2+](i) signaling. We hypothesized that these changes were mediated by increased reactive oxygen species (ROS) production. Methods: MV were co-cultured with recipient VSMC in the presence of high phosphorus and ROS production and cell signaling assessed. Results: The results demonstrated MV endocytosis led to increased ROS production in recipient VSMC with no increase in mitochondrial oxygen consumption or oxidative phosphorylation (OXPHOS), indicating the ROS was not from the mitochondria. The use of inhibitors demonstrated that endocytosis of these MV by VSMC led to a signaling cascade in the cytoplasm beginning with ERK1/2 signaling, then increased [Ca2+](i) and stimulation of ROS production, mediated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX)1/4. Media-derived MV did not induce this cascade, indicating endocytosis itself was not a factor. Furthermore, inhibition of either ERK1/2 activation or [Ca2+](i) reduced vascular calcification. Conclusion: We conclude that endocytosis of pro-mineralizing MV can induce a series of signaling events in normal VSMC that culminate in generation of ROS via activation of NOX1/4. Understanding these pathways will allow the development of future targeted therapeutics.	[Chen, Neal X.; O'Neill, Kalisha D.; Dominguez, James M., II; Moe, Sharon M.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Moe, Sharon M.] Roduebush Vet Affairs Med Ctr, Indianapolis, IN USA		Chen, NX (通讯作者)，Indiana Univ Sch Med, Div Nephrol, 950 West Walnut St,R2 202, Indianapolis, IN 46202 USA.	xuechen@iu.edu		Chen, Neal/0000-0002-3309-0802	Veterans Administration Merit Award from United States (US) Department of Veterans Affairs [IBI01BX001471]; Biomedical Laboratory Research and Development Service (SMM); NIH O'Brien CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30-DK079312]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by a Veterans Administration Merit Award from United States (US) Department of Veterans Affairs IBI01BX001471, Biomedical Laboratory Research and Development Service (SMM), and the NIH O'Brien Center P30-DK079312.	Banerjee J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2872156; Biruete A, 2020, AM J NEPHROL, V51, P381, DOI 10.1159/000506729; Camargo LL, 2018, HYPERTENSION, V72, P235, DOI 10.1161/HYPERTENSIONAHA.118.10824; Chaturvedi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131589; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Chen NX, 2007, AM J PHYSIOL-RENAL, V292, pF599, DOI 10.1152/ajprenal.00303.2006; Chen NX, 2020, J BONE MINER RES, V35, P608, DOI 10.1002/jbmr.3925; Chen NX, 2018, KIDNEY INT, V93, P343, DOI 10.1016/j.kint.2017.07.019; Chen NX, 2015, CURR OSTEOPOROS REP, V13, P372, DOI 10.1007/s11914-015-0293-9; Chen NX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064558; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Chen NX, 2010, KIDNEY INT, V77, P436, DOI 10.1038/ki.2009.481; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1489, DOI 10.1093/ndt/gfh125; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dusso A, 2018, KIDNEY INT, V93, P298, DOI 10.1016/j.kint.2017.08.036; Furmanik M, 2020, CIRC RES, V127, P911, DOI 10.1161/CIRCRESAHA.119.316159; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Hutcheson JD, 2018, CURR OPIN CARDIOL, V33, P290, DOI 10.1097/HCO.0000000000000510; Khalid S, 2020, FREE RADICAL BIO MED, V153, P103, DOI 10.1016/j.freeradbiomed.2020.04.008; Kholodenko BN, 2002, TRENDS CELL BIOL, V12, P173, DOI 10.1016/S0962-8924(02)02251-1; McNerny EMB, 2019, BONE, V125, P16, DOI 10.1016/j.bone.2019.05.002; Meng YY, 2018, FOLIA BIOL-PRAGUE, V64, P103; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Moe SM, 2017, BONE, V100, P94, DOI 10.1016/j.bone.2016.08.022; Moe SM, 2015, J BONE MINER RES, V30, P539, DOI 10.1002/jbmr.2372; Moe SM, 2011, J BONE MINER RES, V26, P2672, DOI 10.1002/jbmr.485; Moe SM, 2009, J AM SOC NEPHROL, V20, P1162, DOI 10.1681/ASN.2009040409; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI [10.1089/ars.2009.2625, 10.1089/ARS.2009.2625]; Sigrist M, 2006, NEPHROL DIAL TRANSPL, V21, P707, DOI 10.1093/ndt/gfi236; Sun ZQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0897-7; Touyz RM, 2019, EXP PHYSIOL, V104, P605, DOI 10.1113/EP086204; Vorland CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207601; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x; Zimmerman MC, 2011, HYPERTENSION, V58, P446, DOI 10.1161/HYPERTENSIONAHA.111.177006	41	2	2	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					585	594	1358863X211024721	10.1177/1358863X211024721		AUG 2021	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000680149500001	34338093				2022-04-28	
J	Kadian-Dodov, D; Celestin, C; Tefera, L; Olin, J				Kadian-Dodov, Daniella; Celestin, Carmel; Tefera, Leben; Olin, Jeffrey			SVM Communications: Membership spotlight	VASCULAR MEDICINE			English	Editorial Material							VASCULAR MEDICINE		[Kadian-Dodov, Daniella; Olin, Jeffrey] Icahn Sch Med Mt Sinai, Vasc Med Sect, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Celestin, Carmel] Cleveland Clin Florida, Vasc Med, Weston, FL USA; [Tefera, Leben] Cleveland Clin, Vasc Med, Main Campus, Cleveland, OH 44106 USA		Kadian-Dodov, D (通讯作者)，Icahn Sch Med Mt Sinai, One Gustave L Levy Pl,Box 1033, New York, NY 10029 USA.	daniella.kadian-dodov@mountsinai.org		Tefera, Leben/0000-0001-9640-6774			Olin JW, 2000, VASC MED, V5, P205; Olin JW, 2001, VASC MED, V6, P129, DOI 10.1177/1358836X0100600301	2	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					475	477		10.1177/1358863X211024715			3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000683828000019	34355595	Bronze			2022-04-28	
J	Lou, JY; Kennedy, KF; Menard, MT; Abbott, JD; Secemsky, EA; Goodney, PP; Saad, M; Soukas, PA; Hyder, ON; Aronow, HD				Lou, Jun-Yang; Kennedy, Kevin F.; Menard, Matthew T.; Abbott, J. Dawn; Secemsky, Eric A.; Goodney, Philip P.; Saad, Marwan; Soukas, Peter A.; Hyder, Omar N.; Aronow, Herbert D.			North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative	VASCULAR MEDICINE			English	Article						COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery	IMPACT	Introduction: The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Methods: Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative(R). Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. Results: The final cohort comprised 57,181 patients from 147 US and Canadian sites. Overall procedure volumes fell 35.2% (95% CI 31.9%, 38.4%, p < 0.001) during and 19.8% (95% CI 16.8%, 22.9%, p < 0.001) following the surge, compared with presurge months. Procedure volumes fell 71.1% for claudication (95% CI 55.6%, 86.4%, p < 0.001) and 15.9% for chronic limb-threatening ischemia (CLTI) (95% CI 11.9%, 19.8%, p < 0.001) but remained unchanged for acute limb ischemia (ALI) when comparing surge to presurge months. Adjusted mortality was significantly higher among those with claudication (0.5% vs 0.1%; OR 4.38 [95% CI 1.42, 13.5], p = 0.01) and ALI (6.4% vs 4.4%; OR 2.63 [95% CI 1.39, 4.98], p = 0.003) when comparing postsurge with presurge periods. Conclusion: The first North American COVID-19 pandemic surge was associated with a significant and sustained decline in both elective and nonelective lower-extremity vascular procedural volumes. When compared with presurge patients, in-hospital mortality increased for those with claudication and ALI following the surge.	[Lou, Jun-Yang] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Menard, Matthew T.] Harvard Med Sch, Brigham & Womens Hosp, Div Vasc & Endovasc Surg, Boston, MA 02115 USA; [Abbott, J. Dawn; Saad, Marwan; Soukas, Peter A.; Hyder, Omar N.; Aronow, Herbert D.] Brown Univ, Alpert Med Sch, Div Cardiol, 593 Eddy St,APC 730, Providence, RI 02903 USA; [Secemsky, Eric A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02115 USA; [Goodney, Philip P.] Dartmouth Hitchcock Med Ctr, Sect Vasc Surg, Lebanon, NH 03766 USA		Aronow, HD (通讯作者)，Brown Univ, Alpert Med Sch, Div Cardiol, 593 Eddy St,APC 730, Providence, RI 02903 USA.	herbert.aronow@lifespan.org	Abbott, J/AAU-4065-2021	Aronow, Herbert/0000-0002-9061-7893; Lou, Jun-Yang/0000-0003-2628-1288; Secemsky, Eric/0000-0003-3861-3163			Ahn SS, 2020, J ENDOVASC THER, V27, P956, DOI 10.1177/1526602820949970; American College of Surgeons, 2020, COVID 19 EXECUTIVE O; American College of Surgeons, 2020, COVID 19 GUID TRIAG; Aziz F, 2021, J VASC SURG, V73, P4, DOI 10.1016/j.jvs.2020.08.118; Bashar AHM, 2021, ANN VASC SURG, V70, P306, DOI 10.1016/j.avsg.2020.08.114; Bellosta R, 2020, J VASC SURG, V72, P1864, DOI 10.1016/j.jvs.2020.04.483; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Brant LCC, 2020, HEART, V106, P1898, DOI 10.1136/heartjnl-2020-317663; Columbo JA, 2020, CIRCULATION, V141, P946, DOI 10.1161/CIRCULATIONAHA.119.043963; Correia M, 2020, ANN VASC SURG, V69, P100, DOI 10.1016/j.avsg.2020.08.002; de Havenon Adam, 2020, medRxiv, DOI 10.1101/2020.05.07.20083386; Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011; Jones WS, 2019, AM HEART J, V216, P74, DOI 10.1016/j.ahj.2019.07.007; Kansagra AP, 2020, NEW ENGL J MED, V383, P400, DOI 10.1056/NEJMc2014816; Khera Amit, 2020, Am J Prev Cardiol, V1, P100009, DOI 10.1016/j.ajpc.2020.100009; Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013; Lai PH, 2020, JAMA CARDIOL, V5, P1154, DOI 10.1001/jamacardio.2020.2488; Lancaster EM, 2020, J VASC SURG, V72, P1850, DOI 10.1016/j.jvs.2020.08.132; Lange SJ, 2020, MMWR-MORBID MORTAL W, V69, P795, DOI 10.15585/mmwr.mm6925e2; Latz CA, 2021, J VASC SURG, V73, P372, DOI 10.1016/j.jvs.2020.05.032; Mascia D, 2020, ANN VASC SURG, V69, P90, DOI 10.1016/j.avsg.2020.07.022; Mouawad NJ, 2021, J VASC SURG, V73, P772, DOI 10.1016/j.jvs.2020.08.036; Patient Safety Organization, 2019, VASCULAR QUALITY INI; Peragine C, 2020, CLIN INFECT DIS, V71, P2897, DOI 10.1093/cid/ciz1183; Rolls A, 2020, BRIT J SURG, V107, pE311, DOI 10.1002/bjs.11765; Schuivens PME, 2020, ANN VASC SURG, V69, P74, DOI 10.1016/j.avsg.2020.07.025; Siracuse JJ, 2016, J VASC SURG, V63, P958, DOI 10.1016/j.jvs.2015.09.063; Vascular Quality Initiative, 2019, VASC MED CONS REG; Wanken ZJ, 2020, CIRCULATION, V141, P866, DOI 10.1161/CIRCULATIONAHA.119.043625; Welt FGP, 2020, J AM COLL CARDIOL, V75, P2372, DOI 10.1016/j.jacc.2020.03.021; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787; Wu JH, 2021, HEART, V107, P113, DOI 10.1136/heartjnl-2020-317912; Yong CM, 2020, CATHETER CARDIO INTE, V96, P1080, DOI 10.1002/ccd.29262	33	3	3	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					613	623	1358863X211021918	10.1177/1358863X211021918		JUN 2021	11	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000667922900001	34169796	Bronze			2022-04-28	
J	Majid, S; Keith, RJ; Fetterman, JL; Weisbrod, RM; Nystoriak, J; Wilson, T; Stokes, AC; Blaha, MJ; Srivastava, S; Robertson, RM; Bhatnagar, A; Hamburg, NM				Majid, Sana; Keith, Rachel J.; Fetterman, Jessica L.; Weisbrod, Robert M.; Nystoriak, Jessica; Wilson, Tabitha; Stokes, Andrew C.; Blaha, Michael J.; Srivastava, Sanjay; Robertson, Rose Marie; Bhatnagar, Aruni; Hamburg, Naomi M.			Lipid profiles in users of combustible and electronic cigarettes	VASCULAR MEDICINE			English	Article						e-cigarettes; electronic cigarettes; fasting glucose; lipids; smoking; vaping	CARDIOVASCULAR-DISEASE; SMOKING; CHOLESTEROL; RISK	Electronic cigarette use has especially risen among adolescents and young adults. The aim of this study was to investigate fasting blood glucose and lipid profiles in chronic combustible cigarette and electronic cigarette users. We evaluated participants aged 21 to 45 (n = 525, mean age 31 +/- 7 years, 45% women) without established cardiovascular disease or risk factors who were combustible cigarette users (n = 290), electronic cigarette users (n = 131; 65 sole users and 66 dual users), or never users (n = 104). In the first wave of enrollment (2014-2017), electronic cigarette users reported their products as first, second and third generation devices (e-cig users) and were all largely current (i.e. dual) or former (sole) combustible cigarette users, whereas in the second wave of enrollment (2019-2020), electronic cigarette users all reported pod-based device use (pod users) and included more sole users who were never smokers. In multivariable-adjusted analyses comparing to never users, both sole e-cig users and combustible cigarette users had higher glucose and triglycerides and lower high-density lipoprotein (HDL) cholesterol levels. Dual e-cig users showed higher triglycerides and very-low-density lipoprotein cholesterol, and lower HDL cholesterol compared to never users. In contrast, pod users (both sole and dual) had lipid profiles and glucose levels similar to never users. Overall, users of early generation electronic cigarettes display adverse metabolic profiles. In contrast, pod-based electronic cigarette users have similar lipid profiles to never users. Future studies are needed to understand the cumulative effects of electronic cigarette use on cardiometabolic health.	[Majid, Sana; Fetterman, Jessica L.; Weisbrod, Robert M.; Hamburg, Naomi M.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Majid, Sana; Fetterman, Jessica L.; Weisbrod, Robert M.; Hamburg, Naomi M.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 72 E Concord St,E-748, Boston, MA 02118 USA; [Keith, Rachel J.; Nystoriak, Jessica; Wilson, Tabitha; Srivastava, Sanjay; Bhatnagar, Aruni] Univ Louisville, Sch Med, Envirome Inst, Louisville, KY 40292 USA; [Stokes, Andrew C.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Blaha, Michael J.] Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD USA; [Robertson, Rose Marie] Amer Heart Assoc, Dallas, TX USA		Hamburg, NM (通讯作者)，Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 72 E Concord St,E-748, Boston, MA 02118 USA.	nhamburg@bu.edu		Majid, Sana/0000-0002-9968-0178	National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5P50HL120163, U54HL120163]; American Heart AssociationAmerican Heart Association [20YVNR35500014]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Numbers 5P50HL120163 and U54HL120163. Dr Hamburg is supported by a grant from the American Heart Association 20YVNR35500014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the American Heart Association.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bandi P, 2021, AM J PREV MED, V60, P151, DOI 10.1016/j.amepre.2020.07.026; Barrington-Trimis JL, 2018, NEW ENGL J MED, V379, P1099, DOI 10.1056/NEJMp1805758; Benowitz NL, 2017, NAT REV CARDIOL, V14, P447, DOI 10.1038/nrcardio.2017.36; Benowitz NL, 2016, TRENDS CARDIOVAS MED, V26, P515, DOI 10.1016/j.tcm.2016.03.001; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Eaton DL., 2018, PUBLIC HLTH CONSEQUE; GARRISON RJ, 1978, ATHEROSCLEROSIS, V30, P17, DOI 10.1016/0021-9150(78)90149-1; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Jain Ram B, 2018, J Circ Biomark, V7, p1849454418779310, DOI 10.1177/1849454418779310; Keith RJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019850; Kim T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237983; MacDonald A, 2019, VASC HEALTH RISK MAN, V15, P159, DOI 10.2147/VHRM.S175970; Madison MC, 2019, J CLIN INVEST, V129, P4290, DOI 10.1172/JCI128531; Marz W, 2017, CLIN RES CARDIOL, V106, P663, DOI 10.1007/s00392-017-1106-1; Middlekauff HR, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02557-9; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; Orimoloye OA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226744; Selya AS, 2017, SOC SCI MED, V174, P213, DOI 10.1016/j.socscimed.2016.12.014; Strongin RM, 2019, ANNU REV ANAL CHEM, V12, P23, DOI 10.1146/annurev-anchem-061318-115329; Tan XJ, 2008, J CLIN LAB ANAL, V22, P159, DOI 10.1002/jcla.20235; Vallone DM, 2020, JAMA PEDIATR, V174, P277, DOI 10.1001/jamapediatrics.2019.5436; WILSON MF, 1990, AM J CARDIOL, V66, P731, DOI 10.1016/0002-9149(90)91139-W	26	1	1	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					483	488	1358863X211009313	10.1177/1358863X211009313		MAY 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000652873100001	34013801				2022-04-28	
J	Slysz, JT; Rejeski, WJ; Treat-Jacobson, D; Bazzano, LA; Forman, DE; Manini, TM; Criqui, MH; Tian, L; Zhao, LH; Zhang, DX; Guralnik, JM; Ferrucci, L; Kibbe, MR; Polonsky, TS; Spring, B; Sufit, R; Leeuwenburgh, C; McDermott, MM				Slysz, Joshua T.; Rejeski, W. Jack; Treat-Jacobson, Diane; Bazzano, Lydia A.; Forman, Daniel E.; Manini, Todd M.; Criqui, Michael H.; Tian, Lu; Zhao, Lihui; Zhang, Dongxue; Guralnik, Jack M.; Ferrucci, Luigi; Kibbe, Melina R.; Polonsky, Tamar S.; Spring, Bonnie; Sufit, Robert; Leeuwenburgh, Christiaan; McDermott, Mary M.			Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial	VASCULAR MEDICINE			English	Article						ankle&#8211; brachial index (ABI); atherosclerosis; six-minute walk; peripheral artery disease (PAD)		This study investigated cross-sectional associations of peripheral artery disease (PAD) severity (defined by the ankle-brachial index (ABI)) and amounts of daily sustained physical activity (PA) (defined as > 100 activity counts per minute lasting 5 consecutive minutes or more). This study also investigated associations of amounts of daily sustained PA with 6-minute walk (6MW) distance and the Short Form-36 physical functioning domain (SF-36 PF) score in cross-sectional analyses and with serious adverse events (SAEs) in longitudinal analyses of people with PAD. PA was measured continuously for 10 days using a tri-axial accelerometer at baseline in 277 participants with PAD randomized to the LITE clinical trial. In regression analyses, each 0.15 lower ABI value was associated with a 5.67% decrease in the number of daily bouts of sustained PA (95% CI: 3.85-6.54; p < 0.001). Every additional bout of sustained PA per day was associated with a 4.56-meter greater 6MW distance (95% CI: 2.67-6.46; p < 0.0001), and a 0.81-point improvement in SF-36 PF score (95% CI: 0.34-1.28; p < 0.001). Participants with values of daily bouts of sustained PA below the median had higher rates of SAEs during follow-up, compared to participants above the median (41% vs 24%; p = 0.002). In conclusion, among participants with PAD, lower ABI values were associated with fewer bouts of daily sustained PA. A greater number of bouts of daily sustained PA were associated with better 6MW performance and SF-36 PF score, and, in longitudinal analyses, lower rates of SAEs. Clinicaltrials.gov ID: NCT02538900.	[Slysz, Joshua T.; Zhao, Lihui; Zhang, Dongxue; Spring, Bonnie; Sufit, Robert; McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Hlth & Exercise Sci & Geriatr Med, Winston Salem, NC 27101 USA; [Treat-Jacobson, Diane] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Bazzano, Lydia A.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Forman, Daniel E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Manini, Todd M.; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Tian, Lu] Stanford Univ, Dept Biomed Data Sci, Palo Alto, CA 94304 USA; [Guralnik, Jack M.] Univ Maryland, Dept Epidemiol, Baltimore, MD USA; [Ferrucci, Luigi] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Kibbe, Melina R.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Polonsky, Tamar S.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA		McDermott, MM (通讯作者)，Northwestern Univ, Feinberg Sch Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	mdm608@northwestern.edu		tian, lu/0000-0002-5893-0169	National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL122846]; American's Heart Association's strategically focused vascular research network [18SFRN339700097]; National Institute on Aging (intramural division) [AG P30AG059988]; Jesse Brown VA Medical CenterUS Department of Veterans Affairs	This study was funded by the National Heart Lung and Blood Institute R01-HL122846. Supported by the American's Heart Association's strategically focused vascular research network (18SFRN339700097), National Institute on Aging (intramural division), AG P30AG059988, and by the Jesse Brown VA Medical Center.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Amirhamzeh MMR, 1997, EUR J VASC ENDOVASC, V13, P301, DOI 10.1016/S1078-5884(97)80102-5; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Criqui M H, 1996, Vasc Med, V1, P65; Fanning J, 2020, J AM GERIATR SOC, V68, P1476, DOI 10.1111/jgs.16386; Fitzgerald JD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001288; Gardner AW, 2008, J VASC SURG, V47, P117, DOI 10.1016/j.jvs.2007.09.033; Garg PK, 2006, CIRCULATION, V114, P242, DOI 10.1161/CIRCULATIONAHA.105.605246; Garg PK, 2009, CIRCULATION, V119, P251, DOI 10.1161/CIRCULATIONAHA.108.791491; Gommans LNM, 2016, J VASC SURG, V63, P983, DOI 10.1016/j.jvs.2015.10.060; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Kelly Louise A, 2013, BMC Med Phys, V13, P5, DOI 10.1186/1756-6649-13-5; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; Mankowski RT, 2017, J AM GERIATR SOC, V65, P2251, DOI 10.1111/jgs.15037; Martin KR, 2014, J AM GERIATR SOC, V62, P1263, DOI 10.1111/jgs.12893; McDermott MM, 2008, J AM COLL CARDIOL, V51, P1482, DOI 10.1016/j.jacc.2007.12.034; McDermott MM, 2007, J AM COLL CARDIOL, V50, P974, DOI 10.1016/j.jacc.2007.05.030; McDermott MM, 2021, JAMA-J AM MED ASSOC, V325, P1266, DOI 10.1001/jama.2021.2536; McDermott MM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001846; McDermott MM, 2014, CIRCULATION, V130, P61, DOI 10.1161/CIRCULATIONAHA.114.007002; McDermott MM, 2010, VASC MED, V15, P251, DOI 10.1177/1358863X10365181; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2002, J AM GERIATR SOC, V50, P247, DOI 10.1046/j.1532-5415.2002.50055.x; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; McMinn D., 2013, INT J EXERC SCI, V6, P217; Parsons TJ, 2016, ATHEROSCLEROSIS, V247, P28, DOI 10.1016/j.atherosclerosis.2016.01.038; Santos-Lozano A, 2012, MED ENG PHYS, V34, P787, DOI 10.1016/j.medengphy.2012.02.005; Schrack JA, 2019, J GERONTOL A-BIOL, V74, P560, DOI 10.1093/gerona/gly243; Sieminski D J, 1997, Vasc Med, V2, P286; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; van Schooten KS, 2015, J AGING PHYS ACTIV, V23, P9, DOI [10.1123/japa.2013-0103, 10.1123/JAPA.2013-0103]; Wanigatunga AA, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12352	38	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					497	506	1358863X21989430	10.1177/1358863X21989430		APR 2021	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cardiovascular System & Cardiology	WC1IH	WOS:000638979800001	33829920				2022-04-28	
J	Terwilliger, ZS; Ryan, TE; Goldberg, EJ; Schmidt, CA; Yamaguchi, DJ; Karnekar, R; Brophy, P; Green, TD; Zeczycki, TN; Mac Gabhann, F; Annex, BH; McClung, JM				Terwilliger, Zoe S.; Ryan, Terence E.; Goldberg, Emma J.; Schmidt, Cameron A.; Yamaguchi, Dean J.; Karnekar, Reema; Brophy, Patricia; Green, Thomas D.; Zeczycki, Tonya N.; Mac Gabhann, Feilim; Annex, Brian H.; McClung, Joseph M.			Racial differences in the limb skeletal muscle transcriptional programs of patients with critical limb ischemia	VASCULAR MEDICINE			English	Article						critical limb ischemia (CLI); genetics; health disparities; ischemia; mitochondria; peripheral artery disease (PAD); skeletal muscle		Critical limb ischemia (CLI) is the most severe manifestation of peripheral artery disease (PAD) and is characterized by high rates of morbidity and mortality. As with most severe cardiovascular disease manifestations, Black individuals disproportionately present with CLI. Accordingly, there remains a clear need to better understand the reasons for this discrepancy and to facilitate personalized therapeutic options specific for this population. Gastrocnemius muscle was obtained from White and Black healthy adult volunteers and patients with CLI for whole transcriptome shotgun sequencing (WTSS) and enrichment analysis was performed to identify alterations in specific Reactome pathways. When compared to their race-matched healthy controls, both White and Black patients with CLI demonstrated similar reductions in nuclear and mitochondrial encoded genes and mitochondrial oxygen consumption across multiple substrates, indicating a common bioenergetic paradigm associated with amputation outcomes regardless of race. Direct comparisons between tissues of White and Black patients with CLI revealed hemostasis, extracellular matrix organization, platelet regulation, and vascular wall interactions to be uniquely altered in limb muscles of Black individuals. Among traditional vascular growth factor signaling targets, WTSS revealed only Tie1 to be significantly altered from White levels in Black limb muscle tissues. Quantitative reverse transcription polymerase chain reaction validation of select identified targets verified WTSS directional changes and supports reductions in MMP9 and increases in NUDT4P1 and GRIK2 as unique to limb muscles of Black patients with CLI. This represents a critical first step in better understanding the transcriptional program similarities and differences between Black and White patients in the setting of amputations related to CLI and provides a promising start for therapeutic development in this population.	[Terwilliger, Zoe S.; Goldberg, Emma J.; Schmidt, Cameron A.; Karnekar, Reema; Brophy, Patricia; Green, Thomas D.; Zeczycki, Tonya N.; McClung, Joseph M.] East Carolina Univ, Brody Med Ctr, Diabet & Obes Inst, Greenville, NC 27834 USA; [Terwilliger, Zoe S.; Goldberg, Emma J.; Schmidt, Cameron A.; Karnekar, Reema; Green, Thomas D.; McClung, Joseph M.] East Carolina Univ, Brody Med Ctr, Dept Physiol, Greenville, NC 27834 USA; [Ryan, Terence E.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Yamaguchi, Dean J.; McClung, Joseph M.] East Carolina Univ, Brody Med Ctr, Dept Cardiovasc Sci, Greenville, NC 27834 USA; [Yamaguchi, Dean J.] East Carolina Univ, Brody Med Ctr, Div Surg, Greenville, NC 27834 USA; [Zeczycki, Tonya N.] East Carolina Univ, Brody Med Ctr, Dept Biochem, Greenville, NC 27834 USA; [Mac Gabhann, Feilim] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA; [Mac Gabhann, Feilim] Johns Hopkins Sch Med, Inst Computat Med, Baltimore, MD USA; [Annex, Brian H.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Annex, Brian H.] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA		McClung, JM (通讯作者)，East Carolina Univ, Diabet & Obes Inst, East Carolina Heart Inst, Brody Sch Med, Off 4109,Mail Stop 743,115 Heart Dr, Greenville, NC 27834 USA.	mcclungj@ecu.edu		Schmidt, Cameron/0000-0001-6628-6329; Zeczycki, Tonya/0000-0002-5216-1960	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL125695, HL150003, HL141325, HL139822-01A1, GM129074]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by NIH grants HL125695 (Joseph McClung), HL150003 (Brian Annex), HL141325 (Brian Annex), HL139822-01A1 (Brian Annex and Joseph McClung), and GM129074 (Feilim Mac Gabhann).	Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Boulberdaa M, 2016, MOL THER, V24, P978, DOI 10.1038/mt.2016.41; Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Cheng D, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4976845; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0372-y; Fiedler J, 2015, J AM COLL CARDIOL, V66, P2005, DOI 10.1016/j.jacc.2015.07.081; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Kalbaugh CA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003796; Leeper NJ, 2013, J VASC SURG, V57, P728, DOI 10.1016/j.jvs.2012.07.051; Lejay A, 2014, INT J BIOCHEM CELL B, V50, P101, DOI 10.1016/j.biocel.2014.02.013; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Luo C, 2018, GENE, V662, P103, DOI 10.1016/j.gene.2018.04.023; Makris KI, 2007, VASCULAR, V15, P336, DOI 10.2310/6670.2007.00054; McClung JM, 2017, CIRCULATION, V136, P281, DOI 10.1161/CIRCULATIONAHA.116.024873; Mentias A, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.120.009459; Myers VD, 2018, JACC-BASIC TRANSL SC, V3, P122, DOI 10.1016/j.jacbts.2017.09.009; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perez-Cremades D, 2020, ARTERIOSCL THROM VAS, V40, P523, DOI 10.1161/ATVBAHA.119.312860; Ristagno G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00823; Rodriguez AE, 2016, AUTOPHAGY, V12, P287, DOI 10.1080/15548627.2015.1124225; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Ryan TE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139628; Ryan TE, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123235; Ryan TE, 2016, J MOL CELL CARDIOL, V97, P191, DOI 10.1016/j.yjmcc.2016.05.015; Ryan TE, 2014, J PHYSIOL-LONDON, V592, P3231, DOI 10.1113/jphysiol.2014.274456; Vindis C, 2015, BRIT J PHARMACOL, V172, P2167, DOI 10.1111/bph.13052; Zhou YJ, 2013, VASC MED, V18, P85, DOI 10.1177/1358863X13483864	31	3	3	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					247	258	1358863X20983918	10.1177/1358863X20983918		MAR 2021	12	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000627089000001	33685287	Green Accepted			2022-04-28	
J	Ozen, M; Zhu, F; Ma, C; Bhanot, S; Arslan, B; Turba, UC				Ozen, Merve; Zhu, Fang; Ma, Chen; Bhanot, Shelly; Arslan, Bulent; Turba, Ulku Cenk			Outcomes of subintimal arterial flossing with antegrade-retrograde intervention on patients with critical limb ischemia and tissue loss	VASCULAR MEDICINE			English	Letter						angioplasty; critical limb ischemia (CLI); endovascular therapy; peripheral artery disease (PAD); subintimal arterial flossing with the antegrade-retrograde intervention (SAFARI)	RECANALIZATION		[Ozen, Merve] Univ Kentucky, Sch Med, Dept Radiol, Lexington, KY 40536 USA; [Zhu, Fang] Barnes Jewish Hosp, Dept Radiol, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Ma, Chen] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Bhanot, Shelly; Arslan, Bulent; Turba, Ulku Cenk] Rush Univ, Dept Radiol, Med Ctr, Chicago, IL 60612 USA		Ozen, M (通讯作者)，Univ Kentucky, Dept Radiol, 800 Rose St, Lexington, KY 40536 USA.	merve.ozen@uky.edu		Bhanot, Shelly/0000-0001-8500-4374			Bazan HA, 2014, J VASC SURG, V60, P375, DOI 10.1016/j.jvs.2014.02.038; Dillingham TR, 2002, SOUTH MED J, V95, P875; Liang GZ, 2016, CARDIOVASC INTER RAD, V39, P1692, DOI 10.1007/s00270-016-1449-4; Montero-Baker M, 2008, J ENDOVASC THER, V15, P594, DOI 10.1583/08-2440.1; Reinecke H, 2015, EUR HEART J, V36, P932, DOI 10.1093/eurheartj/ehv006; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Spinosa DJ, 2005, J VASC INTERV RADIOL, V16, P37, DOI 10.1097/01.RVI.0000141336.53745.4A; Tsuchiya T, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115597087	8	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		207	209	1358863X20964573	10.1177/1358863X20964573		OCT 2020	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000608754500001	33111637				2022-04-28	
J	Fikani, A; Lermusiaux, P; Della Schiava, N; Millon, A				Fikani, Amine; Lermusiaux, Patrick; Della Schiava, Nellie; Millon, Antoine			Images in Vascular Medicine: Vasa vasorum associated with endoleak after endovascular repair of abdominal aortic aneurysm	VASCULAR MEDICINE			English	Article									[Fikani, Amine; Lermusiaux, Patrick; Della Schiava, Nellie; Millon, Antoine] Louis Pradel Hosp, Dept Vasc Surg, 59 Blvd Pinel, F-69677 Lyon, France; [Fikani, Amine; Lermusiaux, Patrick; Della Schiava, Nellie; Millon, Antoine] Claude Bernard Univ, Lyon, France; [Fikani, Amine] St Joseph Univ, Beirut, Lebanon		Fikani, A (通讯作者)，Louis Pradel Hosp, Dept Vasc Surg, 59 Blvd Pinel, F-69677 Lyon, France.	aminefikani@gmail.com	Carmen, Team3/Y-7384-2019	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236			Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Mehta M, 2005, J ENDOVASC THER, V12, P183, DOI 10.1583/04-1402.1; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Sanada JI, 1998, CARDIOVASC INTER RAD, V21, P45, DOI 10.1007/s002709900210; Torikai H, 2018, CARDIOVASC INTER RAD, V41, P186, DOI 10.1007/s00270-017-1778-y	5	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					89	90	1358863X20963822	10.1177/1358863X20963822		OCT 2020	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000579841300001	33064965	Green Published, Bronze			2022-04-28	
J	Aronow, HD				Aronow, Herbert D.			SVM Communications: Message from the President - Strength in Members	VASCULAR MEDICINE			English	Editorial Material									[Aronow, Herbert D.] Brown Univ, Alpert Med Sch, Lifespan Cardiovasc Inst, 593 Eddy St,RIH APC 730, Providence, RI 02903 USA		Aronow, HD (通讯作者)，Brown Univ, Alpert Med Sch, Lifespan Cardiovasc Inst, 593 Eddy St,RIH APC 730, Providence, RI 02903 USA.	Herbert.Aronow@Lifespan.org		Aronow, Herbert/0000-0002-9061-7893				0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					107	108	1358863X211063931	10.1177/1358863X211063931		DEC 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000730665300001	34894892	Bronze			2022-04-28	
J	Dicks, AB; Gray, BH				Dicks, Andrew B.; Gray, Bruce H.			Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster	VASCULAR MEDICINE			English	Editorial Material									[Dicks, Andrew B.; Gray, Bruce H.] Prisma Hlth, Vasc Hlth Alliance, 200 Patewood Dr C300, Greenville, SC 29615 USA		Dicks, AB (通讯作者)，Prisma Hlth, Vasc Hlth Alliance, 200 Patewood Dr C300, Greenville, SC 29615 USA.	Andrew.Dicks@prismahealth.org	Dicks, Andrew/AGI-3067-2022				Baigrie D, 2021, STATPEARLS; Bostan E, 2021, INT J DERMATOL, V60, P1305, DOI 10.1111/ijd.15777; Cohen SR, 2021, INT J DERMATOL, V60, P1032, DOI 10.1111/ijd.15623; Erler A, 2021, ARTHRITIS RHEUMATOL, V73, P2188, DOI 10.1002/art.41910; McMahon DE, 2022, J AM ACAD DERMATOL, V86, P113, DOI 10.1016/j.jaad.2021.09.002	5	2	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					100	101	1358863X211055507	10.1177/1358863X211055507		NOV 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000714006700001	34720009	Bronze			2022-04-28	
J	Joao, AA; Sousa, M; Gomes, A; Germano, A; Correia, P; Nunes, V				Joao, Ana Alagoa; Sousa, Marta; Gomes, Antonio; Germano, Ana; Correia, Pedro; Nunes, Vitor			Images in Vascular Medicine: Numb and painful forearm - a case of vascular access-induced monomelic neuropathy	VASCULAR MEDICINE			English	Editorial Material									[Joao, Ana Alagoa; Sousa, Marta; Gomes, Antonio; Nunes, Vitor] Hosp Prof Doutor Fernando Fonseca, EPE, Gen Surg Dept, IC19 Venteira, P-2720276 Lisbon, Portugal; [Germano, Ana] Hosp Prof Doutor Fernando Fonseca, EPE, Radiol Dept, Lisbon, Portugal; [Correia, Pedro] Hosp Prof Doutor Fernando Fonseca, EPE, Nephrol Dept, Lisbon, Portugal		Joao, AA (通讯作者)，Hosp Prof Doutor Fernando Fonseca, EPE, Gen Surg Dept, IC19 Venteira, P-2720276 Lisbon, Portugal.	ana.ajoao@live.com.pt		Sousa, Marta/0000-0003-1687-942X; Alagoa Joao, Ana/0000-0002-6261-6885			Han JS, 2013, KOREAN J INTERN MED, V28, P251, DOI 10.3904/kjim.2013.28.2.251; Miles AM, 2000, SEMIN DIALYSIS, V13, P312, DOI 10.1046/j.1525-139x.2000.00082.x; WILBOURN AJ, 1983, NEUROLOGY, V33, P447, DOI 10.1212/WNL.33.4.447; Wilson SE., 2010, VASCULAR ACCESS PRIN; Wodicka R, 2010, J HAND SURG-AM, V35A, P842, DOI 10.1016/j.jhsa.2009.08.014	5	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2022	27	2			SI		205	206	1358863X211051429	10.1177/1358863X211051429		OCT 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	0I8MI	WOS:000712358300001	34702096				2022-04-28	
J	Khairani, CD; Barns, BM; Rizzo, SM; Pfeferman, MB; Snyder, JE; Piazza, G; Goldhaber, SZ; Campia, U				Khairani, Candrika Dini; Barns, Briana M.; Rizzo, Samantha M.; Pfeferman, Mariana B.; Snyder, Julia E.; Piazza, Gregory; Goldhaber, Samuel Z.; Campia, Umberto			Characteristics and management of type A acute aortic syndromes at a single academic medical center: insights from the code aorta registry	VASCULAR MEDICINE			English	Meeting Abstract									[Khairani, Candrika Dini; Barns, Briana M.; Rizzo, Samantha M.; Snyder, Julia E.; Piazza, Gregory; Goldhaber, Samuel Z.; Campia, Umberto] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Rizzo, Samantha M.] Georgetown Univ, Sch Med, Washington, DC USA; [Pfeferman, Mariana B.] Univ Santo Amaro, Sao Paulo, Brazil									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1265	NP5	NP6					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100024					2022-04-28	
J	Mathew, S; Densley, A; Pedersen, E				Mathew, Steve; Densley, Ashton; Pedersen, Erik			Spinal dural AVF-a rare differential for claudication	VASCULAR MEDICINE			English	Meeting Abstract									[Mathew, Steve; Densley, Ashton; Pedersen, Erik] Creighton Univ, Sch Med, Dept Radiol, Omaha, NE USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1423	NP34	NP34					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100075					2022-04-28	
J	Morilla, M; Tanque, M				Morilla, Muriel; Tanque, Maribel			Diagnostic evaluation of arterial foot flow using plantar acceleration time	VASCULAR MEDICINE			English	Meeting Abstract									[Morilla, Muriel; Tanque, Maribel] Philippine Heart Ctr, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1395	NP18	NP19					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100044					2022-04-28	
J	Ito, N; Hishikari, K; Yoshikawa, H; Tsujihata, S; Abe, F; Kanno, Y; Iiya, M; Murai, T; Hikita, H; Takahashi, A; Yonetsu, T; Sasano, T				Ito, Naruhiko; Hishikari, Keiichi; Yoshikawa, Hiroshi; Tsujihata, Shihoko; Abe, Fumiyuki; Kanno, Yoshinori; Iiya, Munehiro; Murai, Tadashi; Hikita, Hiroyuki; Takahashi, Atsushi; Yonetsu, Taishi; Sasano, Tetsuo			Angiographic flow velocity predicts lower limb outcomes after endovascular therapy: Application of the frame count method	VASCULAR MEDICINE			English	Article						angiography; endovascular therapy (EVT); flow velocity; limb patency; peripheral artery disease (PAD); superficial femoral artery (SFA); TIMI frame count	PERIPHERAL ARTERIAL-DISEASE; SUPERFICIAL FEMORAL-ARTERY; MAGNETIC-RESONANCE ANGIOGRAPHY; NITINOL STENT IMPLANTATION; PACLITAXEL-ELUTING STENTS; ANKLE-BRACHIAL INDEX; BALLOON ANGIOPLASTY; RISK STRATIFICATION; CLAUDICATION; PATENCY	Introduction: Several factors related to lesion characteristics and endovascular therapy (EVT) procedures have been reported to affect primary patency after EVT. However, it is unknown why these factors were associated with primary patency. We hypothesized patency failure was related to poor blood flow in affected arteries. Methods: This retrospective study included 131 consecutive patients who had received EVT with bare metal stents for peripheral artery disease caused by femoropopliteal artery lesions. Based on the tertile post-EVT flow velocity of the superficial femoral artery (SFA), patients were divided into high (n = 43), middle (n = 44), and low (n = 44) flow velocity groups. Flow velocity was measured using the frame count method. We measured incidence of major adverse limb events (MALE), composed of target lesion revascularization (TLR), non-TLR, and major amputation. Results: At a median follow-up period of 22.7 months, MALE had occurred in 7 (16.3%), 10 (22.7%), and 29 (65.9%) of patients from the high, middle, and low SFA flow velocity groups, respectively (p < 0.001). Kaplan-Meier analysis showed incidence of MALE was significantly higher in the patients of low SFA flow velocity (log-rank test chi(2) = 38.8, p < 0.001). Multivariate analysis found low SFA flow velocity to be an independent predictor for MALE (hazard ratio: 4.42; 95% CI: 2.27 to 8.60; p < 0.001) as was ankle-brachial index. Conclusion: Post-EVT SFA flow velocity for femoropopliteal artery lesions treated with bare metal stents is an independent predictor of limb patency. The frame count method for assessing arterial flow velocity is convenient and has potential for wide applications in EVT.	[Ito, Naruhiko; Hishikari, Keiichi; Yoshikawa, Hiroshi; Tsujihata, Shihoko; Abe, Fumiyuki; Kanno, Yoshinori; Iiya, Munehiro; Murai, Tadashi; Hikita, Hiroyuki; Takahashi, Atsushi] Yokosuka Kyosai Hosp, Dept Cardiol, 1-16 Yonegahama Dori, Yokosuka, Kanagawa 2388558, Japan; [Yonetsu, Taishi; Sasano, Tetsuo] Tokyo Med & Dent Univ, Cardiovasc Med, Bunkyo Ku, Tokyo, Japan		Ito, N (通讯作者)，Yokosuka Kyosai Hosp, Dept Cardiol, 1-16 Yonegahama Dori, Yokosuka, Kanagawa 2388558, Japan.	nito0516@yahoo.co.jp					Aarnoudse W, 2004, CIRCULATION, V110, P2137, DOI 10.1161/01.CIR.0000143893.18451.0E; Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Al-Badri A, 2019, ARTERIOSCL THROM VAS, V39, P1492, DOI 10.1161/ATVBAHA.119.312378; Bonaca MP, 2020, NEW ENGL J MED, V382, P1994, DOI 10.1056/NEJMoa2000052; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Dake MD, 2013, J AM COLL CARDIOL, V61, P2417, DOI 10.1016/j.jacc.2013.03.034; Dake MD, 2011, CIRC-CARDIOVASC INTE, V4, P495, DOI 10.1161/CIRCINTERVENTIONS.111.962324; Dick P, 2009, CATHETER CARDIO INTE, V74, P1090, DOI 10.1002/ccd.22128; Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1; Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286; Heffernan KS, 2010, CLIN CARDIOL, V33, P94, DOI 10.1002/clc.20705; Hikita H, 2009, SCAND CARDIOVASC J, V43, P298, DOI 10.1080/14017430902785493; Ihnat DM, 2008, J VASC SURG, V47, P967, DOI 10.1016/j.jvs.2007.12.050; Iida O, 2011, J ENDOVASC THER, V18, P753, DOI 10.1583/11-3581.1; Ikeoka K, 2018, J ATHEROSCLER THROMB, V25, P1128, DOI 10.5551/jat.43117; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468; Matsue Y, 2014, ATHEROSCLEROSIS, V232, P186, DOI 10.1016/j.atherosclerosis.2013.11.038; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415; Miki K, 2016, HEART VESSELS, V31, P519, DOI 10.1007/s00380-014-0625-1; Narula N, 2018, J AM COLL CARDIOL, V72, P2152, DOI 10.1016/j.jacc.2018.08.002; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Ouwendijk R, 2008, AM J ROENTGENOL, V190, P1349, DOI 10.2214/AJR.07.3359; Rocha-Singh KJ, 2015, CATHETER CARDIO INTE, V86, P164, DOI 10.1002/ccd.25895; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Sakamoto Y, 2013, CATHETER CARDIO INTE, V82, pE251, DOI 10.1002/ccd.24935; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Xu DC, 2013, CAN J CARDIOL, V29, P492, DOI 10.1016/j.cjca.2012.06.014	32	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					39	46	1358863X211025613	10.1177/1358863X211025613		JUL 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000676988400001	34286654				2022-04-28	
J	Cheng, C; Nguyen, MN; Nayernama, A; Jones, SC; Brave, M; Agrawal, S; Amiri-Kordestani, L; Woronow, D				Cheng, Connie; Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S. Christopher; Brave, Michael; Agrawal, Sundeep; Amiri-Kordestani, Laleh; Woronow, Daniel			Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature	VASCULAR MEDICINE			English	Review						arterial aneurysm; arterial dissection; vascular endothelial growth factor; VEGF	TYROSINE KINASE INHIBITORS; ACUTE AORTIC DISSECTION; PATIENT; ANGIOGENESIS; SUNITINIB; THERAPY; CANCER; RISK	The US Food and Drug Administration (FDA) has approved multiple systemic vascular endothelial growth factor (VEGF) inhibitors since 2004 to treat various malignancies. Inhibition of the VEGF signaling pathway can result in impairment of vascular wall integrity through medial degeneration and endothelial dysfunction, potentially resulting in arterial (including aortic) aneurysm/dissection. We performed a postmarketing review to evaluate arterial aneurysm/dissection as a potential safety risk for patients with cancer treated with VEGF inhibitors. We searched the FDA Adverse Event Reporting System (FAERS) database and literature for reports of arterial (including aortic) aneurysm/dissection with VEGF inhibitors currently approved by the FDA for a cancer indication. We identified 240 cases of arterial aneurysm/dissection associated with VEGF inhibitors. The median time to onset of an arterial aneurysm/dissection event from the initiation of a VEGF inhibitor was 94 days (range 1-1955 days). Notably, 22% (53/240) of cases reported fatal outcomes related to arterial aneurysm/dissection. We determined the drug-event association as probable in 15 cases that lacked relevant confounding factors for arterial aneurysm/dissection, which is supported by unremarkable computed tomography (CT) findings prior to starting VEGF inhibitor therapy, despite nondrug-associated background arterial aneurysm/dissection generally demonstrating preexisting arterial abnormalities. FAERS and literature case-level evidence suggests that VEGF inhibitors may have contributed to arterial aneurysm/dissection, as a class effect, based on short onset relative to natural history of disease and biologic plausibility. Cardiovascular and oncology healthcare professionals should be aware of this rare, but life-threatening safety risk associated with VEGF inhibitors.	[Cheng, Connie; Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S. Christopher; Woronow, Daniel] US FDA, Div Pharmacovigilance, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA; [Brave, Michael; Agrawal, Sundeep; Amiri-Kordestani, Laleh] US FDA, Div Oncol, Off Oncol Dis, Ctr Drug Evaluat &, Silver Spring, MD USA		Cheng, C (通讯作者)，US FDA, Div Pharmacovigilance, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	connie.cheng@fda.hhs.gov		Nadeau Nguyen, Michelle/0000-0002-2620-1885			Abe H, 2011, GEN THORAC CARDIOVAS, V59, P559, DOI 10.1007/s11748-010-0694-8; Adachi T, 2018, J VASC SURG CASES IN, V4, P147, DOI 10.1016/j.jvscit.2018.02.003; Adams JN, 1998, LANCET, V352, P1722, DOI 10.1016/S0140-6736(05)79822-6; [Anonymous], 2017, COMMON TERMINOLOGY C; [Anonymous], 2005, US WHO UMC SYST STAN; Aragon-Ching JB, 2008, ACTA ONCOL, V47, P1600, DOI 10.1080/02841860801978905; Berk F., 2008, J NUCL MED, V49, P259; Bhave NM, 2018, JACC-CARDIOVASC IMAG, V11, P903, DOI 10.1016/j.jcmg.2018.03.009; Bonnet C, 2015, REV NEUROL-FRANCE, V171, P677, DOI 10.1016/j.neurol.2015.03.010; Casak SJ, 2018, CLIN CANCER RES, V24, P4365, DOI 10.1158/1078-0432.CCR-18-0566; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Clouse WD, 2004, MAYO CLIN PROC, V79, P176, DOI 10.4065/79.2.176; Cortes JE, 2018, BLOOD, V132, P393, DOI 10.1182/blood-2016-09-739086; CRAWFORD ES, 1986, J VASC SURG, V3, P578, DOI 10.1067/mva.1986.avs0030578; Cuellar S, 2019, AM J HEALTH-SYST PH, V76, P1725, DOI 10.1093/ajhp/zxz190; Formiga MND, 2015, SAO PAULO MED J, V133, P275, DOI 10.1590/1516-3180.2013.7380002; Daneman N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010077; DAPUNT OE, 1994, J THORAC CARDIOV SUR, V107, P1323, DOI 10.1016/S0022-5223(94)70054-0; Edeline J, 2010, ANN ONCOL, V21, P186, DOI 10.1093/annonc/mdp480; El-Kenawi AE, 2013, BRIT J PHARMACOL, V170, P712, DOI 10.1111/bph.12344; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Faraji AH, 2013, CLIN NEUROL NEUROSUR, V115, P632, DOI 10.1016/j.clineuro.2012.06.015; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fornaro L, 2010, ANN ONCOL, V21, P181, DOI [10.1093/annonc/mdp469, 10.1093/annonc/mdp468]; Funahashi Y, 2014, AKTUEL UROL, V45, P132, DOI 10.1055/s-0033-1363274; Germain DP, 2004, ANN GENET-PARIS, V47, P1, DOI 10.1016/j.anngen.2003.07.002; Ghatalia P, 2015, CRIT REV ONCOL HEMAT, V94, P228, DOI 10.1016/j.critrevonc.2014.12.008; Groden PJ, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00220; Harris CG, 2014, ANN CARDIOTHORAC SUR, V3, P339, DOI 10.3978/j.issn.2225-319X.2014.05.10; Hatem R, 2017, CAN J CARDIOL, V33, DOI 10.1016/j.cjca.2017.03.002; Hiranuma K, 2018, TAIWAN J OBSTET GYNE, V57, P750, DOI 10.1016/j.tjog.2018.08.026; HIRSCH A, 2006, J AM COLL CARDIOL, V113, P654; Howard DPJ, 2014, ANN CARDIOTHORAC SUR, V3, P278, DOI 10.3978/j.issn.2225-319X.2014.05.14; Jibawi A, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/516146; Koda Takamaru, 2016, Gan To Kagaku Ryoho, V43, P1815; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Lardieri A, 2018, AM J HEMATOL, V93, pE333, DOI 10.1002/ajh.25220; Lee CC, 2018, J AM COLL CARDIOL, V72, P1369, DOI 10.1016/j.jacc.2018.06.067; Maitland ML, 2009, CLIN CANCER RES, V15, P6250, DOI 10.1158/1078-0432.CCR-09-0058; Mancini MC., 2019, MEDSCAPE; Mantia-Smaldone Gina M, 2013, Gynecol Oncol Case Rep, V5, P37, DOI 10.1016/j.gynor.2013.04.002; Momeni M, 2016, ASIA-PAC J CLIN ONCO, V12, pE196, DOI 10.1111/ajco.12129; Moslehi JJ, 2015, J CLIN ONCOL, V33, P4210, DOI 10.1200/JCO.2015.62.4718; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Murakami S, 2013, INTERNAL MED, V52, P589, DOI 10.2169/internalmedicine.52.6632; Niwa N, 2015, ACTA ONCOL, V54, P561, DOI 10.3109/0284186X.2014.963887; Oshima Y, 2017, CIRCULATION, V135, P815, DOI 10.1161/CIRCULATIONAHA.116.025144; Pacini D, 2008, ANN THORAC SURG, V86, P1518, DOI 10.1016/j.athoracsur.2008.07.039; Pasternak B, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k678; Patel Urvi J, 2017, J Adv Pract Oncol, V8, P757; Rini BI, 2015, TARGET ONCOL, V10, P45, DOI 10.1007/s11523-014-0307-z; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Saussele S, 2020, ACTA HAEMATOL-BASEL, V143, P217, DOI 10.1159/000501927; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Taheri N., 2013, EUR SURG, V45, pS20; Takada M, 2018, INT HEART J, V59, P1174, DOI 10.1536/ihj.17-461; Takenaka T, 2013, INTERACT CARDIOV TH, V16, P270, DOI 10.1093/icvts/ivs489; Touyz RM, 2018, J AM SOC HYPERTENS, V12, P409, DOI 10.1016/j.jash.2018.03.008; Tsuchiya A, 2018, CLIN CASE REP, V6, P1643, DOI 10.1002/ccr3.1674; U.S. Food and Drug Administration (FDA), 2018, QUEST ANSW FDAS ADV; US Department of Health and Human Services Office for Human Research Protections, 2016, EX PUBL BEN SERV, V101; US Food and Drug Administration, 2020, STIVARGA REG TABL; US Food and Drug Administration, 2020, INLYTA AX TABL; US Food and Drug Administration, 2020, NEXAVAR SOR TABL; US Food and Drug Administration, 2020, VOTRIENT PAZ TABL; US Food and Drug Administration, 2020, COMETRIQ CAB TABL; US Food and Drug Administration, 2020, CABOMETYX CAB TABL; US Food and Drug Administration, 2020, LENVIMA LENV CAPS; US Food and Drug Administration, 2020, SUTENT SUN MAL CAPS; US Food and Drug Administration, 2020, CAPRELSA VAND TABL; US Food and Drug Administration, 2020, ZALTRAP ZIV AFL INJ; US Food and Drug Administration, 2020, CYRAMZA RAM INJ; US Food and Drug Administration, 2020, ICLUSIG PON TABL; US Food and Drug Administration, 2020, AVASTIN BEV INJ; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Verma S, 2014, NEW ENGL J MED, V370, P1920, DOI 10.1056/NEJMra1207059; Waliany S, 2019, JACC-CARDIOONCOL, V1, P24, DOI 10.1016/j.jaccao.2019.08.012; Wiles B, 2021, J VASC SURG, V73, P850, DOI 10.1016/j.jvs.2020.05.069; Xu L, 2017, CLIN RES HEPATOL GAS, V41, pE24, DOI 10.1016/j.clinre.2016.12.005; Zenoni D, 2020, EUR J HOSP PHARM, V27, P117, DOI 10.1136/ejhpharm-2019-001879; Zirlik K, 2018, ONCOL RES TREAT, V41, P166, DOI 10.1159/000488087	83	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					526	534	1358863X211006470	10.1177/1358863X211006470		APR 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000641096100001	33840328				2022-04-28	
J	Lee, YH; Cha, SI; Park, J; Lim, JK; Lee, WK; Park, JE; Choi, SH; Seo, H; Yoo, SS; Lee, SY; Lee, J; Kim, CH; Park, JY				Lee, Yong Hoon; Cha, Seung-Ick; Park, Jongmin; Lim, Jae Kwang; Lee, Won Kee; Park, Ji-Eun; Choi, Sun Ha; Seo, Hyewon; Yoo, Seung-Soo; Lee, Shin-Yup; Lee, Jaehee; Kim, Chang-Ho; Park, Jae-Yong			History of ischemic stroke associated with worse clinical outcomes in patients with pulmonary embolism	VASCULAR MEDICINE			English	Letter; Early Access						computed tomography (CT); pulmonary embolism (PE); stroke	VENOUS THROMBOEMBOLISM		[Lee, Yong Hoon; Cha, Seung-Ick; Park, Ji-Eun; Choi, Sun Ha; Seo, Hyewon; Yoo, Seung-Soo; Lee, Shin-Yup; Lee, Jaehee; Kim, Chang-Ho; Park, Jae-Yong] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Park, Jongmin; Lim, Jae Kwang] Kyungpook Natl Univ, Sch Med, Dept Radiol, Daegu, South Korea; [Lee, Won Kee] Kyungpook Natl Univ, Med Res Collaborat Ctr, Biostat, Daegu, South Korea		Cha, SI (通讯作者)，Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea.	sicha@knu.ac.kr		PARK, JONGMIN/0000-0001-9240-4181			Arboix A, 2015, WORLD J CLIN CASES, V3, P418, DOI 10.12998/wjcc.v3.i5.418; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Keller K, 2020, J NEUROL SCI, V419, DOI 10.1016/j.jns.2020.117174; Nauffal D, 2012, J THROMB HAEMOST, V10, P1752, DOI 10.1111/j.1538-7836.2012.04829.x; Piazza G, 2014, CLIN APPL THROMB-HEM, V20, P43, DOI 10.1177/1076029613487430; Pongmoragot J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000372; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Turpie AGG, 2002, BMJ-BRIT MED J, V325, P887, DOI 10.1136/bmj.325.7369.887; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	9	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.											1358863X211055772	10.1177/1358863X211055772		NOV 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XH8QQ	WOS:000725692800001	34802301				2022-04-28	
J	Comia, MA; Samonte, P				Comia, Marrah Angela; Samonte, Precious			A case report on hybrid procedure in the treatment of a 75-year-old male with thoracoabdominal aneurysm	VASCULAR MEDICINE			English	Meeting Abstract									[Comia, Marrah Angela; Samonte, Precious] Philippine Heart Ctr, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1403	NP31	NP31					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100070					2022-04-28	
J	Peritz, D; Henkin, S				Peritz, David; Henkin, Stan			Multiple intra-cardiac thrombi associated with acute pulmonary embolism	VASCULAR MEDICINE			English	Meeting Abstract									[Peritz, David; Henkin, Stan] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1294	NP26	NP26					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100060					2022-04-28	
J	Raja, A; Wadhera, R; Chen, SY; Choi, E; Shen, C; Figueroa, J; Yeh, R; Secemsky, E				Raja, Aishwarya; Wadhera, Rishi; Chen, Siyan; Choi, Eunhee; Shen, Changyu; Figueroa, Jose; Yeh, Robert; Secemsky, Eric			Association of clinical setting with sociodemographics and outcomes following endovascular femoropopliteal artery revascularization	VASCULAR MEDICINE			English	Meeting Abstract									[Raja, Aishwarya; Wadhera, Rishi; Chen, Siyan; Choi, Eunhee; Shen, Changyu; Yeh, Robert; Secemsky, Eric] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA; [Shen, Changyu; Figueroa, Jose; Yeh, Robert; Secemsky, Eric] Harvard Med Sch, Boston, MA 02115 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1303	NP8	NP9					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100029					2022-04-28	
J	Samson, A; Patricio, M; Beluso, MV; Nava, N; Alajar, E				Samson, Ace; Patricio, Marion; Beluso, Michael Vic; Nava, Nalene; Alajar, Elaine			Quality of care and outcomes of lower extremity peripheral artery disease (PAD) on adult diabetic patients admitted in a tertiary hospital in the Philippines	VASCULAR MEDICINE			English	Meeting Abstract									[Samson, Ace; Patricio, Marion; Beluso, Michael Vic; Nava, Nalene; Alajar, Elaine] Univ Philippines, Philippine Gen Hosp, Manila, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1425	NP20	NP21					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100048					2022-04-28	
J	Tanda, E; Ruiu, G; Pistincu, G; Camparini, S				Tanda, Elisabetta; Ruiu, Giovanni; Pistincu, Giulia; Camparini, Stefano			Images in vascular medicine: Foreign body reaction to surgical clips after subfascial endoscopic perforator surgery	VASCULAR MEDICINE			English	Editorial Material									[Tanda, Elisabetta; Ruiu, Giovanni; Pistincu, Giulia; Camparini, Stefano] San Michele Hosp, Vasc Surg Serv, Cardiovasc Dept, ARNAS G Brotzu, Cagliari, CA, Italy; [Tanda, Elisabetta; Pistincu, Giulia] Univ Cagliari, Dept Surg, Monserrato, CA, Italy		Tanda, E (通讯作者)，San Michele Hosp, Cardiovasc Dept, Vasc Surg, ARNAS Brotzu, Piazzale Alessandro Ricchi 1, I-09134 Cagliari, CA, Italy.	tanda.elisabetta@gmail.com					Iafrati MD, 2002, J VASC SURG, V36, P1167, DOI 10.1067/mva.2002.129642; Lurie F, 2019, RUTHERFORDS VASCULAR, P2067	2	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					670	671	1358863X211015314	10.1177/1358863X211015314		MAY 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000652892100001	34016001	Bronze			2022-04-28	
J	Newman, J; Brailovsky, Y; Allen, S; Bontekoe, E; Masic, D; Walenga, J; Fareed, J; Darki, A				Newman, Joshua; Brailovsky, Yevgeniy; Allen, Sorcha; Bontekoe, Emily; Masic, Dalila; Walenga, Jeanine; Fareed, Jawed; Darki, Amir			Angiopoietin-2 correlates with pulmonary embolism severity, right ventricular dysfunction, and intensive care unit admission	VASCULAR MEDICINE			English	Article						biomarkers; pulmonary embolism (PE); risk stratification		Risk stratification of acute pulmonary embolism (PE) is important to identify patients at risk for hemodynamic collapse who would benefit from more aggressive therapies. Angiopoietin-2 (Ang-2) is a signaling molecule involved in angiogenesis and is upregulated in response to tissue hypoxia. We aimed to assess the association of Ang-2 with (1) PE severity, (2) echocardiographic and invasive hemodynamic markers of right ventricular (RV) dysfunction, and (3) need for intensive treatment. Patients presenting to our institution with acute PE were included in a prospective database and blood samples were collected and stored for later analysis. A total of 65 patients were included in the study. Ang-2 correlated with PE risk stratification and echocardiographic and invasive hemodynamic markers of RV dysfunction and pulmonary hypertension. An Ang-2 level of > 4101 pg/mL had an odds ratio of 7.4 (95% CI: 1.53-12.5, p < 0.01) for intensive care unit (ICU) admission. In conclusion, Ang-2 correlates with PE severity, RV dysfunction, and need for ICU admission. Ang-2 holds promise as a novel marker that can aid in risk stratification for this patient population.	[Newman, Joshua; Allen, Sorcha; Masic, Dalila; Darki, Amir] Loyola Univ Med Ctr, Div Cardiovasc Med, Dept Med, Maywood, IL 60153 USA; [Brailovsky, Yevgeniy] Sidney Kimmel Sch Med, Jefferson Heart Inst, Adv Heart Failure Mech Circulatory Support Heart, Philadelphia, PA USA; [Bontekoe, Emily; Walenga, Jeanine; Fareed, Jawed] Loyola Univ Chicago, Cardiovasc Res Inst, Hlth Sci Campus, Maywood, IL USA		Newman, J (通讯作者)，Loyola Univ Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.	Joshua.Newman@lumc.edu		Masic, Dalila/0000-0002-1621-9571; Newman, Joshua/0000-0003-1706-0985	Loyola University Chicago Health Science's Campus Cardiovascular Research Institute	This work was supported by a grant from the Loyola University Chicago Health Science's Campus Cardiovascular Research Institute. The funder had no role in the study design, data analysis, or manuscript preparation.	Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Barnes GD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10779; Becattini C, 2008, THROMB HAEMOSTASIS, V100, P747, DOI 10.1160/TH08-06-0356; Bova C, 2014, EUR RESPIR J, V44, P694, DOI 10.1183/09031936.00006114; Eleuteri E, 2011, EUR J CARDIOV PREV R, V18, P607, DOI 10.1177/1741826710389410; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Jaquet E, 2018, J THROMB HAEMOST, V16, P1313, DOI 10.1111/jth.14137; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Kumpers P, 2010, EUR HEART J, V31, P2291, DOI 10.1093/eurheartj/ehq226; Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Link A, 2013, EUR HEART J, V34, P1651, DOI 10.1093/eurheartj/ehs487; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Poss J, 2015, EUR J HEART FAIL, V17, P1152, DOI 10.1002/ejhf.342; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Wendelboe AM, 2016, CIRC RES, V118, P1340, DOI 10.1161/CIRCRESAHA.115.306841; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zondag W, 2011, J THROMB HAEMOST, V9, P1500, DOI 10.1111/j.1538-7836.2011.04388.x	20	1	1	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					556	560	1358863X211002276	10.1177/1358863X211002276		APR 2021	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000641120300001	33840325				2022-04-28	
J	Msheik, A; Kaspar, C; Mailhac, A; Hoballah, JJ; Tamim, H; Dakik, HA				Msheik, Ahmad; Kaspar, Chris; Mailhac, Aurelie; Hoballah, Jamal J.; Tamim, Hani; Dakik, Habib A.			Performance of the AUB-HAS2 Cardiovascular Risk Index in vascular surgery patients	VASCULAR MEDICINE			English	Article						AUB-HAS2 index; preoperative cardiovascular evaluation; vascular surgery; risk assessment		The American University of Beirut (AUB)-HAS2 risk index is a recently published tool for preoperative cardiovascular evaluation. It is based on six data elements: history of Heart disease, symptoms of Heart disease (angina or dyspnea), Age > 75 years, Anemia (hemoglobin < 12 mg/dL), emergency Surgery, and vascular Surgery. This study analyzes the performance of a modified AUB-HAS2 index (excluding the vascular surgery element) in a broad spectrum of vascular surgery procedures. The study population consisted of 90,476 vascular surgeries registered in the American College of Surgeons National Surgical Quality Improvement Program database. The performance of the AUB-HAS2 index was studied in seven groups: carotid endarterectomy (CEA), open abdominal aortic aneurysm surgical repair (OAAA), endovascular aortic aneurysm repair, supra-inguinal bypass, infra-inguinal bypass, lower extremity thrombo-endarterectomy, and lower extremity angioplasty. The outcome measure was death, myocardial infarction, or stroke at 30 days after surgery. Each patient was given an AUB-HAS2 score of 0, 1, 2, or > 2 depending on the number of data elements s/he has. The AUB-HAS2 index was able to stratify risk in the majority of patients into low (< 3%, score 0), intermediate (3-10%, score 1-2), and high (> 10%, score > 2) (p < 0.0001). The receiver operating curve had an area of 0.71 in the overall group and it ranged from 0.60 in CEA patients to 0.75 in OAAA patients. In conclusion, the AUB-HAS2 index is a simple tool that can quickly and effectively stratify the risk of patients undergoing a broad spectrum of vascular surgeries into low, intermediate, and high.	[Msheik, Ahmad; Kaspar, Chris; Dakik, Habib A.] Amer Univ Beirut, Dept Internal Med, Med Ctr, Beirut, Lebanon; [Mailhac, Aurelie; Tamim, Hani] Amer Univ Beirut, Med Ctr, Biostat Unit, Beirut, Lebanon; [Hoballah, Jamal J.] Amer Univ Beirut, Med Ctr, Dept Surg, Beirut, Lebanon		Dakik, HA (通讯作者)，Amer Univ Beirut, Beirut 11072020, Lebanon.	hd01@aub.edu.lb		Dakik, Habib/0000-0001-6436-600X			American College of Surgeons, 2017, USER GUIDE 2015 ACS; Bertges DJ, 2016, J VASC SURG, V64, P1411, DOI 10.1016/j.jvs.2016.04.045; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385; Dakik HA, 2022, EUR HEART J-QUAL CAR, V8, P96, DOI 10.1093/ehjqcco/qcaa077; Dakik HA, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.016228; Dakik HA, 2019, J AM COLL CARDIOL, V73, P3067, DOI 10.1016/j.jacc.2019.04.023; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Gualandro DM, 2017, J VASC SURG, V66, P1826, DOI 10.1016/j.jvs.2017.05.100; Gupta PK, 2013, J VASC SURG, V57, P318, DOI 10.1016/j.jvs.2012.08.116; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Landesberg G, 2004, J AM COLL CARDIOL, V44, P569, DOI 10.1016/j.jacc.2004.03.073; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Mackey WC, 2006, J VASC SURG, V43, P533, DOI 10.1016/j.jvs.2005.11.013; Ramanan B, 2013, J VASC SURG, V58, P871, DOI 10.1016/j.jvs.2013.03.024; Volkers EJ, 2018, STROKE, V49, P1880, DOI 10.1161/STROKEAHA.117.020486	17	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					535	541	1358863X21996806	10.1177/1358863X21996806		APR 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000637148700001	33813967				2022-04-28	
J	Finn, MT; Gogia, S; Ingrassia, JJ; Cohen, M; Madhavan, MV; Nouri, SN; Brailovsky, Y; Masoumi, A; Fried, JA; Uriel, N; Agerstrand, CI; Eisenberger, A; Einstein, AJ; Brodie, D; Rosenzweig, EB; Leon, MB; Takeda, K; Pucillo, A; Green, P; Kirtane, AJ; Parikh, SA; Sethi, SS				Finn, Matthew T.; Gogia, Shawn; Ingrassia, Joseph J.; Cohen, Matthew; Madhavan, Mahesh, V; Nabavi Nouri, Shayan; Brailovsky, Yevgeniy; Masoumi, Amir; Fried, Justin A.; Uriel, Nir; Agerstrand, Cara, I; Eisenberger, Andrew; Einstein, Andrew J.; Brodie, Daniel; Rosenzweig, Erika; Leon, Martin B.; Takeda, Koji; Pucillo, Anthony; Green, Philip; Kirtane, Ajay J.; Parikh, Sahil A.; Sethi, Sanjum S.			Pulmonary Embolism Response Team utilization during the COVID-19 pandemic	VASCULAR MEDICINE			English	Article						COVID-19; pulmonary embolism response team (PERT); venous thromboembolism		Coronavirus disease 2019 (COVID-19) may predispose patients to venous thromboembolism (VTE). Limited data are available on the utilization of the Pulmonary Embolism Response Team (PERT) in the setting of the COVID-19 global pandemic. We performed a single-center study to evaluate treatment, mortality, and bleeding outcomes in patients who received PERT consultations in March and April 2020, compared to historical controls from the same period in 2019. Clinical data were abstracted from the electronic medical record. The primary study endpoints were inpatient mortality and GUSTO moderate-to-severe bleeding. The frequency of PERT utilization was nearly threefold higher during March and April 2020 (n = 74) compared to the same period in 2019 (n = 26). During the COVID-19 pandemic, there was significantly less PERT-guided invasive treatment (5.5% vs 23.1%, p = 0.02) with a numerical but not statistically significant trend toward an increase in the use of systemic fibrinolytic therapy (13.5% vs 3.9%, p = 0.3). There were nonsignificant trends toward higher in-hospital mortality or moderate-to-severe bleeding in patients receiving PERT consultations during the COVID-19 period compared to historical controls (mortality 14.9% vs 3.9%, p = 0.18 and moderate-to-severe bleeding 35.1% vs 19.2%, p = 0.13). In conclusion, PERT utilization was nearly threefold higher during the COVID-19 pandemic than during the historical control period. Among patients evaluated by PERT, in-hospital mortality or moderate-to-severe bleeding were not significantly different, despite being numerically higher, while invasive therapy was utilized less frequently during the COVID-19 pandemic.	[Finn, Matthew T.; Gogia, Shawn; Cohen, Matthew; Madhavan, Mahesh, V; Nabavi Nouri, Shayan; Brailovsky, Yevgeniy; Masoumi, Amir; Fried, Justin A.; Uriel, Nir; Einstein, Andrew J.; Rosenzweig, Erika; Leon, Martin B.; Pucillo, Anthony; Green, Philip; Kirtane, Ajay J.; Parikh, Sahil A.; Sethi, Sanjum S.] Columbia Irving Med Ctr, Dept Cardiol, New York, NY USA; [Finn, Matthew T.; Madhavan, Mahesh, V; Uriel, Nir; Leon, Martin B.; Kirtane, Ajay J.; Parikh, Sahil A.; Sethi, Sanjum S.] Cardiovasc Res Fdn, New York, NY USA; [Ingrassia, Joseph J.] Hartford Hosp, Intevent Cardiol, Hartford, CT 06115 USA; [Agerstrand, Cara, I; Brodie, Daniel] Columbia Irving Med Ctr, Dept Pulmonol, New York, NY USA; [Eisenberger, Andrew] Columbia Irving Med Ctr, Dept Hematol Oncol, New York, NY USA; [Rosenzweig, Erika] Columbia Irving Med Ctr, Dept Pediat Cardiol, New York, NY USA; [Takeda, Koji] Columbia Irving Med Ctr, Dept Cardiothorac Surg, New York, NY USA		Sethi, SS (通讯作者)，Columbia Univ, Med Ctr, Div Cardiol, 161 Ft Washington Ave,Herbert Irving Pavil, New York, NY 10032 USA.	sss2270@cumc.columbia.edu	Sethi, Sanjum S./AAO-2601-2020	Sethi, Sanjum S./0000-0002-3438-7034; Cohen, Matthew/0000-0001-9087-2678	American Heart Association COVID-19 Rapid Response Grant ResearchAmerican Heart Association; National Heart, Lung, and Blood Institute of the US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL007854]	This research was supported by the American Heart Association COVID-19 Rapid Response Grant Research. This research was further supported by an institutional grant (to Dr Madhavan) from the National Heart, Lung, and Blood Institute of the US National Institutes of Health to Columbia University Irving Medical Center (T32 HL007854).	Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Chauhan AJ, 2020, J THROMB HAEMOST, V18, P2110, DOI 10.1111/jth.14981; Colling ME, 2020, VASC MED, V25, P471, DOI 10.1177/1358863X20932640; Connors JM, 2020, J THROMB HAEMOST, V18, P1559, DOI 10.1111/jth.14849; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Mossa-Basha Mahmud, 2020, Radiology, V296, pE26, DOI 10.1148/radiol.2020201326; Ng JJ, 2020, J INFECTION, V81, P661, DOI 10.1016/j.jinf.2020.05.009; Patel MR, 2015, J AM COLL CARDIOL, V65, P931, DOI 10.1016/j.jacc.2014.12.036; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; Prasad N, 2020, INDIAN J NEPHROL, V30, P161, DOI 10.4103/ijn.IJN_120_20; Provias Tim, 2014, Hosp Pract (1995), V42, P31, DOI 10.3810/hp.2014.02.1089; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.7681, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Root CW, 2018, J MULTIDISCIP HEALTH, V11, P187, DOI 10.2147/JMDH.S151196; Schultz J, 2019, PULM CIRC, V9, DOI 10.1177/2045894018824563; Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018; Stam HJ, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2677; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Vranckx P, 2016, J AM COLL CARDIOL, V67, P2135, DOI 10.1016/j.jacc.2016.02.056	23	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					426	433	1358863X21995896	10.1177/1358863X21995896		APR 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000637140200001	33818200	Green Published, hybrid			2022-04-28	
J	Foley, KM; Kennedy, KF; Secemsky, EA; Goodney, PP; Shishehbor, MH; Banerjee, S; Soukas, P; Hyder, ON; Abbott, JD; Aronow, HD				Foley, Katelyn M.; Kennedy, Kevin F.; Secemsky, Eric A.; Goodney, Phillip P.; Shishehbor, Mehdi H.; Banerjee, Subhash; Soukas, Peter; Hyder, Omar N.; Abbott, J. Dawn; Aronow, Herbert D.			Critical limb ischemia treatment variability in the us: an analysis of the 2016-2018 nationwide inpatient sample	VASCULAR MEDICINE			English	Meeting Abstract									[Foley, Katelyn M.; Soukas, Peter; Hyder, Omar N.; Abbott, J. Dawn; Aronow, Herbert D.] Brown Univ, Providence, RI 02912 USA; [Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Shishehbor, Mehdi H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Banerjee, Subhash] Univ Texas Southwestern, Dallas, TX USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1414	NP19	NP20					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100046					2022-04-28	
J	Jegonia, FJ; Posas, FE; Martinez, M; Alzate, F; Cuezon, T; Mendoza, EF; San Miguel, CA				Jegonia, Felisse Julien; Posas, Fabio Enrique; Martinez, Marvin; Alzate, Ferdinand; Cuezon, Terence; Mendoza, Elisa Francesca; San Miguel, Camille Anne			Hybrid superior mesenteric artery and celiac artery bypass grafting from the right external iliac artery after aorto-bilateral common iliac artery endovascular repair in an 84-year-old Filipino with chronic mesenteric ischemia and extensive vasculopathy	VASCULAR MEDICINE			English	Meeting Abstract									[Jegonia, Felisse Julien; Posas, Fabio Enrique; Martinez, Marvin; Alzate, Ferdinand; Cuezon, Terence; Mendoza, Elisa Francesca; San Miguel, Camille Anne] St Lukes Med Ctr Global City, Taguig, Metro Manila, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1239	NP24	NP25					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100056					2022-04-28	
J	Rodriguez, ZK; Magsombol, EB				Rodriguez, Zabrina Kay; Magsombol, Edward Benjie			Conservatively treated complicated penetrating atherosclerotic ulcer of the infrarenal aorta and left common iliac artery in a 79-year-old patient with advanced atherosclerosis of the coronary and peripheral arteries - a case report	VASCULAR MEDICINE			English	Meeting Abstract									[Rodriguez, Zabrina Kay; Magsombol, Edward Benjie] St Lukes Med Ctr Quezon City, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1421	NP33	NP34					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100074					2022-04-28	
J	Song, M; Haymart, B; Kong, XW; Ali, M; Kozlowski, J; Krol, G; Kaatz, S; Froehlich, J; Barnes, G				Song, Melinda; Haymart, Brian; Kong, Xiaowen; Ali, Mona; Kozlowski, Jay; Krol, Gregory; Kaatz, Scott; Froehlich, James; Barnes, Geoff			Combination antithrombotic therapy and bleeding risk: comparing atrial fibrillation and venous thromboembolism	VASCULAR MEDICINE			English	Meeting Abstract									[Song, Melinda; Haymart, Brian; Kong, Xiaowen; Froehlich, James; Barnes, Geoff] Univ Michigan, Ann Arbor, MI 48109 USA; [Ali, Mona] Beaumont Hosp, Royal Oak, MI USA; [Kozlowski, Jay] Detroit Med Ctr, Detroit, MI USA; [Krol, Gregory; Kaatz, Scott] Henry Ford Hosp, Detroit, MI 48202 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1320	NP10	NP10					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100031					2022-04-28	
J	Wheeler, J; Neelati, S				Wheeler, Jason; Neelati, Siri			Portal vein anastomotic stent thrombosis in a polycythemia vera patient after liver transplant	VASCULAR MEDICINE			English	Meeting Abstract									[Wheeler, Jason; Neelati, Siri] Cleveland Clin, Cleveland, OH 44106 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1439	NP37	NP37					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100081					2022-04-28	
J	Khoury, SR; Ratchford, EV				Khoury, Shireen R.; Ratchford, Elizabeth, V			Vascular Medicine Patient Information Page: Subclavian artery stenosis	VASCULAR MEDICINE			English	Article						peripheral artery disease (PAD); subclavian steal; subclavian artery stenosis			[Khoury, Shireen R.; Ratchford, Elizabeth, V] Johns Hopkins Univ, Johns Hopkins Ctr Vasc Med, Sch Med, 600 North Wolfe St, Baltimore, MD 21287 USA; [Khoury, Shireen R.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Khoury, Shireen R.; Ratchford, Elizabeth, V] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Dept Med, Div Cardiol,Sch Med, Baltimore, MD 21287 USA		Ratchford, EV (通讯作者)，Johns Hopkins Univ, Johns Hopkins Ctr Vasc Med, Sch Med, 600 North Wolfe St, Baltimore, MD 21287 USA.	evr@jhmi.edu					Khoury SR, 2020, VASC MED, V25, P507, DOI 10.1177/1358863X20947471; Khoury SR, 2018, VASC MED, V23, P293, DOI 10.1177/1358863X18764836; Litwok Y, 2016, VASC MED, V21, P396, DOI 10.1177/1358863X16650514; Ochoa VM, 2011, VASC MED, V16, P29, DOI 10.1177/1358863X10384174; Ratchford EV, 2017, VASC MED, V22, P442, DOI 10.1177/1358863X17722212	5	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					464	468	1358863X211021160	10.1177/1358863X211021160		JUN 2021	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000666618200001	34154465				2022-04-28	
J	Hammad, TA; Shishehbor, MH				Hammad, Tarek A.; Shishehbor, Mehdi H.			Advances in chronic limb-threatening ischemia	VASCULAR MEDICINE			English	Editorial Material						technology; peripheral artery disease (PAD); wound; revascularization; endovascular	BALLOON ANGIOPLASTY; INFRAPOPLITEAL		Univ Hosp, Harrington Heart & Vasc Inst, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA		Shishehbor, MH (通讯作者)，Case Western Reserve Univ, Sch Med, Harrington Heart & Vasc Inst, Univ Hosp Cleveland, 11100 Euclid Ave,Lakeside 3rd Floor, Cleveland, OH 44106 USA.	shishem@gmail.com					Adams G, 2020, J ENDOVASC THER, V27, P473, DOI 10.1177/1526602820914598; Agarwal S, 2016, J AM COLL CARDIOL, V67, P1901, DOI 10.1016/j.jacc.2016.02.040; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Brodmann M, 2018, J ENDOVASC THER, V25, P499, DOI 10.1177/1526602818783989; BUNTE M, 2013, J ENDOVASC THER, V15, P363; Cioppa A, 2012, CARDIOVASC REVASCULA, V13, P219, DOI 10.1016/j.carrev.2012.04.007; DOTTER C, 1964, EUR HEART J, V30, P654; DUFF S, 2019, CIRC-CARDIOVASC INTE, V15, P187; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; GRAY W, 2019, CARDIOVASC REVASCULA, V12, P2375; Hammad TA, 2020, J ENDOVASC THER, V27, P669, DOI 10.1177/1526602820919951; Katsanos K, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.011245; Muller-Hulsbeck S, 2021, CARDIOVASC INTER RAD, V44, P368, DOI 10.1007/s00270-020-02693-1; Mustapha JA, 2020, VASC HEALTH RISK MAN, V16, P57, DOI 10.2147/VHRM.S230934; Mustapha JA, 2019, J INVASIVE CARDIOL, V31, P205; Nordanstig J, 2020, NEW ENGL J MED, V383, P2538, DOI 10.1056/NEJMoa2005206; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Payne DM, 2020, NTR; Rastan A, 2012, J AM COLL CARDIOL, V60, P587, DOI 10.1016/j.jacc.2012.04.035; Rocha-Singh KJ, 2020, CIRCULATION, V141, P1859, DOI 10.1161/CIRCULATIONAHA.119.044697; Scheinert D, 2012, J AM COLL CARDIOL, V60, P2290, DOI 10.1016/j.jacc.2012.08.989; SHISHEHBOR M, 2016, CURR CARDIOL REP, V63, P1311; SHISHEHBOR M, 2016, EUR J VASC ENDOVASC, V68, P2002; Shishehbor MH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012524; Spreen MI, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.114.002376; TENDERA M, 2011, J AM COLL CARDIOL, V32, P2851; Zeller T, 2014, J AM COLL CARDIOL, V64, P1568, DOI 10.1016/j.jacc.2014.06.1198	27	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		126	130		10.1177/1358863X21998436			5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000638263600003	33825578	Bronze			2022-04-28	
J	Lanzi, S; Boichat, J; Calanca, L; Aubertin, P; Malatesta, D; Mazzolai, L				Lanzi, Stefano; Boichat, Joel; Calanca, Luca; Aubertin, Pauline; Malatesta, Davide; Mazzolai, Lucia			Gait changes after supervised exercise training in patients with symptomatic lower extremity peripheral artery disease	VASCULAR MEDICINE			English	Article						intermittent claudication; lower limb strengthening; multimodal training; Nordic walking; vascular rehabilitation; walking		This study aimed to investigate the effects of supervised exercise training (SET) on walking performance and spatiotemporal gait changes in patients with symptomatic lower extremity peripheral artery disease (PAD). In this single-arm prospective nonrandomized cohort study, patients with Fontaine stage II PAD following a 3-month SET program were included. Before and after SET, a constant-load treadmill test was performed to determine the pain-free and maximal walking distances (PFWD and MWD, respectively). During this test, spatiotemporal gait parameters were assessed. The ankle-brachial index (ABI) and toe-brachial index (TBI) were also measured. Twenty-seven patients with PAD (64.0 +/- 1.9 y, 74% men) were included. Following SET, the PFWD (+68%; p = 0.001) and MWD (+79%; p <= 0.001) significantly increased. The ABI and TBI did not change significantly. Following SET, the stride duration, stride frequency, stride length, and double support phase duration did not change significantly. In contrast, subphases of stance showed significant changes: the loading response (+8%; p = 0.03) and foot-flat (+2%; p = 0.01) phases were significantly longer, whereas the push-off phase (-7%; p = 0.002) was significantly shorter. A significant positive correlation was found between changes in the foot-flat phase and changes in PFWD (r = 0.43, p = 0.03). A significant negative correlation was found between changes in the push-off phase and changes in PFWD (r = -0.39, p = 0.05). No significant correlations were found between changes in relative durations of the subphases of stance and MWD. These results indicate that changes in temporal gait parameters during the foot contact phase potentially constitute an underlying mechanism of delayed claudication distance in patients with symptomatic PAD.	[Lanzi, Stefano; Boichat, Joel; Calanca, Luca; Aubertin, Pauline; Mazzolai, Lucia] Lausanne Univ Hosp, Heart & Vessel Dept, Div Angiol, Ch Mt Paisible 18, CH-1011 Lausanne, Switzerland; [Aubertin, Pauline; Malatesta, Davide] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland		Lanzi, S (通讯作者)，Lausanne Univ Hosp, Heart & Vessel Dept, Div Angiol, Ch Mt Paisible 18, CH-1011 Lausanne, Switzerland.	stefano.lanzi@chuv.ch	Malatesta, Davide/G-5812-2012	Malatesta, Davide/0000-0003-3905-5642; Lanzi, Stefano/0000-0003-1089-6309			Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Calanca L, 2020, VASC ENDOVASC SURG, V54, P605, DOI 10.1177/1538574420940090; Cavagna GA, 2000, J PHYSIOL-LONDON, V528, P657, DOI 10.1111/j.1469-7793.2000.00657.x; Celis R, 2009, J VASC SURG, V49, P127, DOI 10.1016/j.jvs.2008.08.013; Chen SJ, 2008, J BIOMECH, V41, P2506, DOI 10.1016/j.jbiomech.2008.05.011; Crowther RG, 2008, J VASC SURG, V47, P303, DOI 10.1016/j.jvs.2007.10.038; Crowther RG, 2007, J VASC SURG, V45, P1172, DOI 10.1016/j.jvs.2007.01.060; Crowther RG, 2009, HUM MOVEMENT SCI, V28, P494, DOI 10.1016/j.humov.2009.04.003; Dadashi F, 2014, SENSORS-BASEL, V14, P443, DOI 10.3390/s140100443; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Frank U, 2019, VASA, V48, P7, DOI 10.1024/0301-1526/a000834; Gardner AW, 2010, J VASC SURG, V51, P628, DOI 10.1016/j.jvs.2009.09.053; Gardner AW, 2001, J GERONTOL A-BIOL, V56, pM454, DOI 10.1093/gerona/56.7.M454; Gardner AW, 2001, VASC MED, V6, P31, DOI 10.1191/135886301677047365; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Gommans LNM, 2017, J VASC SURG, V66, P515, DOI 10.1016/j.jvs.2017.02.033; Haga M, 2020, J VASC SURG, V71, P979, DOI 10.1016/j.jvs.2019.06.188; King S, 2012, CLIN BIOMECH, V27, P845, DOI 10.1016/j.clinbiomech.2012.05.002; Koutakis P, 2010, J VASC SURG, V52, P340, DOI 10.1016/j.jvs.2010.03.005; Lane R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub4; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Myers SA, 2015, REHABIL RES PRACT, V2015, DOI 10.1155/2015/124023; Oakley C, 2008, EUR J VASC ENDOVASC, V36, P689, DOI 10.1016/j.ejvs.2008.06.036; Parmenter BJ, 2015, VASC MED, V20, P30, DOI 10.1177/1358863X14559092; Parmenter BJ, 2015, SPORTS MED, V45, P231, DOI 10.1007/s40279-014-0261-z; Parmenter BJ, 2011, ATHEROSCLEROSIS, V218, P1, DOI 10.1016/j.atherosclerosis.2011.04.024; Radegran G, 1998, AM J PHYSIOL-HEART C, V274, pH314, DOI 10.1152/ajpheart.1998.274.1.H314; Regensteiner JG, 2008, VASC MED, V13, P15, DOI 10.1177/1358863X07084911; Schieber MN, 2020, J VASC SURG, V71, P575, DOI 10.1016/j.jvs.2019.05.044; Schieber MN, 2017, J VASC SURG, V66, P178, DOI 10.1016/j.jvs.2017.01.051; Stewart KJ, 2002, NEW ENGL J MED, V347, P1941, DOI 10.1056/NEJMra021135; Szymczak M, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0727-1; Treat-Jacobson D, 2019, CIRCULATION, V139, pE10, DOI 10.1161/CIR.0000000000000623; Vieira MF, 2017, ANN BIOMED ENG, V45, P1560, DOI 10.1007/s10439-017-1820-x	37	4	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					259	266	1358863X20984831	10.1177/1358863X20984831		FEB 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000620762700001	33571070				2022-04-28	
J	Bonou, M; Kapelios, CJ; Athanasiadi, E; Mavrogeni, SI; Psichogiou, M; Barbetseas, J				Bonou, Maria; Kapelios, Chris J.; Athanasiadi, Eleni; Mavrogeni, Sophie, I; Psichogiou, Mina; Barbetseas, John			Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV	VASCULAR MEDICINE			English	Review						atherosclerosis; cardiomyopathy; HIV; multi-modality imaging; peripheral artery disease (PAD); risk stratification		Cardiovascular disease (CVD) has emerged as a leading cause of non-HIV-related mortality among people living with HIV (PLWH). Despite the growing CVD burden in PLWH, there is concern that general population risk score models may underestimate CVD risk in these patients. Imaging modalities have received mounting attention lately to better understand the pathophysiology of subclinical CVD and provide improved risk assessment in this population. To date, traditional and well-established techniques such as echocardiography, pulse wave velocity, and carotid intima thickness continue to be the basis for the diagnosis and subsequent monitoring of vascular atherosclerosis and heart failure. Furthermore, novel imaging tools such as cardiac computed tomography (CT) and cardiac CT angiography (CCTA), positron emission tomography/CT (PET/CT), and cardiac magnetic resonance (CMR) have provided new insights into accelerated cardiovascular abnormalities in PLWH and are currently evaluated with regards to their potential to improve risk stratification.	[Bonou, Maria; Kapelios, Chris J.; Athanasiadi, Eleni; Barbetseas, John] Laikon Gen Hosp, Dept Cardiol Dept, Athens, Greece; [Mavrogeni, Sophie, I] Onassis Cardiac Surg Ctr, Cardiol Clin, Athens, Greece; [Psichogiou, Mina] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Sch Med, Dept Internal Med 1, Athens, Greece		Kapelios, CJ (通讯作者)，Laikon Gen Hosp, Cardiol Dept, 17 Agiou Thoma St, Athens 11527, Greece.	chriskapel@hotmail.com	Mavrogeni, Sophie/AAV-2105-2021				Agu CE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7496-4; Alencherry B, 2019, OPEN HEART, V6, DOI 10.1136/openhrt-2019-001046; Awotedu, 2015, CLIN MICROBIOL, V4, P1; Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Bahrami H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003371; Belkin MN, 2018, CURR OPIN CARDIOL, V33, P317, DOI 10.1097/HCO.0000000000000513; Botha S, 2014, HEART LUNG CIRC, V23, P119, DOI 10.1016/j.hlc.2013.07.019; Brener M, 2014, AIDS, V28, P1635, DOI 10.1097/QAD.0000000000000116; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Buggey J, 2020, HEART, V106, P147, DOI 10.1136/heartjnl-2019-315346; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Butler J, 2020, J CARD FAIL, V26, P371, DOI 10.1016/j.cardfail.2019.10.011; Cedarbaum E, 2019, AIDS, V33, P2025, DOI 10.1097/QAD.0000000000002319; Collier P, 2017, J AM COLL CARDIOL, V69, P1043, DOI 10.1016/j.jacc.2016.12.012; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; D'Ascenzo F, 2015, ATHEROSCLEROSIS, V240, P197, DOI 10.1016/j.atherosclerosis.2015.03.019; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Diaz-Zamudio M, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0193-2; Erqou S, 2019, JACC-HEART FAIL, V7, P98, DOI 10.1016/j.jchf.2018.10.006; Feinstein MJ, 2019, CIRCULATION, V140, pE98, DOI 10.1161/CIR.0000000000000695; Figueroa AL, 2013, JACC-CARDIOVASC IMAG, V6, P1250, DOI 10.1016/j.jcmg.2013.08.006; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; Fourie CMT, 2015, ATHEROSCLEROSIS, V240, P154, DOI 10.1016/j.atherosclerosis.2015.03.015; Freiberg MS, 2017, JAMA CARDIOL, V2, P536, DOI 10.1001/jamacardio.2017.0264; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gonzalez A, 2018, J AM COLL CARDIOL, V71, P1696, DOI 10.1016/j.jacc.2018.02.021; Gonzalez-Cordon A, 2018, HIV MED, V19, P497, DOI 10.1111/hiv.12619; Grinspoon SK, 2019, AM HEART J, V212, P23, DOI 10.1016/j.ahj.2018.12.016; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Guaraldi G, 2020, ATHEROSCLEROSIS, V297, P127, DOI 10.1016/j.atherosclerosis.2020.02.014; Guaraldi G, 2011, AIDS, V25, P1199, DOI 10.1097/QAD.0b013e3283474b9f; Hadamitzky M, 2013, EUR HEART J, V34, P3277, DOI 10.1093/eurheartj/eht293; Hanna DB, 2015, CLIN INFECT DIS, V61, P640, DOI 10.1093/cid/civ325; Henrich TJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02077; Ho JE, 2012, AIDS, V26, P1115, DOI 10.1097/QAD.0b013e328352ce54; Holloway CJ, 2013, CIRCULATION, V128, P814, DOI 10.1161/CIRCULATIONAHA.113.001719; Hsu DNC, 2020, AIDS, V34, P519, DOI 10.1097/QAD.0000000000002389; Hsue PY, 2019, CAN J CARDIOL, V35, P238, DOI 10.1016/j.cjca.2018.12.024; Hsue PY, 2019, CLIN INFECT DIS, V68, P1877, DOI 10.1093/cid/ciy781; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Hurlimann D, 2006, HEART, V92, P110, DOI 10.1136/hrt.2004.056523; Kapelios CJ, 2020, JAIDS-J ACQ IMM DEF, V83, P504, DOI 10.1097/QAI.0000000000002286; Kelly C, 2019, J INFECT DIS, V219, P1948, DOI 10.1093/infdis/jiz015; Kengne AP, 2019, LANCET GLOB HEALTH, V7, pE980, DOI 10.1016/S2214-109X(19)30293-1; Knudsen A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy205; Knudsen A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001886; Knudsen A, 2015, J NUCL CARDIOL, V22, P372, DOI 10.1007/s12350-014-0032-0; Knudsen AD, 2018, JAIDS-J ACQ IMM DEF, V79, P381, DOI 10.1097/QAI.0000000000001795; Kovari H, 2020, CLIN INFECT DIS, V70, P884, DOI 10.1093/cid/ciz283; Kristoffersen US, 2010, NUCL MED COMMUN, V31, P874, DOI 10.1097/MNM.0b013e32833d82e6; Kwiatkowska W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113857; Lai H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002529; Lawal IO, 2019, J NUCL CARDIOL, V26, P1258, DOI 10.1007/s12350-018-1207-x; Lo J, 2015, LANCET HIV, V2, pE52, DOI 10.1016/S2352-3018(14)00032-0; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Longenecker CT, 2018, AIDS, V32, P89, DOI 10.1097/QAD.0000000000001682; Longenecker CT, 2017, AM J CARDIOL, V120, P1427, DOI 10.1016/j.amjcard.2017.07.019; Luetkens JA, 2016, CIRC-CARDIOVASC IMAG, V9; Macatangay BJC, 2020, J INFECT DIS, V221, P1598, DOI 10.1093/infdis/jiz344; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Leite LHM, 2017, ARCH CARDIOVASC DIS, V110, P495, DOI 10.1016/j.acvd.2017.03.001; Marincowitz C, 2019, FEBS J, V286, P1256, DOI 10.1111/febs.14657; Mee TC, 2018, ANTIVIR THER, V23, P695, DOI 10.3851/IMP3258; Metkus TS, 2015, HIV MED, V16, P635, DOI 10.1111/hiv.12262; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Ntusi N, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004430; O'Brien MP, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw278; O'Keefe KJ, 2013, AIDS CARE, V25, P1145, DOI 10.1080/09540121.2012.752565; Palella FJ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw098; Phan BAP, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005995; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Psichogiou M, 2019, ANGIOLOGY, V70, P448, DOI 10.1177/0003319718801093; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; Raggi P, 2015, J CARDIOVASC COMPUT, V9, P553, DOI 10.1016/j.jcct.2015.08.002; Rose H, 2013, ATHEROSCLEROSIS, V229, P206, DOI 10.1016/j.atherosclerosis.2013.04.010; Savvoulidis P, 2019, CAN J CARDIOL, V35, P299, DOI 10.1016/j.cjca.2018.10.009; Scherzer R, 2011, AIDS, V25, P1405, DOI 10.1097/QAD.0b013e32834884e6; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Sliwa K, 2012, EUR HEART J, V33, P866, DOI 10.1093/eurheartj/ehr398; So-Armah K, 2018, CURR HIV-AIDS REP, V15, P233, DOI 10.1007/s11904-018-0400-5; Stein JH, 2014, JACC-CARDIOVASC IMAG, V7, P515, DOI 10.1016/j.jcmg.2013.08.019; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Sun DD, 2015, ATHEROSCLEROSIS, V242, P109, DOI 10.1016/j.atherosclerosis.2015.06.059; Tarr PE, 2018, EUR HEART J, V39, P2147, DOI 10.1093/eurheartj/ehy163; Tawakol A, 2017, JAMA CARDIOL, V2, P163, DOI 10.1001/jamacardio.2016.4728; Tawakol A, 2014, JAIDS-J ACQ IMM DEF, V66, P164, DOI 10.1097/QAI.0000000000000138; Tawakol A, 2013, J AM COLL CARDIOL, V62, P909, DOI 10.1016/j.jacc.2013.04.066; Thiara DK, 2015, J INFECT DIS, V212, P1544, DOI 10.1093/infdis/jiv274; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Tzanis G, 2018, INT J CARDIOL, V262, P20, DOI 10.1016/j.ijcard.2018.03.102; UNAIDS, 2019, GLOB HIV STAT 2018; UNAIDS, 2013, HIV AGING; Vos AG, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013466; Vos AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169986; Ye YC, 2010, JAIDS-J ACQ IMM DEF, V53, P276, DOI 10.1097/QAI.0b013e3181ba1c31; Yen YF, 2019, JAIDS-J ACQ IMM DEF, V80, P255, DOI [10.1097/qai.0000000000001917, 10.1097/QAI.0000000000001917]; Zanni MV, 2016, JAMA CARDIOL, V1, P474, DOI 10.1001/jamacardio.2016.0846	98	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					326	337	1358863X20978702	10.1177/1358863X20978702		JAN 2021	12	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000618427000001	33475050				2022-04-28	
J	Rathakrishnan, B; Secemsky, EA				Rathakrishnan, Bharath; Secemsky, Eric A.			Turning the tide: Evolution of below-the-knee endovascular intervention	VASCULAR MEDICINE			English	Editorial Material							PERIPHERAL ARTERIAL-DISEASE; TASC II; CLASSIFICATION		[Rathakrishnan, Bharath; Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Dept Med, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA; [Rathakrishnan, Bharath; Secemsky, Eric A.] Harvard Med Sch, Boston, MA 02115 USA; [Rathakrishnan, Bharath; Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA		Secemsky, EA (通讯作者)，Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, 375 Longwood Ave,4th Floor, Boston, MA 02215 USA.	esecemsk@bidmc.harvard.edu		Secemsky, Eric/0000-0003-3861-3163	NIH/NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL150290]	Eric Secemsky is funded by NIH/NHLBI K23HL150290 and Harvard Medical School's Shore Faculty Development Award Bharath Rathakrishnan has nothing to disclose.	Guez D, 2020, AM J ROENTGENOL, V214, P962, DOI 10.2214/AJR.19.21967; Hardman RL, 2014, SEMIN INTERVENT RAD, V31, P378, DOI 10.1055/s-0034-1393976; Jaff MR, 2015, CATHETER CARDIO INTE, V86, P611, DOI 10.1002/ccd.26122; Janko PJ, 2018, ARCH IRAN MED, V21, P118; Katsanos K, 2020, J VASC INTERV RADIOL, V31, P202, DOI 10.1016/j.jvir.2019.11.015; Klein AJ, 2016, TRENDS CARDIOVAS MED, V26, P495, DOI 10.1016/j.tcm.2016.02.007; Kok HK, 2017, DIAGN INTERV RADIOL, V23, P360, DOI 10.5152/dir.2017.17040; Muller AM, 2021, VASC MED, V26, P18, DOI 10.1177/1358863X20967091	8	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					26	27	1358863X20978281	10.1177/1358863X20978281		DEC 2020	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000608768600001	33314979	Bronze			2022-04-28	
J	Barns, B; Khairani, C; Rizzo, SM; Pfeferman, MB; Snyder, JE; Piazza, G; Goldhaber, SZ; Campia, U				Barns, Briana; Khairani, Candrika; Rizzo, Samantha M.; Pfeferman, Mariana B.; Snyder, Julia E.; Piazza, Gregory; Goldhaber, Samuel Z.; Campia, Umberto			Management of type B acute aortic syndromes at a single academic medical center: insights from the code aorta registry	VASCULAR MEDICINE			English	Meeting Abstract									[Barns, Briana; Khairani, Candrika; Snyder, Julia E.; Piazza, Gregory; Goldhaber, Samuel Z.; Campia, Umberto] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Rizzo, Samantha M.] Georgetown Univ, Sch Med, Washington, DC USA; [Pfeferman, Mariana B.] Univ Santo Amaro, Sao Paulo, Brazil									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1385	NP17	NP17					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100042					2022-04-28	
J	Mathew, S; Densley, A; Kruse, M				Mathew, Steve; Densley, Ashton; Kruse, Matthew			Unique presentations of aortic graft infection-small bowel obstruction and gastrointestinal bleeding	VASCULAR MEDICINE			English	Meeting Abstract									[Mathew, Steve; Densley, Ashton; Kruse, Matthew] Creighton Univ, Sch Med, Dept Radiol, Omaha, NE USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1434	NP36	NP36					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100079					2022-04-28	
J	Kum, S; Ipema, J; Huizing, E; Tan, YK; Lim, D; Lok, IYH; Hazenberg, CEVB; Unlu, C				Kum, Steven; Ipema, Jetty; Huizing, Eline; Tan, Yih K.; Lim, Darryl; Lok, Ian Y. H.; Hazenberg, Constantijn E. V. B.; Unlu, Cagdas			Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia	VASCULAR MEDICINE			English	Article						chronic limb-threatening ischemia (CLTI); drug-eluting stents; femoropopliteal; paclitaxel; peripheral artery disease (PAD)		The fluoropolymer-coated, paclitaxel-eluting Eluvia stent has shown promising results for the endovascular treatment of femoropopliteal artery lesions in patients with claudication. The aim of the current study was to evaluate efficacy and safety outcomes of the Eluvia stent for the treatment of long femoropopliteal lesions in Asian patients. This is a single-center, retrospective study. The primary endpoint was primary patency at 1 year. Secondary outcomes were 30-days complication rate, technical success, 1-year freedom from clinically driven target lesion revascularization (CD-TLR), limb salvage, survival, amputation-free survival (AFS), wound healing, and clinical improvement. A total of 64 patients with 67 femoropopliteal lesions were included; 78% suffered from diabetes and 84% had chronic limb-threatening ischemia (CLTI). Of those with ischemic wounds, 79% did not have run-off to the foot. Mean lesion length was 193 +/- 128 mm and 52% were severely calcified. Primary patency at 1 year was 84% in the overall cohort and 91% in patients with complete lesion coverage with the Eluvia stent. Technical success was achieved in 100% of the cases and 30-day complications occurred in six patients. Twelve-month freedom from CD-TLR, limb salvage, survival, and AFS were 92%, 93%, 85%, and 80%, respectively. In 80% of patients, complete wound healing was experienced and 84% had clinical improvement after 1 year. The Eluvia stent showed promising 12-month patency and clinical results for femoropopliteal treatment in this CLTI-dominant patient population with severely calcified, long lesions. Patient numbers were, however, small; larger trials are required to validate these findings. Aneurysmal change seen in some cases also needs further investigation.	[Kum, Steven; Tan, Yih K.; Lim, Darryl] Changi Gen Hosp, Dept Surg, Singapore, Singapore; [Ipema, Jetty; Huizing, Eline; Unlu, Cagdas] Northwest Clin, Dept Vasc Surg, Alkmaar, Netherlands; [Lok, Ian Y. H.] Univ New South Wales, Sydney, NSW, Australia; [Hazenberg, Constantijn E. V. B.] Univ Med Ctr Utrecht, Div Vasc Surg, Dept Surg, Utrecht, Netherlands		Kum, S (通讯作者)，Changi Gen Hosp, Dept Surg, Vasc Serv, 2 Simei St 3, Singapore 529889, Singapore.	stevenkum.dr@gmail.com		Huizing, Eline/0000-0002-5297-2640			Aboyans V, 2018, EUR J VASC ENDOVASC, V55, P305, DOI 10.1016/j.ejvs.2017.07.018; Barbato E, 2017, EUROINTERVENTION, V13, P696, DOI 10.4244/EIJ-D-17-00473; Bisdas T, 2018, JACC-CARDIOVASC INTE, V11, P957, DOI 10.1016/j.jcin.2018.03.046; Bosiers M, 2013, J CARDIOVASC SURG, V54, P115; Boston Scientific, 2020, ELUVIA DRUG ELUTING; Dake MD, 2016, CIRCULATION, V133, P1472, DOI 10.1161/CIRCULATIONAHA.115.016900; Dake MD, 2011, J VASC INTERV RADIOL, V22, P603, DOI 10.1016/j.jvir.2010.12.027; Davaine JM, 2015, EUR J VASC ENDOVASC, V50, P631, DOI 10.1016/j.ejvs.2015.07.018; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Golzar J, 2020, J ENDOVASC THER, V27, P296, DOI 10.1177/1526602820901723; Gray WA, 2018, LANCET, V392, P1541, DOI 10.1016/S0140-6736(18)32262-1; Iida O, 2015, JACC-CARDIOVASC INTE, V8, P1105, DOI 10.1016/j.jcin.2015.03.022; Muller-Hulsbeck S, 2016, EXPERT OPIN DRUG DEL, V13, P1639, DOI 10.1080/17425247.2016.1230098; Muller-Hulsbeck S, 2016, J ENDOVASC THER, V23, P701, DOI 10.1177/1526602816650206; Muradin GSR, 2001, RADIOLOGY, V221, P137, DOI 10.1148/radiol.2211010039; Mwipatayi BP, 2008, J VASC SURG, V47, P461, DOI 10.1016/j.jvs.2007.07.059; Soga Y, 2020, CARDIOVASC INTER RAD, V43, P215, DOI 10.1007/s00270-019-02355-x; Soga Y, 2020, J ATHEROSCLER THROMB, V27, P164, DOI 10.5551/jat.50369; Varcoe RL, 2017, J ENDOVASC THER, V24, P337, DOI 10.1177/1526602817698935; Vent PA, 2017, ANN VASC SURG, V43, P166, DOI 10.1016/j.avsg.2016.10.058; Yokoi H, 2016, JACC-CARDIOVASC INTE, V9, P271, DOI 10.1016/j.jcin.2015.09.035; Zeller T, 2014, J ENDOVASC THER, V21, P359, DOI 10.1583/13-4630MR.1; Zhou Y, 2020, J ENDOVASC THER, V27, P42, DOI 10.1177/1526602819895996	23	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					267	272	1358863X20987894	10.1177/1358863X20987894		MAR 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000630566400001	33733963				2022-04-28	
J	Solomon, AL; Ratchford, EV; Armitage, KB; Kovacic, JC				Solomon, Alexandra L.; Ratchford, Elizabeth, V; Armitage, Keith B.; Kovacic, Jason C.			Vascular Disease Patient Information Page: Vascular considerations with COVID-19 vaccines	VASCULAR MEDICINE			English	Editorial Material						COVID-19 vaccine; SARS-CoV-2 vaccine; thrombosis; vaccine-induced immune thrombotic thrombocytopenia (VITT)			[Solomon, Alexandra L.] Boston Univ, Sch Med, Boston Med Ctr, Dept Med,Sect Cardiovasc Med, Boston, MA 02118 USA; [Ratchford, Elizabeth, V] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21205 USA; [Armitage, Keith B.] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Kovacic, Jason C.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Kovacic, Jason C.] Univ NSW, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Kovacic, Jason C.] Icahn Sch Med Mt Sinai, Cardiovasc Res Inst, New York, NY 10029 USA		Ratchford, EV (通讯作者)，Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21205 USA.	evr@jhmi.edu		Solomon, Alexandra/0000-0003-2363-886X	Janssen Biotech, Inc.Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL130423, R01HL135093, R01HL148167]; Bourne Foundation; New South Wales health grant [RG194194]	Dr Alexandra Solomon currently holds the position of Anticoagulation Forum Ansell Fellow at Boston Medical Center. Boston Medical Center received an Anticoagulation Forum Ansell Fellowship Award, which was supported by an unrestricted educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Dr Elizabeth Ratchford's work was supported in part by the generosity of David Kotick (1926-2021). Dr Jason Kovacic acknowledges support from NIH (R01HL130423, R01HL135093, R01HL148167), New South Wales health grant RG194194, and the Bourne Foundation.	Bikdeli B, 2021, J AM COLL CARDIOL, V78, P408, DOI 10.1016/j.jacc.2021.06.001; Bozkurt B, 2021, CIRCULATION, V144, P471, DOI 10.1161/CIRCULATIONAHA.121.056135; Cines DB, 2021, NEW ENGL J MED, V384, P2254, DOI 10.1056/NEJMe2106315; Hippisley-Cox J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1931; Idiculla PS, 2020, EUR NEUROL, V83, P369, DOI 10.1159/000509802; Pavord S, 2021, NEW ENGL J MED, V385, P1680, DOI 10.1056/NEJMoa2109908; Schmaier AA, 2020, VASC MED, V25, P604, DOI 10.1177/1358863X20963804; Singer Mendel E, 2022, medRxiv, DOI 10.1101/2021.07.23.21260998; Tefera L, 2021, VASC MED, V26, P579, DOI 10.1177/1358863X211030326	9	0	0	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					102	106	1358863X211066128	10.1177/1358863X211066128		DEC 2021	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000736596600001	34937458	Bronze			2022-04-28	
J	Bradel, L; Elbebawy, B; Bandlamudi, M; Birkman, J; DeLuccia, W; Stephenson, K				Bradel, Laura; Elbebawy, Bishoy; Bandlamudi, Manav; Birkman, Joseph; DeLuccia, William; Stephenson, Kent			An atypical presentation of aortic dissection and rupture involving coronary grafts	VASCULAR MEDICINE			English	Meeting Abstract									[Bradel, Laura; Elbebawy, Bishoy; Bandlamudi, Manav; Birkman, Joseph; DeLuccia, William; Stephenson, Kent] Arnot Ogden Med Ctr, Elmira, NY USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1410	NP31	NP32					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100071					2022-04-28	
J	Ranka, S; Chan, WC; Tadros, P; Wiley, M; Hockstad, E; Gupta, K				Ranka, Sagar; Chan, Wan-Chi; Tadros, Peter; Wiley, Mark; Hockstad, Eric; Gupta, Kamal			Do statins impact long-term mortality peripheral artery disease patients who have end stage renal disease?	VASCULAR MEDICINE			English	Meeting Abstract									[Ranka, Sagar; Chan, Wan-Chi; Tadros, Peter; Wiley, Mark; Hockstad, Eric; Gupta, Kamal] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA				Ranka, Sagar/AGX-3416-2022					0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1272	NP6	NP7					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100025					2022-04-28	
J	Villanueva, P				Villanueva, P.			The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral artery disease: A meta-analysis	VASCULAR MEDICINE			English	Meeting Abstract									[Villanueva, P.] Philippine Gen Hosp, Manila, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1223	NP5	NP5					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100023					2022-04-28	
J	Bikdeli, B; Yanamandala, M; Wang, XW; Campia, U; Gravereaux, EC; Padera, RF; Gerhard-Herman, M; Piazza, G; Goldhaber, SZ				Bikdeli, Behnood; Yanamandala, Mounica; Wang, Xiaowen; Campia, Umberto; Gravereaux, Edwin C.; Padera, Robert F.; Gerhard-Herman, Marie; Piazza, Gregory; Goldhaber, Samuel Z.			Images in Vascular Medicine: Pulmonary embolism and acute aortic syndromes - Double trouble when vascular medicine emergencies meet	VASCULAR MEDICINE			English	Editorial Material									[Bikdeli, Behnood; Yanamandala, Mounica; Wang, Xiaowen; Campia, Umberto; Gerhard-Herman, Marie; Piazza, Gregory; Goldhaber, Samuel Z.] Brigham & Womens Hosp, Harvard Med Sch, Cardiovasc Med Div, Boston, MA USA; [Bikdeli, Behnood] Yale YNHH Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Bikdeli, Behnood] CRF, New York, NY USA; [Gravereaux, Edwin C.] Brigham & Womens Hosp, Harvard Med Sch, Div Vasc & Endovasc Surg, Boston, MA USA; [Padera, Robert F.] Brigham & Womens Hosp, Harvard Med Sch, Dept Pathol, Boston, MA USA		Bikdeli, B (通讯作者)，Brigham & Womens Hosp, Cardiovasc Med Div, 75 Francis St,Shapiro 5,Suite 5156, Boston, MA 02115 USA.	bbikdeli@bwh.harvard.edu	Campia, Umberto/J-3114-2018	Campia, Umberto/0000-0002-7894-3565			Kim G, 2019, RADIOL CLIN N AM, V57, P787, DOI 10.1016/j.rcl.2019.02.012; Kolte D, 2019, J AM COLL CARDIOL, V73, P2477, DOI 10.1016/j.jacc.2019.03.463; Ramponi Fabio, 2018, Aorta (Stamford), V6, P34, DOI 10.1055/s-0038-1639345	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					97	99	1358863X211029695	10.1177/1358863X211029695		JUL 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000675689200001	34281444	Bronze			2022-04-28	
J	Shoji, K; Zen, K; Maeno, M; Yanishi, K; Shiraishi, H; Matoba, S				Shoji, Keisuke; Zen, Kan; Maeno, Misato; Yanishi, Kenji; Shiraishi, Hirokazu; Matoba, Satoaki			Images in Vascular Medicine: Hydrophilic polymer emboli after percutaneous coronary intervention due to severe tortuosity and a calcified nodule of the aortic access route	VASCULAR MEDICINE			English	Editorial Material									[Shoji, Keisuke; Zen, Kan; Yanishi, Kenji; Shiraishi, Hirokazu; Matoba, Satoaki] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Maeno, Misato] Kyoto Prefectural Univ Med, Dept Dermatol, Kyoto, Japan		Shoji, K (通讯作者)，Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kamigyo Ku, 465 Kajii Cho Kawaramachi Hirokoji, Kyoto 6028566, Japan.	shjksk@koto.kpu-m.ac.jp		Shoji, Keisuke/0000-0002-3854-7760			Chopra AM, 2017, CARDIOVASC PATHOL, V30, P45, DOI 10.1016/j.carpath.2017.06.004; Hickey TBM, 2019, CARDIOVASC PATHOL, V40, P12, DOI 10.1016/j.carpath.2019.01.003; U.S. Food and Drug Administration, 2015, LUBR COAT SEP INTR M	3	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					572	573	1358863X211011545	10.1177/1358863X211011545		MAY 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000652884800001	34011214	Bronze			2022-04-28	
J	Evans, NS; Ratchford, EV				Evans, Natalie S.; Ratchford, Elizabeth, V			Vascular Disease Patient Information Page: Compression therapy	VASCULAR MEDICINE			English	Article						compression socks; compression stockings; edema; swelling; venous insufficiency			[Evans, Natalie S.] Case Western Reserve Univ, Harrington Heart & Vasc Inst, Univ Hosp, Sch Med,Cleveland Med Ctr, Cleveland, OH 44106 USA; [Ratchford, Elizabeth, V] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21287 USA		Ratchford, EV (通讯作者)，Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 600 North Wolfe St, Baltimore, MD 21287 USA.	evr@jhmi.edu	Ratchford, Elizabeth/AAO-2722-2021	Ratchford, Elizabeth/0000-0002-2244-5604			Evans NS, 2014, VASC MED, V19, P331, DOI 10.1177/1358863X14543131; Heller JA, 2015, VASC MED, V20, P88, DOI 10.1177/1358863X14566224; Ratchford EV, 2014, VASC MED, V19, P218, DOI 10.1177/1358863X14534803; Rockson SG, 2016, VASC MED, V21, P77, DOI 10.1177/1358863X15620852	4	0	0	1	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					352	355	1358863X211002263	10.1177/1358863X211002263		APR 2021	4	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000638976900001	33829923	Bronze			2022-04-28	
J	Lanzi, S; Pousaz, A; Buso, G; Mazzolai, L; Calanca, L				Lanzi, Stefano; Pousaz, Anina; Buso, Giacomo; Mazzolai, Lucia; Calanca, Luca			Partial home confinement during the COVID-19 pandemic, physical function, and physical activity in patients with symptomatic lower extremity peripheral artery disease	VASCULAR MEDICINE			English	Letter						intermittent claudication; physical inactivity; vascular rehabilitation; walking performance			[Lanzi, Stefano; Pousaz, Anina; Buso, Giacomo; Mazzolai, Lucia; Calanca, Luca] Lausanne Univ Hosp, Div Angiol, Heart & Vessel Dept, Ch Mt Paisible 18, CH-1011 Lausanne, Switzerland		Lanzi, S (通讯作者)，Lausanne Univ Hosp, Div Angiol, Heart & Vessel Dept, Ch Mt Paisible 18, CH-1011 Lausanne, Switzerland.	stefano.lanzi@chuv.ch		Lanzi, Stefano/0000-0003-1089-6309			Aboyans V, 2017, KARDIOL POL, V75, P1065, DOI 10.5603/KP.2017.0216; Bean JF, 2007, ARCH PHYS MED REHAB, V88, P604, DOI 10.1016/j.apmr.2007.02.004; Calanca L, 2020, VASC ENDOVASC SURG, V54, P605, DOI 10.1177/1538574420940090; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harwood AE, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000897; Lane R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub4; McDermott MM, 2021, J VASC SURG, V73, P267, DOI 10.1016/j.jvs.2020.03.052; Narici M, 2021, EUR J SPORT SCI, V21, P614, DOI 10.1080/17461391.2020.1761076; Treat-Jacobson D, 2019, CIRCULATION, V139, pE10, DOI 10.1161/CIR.0000000000000623	10	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					437	439	1358863X21995579	10.1177/1358863X21995579		MAR 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000630580300001	33733966	Green Published, hybrid			2022-04-28	
J	Chan, WC; Ranka, S; Stack, B; Lancaster, P; Tayeb, T; Gheith, Z; Hance, K; Thors, A; Wiley, M; Tadros, P; Hockstad, E; Gupta, K				Chan, Wan-Chi; Ranka, Sagar; Stack, Brianna; Lancaster, Payton; Tayeb, Taher; Gheith, Zaid; Hance, Kirk; Thors, Axel; Wiley, Mark; Tadros, Peter; Hockstad, Eric; Gupta, Kamal			Adverse limb related outcomes in end stage renal disease patients with peripheral artery disease: an analysis from USRDS database	VASCULAR MEDICINE			English	Meeting Abstract									[Chan, Wan-Chi; Ranka, Sagar; Stack, Brianna; Lancaster, Payton; Tayeb, Taher; Gheith, Zaid; Hance, Kirk; Thors, Axel; Wiley, Mark; Tadros, Peter; Hockstad, Eric; Gupta, Kamal] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA				Ranka, Sagar/AGX-3416-2022					0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1362	NP15	NP15					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100040					2022-04-28	
J	Kurianov, P; Lipin, A; Antropov, A; Atmadzas, K; Gruzdev, N; Tankaeva, Z; Atmadzas, A; Orlov, A; Borisov, A; Sobolev, R; Eminov, Y				Kurianov, Pavel; Lipin, Alexandr; Antropov, Alexey; Atmadzas, Kirill; Gruzdev, Nikita; Tankaeva, Zaynab; Atmadzas, Alisa; Orlov, Anton; Borisov, Alexey; Sobolev, Roman; Eminov, Yanis			Propensity-matched analysis does not support angiosome-guided revascularization of multilevel peripheral artery disease (PAD)	VASCULAR MEDICINE			English	Article						angiosome; critical limb ischemia (CLI); endovascular therapy; peripheral artery disease (PAD)	CRITICAL LIMB ISCHEMIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ENDOVASCULAR THERAPY; DIABETIC FOOT; BYPASS; PATTERNS; OUTCOMES; SALVAGE; IMPACT; INTERVENTIONS	Background: This retrospective comparative cohort study evaluated the clinical outcome of angiosome-guided endovascular arterial reconstructions in chronic limb-threatening ischemia (CLTI) due to multilevel peripheral artery disease (PAD). Methods: Patients treated in an endovascular fashion for CLTI with tissue loss due to multilevel PAD were analyzed. Limbs were classified as having undergone either angiosome-guided (direct) revascularization (DR) or nonangiosomic (indirect) revascularization (IR). DR was defined as uninterrupted in-line flow to the affected angiosome, revascularization through the pedal arch was also considered direct. Groups were adjusted with propensity score (PS) matching and compared for amputation-free survival (AFS), freedom from major adverse limb events (MALE), and healing rate at 12 months. Results: A total of 174 patients (81 men, mean age 70.0 +/- 10.4 y) were included. PS matching produced two groups of 55 patients each: DR (24 men, mean age 71.7 +/- 10.7 y) and IR (26 men, mean age 72.0 +/- 9.4 y). The matched groups had no significant differences in baseline variables. At 12 months there were no significant differences in AFS (73.2% vs 71.6%; p = 0.841), freedom from MALE (71.7% vs 66.1%; p = 0.617), and healing rate (72.7% vs 72.0%; p = 1.000) between DR and IR, respectively. Conclusion: This study failed to support the use of angiosome concept in CLTI due to multilevel disease.	[Kurianov, Pavel] St George Hosp, Ctr Diabet Foot & Surg Infect, 1 Severny Prospect Str, St Petersburg 194354, Russia; [Lipin, Alexandr; Antropov, Alexey; Atmadzas, Kirill; Gruzdev, Nikita; Atmadzas, Alisa; Orlov, Anton; Borisov, Alexey; Sobolev, Roman; Eminov, Yanis] Hosp 14, Limb Salvage Ctr, St Petersburg, Russia; [Tankaeva, Zaynab] Almazov Natl Med Res Ctr, St Petersburg, Russia		Kurianov, P (通讯作者)，St George Hosp, Ctr Diabet Foot & Surg Infect, 1 Severny Prospect Str, St Petersburg 194354, Russia.	pkurjanov@gmail.com		Kurianov, Pavel/0000-0001-5844-2547; Lipin, Aleksandr/0000-0002-8347-8821			Acin F, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/270539; Alexandrescu V, 2011, J ENDOVASC THER, V18, P376, DOI 10.1583/10-3260.1; Alexandrescu VA, 2020, J ENDOVASC THER, V27, P20, DOI 10.1177/1526602819885131; Attinger CE, 2006, PLAST RECONSTR SURG, V117, p261S, DOI 10.1097/01.prs.0000222582.84385.54; Benoit E, 2012, J VASC SURG, V55, P781, DOI 10.1016/j.jvs.2011.10.089; Chung J, 2017, ANN VASC SURG, V40, P198, DOI 10.1016/j.avsg.2016.11.003; Clark TWI, 2001, J VASC INTERV RADIOL, V12, P923, DOI 10.1016/S1051-0443(07)61570-X; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Fossaceca R, 2013, CARDIOVASC INTER RAD, V36, P637, DOI 10.1007/s00270-012-0544-4; Hata Y, 2019, ANN VASC DIS, V12, P315, DOI 10.3400/avd.ra.19-00042; Iida O, 2014, J ENDOVASC THER, V21, P607, DOI 10.1583/14-4692R.1; Iida O, 2010, CATHETER CARDIO INTE, V75, P830, DOI 10.1002/ccd.22319; Jeon EY, 2016, DIAGN INTERV RADIOL, V22, P52, DOI 10.5152/dir.2015.15129; Kobayashi N, 2017, J VASC SURG, V65, P744, DOI 10.1016/j.jvs.2016.08.106; Kret MR, 2014, J VASC SURG, V59, P121, DOI 10.1016/j.jvs.2013.06.075; Lo RC, 2014, J VASC SURG, V59, P409, DOI 10.1016/j.jvs.2013.07.114; Lofberg AM, 2001, J VASC SURG, V34, P114, DOI 10.1067/mva.2001.113486; Mii S, 2017, ANN VASC SURG, V41, P196, DOI 10.1016/j.avsg.2016.09.024; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Mustapha JA, 2020, CATHETER CARDIO INTE, V95, P447, DOI 10.1002/ccd.28639; Mustapha JA, 2017, J CARDIOVASC SURG, V58, P383, DOI 10.23736/S0021-9509.17.09878-0; Myint M, 2016, J ENDOVASC THER, V23, P433, DOI 10.1177/1526602816639543; Narula N, 2018, J AM COLL CARDIOL, V72, P2152, DOI 10.1016/j.jacc.2018.08.002; Neville RF, 2009, ANN VASC SURG, V23, P367, DOI 10.1016/j.avsg.2008.08.022; Rashid H, 2013, J VASC SURG, V57, P1219, DOI 10.1016/j.jvs.2012.10.129; Ricco JB, 2017, J VASC SURG, V66, P1479, DOI 10.1016/j.jvs.2017.04.074; Rueda CA, 2008, J VASC SURG, V47, P995, DOI 10.1016/j.jvs.2007.11.055; Sigterman TA, 2016, ANN VASC SURG, V33, P167, DOI 10.1016/j.avsg.2015.11.019; Soderstrom M, 2013, J VASC SURG, V57, P427, DOI 10.1016/j.jvs.2012.07.057; Stegemann E, 2016, ANGIOLOGY, V67, P875, DOI 10.1177/0003319715614701; Taylor GI, 1998, PLAST RECONSTR SURG, V102, P599, DOI 10.1097/00006534-199809030-00001; Troisi N, 2017, INT ANGIOL, V36, P438, DOI 10.23736/S0392-9590.17.03809-3; Varela C, 2010, VASC ENDOVASC SURG, V44, P654, DOI 10.1177/1538574410376601; Wang JR, 2018, ANN SURG, V267, P846, DOI 10.1097/SLA.0000000000002344; Weaver ML, 2018, J VASC SURG, V68, P1473, DOI 10.1016/j.jvs.2018.01.060; Zheng XT, 2016, ANN VASC SURG, V32, P41, DOI 10.1016/j.avsg.2015.09.021	36	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					47	54	1358863X211038627	10.1177/1358863X211038627		SEP 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000703150300001	34569374				2022-04-28	
J	Islam, SJ; Beydoun, N; Mehta, A; Kim, JH; Ko, YA; Jin, QC; Baltrus, P; Topel, ML; Liu, C; Mujahid, MS; Vaccarino, V; Sims, M; Ejaz, K; Searles, C; Dunbar, SB; Lewis, TT; Taylor, HA; Pemu, P; Quyyumi, AA				Islam, Shabatun J.; Beydoun, Nour; Mehta, Anurag; Kim, Jeong Hwan; Ko, Yi-An; Jin, Qingchun; Baltrus, Peter; Topel, Matthew L.; Liu, Chang; Mujahid, Mahasin S.; Vaccarino, Viola; Sims, Mario; Ejaz, Kiran; Searles, Charles; Dunbar, Sandra B.; Lewis, Tene T.; Taylor, Herman A.; Pemu, Priscilla; Quyyumi, Arshed A.			Association of physical activity with arterial stiffness among Black adults	VASCULAR MEDICINE			English	Article						arterial stiffness; Black Americans; epidemiology; hypertension; racial disparities	PULSE-WAVE VELOCITY; AFRICAN-AMERICANS; SCIENTIFIC STATEMENT; AORTIC STIFFNESS; ENDOTHELIUM; RISK; HYPERTENSION; DISPARITIES; PREDICTION; EXERCISE	Arterial stiffness is a precursor for the development of hypertension and premature cardiovascular disease (CVD). Physical activity has been associated with lower arterial stiffness among largely White populations, but the types of activity required and whether these findings apply to Black adults remain unknown. We examined whether physical activity levels were associated with arterial stiffness among Black adults in two independent cohorts. In the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity, 378 Black adults (age 52.8 +/- 10.3, 39.7% male) without known CVD living in Atlanta, GA were recruited. Arterial stiffness was measured as pulse wave velocity (PWV). Total and domain-specific physical activity were assessed by self-report. Multiple linear regression models were used to investigate differences across physical activity levels after adjusting for age, sex, CVD risk factors, and socioeconomic status. Findings were validated in an independent cohort of Black adults (n = 55, age 50.4 +/- 9.2, 23.6% male). After adjustment for covariates, lower arterial stiffness was associated with higher self-reported levels of sport/exercise (6.92 +/- 1.13 vs 7.75 +/- 1.14, p < 0.001, highest vs lowest quartile) and home/life activities (7.34 +/- 1.24 vs 7.73 +/- 1.07, p = 0.04, highest vs lowest quartile), but not work, active living, or the overall physical activity scores. These findings were replicated in the independent cohort where higher levels of sport/exercise remained associated with lower arterial stiffness (6.66 +/- 0.57 vs 8.21 +/- 0.66, p < 0.001, highest vs lowest quartile). Higher levels of sport/exercise and home/life-related physical activities (in comparison to occupational physical activity) are associated with lower arterial stiffness in Black adults.	[Islam, Shabatun J.; Beydoun, Nour; Mehta, Anurag; Kim, Jeong Hwan; Topel, Matthew L.; Liu, Chang; Vaccarino, Viola; Ejaz, Kiran; Searles, Charles; Quyyumi, Arshed A.] Emory Univ, Dept Med, Div Cardiol, Sch Med, 1462 Clifton Rd NE,Suite 507, Atlanta, GA 30322 USA; [Ko, Yi-An; Jin, Qingchun] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Baltrus, Peter] Morehouse Sch Med, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA; [Baltrus, Peter] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [Liu, Chang; Vaccarino, Viola; Lewis, Tene T.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Mujahid, Mahasin S.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Sims, Mario] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Dunbar, Sandra B.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Taylor, Herman A.; Pemu, Priscilla] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA		Quyyumi, AA (通讯作者)，Emory Univ, Dept Med, Div Cardiol, Sch Med, 1462 Clifton Rd NE,Suite 507, Atlanta, GA 30322 USA.	aquyyum@emory.edu		Islam, Shabatun/0000-0002-0886-9021; Baltrus, Peter/0000-0001-9808-0501	American Heart AssociationAmerican Heart Association [0000031288]; Abraham J & Phyllis Katz Foundation; Byron Williams Jr, MD Fellowship Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HL130025, T32 HL007745-26A1]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The American Heart Association 0000031288, Abraham J & Phyllis Katz Foundation, Byron Williams Jr, MD Fellowship Fund, and the National Institutes of Health T32 HL130025 & T32 HL007745-26A1.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baldo MP, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005477; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Campia U, 2004, CIRCULATION, V109, P3191, DOI 10.1161/01.CIR.0000130590.24107.D3; Campia U, 2002, J AM COLL CARDIOL, V40, P754, DOI 10.1016/S0735-1097(02)02015-6; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Diaz KM, 2017, HYPERTENSION, V69, P421, DOI 10.1161/HYPERTENSIONAHA.116.08398; Dubbert PM, 2005, ETHNIC DIS, V15, pS56; Evenson KR, 2003, ANN EPIDEMIOL, V13, P351, DOI 10.1016/S1047-2797(02)00438-6; Goel A, 2017, JACC-CARDIOVASC IMAG, V10, P54, DOI 10.1016/j.jcmg.2016.07.012; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Horta BL, 2015, ATHEROSCLEROSIS, V243, P148, DOI 10.1016/j.atherosclerosis.2015.09.005; Islam SJ, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015247; James SA, 1998, DIABETES CARE, V21, P555, DOI 10.2337/diacare.21.4.555; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; Kingwell BA, 2000, FASEB J, V14, P1685, DOI 10.1096/fj.99-0896rev; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Marquez DX, 2010, MED SCI SPORT EXER, V42, P1086, DOI 10.1249/MSS.0b013e3181c5ec05; Mason RP, 2005, CIRCULATION, V112, P3795, DOI 10.1161/CIRCULATIONAHA.105.556233; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mitchell GF, 2014, HYPERTENSION, V64, P13, DOI 10.1161/HYPERTENSIONAHA.114.00921; Morris AA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.002154; Nilsson PM, 2009, HYPERTENSION, V54, P3, DOI 10.1161/HYPERTENSIONAHA.109.129114; Oh Young S, 2018, Clin Hypertens, V24, P17, DOI 10.1186/s40885-018-0102-8; Otsuki T, 2007, AM J PHYSIOL-HEART C, V292, pH786, DOI 10.1152/ajpheart.00678.2006; Schutte AE, 2020, ARTERIOSCL THROM VAS, V40, P1044, DOI 10.1161/ATVBAHA.120.313133; Stein CM, 1997, CLIN PHARMACOL THER, V62, P436, DOI 10.1016/S0009-9236(97)90122-3; Tanaka H, 2005, AM J HYPERTENS, V18, P137, DOI 10.1016/j.amjhyper.2004.07.008; Tanaka H, 1998, ARTERIOSCL THROM VAS, V18, P127, DOI 10.1161/01.ATV.18.1.127; Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; United States Census Bureau, 2019, QUICKFACTS ATL CITY; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yoon Sung Sug Sarah, 2015, NCHS Data Brief, P1	37	0	0	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					13	20	1358863X211032725	10.1177/1358863X211032725		SEP 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000700412200001	34549642				2022-04-28	
J	Gupta, T; Manning, P; Kolte, D; Smolderen, KG; Stone, N; Henry, JG; Wang, JY; Gosch, KL; White, CJ; Spertus, J; Abbott, JD				Gupta, Tripti; Manning, Patrick; Kolte, Dhaval; Smolderen, Kim G.; Stone, Nancy; Henry, Jessica G.; Wang, Jingyan; Gosch, Kensey L.; White, Christopher J.; Spertus, John; Dawn Abbott, J.			Exercise therapy referral and participation in patients with peripheral artery disease: Insights from the PORTRAIT registry	VASCULAR MEDICINE			English	Letter						exercise therapy; intermittent claudication; peripheral artery disease (PAD)			[Gupta, Tripti; Henry, Jessica G.; White, Christopher J.] Ochsner Med Ctr, Dept Cardiol, New Orleans, LA USA; [Manning, Patrick; Dawn Abbott, J.] Brown Univ, Dept Cardiol, Providence, RI 02912 USA; [Kolte, Dhaval] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Smolderen, Kim G.] Yale Univ, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA; [Stone, Nancy; Gosch, Kensey L.; Spertus, John] St Lukes Hosp Kansas City, Dept Biomed & Hlth Informat, Kansas City, MO USA; [Wang, Jingyan] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston Sch Publ Hlth, Houston, TX 77030 USA; [Spertus, John] Univ Missouri Kansas City, Dept Internal Med, Sect Cardiovasc Dis, Kansas City, MO USA		Abbott, JD (通讯作者)，Rhode Isl Hosp, 593 Eddy St,APC 814, Providence, RI 02903 USA.	jabbott@lifespan.org	Spertus, John/ABD-3075-2021	Gupta, Tripti/0000-0002-6609-8632; Smolderen, Kim/0000-0001-6104-6254	Johnson JohnsonJohnson & JohnsonJohnson & Johnson USA; AbbottAbbott Laboratories; Cardiva	The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Smolderen receives research grants from Johnson & Johnson, Cardiva, and Abbott, and she is a consultant for Optum Labs. The remaining authors have nothing to disclose.	Abaraogu UO, 2020, THER ADV CARDIO DIS, V14, DOI 10.1177/1753944720924270; Bendermacher BLW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub2; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Gommans LNM, 2014, EUR J VASC ENDOVASC, V48, P169, DOI 10.1016/j.ejvs.2014.04.019; Harwood AE, 2016, ANN VASC SURG, V34, P280, DOI 10.1016/j.avsg.2016.02.009; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Saxon JT, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.012541; Smolderen KG, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003860	8	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					654	656	1358863X211033649	10.1177/1358863X211033649		AUG 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000686013200001	34404282				2022-04-28	
J	Smilowitz, NR; Luttrell-Williams, E; Golpanian, M; Engel, A; Buyon, JP; Katz, SD; Berger, JS				Smilowitz, Nathaniel R.; Luttrell-Williams, Elliot; Golpanian, Michael; Engel, Alexis; Buyon, Jill P.; Katz, Stuart D.; Berger, Jeffrey S.			Microvascular endothelial glycocalyx thickness is associated with brachial artery flow-mediated dilation	VASCULAR MEDICINE			English	Letter						brachial artery reactivity; endothelial function; flow-mediated dilation; glycocalyx; microvascular	DYSFUNCTION		[Smilowitz, Nathaniel R.; Luttrell-Williams, Elliot; Katz, Stuart D.; Berger, Jeffrey S.] New York Univ Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA; [Smilowitz, Nathaniel R.] VA New York Harbor Healthcare Syst, Dept Med, New York, NY USA; [Golpanian, Michael; Engel, Alexis; Buyon, Jill P.] New York Univ Langone Hlth, Dept Med, Div Rheumatol, New York, NY USA; [Berger, Jeffrey S.] New York Univ Sch Med, Dept Surg, New York, NY USA		Berger, JS (通讯作者)，New York Univ Sch Med, Ctr Prevent Cardiovasc Dis, 530 First Ave,Skirball 9R, New York, NY 10016 USA.	jeffrey.berger@nyulangone.org		Buyon, Jill/0000-0002-3852-7129; Stuart, Katz/0000-0003-2340-2021; Berger, Jeffrey/0000-0001-8216-4647; Luttrell-Williams, Elliot/0000-0003-4163-2445	National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)	This study was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL139909 to JPB and JSB). Dr Smilowitz is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K23HL150315. Dr Berger is funded, in part, by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R35HL144993). The National Heart, Lung, and Blood Institute of the National Institutes of Health did not have any direct role in the conduct or reporting of the study findings.	ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Lekakis J, 2011, EUR J CARDIOV PREV R, V18, P775, DOI 10.1177/1741826711398179; Rovas A, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0483-4	7	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					563	565		10.1177/1358863X211026765		JUL 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000675693300001	34278881				2022-04-28	
J	Creager, MA; Bonaca, MP; McDermott, MM; Regensteiner, JG; Gornik, HL				Creager, Mark A.; Bonaca, Marc P.; McDermott, Mary M.; Regensteiner, Judith G.; Gornik, Heather L.			In Memoriam: William R. Hiatt, MD, MSVM (1950-2020)	VASCULAR MEDICINE			English	Biographical-Item							PERIPHERAL ARTERY-DISEASE		[Creager, Mark A.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA; [Bonaca, Marc P.; Regensteiner, Judith G.] Univ Colorado, Sch Med, Denver, CO USA; [Bonaca, Marc P.] Colorado Prevent Ctr, Denver, CO USA; [McDermott, Mary M.] Northwestern Univ, Chicago, IL 60611 USA; [Gornik, Heather L.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Gornik, Heather L.] Case Western Reserve Univ, Cleveland, OH 44106 USA		Creager, MA (通讯作者)，Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA.			Creager, Mark/0000-0001-9758-6447			Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bonaca MP, 2020, NEW ENGL J MED, V382, P1994, DOI 10.1056/NEJMoa2000052; Creager MA, 2015, VASC MED, V20, P60, DOI 10.1177/1358863X14566042; ENGLAND JD, 1992, NEUROLOGY, V42, P994, DOI 10.1212/WNL.42.5.994; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Hess CN, 2018, JAMA-J AM MED ASSOC, V319, P2329, DOI 10.1001/jama.2018.5422; Hiatt WR, 2020, VASC MED, V25, P103, DOI 10.1177/1358863X20905651; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; HIATT WR, 1990, CIRCULATION, V81, P602, DOI 10.1161/01.CIR.81.2.602; Hiatt WR, 1996, J APPL PHYSIOL, V81, P780, DOI 10.1152/jappl.1996.81.2.780; HIATT WR, PUBLICATION LIST; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023	14	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					469	474	1358863X211012052	10.1177/1358863X211012052		JUN 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000658465200001	34078201	Bronze			2022-04-28	
J	Gornik, HL; Rundek, T; Gardener, H; Benenati, JF; Dahiya, N; Hamburg, NM; Kupinski, AM; Leers, SA; Lilly, MP; Lohr, JM; Pellerito, JS; Rholl, KS; Vickery, MA; Hutchisson, MS; Needleman, L				Gornik, Heather L.; Rundek, Tatjana; Gardener, Hannah; Benenati, James F.; Dahiya, Nirvikar; Hamburg, Naomi M.; Kupinski, Ann Marie; Leers, Steven A.; Lilly, Michael P.; Lohr, Joann M.; Pellerito, John S.; Rholl, Kenneth S.; Vickery, Melissa A.; Hutchisson, Marge S.; Needleman, Laurence		IAC Vasc Testing	Optimization of duplex velocity criteria for diagnosis of internal carotid artery (ICA) stenosis: A report of the Intersocietal Accreditation Commission (IAC) Vascular Testing Division Carotid Diagnostic Criteria Committee	VASCULAR MEDICINE			English	Article						carotid artery disease; carotid duplex ultrasound; diagnostic criteria; vascular imaging; diagnostics	70-PERCENT; SOCIETY; DISEASE	Diagnostic criteria to classify severity of internal carotid artery (ICA) stenosis vary across vascular laboratories. Consensus-based criteria, proposed by the Society of Radiologists in Ultrasound in 2003 (SRUCC), have been broadly implemented but have not been adequately validated. We conducted a multicentered, retrospective correlative imaging study of duplex ultrasound versus catheter angiography for evaluation of severity of ICA stenosis. Velocity data were abstracted from bilateral duplex studies performed between 1/1/2009 and 12/31/2015 and studies were interpreted using SRUCC. Percentage ICA stenosis was determined using North American Symptomatic Carotid Endarterectomy Trial (NASCET) methodology. Receiver operating characteristic analysis evaluated the performance of SRUCC parameters compared with angiography. Of 448 ICA sides (from 224 patients), 299 ICA sides (from 167 patients) were included. Agreement between duplex ultrasound and angiography was moderate (kappa = 0.42), with overestimation of degree of stenosis for both moderate (50-69%) and severe (> 70%) ICA lesions. The primary SRUCC parameter for > 50% ICA stenosis of peak-systolic velocity (PSV) of > 125 cm/sec did not meet prespecified thresholds for adequate sensitivity, specificity, and accuracy (sensitivity 97.8%, specificity 64.2%, accuracy 74.5%). Test performance was improved by raising the PSV threshold to > 180 cm/sec (sensitivity 93.3%, specificity 81.6%, accuracy 85.2%) or by adding the additional parameter of ICA/common carotid artery (CCA) PSV ratio > 2.0 (sensitivity 94.3%, specificity 84.3%, accuracy 87.4%). For > 70% ICA stenosis, analysis was limited by a low number of cases with angiographically severe disease. Interpretation of carotid duplex examinations using SRUCC resulted in significant overestimation of severity of ICA stenosis when compared with angiography; raising the PSV threshold for > 50% ICA stenosis to > 180 cm/sec as a single parameter or requiring the ICA/CCA PSV ratio > 2.0 in addition to PSV of > 125 cm/sec for laboratories using the SRUCC is recommended to improve the accuracy of carotid duplex examinations.	[Gornik, Heather L.] Univ Hosp, Harrington Heart & Vasc Inst, 11100 Euclid Ave,Mailstop LKS 5038, Cleveland, OH 44106 USA; [Rundek, Tatjana; Gardener, Hannah] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Benenati, James F.] Baptist Hosp Miami, Miami Cardiac & Vasc Inst, Miami, FL USA; [Dahiya, Nirvikar] Mayo Clin, Dept Radiol, Phoenix, AZ USA; [Hamburg, Naomi M.] Boston Univ, Whitaker Cardiovasc Inst, Boston, MA 02215 USA; [Kupinski, Ann Marie] Albany Med Coll, Albany, NY 12208 USA; [Kupinski, Ann Marie] North Country Vasc Diagnost Inc, Altamont, NY USA; [Leers, Steven A.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA; [Lilly, Michael P.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MA 21201 USA; [Lohr, Joann M.] Wm Jennings Bryan Dorn VA Med Ctr, Dept Surg, Columbia, SC USA; [Pellerito, John S.] Northwell Hlth & Zucker Sch Med Hofstra Northwell, Dept Radiol, Manhasset, NY USA; [Rholl, Kenneth S.] George Washington Univ, Inova Alexandria Hosp, Dept Cardiovasc & Intervent Radiol, Alexandria, VA USA; [Vickery, Melissa A.] Vasc Surg Associates, VSA Vasc Lab, Richmond, VA USA; [Hutchisson, Marge S.] Intersocietal Accreditat Commiss IAC, Vasc Testing Div, Ellicott City, MD USA; [Needleman, Laurence] Thomas Jefferson Univ Hosp, Dept Radiol, Philadelphia, PA 19107 USA		Gornik, HL (通讯作者)，Univ Hosp, Harrington Heart & Vasc Inst, 11100 Euclid Ave,Mailstop LKS 5038, Cleveland, OH 44106 USA.	heather.gornik@uhhospitals.org	Rundek, Tatjana/AAS-4858-2021	Rundek, Tatjana/0000-0002-7115-9815	Intersocietal Accreditation Commission (IAC)	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Intersocietal Accreditation Commission (IAC).	AbuRahma AF, 2011, J VASC SURG, V53, P53, DOI 10.1016/j.jvs.2010.07.045; [Anonymous], 1991, STROKE, V22, P816; [Anonymous], 2019, IAC STANDARDS GUIDEL; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; Beach KW, 2012, VASC ENDOVASC SURG, V46, P466, DOI 10.1177/1538574412452159; Bluth E I, 1988, Radiographics, V8, P487; Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; CHIKOS PM, 1983, STROKE, V14, P885, DOI 10.1161/01.STR.14.6.885; Columbo JA, 2020, CIRCULATION, V141, P946, DOI 10.1161/CIRCULATIONAHA.119.043963; Felbaum DR, 2019, WORLD NEUROSURG, V121, pE962, DOI 10.1016/j.wneu.2018.10.054; FELL G, 1981, CIRCULATION, V64, P1191, DOI 10.1161/01.CIR.64.6.1191; Gornik HL, 2011, CIRCULATION, V124; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Hood DB, 1996, J VASC SURG, V23, P254, DOI 10.1016/S0741-5214(96)70269-0; Huston J, 2000, MAYO CLIN PROC, V75, P1133, DOI 10.4065/75.11.1133; IAC, 2014, IAC VASCULAR TESTING; MIPS Clinical Quality Measures (CQMS), 2019, 195 CQMS; MONETA GL, 1993, J VASC SURG, V17, P152, DOI 10.1016/0741-5214(93)90019-I; Oates CP, 2009, EUR J VASC ENDOVASC, V37, P251, DOI 10.1016/j.ejvs.2008.10.015; ROEDERER GO, 1982, J CARDIOVASC ULTRAS, V1, P373; Roederer GO, 1984, BRUIT, V8, P174; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; TAYLOR DC, 1987, J CLIN ULTRASOUND, V15, P635, DOI 10.1002/jcu.1870150906; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; von Reutern GM, 2012, STROKE, V43, P916, DOI 10.1161/STROKEAHA.111.636084	26	0	0	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					515	525	1358863X211011253	10.1177/1358863X211011253		MAY 2021	11	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000652692500001	34009060	Green Published, hybrid			2022-04-28	
J	Ruiz-Ares, G; Fuentes, B; de Donlebun, JRP; de Lecinana, MA; Gutierrez-Zuniga, R; Rigual, R; Diez-Tejedor, E				Ruiz-Ares, Gerardo; Fuentes, Blanca; Rodriguez-Pardo de Donlebun, Jorge; Alonso de Lecinana, Maria; Gutierrez-Zuniga, Raquel; Rigual, Ricardo; Diez-Tejedor, Exuperio			Usefulness of orbital colour Doppler ultrasound in vascular-related monocular vision loss	VASCULAR MEDICINE			English	Article						monocular vision loss; ocular ischaemia; orbital ultrasound		Acute, painless, monocular vision loss (APMVL) usually has a vascular aetiology. We conducted a prospective observational study from 2011 to 2018 to analyse the added value of colour Doppler imaging to assess orbital vessel blood flow in the diagnosis of APMVL. The study included 67 patients (39 [58.2%] men; mean age, 65.9 years [SD 13.7]) with APMVL evaluated at the Neurosonology Laboratory within the first 5 days of symptom onset, who were classified as having either transient or persistent monocular blindness. The blood flow in the ophthalmic and central retinal arteries was assessed using colour Doppler ultrasound with a linear 7.5-MHz transducer. Thirty-three (49.3%) patients presented transient monocular blindness, with reduced blood flow in either the ophthalmic or central retinal artery. The group with persistent vision loss included 24 cases of central retinal artery occlusion (CRAO) and 10 cases of ischaemic optic neuropathy (35.8% and 14.9%, respectively, of the total sample). These patients were older and had a higher prevalence of hypertension and mild carotid atherosclerosis. Orbital colour Doppler ultrasound (OCDUS) clarified the mechanism/cause of the ischaemia in 11 (16.4%) patients and showed abnormal flow in 46 (68.7%) patients, confirming the vascular origin in 19 (57.6%) of the transient monocular blindness cases. Lower peak systolic velocity was observed in patients with CRAO (p < 0.001), and a velocity < 10 cm/s in the central retinal artery was independently associated with the diagnosis of CRAO. OCDUS can be helpful in confirming the vascular cause and identifying the aetiology of APMVL.	[Ruiz-Ares, Gerardo; Fuentes, Blanca; Rodriguez-Pardo de Donlebun, Jorge; Alonso de Lecinana, Maria; Gutierrez-Zuniga, Raquel; Rigual, Ricardo; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, La Paz Univ Hosp, IdiPAZ Hlth Res Inst, Dept Neurol,Stroke Ctr, Madrid, Spain		Ruiz-Ares, G (通讯作者)，Univ Autonoma Madrid, La Paz Univ Hosp, Dept Neurol, Paseo Castellana 261, Madrid 28046, Spain.; Ruiz-Ares, G (通讯作者)，Univ Autonoma Madrid, La Paz Univ Hosp, Stroke Ctr, Paseo Castellana 261, Madrid 28046, Spain.	adalbertog.ruiz@salud.madrid.org	Fuentes, Blanca/I-2114-2019	Fuentes, Blanca/0000-0002-0363-862X; RUIZ-ARES, GERARDO/0000-0002-8958-4270; Rodriguez-Pardo, Jorge/0000-0002-8926-1287; Alonso de Lecinana, Maria/0000-0002-4302-6580			Akkurt ZM, 2015, CLIN EXP DERMATOL, V40, P507, DOI 10.1111/ced.12625; BELDEN CJ, 1995, RADIOGRAPHICS, V15, P589, DOI 10.1148/radiographics.15.3.7624565; Biousse V, 2018, OPHTHALMOLOGY, V125, P1597, DOI 10.1016/j.ophtha.2018.03.054; Biousse Valerie, 2014, Continuum (Minneap Minn), V20, P838, DOI 10.1212/01.CON.0000453315.82884.a1; Carroll SC, 2006, CLIN EXP OPHTHALMOL, V34, P159, DOI 10.1111/j.1442-9071.2006.01186.x; CHAWLUK JB, 1988, NEUROLOGY, V38, P858, DOI 10.1212/WNL.38.6.858; Costa VP, 1997, OPHTHALMOLOGY, V104, P1994, DOI 10.1016/S0161-6420(97)30066-9; Ertl M, 2014, ULTRASCHALL MED, V35, P422, DOI 10.1055/s-0034-1366113; FISHER M, 1952, AMA ARCH OPHTHALMOL, V47, P167; Grant Edward G, 2003, Ultrasound Q, V19, P190, DOI 10.1097/00013644-200312000-00005; Kwak, 2017, PLOS ONE, V12, P1; Lee Andrew W, 2014, Neurol Clin Pract, V4, P106, DOI 10.1212/CPJ.0b013e3182a9c62a; Luo JY, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/2606147; Naylor AR, 2014, BRIT J OPHTHALMOL, V98, P730, DOI 10.1136/bjophthalmol-2013-304316; Petzold A, 2013, SURV OPHTHALMOL, V58, P42, DOI 10.1016/j.survophthal.2012.02.002; Rinagel M, 2019, AUTOIMMUN REV, V18, P56, DOI 10.1016/j.autrev.2018.07.012; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; Sharma RA, 2019, CURR OPIN NEUROL, V32, P19, DOI 10.1097/WCO.0000000000000634; Toms DA, 2006, J ULTRAS MED, V25, P560; Tranquart F, 2003, J CLIN ULTRASOUND, V31, P258, DOI 10.1002/jcu.10169; Wang H, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/4169135; Wang J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2901028; Wray SH, 2016, SEMIN NEUROL, V36, P425, DOI 10.1055/s-0036-1585452	23	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					302	309	1358863X21993214	10.1177/1358863X21993214		MAR 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000630582600001	33733967				2022-04-28	
J	Marine, L; Huete, A; Valbuena, JR; Mertens, R; Valdes, F; Vargas, JF; Bergoeing, M; Torrealba, JI				Marine, Leopoldo; Huete, Alvaro; Valbuena, Jose Rafael; Mertens, Renato; Valdes, Francisco; Vargas, Jose Francisco; Bergoeing, Michel; Torrealba, Jose Ignacio			Images in Vascular Medicine: B-cell non-Hodgkin's lymphoma mimicking carotid body tumor	VASCULAR MEDICINE			English	Editorial Material									[Marine, Leopoldo; Mertens, Renato; Valdes, Francisco; Vargas, Jose Francisco; Bergoeing, Michel; Torrealba, Jose Ignacio] Pontificia Univ Catolica Chile, Escuela Med, Dept Cirugia Vasc & Endovasc, Apoquindo 3990 Apt 601, Santiago 7550112, Chile; [Huete, Alvaro] Pontificia Univ Catolica Chile, Escuela Med, Dept Radiol, Santiago, Chile; [Valbuena, Jose Rafael] Pontificia Univ Catolica Chile, Escuela Med, Dept Anat Patol, Santiago, Chile		Marine, L (通讯作者)，Pontificia Univ Catolica Chile, Escuela Med, Dept Cirugia Vasc & Endovasc, Apoquindo 3990 Apt 601, Santiago 7550112, Chile.	marinepolo@yahoo.com		Huete, Alvaro/0000-0002-8746-1111; Marine, Leopoldo/0000-0002-2135-4559	Department of Vascular and Endovascular Surgery of the Pontificia Universidad Catolica de Chile	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: funded by the DepartmYontificia Universidad Catolica de Chile.	Torrealba JI, 2016, ANN VASC SURG, V34, P200, DOI 10.1016/j.avsg.2015.12.029; Kuwada C, 2012, OTOLARYNG CLIN N AM, V45, P1273, DOI 10.1016/j.otc.2012.08.012; MACFARLANE DJ, 1995, EUR J NUCL MED, V22, P1347, DOI 10.1007/BF00801625	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					86	88	1358863X20948584	10.1177/1358863X20948584		SEP 2020	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000565677800001	32877318	Bronze			2022-04-28	
J	Aboyans, V; Abola, MTB				Aboyans, Victor; Abola, Maria Teresa B.			The EUCLIDian perspective of global peripheral artery disease (PAD)	VASCULAR MEDICINE			English	Editorial Material						epidemiology; peripheral artery disease (PAD); risk factors; geographical variation; prevention	RISK-FACTORS; OUTPATIENTS; PREVALENCE; OUTCOMES		[Aboyans, Victor] Univ Limoges, Inserm Unit 1094, Limoges, France; [Aboyans, Victor] Univ Limoges, IRD, Limoges, France; [Aboyans, Victor] Dupuytren 2 Univ Hosp, Dept Cardiol, Limoges, France; [Abola, Maria Teresa B.] Univ Philippines, Philippine Heart Ctr, Dept Clin Res, Quezon City, Metro Manila, Philippines; [Abola, Maria Teresa B.] Univ Philippines, Coll Med, Quezon City, Metro Manila, Philippines		Aboyans, V (通讯作者)，Dupuytren 2 Univ Hosp, Dept Cardiol, 2,Martin Luther King Ave, F-87042 Poitiers, France.	victor.aboyans@unilim.fr		Aboyans, Victor/0000-0002-0322-9818			Abtan J, 2017, CLIN CARDIOL, V40, P710, DOI 10.1002/clc.22721; Bauersachs R, 2021, VASA, V50, P294, DOI 10.1024/0301-1526/a000945; BROWN T, 2021, COCHRANE DB SYST REV, V6; Cho HL, 2018, CLIN TRIALS, V15, P509, DOI 10.1177/1740774518792277; de Donato G, 2017, ANN VASC SURG, V41, P300, DOI 10.1016/j.avsg.2016.08.050; Ducrocq G, 2014, EUR J PREV CARDIOL, V21, P1509, DOI 10.1177/2047487313501278; Ferrari R, 2015, EUR J PREV CARDIOL, V22, P1056, DOI 10.1177/2047487314547652; dos Santos MHH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003892; Kim LK, 2015, CATHETER CARDIO INTE, V86, P864, DOI 10.1002/ccd.26065; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Norgren L, 2022, VASC MED, V27, P21, DOI 10.1177/1358863X211038620; Pfeffer MA, 2015, CIRCULATION, V131, P34, DOI 10.1161/CIRCULATIONAHA.114.013255; Sampson UKA, 2014, GLOB HEART, V9, P145, DOI 10.1016/j.gheart.2013.12.008; Svensson K, 2012, CONTEMP CLIN TRIALS, V33, P1197, DOI 10.1016/j.cct.2012.07.014; Vart P, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004995; WOO KS, 1995, BRIT J CLIN PHARMACO, V40, P141	16	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					30	32	1358863X211051425	10.1177/1358863X211051425		OCT 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000710440800001	34665983				2022-04-28	
J	Echevarria, C				Echevarria, Carlos			Pulmonary leukostasis: an important differential of pulmonary embolism	VASCULAR MEDICINE			English	Meeting Abstract									[Echevarria, Carlos] Alta Vista Reg, Burrel Sch Med, Las Vegas, NM USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1350	NP30	NP30					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100067					2022-04-28	
J	Perez, A				Perez, Alejandro			Venous purple toe syndrome: a variant of acrocyanosis	VASCULAR MEDICINE			English	Meeting Abstract									[Perez, Alejandro] Providence Heart Inst, Portland, OR USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1341	NP29	NP29					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100066					2022-04-28	
J	Yusoff, FM; Higashi, Y				Yusoff, Farina M.; Higashi, Yukihito			Low-intensity pulsed ultrasound decreases major amputation in patients with critical limb ischemia: 5-year follow-up study	VASCULAR MEDICINE			English	Meeting Abstract									[Yusoff, Farina M.; Higashi, Yukihito] Hiroshima Univ, Hiroshima, Japan									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1419	NP20	NP20					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100047					2022-04-28	
J	Alih, DZ; Arellano, R; Rivera, K				Alih, Danah Zoraydalyn; Arellano, Rosella; Rivera, Kathleen			Chronic type B aortic dissection in a pregnant patient: a case report	VASCULAR MEDICINE			English	Meeting Abstract									[Alih, Danah Zoraydalyn; Arellano, Rosella; Rivera, Kathleen] Philippine Heart Ctr, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1364	NP31	NP31					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100069					2022-04-28	
J	Bartholomew, JR				Bartholomew, John R.			From the Masters: Lessons learned about the vascular medicine history and physical examination from the past and present	VASCULAR MEDICINE			English	Editorial Material						physical examination; vascular disease history; vascular medicine	DISEASE; PATIENT		[Bartholomew, John R.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Bartholomew, John R.] Cleveland Clin, Sect Vasc Med Sydell & Arnold Miller Family Heart, Vasc & Thorac Inst, 9500 Euclid Ave,Desk J3-5, Cleveland, OH 44195 USA		Bartholomew, JR (通讯作者)，Cleveland Clin, Sect Vasc Med Sydell & Arnold Miller Family Heart, Vasc & Thorac Inst, 9500 Euclid Ave,Desk J3-5, Cleveland, OH 44195 USA.	BARTHOJ@ccf.org					ASHBELL TS, 1967, PLAST RECONSTR SURG, V39, P311, DOI 10.1097/00006534-196703000-00013; BARNHORST DA, 1968, NEW ENGL J MED, V278, P264, DOI 10.1056/NEJM196802012780508; Beckman JA., 2006, VASC MED, P135; Bilal M, 2017, CLIN ANAT, V30, P352, DOI 10.1002/ca.22832; Buerger L., CIRCULATORY DISTURBA, V1924, P162; Collens WS., 1953, PERIPHERAL VASCULAR, V2nd, P24; Dean SM, 2018, PROG CARDIOVASC DIS, V60, P567, DOI 10.1016/j.pcad.2018.03.004; Dean SM, 2015, VASC MED, V20, P268, DOI 10.1177/1358863X15571448; Fairbairn JF., 1980, PERIPHERAL VASCULAR, V5th ed., P16; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; Gallego FD., 2015, INT J MED STUDENTS, V3, P102, DOI DOI 10.5195/IJMS.2015.125; GAYLIS H, 1966, LANCET, V1, P792; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471; Gogalniceanu P, 2018, NEW ENGL J MED, V378, DOI 10.1056/NEJMvcm1406358; GROOM D, 1955, JAMA-J AM MED ASSOC, V159, P639, DOI 10.1001/jama.1955.02960240005002; HURST JW, 1980, NEW ENGL J MED, V302, P862, DOI 10.1056/NEJM198004103021512; INSALL RL, 1989, J ROY SOC MED, V82, P729, DOI 10.1177/014107688908201209; Jauhar S, 2006, NEW ENGL J MED, V354, P548, DOI 10.1056/NEJMp068013; Khan NA, 2006, JAMA-J AM MED ASSOC, V295, P536, DOI 10.1001/jama.295.5.536; Kurtz KJ., 1990, CLIN METHODS HIST PH, V3rd, P101; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; McGee SR, 1998, ARCH INTERN MED, V158, P1357, DOI 10.1001/archinte.158.12.1357; O'Brien D P, 1990, Eur J Vasc Surg, V4, P531, DOI 10.1016/S0950-821X(05)80797-2; PESSIN MS, 1983, STROKE, V14, P246, DOI 10.1161/01.STR.14.2.246; Pickering GW, 1933, BRIT MED J, V1933, P1106, DOI 10.1136/bmj.2.3806.1106; Roelandt JRTC, 2014, EUR HEART J-CARD IMG, V15, P249, DOI 10.1093/ehjci/jet195; Wennberg PW, 2013, CIRCULATION, V128, P2241, DOI 10.1161/CIRCULATIONAHA.113.000502; Young JR., 1996, PERIPHERAL VASCULAR, V2nd ed., P18	28	0	0	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					361	366		10.1177/1358863X211022807			6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000683828000001	34355594	Bronze			2022-04-28	
J	Tefera, L; Cameron, SJ				Tefera, Leben; Cameron, Scott J.			SVM Communications: VITT - what the vascular medicine physician should know	VASCULAR MEDICINE			English	Editorial Material									[Tefera, Leben; Cameron, Scott J.] Heart Vasc & Thorac Inst, Dept Cardiovasc Med, Sect Vasc Med, Cleveland Clin, Desk J3-5,9500 Euclid Ave, Cleveland, OH 44195 USA; [Cameron, Scott J.] Case Western Reserve Univ, Lerner Coll Med, Cleveland, OH USA; [Cameron, Scott J.] Taussig Canc Ctr, Cleveland Clin, Dept Hematol, Cleveland, OH USA; [Cameron, Scott J.] Lerner Res Inst, Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH USA		Cameron, SJ (通讯作者)，Heart Vasc & Thorac Inst, Dept Cardiovasc Med, Sect Vasc Med, Cleveland Clin, Desk J3-5,9500 Euclid Ave, Cleveland, OH 44195 USA.	cameros3@ccf.org	Cameron, Scott/AAW-8429-2021	Cameron, Scott/0000-0002-9616-1540	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL158801-01]	The author(s) disclosed reciept of the following financial support for the research, authorship, and/or publication of this article. The work of Scott J. Cameron was supported by the National Heart, Lung, and Blood Institute (HL158801-01).	American Society of Hematology, 2021, THROMB THROMB SYNDR; Arepally GM, 2017, BLOOD, V129, P2864, DOI 10.1182/blood-2016-11-709873; Cines DB, 2021, NEW ENGL J MED, V384, P2254, DOI 10.1056/NEJMe2106315; Eric Kowarz L.K., 2021, RES SQUARE; Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840; Mastellos DC, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI151092; Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882; Singh B, 2020, DIGEST LIVER DIS, V52, P1407, DOI 10.1016/j.dld.2020.09.025; Tu TM, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105379; von Hundelshausen P, 2021, THROMB HAEMOSTASIS, V121, P1395, DOI 10.1055/a-1481-3039; Whiteheart SW, 2011, BLOOD, V118, P1190, DOI 10.1182/blood-2011-06-359836; World Health Organization, 2021, WHO COR COVID 19 DAS	12	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					579	581		10.1177/1358863X211030326		JUL 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000675676500001	34278880	Green Accepted			2022-04-28	
J	Pamulapati, V; Guitart, JR; Helenowski, IB; Resnick, S; Ho, KJ				Pamulapati, Vivek; Guitart, Joan R.; Helenowski, Irene B.; Resnick, Scott; Ho, Karen J.			Use of computed tomographic and digital subtraction angiography to determine optimal duplex ultrasound criteria for predicting superior mesenteric artery in-stent restenosis	VASCULAR MEDICINE			English	Letter						duplex ultrasound; in-stent restenosis; mesenteric artery stent; vascular imaging/diagnostics			[Pamulapati, Vivek; Guitart, Joan R.; Ho, Karen J.] Northwestern Univ, Feinberg Sch Med, Div Vasc Surg, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA; [Helenowski, Irene B.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Resnick, Scott] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA		Ho, KJ (通讯作者)，Northwestern Univ, Feinberg Sch Med, Div Vasc Surg, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA.	kho1@nm.org			National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL094293]; William H Pearce, MD, Vascular Surgery Student Research Award; Feinberg School of Medicine, Northwestern University	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research reported in this publication was supported in part by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL094293 to VP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. In addition, JG was supported by the William H Pearce, MD, Vascular Surgery Student Research Award, Feinberg School of Medicine, Northwestern University.	AbuRahma AF, 2012, J VASC SURG, V55, P730, DOI 10.1016/j.jvs.2011.10.086; Alahdab F, 2018, J VASC SURG, V67, P1598, DOI 10.1016/j.jvs.2017.12.046; Barnes JA, 2020, ANN VASC SURG, V68, P226, DOI 10.1016/j.avsg.2020.04.064; Green J, 2021, ANN VASC SURG, V74, P294, DOI 10.1016/j.avsg.2020.12.023; Huber TS, 2021, J VASC SURG, V73, p87S, DOI 10.1016/j.jvs.2020.10.029; Lopera JE, 2009, AM J ROENTGENOL, V193, P1439, DOI 10.2214/AJR.09.2372; Mitchell EL, 2009, J VASC SURG, V50, P335, DOI 10.1016/j.jvs.2008.12.071; MONETA GL, 1993, J VASC SURG, V17, P79, DOI 10.1016/0741-5214(93)90011-A; Soult MC, 2016, J VASC SURG, V64, P1366, DOI 10.1016/j.jvs.2016.06.103	9	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					566	568		10.1177/1358863X211025615		JUL 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000675763800001	34269145				2022-04-28	
J	Ho, KM; Rogers, FB; Rao, S; Chamberlain, J; Geelhoed, E				Ho, Kwok M.; Rogers, Frederick B.; Rao, Sudhakar; Chamberlain, Jenny; Geelhoed, Elizabeth			Cost-effectiveness of early placement of vena cava filters to prevent symptomatic pulmonary embolism in patients with contraindications to prophylactic anticoagulant	VASCULAR MEDICINE			English	Article						economic analysis; inferior vena cava (IVC) filters; pulmonary embolism (PE); thrombosis	DEEP-VEIN THROMBOSIS; INTERMITTENT PNEUMATIC COMPRESSION; VENOUS THROMBOEMBOLISM; TRAUMA	Introduction: Vena cava filters have been used as a primary means to prevent symptomatic pulmonary embolism (PE) in trauma patients who cannot be anticoagulated after severe injury, but the economic implications for this practice remain unclear. Methods: Using a healthcare system perspective to analyze the a priori primary outcome of the da Vinci trial, we report the cost-effectiveness of using vena cava filters as a primary means to prevent PE in patients who have contraindications to prophylactic anticoagulation after major trauma. Results: Of the 240 patients enrolled, complete, prospectively collected, hospital cost data during the entire hospital stay - including costs for the filter, medical/nursing/allied health staff, medical supplies, pathology tests, and radiological imaging - were available in 223 patients (93%). Patients allocated to the filter group (n = 114) were associated with a reduced risk of PE (0.9%) compared to those in the control group (n = 109, 5.5%; p = 0.048); and the filter's benefit was more pronounced among those who could not be anticoagulated within 7 days (filter: 0% vs control: 16%, Bonferroni-corrected p = 0.02). Overall, the cost needed to prevent one PE was high (AUD $379,760), but among those who could not be anticoagulated within 7 days, the costs to prevent one PE (AUD $36,156; similar to USD $26,032) and gain one quality-adjusted life-year (AUD $30,903; similar to USD $22,250) were substantially lower. Conclusion: The cost of using a vena cava filter to prevent PE for those who have contraindications to prophylactic anticoagulation within 3 days of injury is prohibitive, unless such contraindications remain for longer than 7 days.	[Ho, Kwok M.; Chamberlain, Jenny] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Rogers, Frederick B.] Univ Penn, Dept Surg, Lancaster, PA USA; [Rao, Sudhakar] Royal Perth Hosp, State Trauma Unit, Perth, WA, Australia; [Geelhoed, Elizabeth] Univ Western Australia, Sch Allied Hlth, Perth, WA, Australia		Ho, KM (通讯作者)，Royal Perth Hosp, Wellington St, Perth, WA 6000, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok/E-3546-2010	Ho, Kwok/0000-0002-6705-6004	Trauma Research Program from the Royal Perth Hospital Medical Research Foundation; Translational Research Project from the Western Australian Department of Health; Clinician Research Fellowship (round 3) from the Raine Medical Research Foundation	This study was jointly funded by the Trauma Research Program from the Royal Perth Hospital Medical Research Foundation, Translational Research Project from the Western Australian Department of Health, and Clinician Research Fellowship (round 3) from the Raine Medical Research Foundation. No financial or nonmonetary (in-kind) support was received from any companies that manufacture vena cava filters or from commercial entities. The funding agencies have no role in the design of the study, data analysis, interpretation of the results, and the decision to submit this manuscript for publication.	Access Economics Pty Limited, 2008, BURD VEN THROMB AUST; Australian Commission on Safety and Quality in Health Care, 2020, VEN THROMB PREV CLIN; Carlin MN, 2017, J SURG RES, V220, P105, DOI 10.1016/j.jss.2017.07.004; Chuang LH, 2018, THROMB RES, V170, P165, DOI 10.1016/j.thromres.2018.08.001; Dasta JF, 2015, THROMB RES, V135, P303, DOI 10.1016/j.thromres.2014.11.024; Fanikos J, 2013, AM J MED, V126, P127, DOI 10.1016/j.amjmed.2012.07.025; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gilligan TC, 2020, J SURG RES, V246, P145, DOI 10.1016/j.jss.2019.09.004; Grosse SD, 2016, THROMB RES, V137, P3, DOI 10.1016/j.thromres.2015.11.033; Ho KM, 2015, BRIT J ANAESTH, V114, P63, DOI 10.1093/bja/aeu195; Ho KM, 2014, ANAESTH INTENS CARE, V42, P709, DOI 10.1177/0310057X1404200605; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Ho KM, 2019, ANAESTH CRIT CARE PA, V38, P305, DOI 10.1016/j.accpm.2019.07.003; Ho KM, 2019, NEW ENGL J MED, V381, P328, DOI 10.1056/NEJMoa1806515; Ho KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016747; Ho KM, 2013, CIRCULATION, V128, P1003, DOI 10.1161/CIRCULATIONAHA.113.002690; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Saunders R, 2018, CLINICOECONOMIC OUTC, V10, P231, DOI 10.2147/CEOR.S157306; Spangler EL, 2010, J VASC SURG, V52, P1537, DOI 10.1016/j.jvs.2010.06.152	20	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					641	647	1358863X211023559	10.1177/1358863X211023559		JUN 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000667858300001	34169797				2022-04-28	
J	Zierler, RE				Zierler, R. Eugene			From Doppler to duplex: A personal early history of the vascular laboratory	VASCULAR MEDICINE			English	Review						Doppler; duplex ultrasound; noninvasive testing; vascular laboratory; history of medicine		In the mid-1970s, a group of clinicians and bioengineers at the University of Washington, under the direction of Dr D Eugene Strandness, Jr, built a prototype duplex scanner that combined B-mode imaging and pulsed Doppler flow detection in a single instrument. At that time, I was a general surgery resident with an interest in vascular disease, and arrangements were made for me to spend a year in the Strandness laboratory. The prototype duplex system was just being completed when I arrived in 1978, and I immediately became involved in a series of validation studies in which patients with carotid disease were scanned and spectral waveform parameters were correlated with independently read contrast arteriograms. This work resulted in the University of Washington duplex criteria for carotid artery disease, which have been widely adopted and modified. Subsequent advances in ultrasound technology expanded the applications of duplex scanning to the peripheral arteries and veins, as well as the abdominal vessels. In 1984, I joined Dr Strandness on the faculty in the Department of Surgery at the University of Washington where I have remained throughout my career. Over the years, I have had the opportunity to participate in many important developments, described in this article, that have helped to make the vascular laboratory the essential clinical resource that it is today.	[Zierler, R. Eugene] Univ Washington, Sch Med, Dept Surg, Div Vasc Surg, Seattle, WA 98195 USA; [Zierler, R. Eugene] Univ Washington, Med Ctr Montlake, DE Strandness Jr Vasc Lab, Seattle, WA 98195 USA; [Zierler, R. Eugene] Harborview Med Ctr, Vasc Lab, Seattle, WA USA		Zierler, RE (通讯作者)，Univ Washington, Dept Surg, Box 356410, Seattle, WA 98195 USA.	gzierler@uw.edu					BAKER DW, 1970, IEEE T SON ULTRASON, VSU17, P170, DOI 10.1109/T-SU.1970.29558; BARBER FE, 1974, IEEE T BIO-MED ENG, VBM21, P109, DOI 10.1109/TBME.1974.324295; Bluth E I, 1988, Radiographics, V8, P487; CHIKOS PM, 1983, STROKE, V14, P885, DOI 10.1161/01.STR.14.6.885; Columbo JA, 2020, CIRCULATION, V141, P946, DOI 10.1161/CIRCULATIONAHA.119.043963; FELL G, 1981, CIRCULATION, V64, P1191, DOI 10.1161/01.CIR.64.6.1191; FRANKLIN DL, 1961, SCIENCE, V134, P564, DOI 10.1126/science.134.3478.564; HARTLEY CJ, 1969, J SURG RES, V9, P575, DOI 10.1016/0022-4804(69)90013-4; HOKANSON DE, 1971, BIOMED ENG, V6, P420; JAGER KA, 1985, ULTRASOUND MED BIOL, V11, P515, DOI 10.1016/0301-5629(85)90164-4; KILLEWICH LA, 1989, CIRCULATION, V79, P810, DOI 10.1161/01.CIR.79.4.810; Kim ESH, 2020, CIRCULATION, V141, P954, DOI 10.1161/CIRCULATIONAHA.120.045411; KOHLER TR, 1986, J VASC SURG, V4, P450, DOI 10.1067/mva.1986.avs0040450; MONETA GL, 1991, J VASC SURG, V14, P511, DOI 10.1016/0741-5214(91)90245-P; MONETA GL, 1992, J VASC SURG, V15, P275, DOI 10.1016/0741-5214(92)90249-8; MOZERSKY DJ, 1971, ARCH SURG-CHICAGO, V103, P663; NICHOLLS SC, 1986, J VASC SURG, V3, P507; NORRIS CS, 1984, J VASC SURG, V1, P192, DOI 10.1067/mva.1984.avs0010192; PHILLIPS DJ, 1989, ULTRASOUND MED BIOL, V15, P205, DOI 10.1016/0301-5629(89)90065-3; PHILLIPS DJ, 1983, ULTRASOUND MED BIOL, V9, P39, DOI 10.1016/0301-5629(83)90108-4; ROEDERER GO, 1982, J CARDIOVASC ULTRAS, V1, P373; Roederer GO, 1984, BRUIT, V8, P174; RUSHMER RF, 1966, J APPL PHYSIOL, V21, P554, DOI 10.1152/jappl.1966.21.2.554; Strandness D E Jr, 1996, Cardiovasc Surg, V4, P273, DOI 10.1016/0967-2109(96)00001-4; STRANDNESS DE, 1990, J VASC SURG, V11, P187, DOI 10.1067/mva.1990.16375; STRANDNESS DE, 1978, PROG CARDIOVASC DIS, V20, P403, DOI 10.1016/0033-0620(78)90027-0; STRANDNESS DE, 1967, AM J SURG, V113, P311, DOI 10.1016/0002-9610(67)90272-3; STRANDNESS DE, 1972, J SURG RES, V12, P419, DOI 10.1016/0022-4804(72)90094-7; STRANDNESS DE, 1966, SURG GYNECOL OBSTETR, V122, P1039; SULLIVAN ED, 1984, J VASC SURG, V1, P465, DOI 10.1067/mva.1984.avs0010465; Zierler RE., 2016, STRANDNESSS DUPLEX S, P31	31	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					338	345	1358863X211002644	10.1177/1358863X211002644		APR 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000638960700001	33829922				2022-04-28	
J	Kilian, A; Clancy, MS; Olitsky, S; Gossage, JR; Faughnan, ME				Kilian, Alexandra; Clancy, Marianne S.; Olitsky, Scott; Gossage, James R.; Faughnan, Marie E.			Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence	VASCULAR MEDICINE			English	Letter						arteriovenous malformation; cerebral; hereditary hemorrhagic telangiectasia (HHT); pulmonary; screening; rare diseases	ARTERIOVENOUS-MALFORMATIONS; RANDOMIZED-TRIAL; PREVALENCE; ARUBA; AGE		[Kilian, Alexandra; Faughnan, Marie E.] Univ Toronto, St Michaels Hosp, Toronto HHT Ctr, Dept Med,Div Respirol, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Clancy, Marianne S.; Olitsky, Scott] Cure HHT, Monkton, MD USA; [Gossage, James R.] Augusta Univ, Div Pulm & Crit Care Med, Dept Med, Augusta, GA USA; [Faughnan, Marie E.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Faughnan, Marie E.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada		Faughnan, ME (通讯作者)，Univ Toronto, St Michaels Hosp, Toronto HHT Ctr, Dept Med,Div Respirol, 30 Bond St, Toronto, ON M5B 1W8, Canada.	marie.faughnan@unityhealth.to					Amin-Hanjani S, 2014, STROKE, V45, P1539, DOI 10.1161/STROKEAHA.113.002696; Brinjikji W, 2017, J NEUROSURG, V127, P302, DOI 10.3171/2016.7.JNS16847; Cockroft KM, 2012, STROKE, V43, P1979, DOI 10.1161/STROKEAHA.112.652032; Donaldson JW, 2014, THORAX, V69, P161, DOI 10.1136/thoraxjnl-2013-203720; Eker OF, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01386-9; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hosman AE, 2017, PEDIATR PULM, V52, P1206, DOI 10.1002/ppul.23704; Howard DH, 2009, HEALTH AFFAIR, V28, P1838, DOI 10.1377/hlthaff.28.6.1838; Kim H, 2015, STROKE, V46, P1362, DOI 10.1161/STROKEAHA.114.007367; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Krings T, 2005, NEURORADIOLOGY, V47, P711, DOI 10.1007/s00234-005-1390-8; Krings T, 2015, AM J NEURORADIOL, V36, P863, DOI 10.3174/ajnr.A4210; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Nishida T, 2012, AM J MED GENET A, V158A, P2829, DOI 10.1002/ajmg.a.35622; Pierot L, 2014, AM J NEURORADIOL, V35, P416, DOI 10.3174/ajnr.A3867; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; Willemse RB, 2000, J NEUROSURG, V92, P779, DOI 10.3171/jns.2000.92.5.0779	18	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					53	55	1358863X20974452	10.1177/1358863X20974452		DEC 2020	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000618441300001	33375920	hybrid, Green Published			2022-04-28	
J	Iglesias, CI; Azofra, EA; Suarez, SB; Marcos, FA; Al-Sibbai, AAZ; Perez, MA				Iglesias, Cristobal Iglesias; Arenas Azofra, Ernesto; Busto Suarez, Sara; alvarez Marcos, Francisco; Zanabili Al-Sibbai, Ahmad Amer; Alonso Perez, Manuel			Incidence of thoracic aortic aneurysms in patients with a previous abdominal aortic aneurysm repair	VASCULAR MEDICINE			English	Letter						abdominal aortic aneurysm (AAA); aneurysm; aortic disease; arterial aneurysm; thoracic aortic aneurysm			[Iglesias, Cristobal Iglesias; Arenas Azofra, Ernesto; Busto Suarez, Sara; alvarez Marcos, Francisco; Zanabili Al-Sibbai, Ahmad Amer; Alonso Perez, Manuel] Asturias Univ Cent Hosp HUCA, Dept Angiol & Vasc Surg, Ave Roma S-N, Oviedo 33011, Asturias, Spain		Iglesias, CI (通讯作者)，Asturias Univ Cent Hosp HUCA, Dept Angiol & Vasc Surg, Ave Roma S-N, Oviedo 33011, Asturias, Spain.	cristobal.iglesiasiglesias@gmail.com	Iglesias-Iglesias, Cristóbal/AAD-8764-2022	Iglesias-Iglesias, Cristóbal/0000-0002-3388-2711; Arenas Azofra, Ernesto/0000-0002-2913-5932; Busto Suarez, Sara/0000-0002-8848-6716			Chaer RA, 2012, J VASC SURG, V56, P1261, DOI 10.1016/j.jvs.2012.04.056; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Clouse WD, 1998, JAMA-J AM MED ASSOC, V280, P1926, DOI 10.1001/jama.280.22.1926; Cohen J, 2017, PHYSIOL BEHAV, V176, P139, DOI DOI 10.1016/J.PHYSBEH.2017.03.040; DAPUNT OE, 1994, J THORAC CARDIOV SUR, V107, P1323, DOI 10.1016/S0022-5223(94)70054-0; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Kalman PG, 1999, J VASC SURG, V29, P442, DOI 10.1016/S0741-5214(99)70272-7; PLATE G, 1985, ARCH SURG-CHICAGO, V120, P590; Robinson D, 1997, AUST NZ J SURG, V67, P640, DOI 10.1111/j.1445-2197.1997.tb04615.x; Schlosser FJV, 2008, J VASC SURG, V48, P761, DOI 10.1016/j.jvs.2008.02.006; Wanhainen A, 2019, EUR J VASC ENDOVASC, V57, P8, DOI 10.1016/j.ejvs.2018.09.020	11	0	0	4	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					50	52	1358863X20960513	10.1177/1358863X20960513		OCT 2020	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000578527100001	33043857				2022-04-28	
J	Pichert, MD; Smolderen, KG; Castro-Dominguez, Y; Jelani, QU; Nagpal, S; Provance, JB; Huang, JM; Malik, AO; Secemsky, EA; Derbas, LA; Mena-Hurtado, CI				Pichert, Matthew D.; Smolderen, Kim G.; Castro-Dominguez, Yulanka; Jelani, Qurat-Ul-Ain; Nagpal, Sameer; Provance, Jeremy B.; Huang, Jiaming; Malik, Ali O.; Secemsky, Eric A.; Derbas, Laith A.; Mena-Hurtado, Carlos, I			Trends in drug-coated device use for peripheral artery disease: Insights from the Vascular Quality Initiative (VQI)	VASCULAR MEDICINE			English	Letter						drug coated balloon; peripheral artery disease (PAD); utilization	BALLOON		[Pichert, Matthew D.; Smolderen, Kim G.; Jelani, Qurat-Ul-Ain; Nagpal, Sameer; Provance, Jeremy B.; Mena-Hurtado, Carlos, I] Yale Univ, Sch Med, Vasc Med Outcomes Program, Dept Internal Med,Sect Cardiovasc Med, 789 Howard Ave, New Haven, CT 06510 USA; [Smolderen, Kim G.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Castro-Dominguez, Yulanka] Univ Hosp, Dept Cardiol, Cleveland, OH USA; [Huang, Jiaming] Dana Farber Canc Inst, Boston, MA 02115 USA; [Malik, Ali O.] St Lukes Mid Amer Heart Inst, Kansas City, MI USA; [Malik, Ali O.] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MI USA; [Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Dept Med, Smith Ctr Outcomes Res Cardiol, Div Cardiol, Boston, MA 02215 USA; [Derbas, Laith A.] Rush Univ, Div Cardiol, Chicago, IL 60612 USA		Mena-Hurtado, CI (通讯作者)，Yale Univ, Sch Med, Vasc Med Outcomes Program, Dept Internal Med,Sect Cardiovasc Med, 789 Howard Ave, New Haven, CT 06510 USA.	Carlos.mena-hurtado@yale.edu		Pichert, Matthew/0000-0002-6947-2749; derbas, laith/0000-0002-5645-8390; Smolderen, Kim/0000-0001-6104-6254; Castro Dominguez, Yulanka/0000-0003-0620-0444; Secemsky, Eric/0000-0003-3861-3163; Jelani, Qurat-ul-ain/0000-0003-3393-8348			Dake MD, 2011, CIRC-CARDIOVASC INTE, V4, P495, DOI 10.1161/CIRCINTERVENTIONS.111.962324; Katsanos K, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.011245; Mohapatra A, 2020, J VASC SURG, V71, P560, DOI 10.1016/j.jvs.2019.05.034; Nordanstig J, 2020, NEW ENGL J MED, V383, P2538, DOI 10.1056/NEJMoa2005206; Scheinert D, 2014, JACC-CARDIOVASC INTE, V7, P11, DOI 10.1016/j.jcin.2013.05.022	5	0	0	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					73	74	1358863X211043567	10.1177/1358863X211043567		OCT 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000705737200001	34610776				2022-04-28	
J	Waqar, F				Waqar, Fahad			Dual basilic vein access for catheter directed thrombolytic therapy in acute pulmonary embolism: a single-center experience	VASCULAR MEDICINE			English	Meeting Abstract									[Waqar, Fahad] Univ Cincinnati, Coll Med, Cincinnati, OH USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1186	NP23	NP23					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100053					2022-04-28	
J	Betz, T; Toepel, I; Pfister, K; Lang, M; Steinbauer, M; Uhl, C; Zeman, F; Schierling, W				Betz, Thomas; Toepel, Ingolf; Pfister, Karin; Lang, Malisia; Steinbauer, Markus; Uhl, Christian; Zeman, Florian; Schierling, Wilma			Impact of chronic kidney disease on the outcomes of infrapopliteal venous, and heparin-bonded expanded polytetrafluoroethylene bypass surgeries: A retrospective cohort study	VASCULAR MEDICINE			English	Article						chronic limb-threatening ischemia (CLTI); dialysis; heparin-bonded expanded polytetrafluoroethylene (HePTFE); peripheral artery disease (PAD); vascular surgery; chronic kidney disease (CKD)	CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERY-DISEASE; VEIN; REVASCULARIZATION; FEMOROPOPLITEAL; MANAGEMENT; GRAFTS; RISK	The aim of this study was to analyze the results of infrapopliteal venous and prosthetic bypass surgeries for patients with chronic limb-threatening ischemia (CLTI) and moderate to severe chronic kidney disease (CKD). All consecutive patients undergoing infrapopliteal bypass surgeries at two academic vascular centers between March 2002 and November 2018 were included in this retrospective study. During this timeframe, infrapopliteal grafts were performed for 487 patients. Of these patients, 160 (32.9%; group 1) had normal renal function, 248 (50.9%; group 2) had moderate CKD, and 79 (16.2%; group 3) had severe CKD according to the Kidney Disease Improving Global Outcomes guidelines. After 5 years' follow-up, the primary patency rate was 46.0% and the secondary patency rate was 54.9% without statistical significance noted between the CKD groups. Limb salvage (65.3%, p = 0.024) and long-term survival (19.6%, p < 0.001) were considerably lower in patients with severe CKD. In subgroup analysis, vein grafts had significantly better long-term patency rates compared to prosthetic grafts, regardless of CKD group. However, in patients with severe CKD, patency rates of vein and heparin-bonded expanded polytetrafluoroethylene (HePTFE) grafts were comparable at the 1-year mark. Our study shows that autologous vein grafts remain the first choice for infrapopliteal bypass surgeries in patients with CKD. HePTFE grafts showed good short-term results in patients with severe CKD. Given the short life expectancy of these high-risk patients, prosthetic HePTFE grafts may be reasonable in this population if a suitable vein is absent.	[Betz, Thomas; Toepel, Ingolf; Steinbauer, Markus; Uhl, Christian] Barmherzige Bruder Hosp, Dept Vasc Surg, Prufeningerstr 86, D-93049 Regensburg, Germany; [Pfister, Karin; Lang, Malisia; Schierling, Wilma] Univ Med Ctr, Dept Vasc Surg, Regensburg, Germany; [Zeman, Florian] Univ Med Ctr, Ctr Clin Studies, Regensburg, Germany		Betz, T (通讯作者)，Barmherzige Bruder Hosp, Dept Vasc Surg, Prufeningerstr 86, D-93049 Regensburg, Germany.	thomas.betz@barmherzige-regensburg.de		Betz, Thomas/0000-0003-1539-245X			Albers M, 2007, J VASC SURG, V45, P536, DOI 10.1016/j.jvs.2006.11.036; Arhuidese I, 2017, SURGERY, V162, P1071, DOI 10.1016/j.surg.2017.04.026; Azuma N, 2017, ANN VASC DIS, V10, P178, DOI 10.3400/avd.ra.17-00076; Ballotta E, 2007, J NEPHROL, V20, P80; Biancari F, 2012, SCAND J SURG, V101, P138, DOI 10.1177/145749691210100211; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Daenens K, 2009, J VASC SURG, V49, P1210, DOI 10.1016/j.jvs.2008.12.009; Deutsch M, 2001, EUR J VASC ENDOVASC, V21, P508, DOI 10.1053/ejvs.2001.1361; Hess CN, 2017, CIRCULATION, V135, P2534, DOI 10.1161/CIRCULATIONAHA.117.024469; Kodama A, 2014, EUR J VASC ENDOVASC, V48, P695, DOI 10.1016/j.ejvs.2014.08.022; Lacroix P, 2013, J VASC SURG, V58, P966, DOI 10.1016/j.jvs.2013.04.007; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Linni K, 2012, J VASC SURG, V56, P126, DOI 10.1016/j.jvs.2011.10.135; Luders F, 2016, CLIN J AM SOC NEPHRO, V11, P216, DOI 10.2215/CJN.05600515; Luders F, 2017, ANGIOLOGY, V68, P145, DOI 10.1177/0003319716638797; Neville RF, 2012, J VASC SURG, V56, P1008, DOI 10.1016/j.jvs.2012.03.020; Patel VI, 2014, J VASC SURG, V59, P368, DOI 10.1016/j.jvs.2013.09.006; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Samson RH, 2016, J VASC SURG, V64, P638, DOI 10.1016/j.jvs.2016.03.414; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Uhl C, 2015, VASCULAR, V23, P607, DOI 10.1177/1708538114568701	21	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					55	62	1358863X211036751	10.1177/1358863X211036751		SEP 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000700413000001	34549643				2022-04-28	
J	Lilja, E; Gottsater, A; Miftaraj, M; Ekelund, J; Eliasson, B; Svensson, AM; Zarrouk, M; Acosta, S				Lilja, Erika; Gottsater, Anders; Miftaraj, Mervete; Ekelund, Jan; Eliasson, Bjorn; Svensson, Ann-Marie; Zarrouk, Moncef; Acosta, Stefan			Diabetes mellitus was not associated with lower amputation-free survival after open revascularization for chronic limb-threatening ischemia - A nationwide propensity score adjusted analysis	VASCULAR MEDICINE			English	Article						amputation; bypass; chronic limb-threatening ischemia (CLTI); diabetes mellitus	PERIPHERAL ARTERIAL-DISEASE; SAPHENOUS-VEIN BYPASS; OUTCOMES; REGRESSION; SURGERY; EVENTS; IMPACT; RISK	The risk of major amputation is higher after urgently planned endovascular therapy for chronic limb-threatening ischemia (CLTI) in patients with diabetes mellitus (DM). The aim of this nationwide cohort study was to compare outcomes between patients with and without DM following urgently planned open revascularization for CLTI from 2010 to 2014. Out of 1537 individuals registered in the Swedish Vascular Registry, 569 were registered in the National Diabetes Register. A propensity score adjusted Cox regression analysis was conducted to compare outcome between the groups with and without DM. Median follow-up was 4.3 years and 4.5 years for patients with and without DM, respectively. Patients with DM more often had foot ulcers (p = 0.034) and had undergone more previous amputations (p = 0.001) at baseline. No differences in mortality, cardiovascular death, major adverse cardiovascular events (MACE), or major amputation were observed between groups. The incidence rate of stroke was 70% higher (95% CI: 1.11-2.59; p = 0.0137) and the incidence rate of acute myocardial infarction (AMI) 39% higher (95% CI: 1.00-1.92; p = 0.0472) among patients with DM in comparison to those without. Open vascular surgery remains a first-line option for a substantial number of patients with CLTI, especially for limb salvage in patients with DM. The higher incidence rates of stroke and AMI among patients with DM following open vascular surgery for infrainguinal CLTI require specific consideration preoperatively with the aim of optimizing medical treatment to improve cardiovascular outcome postoperatively.	[Lilja, Erika; Gottsater, Anders; Zarrouk, Moncef; Acosta, Stefan] Lund Univ, Dept Clin Sci, Jan Waldenstroms G 35, S-21421 Malmo, Sweden; [Gottsater, Anders; Zarrouk, Moncef; Acosta, Stefan] Skane Univ Hosp, Dept Cardiothorac Surg & Vasc Dis, Vasc Ctr, Malmo, Sweden; [Miftaraj, Mervete; Ekelund, Jan; Svensson, Ann-Marie] Natl Diabet Register, Ctr Registers, Gothenburg, Sweden; [Eliasson, Bjorn] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden		Lilja, E (通讯作者)，Lund Univ, Dept Clin Sci, Jan Waldenstroms G 35, S-21421 Malmo, Sweden.	erika.lilja@med.lu.se		Lilja, Erika/0000-0001-9965-8133; Acosta, Stefan/0000-0002-3225-0798; Gottsater, Anders/0000-0003-0865-0000	Region Skane [430751]; Hulda Ahlmroth Foundation; Swedish Government under the LUA/ALF agreement; Research Funds at Skane University Hospital	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Stefan Acosta and Anders Gottsater were supported by grants from Research Funds at Skane University Hospital, Region Skane (430751), the Hulda Ahlmroth Foundation, and from the Swedish Government under the LUA/ALF agreement. The funders did not have any role in study design, analysis, interpretation, or writing of the manuscript.	Abu Dabrh AM, 2015, J VASC SURG, V62, P1642, DOI 10.1016/j.jvs.2015.07.065; Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Arvela E, 2012, ANN VASC SURG, V26, P396, DOI 10.1016/j.avsg.2011.08.013; Ballotta E, 2014, J VASC SURG, V59, P708, DOI 10.1016/j.jvs.2013.08.103; Beaulieu RJ, 2020, JAMA SURG, V155, P131, DOI 10.1001/jamasurg.2019.4908; Bonaca MP, 2020, NEW ENGL J MED, V382, P1994, DOI 10.1056/NEJMoa2000052; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Butt T, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107551; Butt T, 2019, VASC ENDOVASC SURG, V53, P118, DOI 10.1177/1538574418813746; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chen R, 2016, AM J MED SCI, V351, P380, DOI 10.1016/j.amjms.2016.01.011; Clark N, 2003, DIABETES CARE, V26, P3333; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Darling JD, 2018, J VASC SURG, V67, P1159, DOI 10.1016/j.jvs.2017.06.119; Djerf H, 2020, EUR J VASC ENDOVASC, V59, P817, DOI 10.1016/j.ejvs.2019.11.023; Eliasson B, 2014, DIABETES RES CLIN PR, V106, pS291, DOI 10.1016/S0168-8227(14)70732-6; Fransson T, 2010, VASA, V39, P59, DOI 10.1024/0301-1526/a000006; Fridh EB, 2017, EUR J VASC ENDOVASC, V54, P480, DOI 10.1016/j.ejvs.2017.07.005; Fridh EB, 2018, EUR J VASC ENDOVASC, V56, P681, DOI 10.1016/j.ejvs.2018.06.003; Hogh A, 2013, EUR J PREV CARDIOL, V20, P763, DOI 10.1177/2047487312449592; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Liang P, 2018, J VASC SURG, V68, P487, DOI 10.1016/j.jvs.2017.11.081; Lilja E, 2021, J DIABETES COMPLICAT, V35, DOI 10.1016/j.jdiacomp.2020.107675; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Malmstedt J, 2008, DIABETES CARE, V31, P887, DOI 10.2337/dc07-2424; Martens EP, 2008, PHARMACOEPIDEM DR S, V17, P1, DOI 10.1002/pds.1520; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Nationella Diabetesregistret, 2019, RSRAPP; Olen O, 2012, DIGEST LIVER DIS, V44, P471, DOI 10.1016/j.dld.2012.01.006; Socialstyrelsen, 2019, SWED CANC REG; Troeng T, 2008, EUR J VASC ENDOVASC, V36, P705, DOI 10.1016/j.ejvs.2008.08.017; Vascular Registry in Sweden, 2020, RSRAPP; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wallaert JB, 2012, J VASC SURG, V56, P1317, DOI 10.1016/j.jvs.2012.04.011; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wolfe JHN, 1997, EUR J VASC ENDOVASC, V13, P578, DOI 10.1016/S1078-5884(97)80067-6	38	0	0	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					507	514	1358863X211008249	10.1177/1358863X211008249		MAY 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000652852600001	34004125	Green Published, hybrid			2022-04-28	
J	Kreuzpointner, R; Johner, F; Roth-Zetzsche, S; Kucher, N; Barco, S				Kreuzpointner, Robert; Johner, Fabian; Roth-Zetzsche, Stephanie; Kucher, Nils; Barco, Stefano			Clinical presentation and long-term follow-up of 45 patients with Mondor disease: A single-center longitudinal study	VASCULAR MEDICINE			English	Article						Mondor disease; cohort study; risk factors; superficial vein thrombophlebitis; venous thromboembolism (VTE); thrombosis		Mondor disease is characterized by an acute painful thrombophlebitis occurring at specific anatomical sites. Data on its incidence, characteristics of clinical presentation, and course are unavailable to date. We studied the course of Mondor disease in patients diagnosed and followed at the University Hospital Zurich (Switzerland) between 2004 and 2020. The primary study outcomes were a diagnosis of active cancer either at the time of clinical diagnosis of Mondor disease or within 1 year, as well as 1-year all-cause death and recurrent Mondor disease. We included 45 patients and classified them into one of the three Mondor disease subgroups: thoracic (n = 26), penile (n = 12), or axillary (n = 7). The median age was 39 (Q1-Q3: 30-45) years and 44% of patients were men. Surgery was the likely cause of Mondor disease in 53.8% of patients with a thoracic form, 41.7% of those with a penile location, and all of those with an axillary location. Known active cancer was present in nine (20%) of 45 patients at baseline. One-year follow-up was available for 43 patients (median 94 months), whereas 6-month data were available for the remaining two patients. During the available follow-up, no patient had a new diagnosis of cancer. In conclusion, one in five patients with Mondor disease had known cancer at the time of diagnosis. During follow-up, the rate of new cancer diagnosis and death was negligible, providing reassurance about the good prognosis of this condition. Based on these preliminary data, extended cancer screening besides what is recommended by current guidelines for the general population might not be necessary in patients with Mondor disease.	[Kreuzpointner, Robert; Johner, Fabian; Roth-Zetzsche, Stephanie; Kucher, Nils; Barco, Stefano] Univ Hosp Zurich, Clin Angiol, Ramistr 100,RAE C 04, CH-8091 Zurich, Switzerland; [Barco, Stefano] Univ Hosp Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany		Barco, S (通讯作者)，Univ Hosp Zurich, Clin Angiol, Ramistr 100,RAE C 04, CH-8091 Zurich, Switzerland.	stefano.barco@usz.ch	Barco, Stefano/V-4901-2017	Barco, Stefano/0000-0002-2618-347X	German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EO1003, 01EO1503]	The work of Stefano Barco was partly supported by the German Federal Ministry of Education and Research (BMBF 01EO1003 and 01EO1503).	Amano M, 2018, INTERNAL MED, V57, P2607, DOI 10.2169/internalmedicine.0495-17; Barco S, 2020, J THROMB HAEMOST, V18, P1598, DOI 10.1111/jth.14805; Bartolo Mauro, 1993, Recenti Progressi in Medicina, V84, P737; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; CATANIA S, 1992, CANCER-AM CANCER SOC, V69, P2267, DOI 10.1002/1097-0142(19920501)69:9<2267::AID-CNCR2820690910>3.0.CO;2-U; COURTNEY SP, 1989, POSTGRAD MED J, V65, P779, DOI 10.1136/pgmj.65.768.779; Dionysiou, 2017, OXF MED CASE REPORTS, V2017; Kreuzpointner R., 2018, RHEINISCHES ARZTEBL, V7, P32; Kreuzpointner R, 2020, GYNAKOLOGE, V53, P139, DOI 10.1007/s00129-019-04540-y; MONDOR H, 1951, PRESSE MED, V59, P1533; Mulder FI, 2020, J THROMB HAEMOST, V18, P2622, DOI 10.1111/jth.15001; Valerio L, 2021, J INTERN MED, V289, P325, DOI 10.1111/joim.13114; van Es N, 2020, HAMOSTASEOLOGIE, V40, P270, DOI 10.1055/a-1150-2286	13	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					409	414	1358863X211000420	10.1177/1358863X211000420		APR 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000638972200001	33829921				2022-04-28	
J	Albaghdadi, MS; Young, MN; Chowdhury, MM; Assmann, S; Hamza, T; Siami, S; Villarreal, M; Strong, M; Menard, M; Farber, A; Rosenfield, K				Albaghdadi, Mazen S.; Young, Michael N.; Chowdhury, Mohammed M.; Assmann, Susan; Hamza, Taye; Siami, Sandra; Villarreal, Maria; Strong, Michael; Menard, Matthew; Farber, Alik; Rosenfield, Kenneth			Clinical practice patterns and ascertainment bias for cardiovascular events in a randomized trial: A survey of investigators in the BEST-CLI trial	VASCULAR MEDICINE			English	Article						bias; critical limb ischemia (CLI); randomized controlled trial; revascularization		Ascertainment bias is a well-recognized source of bias in research, but few studies have systematically analyzed sources of ascertainment bias in randomized trials in which blinding is not possible and endpoint assessment is not protocolized. In the current study, we sought to evaluate differences in the clinical practice patterns of trial investigators with respect to bias in the ascertainment of pre-revascularization patient risk and the incidence of secondary endpoints post-revascularization. We conducted a cross-sectional survey of active investigators (n = 936) from the Best Endovascular Versus Best Surgical Therapy for Patients with Critical Limb Ischemia (BEST-CLI) trial. The total survey response rate was 19.6% (183/936). Vascular surgeons were more likely than nonsurgical interventionalists to order tests for cardiac complications after both surgical bypass (p < 0.001) and endovascular revascularization (p = 0.038). Post-procedure, investigators were more likely to order additional testing for cardiac complications in open surgery versus endovascular cases (7% vs 16% never, 41% vs 65% rarely, 43% vs 17% sometimes, 9% vs 2% always, respectively; p < 0.0001). Significant variation in practice patterns exist in the pre- and post-procedure assessment of cardiac risk and events for patients with CLI undergoing revascularization. Variation in the ascertainment of risk and outcomes according to the type of revascularization procedure and physician specialty should be considered when interpreting the results of clinical studies, such as the BEST-CLI trial. ClinicalTrials.gov Identifier: NCT02060630	[Albaghdadi, Mazen S.; Rosenfield, Kenneth] Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St, Boston, MA 02114 USA; [Albaghdadi, Mazen S.; Rosenfield, Kenneth] Harvard Med Sch, Massachusetts Gen Hosp, Sect Vasc Med, Boston, MA 02114 USA; [Albaghdadi, Mazen S.] Univ Toronto, Dept Med, Div Cardiol, Toronto, ON, Canada; [Young, Michael N.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Cardiol Div, Lebanon, NH 03766 USA; [Chowdhury, Mohammed M.] Univ Cambridge, Addenbrookes Hosp, Dept Vasc & Endovasc Surg, Dept Surg, Cambridge, England; [Assmann, Susan; Hamza, Taye; Siami, Sandra] HealthCore New England Res Inst Inc, Watertown, MA USA; [Villarreal, Maria] Boston Univ, Boston Med Ctr, Dept Vasc Surg, Boston, MA 02215 USA; [Strong, Michael; Menard, Matthew; Farber, Alik] Harvard Med Sch, Brigham & Womens Hosp, Dept Vasc Surg, Boston, MA 02114 USA		Albaghdadi, MS (通讯作者)，Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St, Boston, MA 02114 USA.; Albaghdadi, MS (通讯作者)，Harvard Med Sch, Massachusetts Gen Hosp, Sect Vasc Med, Boston, MA 02114 USA.	malbaghdadi@mgh.harvard.edu			British Heart FoundationBritish Heart Foundation [FS/16/29/31957] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01 HL107407] Funding Source: Medline		Agarwal S, 2016, J AM COLL CARDIOL, V67, P1901, DOI 10.1016/j.jacc.2016.02.040; Benoit E, 2012, J VASC SURG, V55, P781, DOI 10.1016/j.jvs.2011.10.089; Bhatti F, 2006, HEART, V92, P1817, DOI 10.1136/hrt.2005.083204; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Devereaux PJ, 2017, JAMA-J AM MED ASSOC, V317, P1642, DOI 10.1001/jama.2017.4360; Farooq V, 2013, J AM COLL CARDIOL, V61, P2492, DOI 10.1016/j.jacc.2013.03.018; Flaherty JD, 2005, NEW ENGL J MED, V353, P735; Fleisher LA, 2014, CIRCULATION, V130, P2215, DOI 10.1161/CIR.0000000000000105; Ford MK, 2010, ANN INTERN MED, V152, P26, DOI 10.7326/0003-4819-152-1-201001050-00007; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Landry GJ, 2007, J VASC SURG, V45, p141A, DOI 10.1016/j.jvs.2007.02.052; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; McNulty EJ, 2011, JACC-CARDIOVASC INTE, V4, P1020, DOI 10.1016/j.jcin.2011.06.010; Menard MT, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003219; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Piaggio Gilda, 2003, BMC Med Res Methodol, V3, P19, DOI 10.1186/1471-2288-3-19; Probst P, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0226-4; Shishehbor MH, 2016, J AM COLL CARDIOL, V68, P2002, DOI 10.1016/j.jacc.2016.04.071; Testa L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179060	19	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		180	186		10.1177/1358863X21995897			7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000638263600010	33825577				2022-04-28	
J	Trihan, JE; Adam, M; Jidal, S; Aichoun, I; Coudray, S; Laurent, J; Chaussavoine, L; Chausserie, S; Guillaumat, J; Laneelle, D; Perez-Martin, A				Trihan, Jean-Eudes; Adam, Michael; Jidal, Sara; Aichoun, Isabelle; Coudray, Sarah; Laurent, Jeremy; Chaussavoine, Laurent; Chausserie, Sebastien; Guillaumat, Jerome; Laneelle, Damien; Perez-Martin, Antonia			Performance of the Wells score in predicting deep vein thrombosis in medical and surgical hospitalized patients with or without thromboprophylaxis: The R-WITT study	VASCULAR MEDICINE			English	Article						anticoagulation; deep vein thrombosis (DVT); hospitalized; medical and surgical inpatients; thromboprophylaxis; Wells score	VENOUS THROMBOEMBOLISM RISK; CLINICAL-ASSESSMENT; D-DIMER; MODEL; METAANALYSIS; PROPHYLAXIS; MANAGEMENT; DIAGNOSIS; ACCURACY; DURATION	The Wells score had shown weak performance to determine pre-test probability of deep vein thrombosis (DVT) for inpatients. So, we evaluated the impact of thromboprophylaxis on the utility of the Wells score for risk stratification of inpatients with suspected DVT. This bicentric cross-sectional study from February 1, 2018 to January 31, 2019 included consecutive medical and surgical inpatients who underwent lower limb ultrasound study for suspected DVT. Wells score clinical predictors were assessed by both ordering and vascular physicians within 24 h after clinical suspicion of DVT. Primary outcome was the Wells score's accuracy for pre-test risk stratification of suspected DVT, accounting for anticoagulation (AC) treatment (thromboprophylaxis for > 72 hours or long-term anticoagulation). We compared prevalence of proximal DVT among the low, moderate and high pre-test probability groups. The discrimination accuracy was defined as area under the receiver operating characteristics (ROC) curve. Of the 415 included patients, 30 (7.2%) had proximal DVT. Prevalence of proximal DVT was lower than expected in all pre-test probability groups. The prevalence in low, moderate and high pre-test probability groups was 0.0%, 3.1% and 8.2% (p = 0.22) and 1.7%, 4.2% and 25.8% (p < 0.001) for inpatients with or without AC, respectively. Area under ROC curves for discriminatory accuracy of the Wells score, for risk of proximal DVT with or without AC, was 0.72 and 0.88, respectively. The Wells score performed poorly for discrimination of risk for proximal DVT in hospitalized patients with AC but performed reasonably well among patients without AC; and showed low inter-rater reliability between physicians. ClinicalTrials.gov Identifier: NCT03784937.	[Trihan, Jean-Eudes] Univ Hosp Poitiers, Vasc Med Dept, 2 Rue Miletrie, F-86021 Poitiers, France; [Adam, Michael; Jidal, Sara; Aichoun, Isabelle; Coudray, Sarah; Laurent, Jeremy; Perez-Martin, Antonia] Univ Hosp Nimes, Vasc Med Dept, Nimes, Languedoc Rouss, France; [Chaussavoine, Laurent; Chausserie, Sebastien; Guillaumat, Jerome; Laneelle, Damien] Univ Hosp Caen, Vasc Med Dept, Caen, Basse Normandie, France		Trihan, JE (通讯作者)，Univ Hosp Poitiers, Vasc Med Dept, 2 Rue Miletrie, F-86021 Poitiers, France.	j.eudes.trihan@gmail.com	TRIHAN, Jean-Eudes/AAD-8994-2021; Laneelle, Damien/X-3908-2019	TRIHAN, Jean-Eudes/0000-0002-3999-3738; Laneelle, Damien/0000-0002-0598-3929			Ambid-Lacombe C, 2009, J MAL VASCUL, V34, P211, DOI 10.1016/j.jmv.2009.02.004; Amin A., 2019, DRUGS CONTEXT, V8; Amin AN, 2012, J HOSP MED, V7, P231, DOI 10.1002/jhm.1002; Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Bahl V, 2010, ANN SURG, V251, P344, DOI 10.1097/SLA.0b013e3181b7fca6; Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x; Caprini JA, 2005, DM-DIS MON, V51, P70, DOI 10.1016/j.disamonth.2005.02.003; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI 10.1037/1040-3590.6.4.284; Constans J, 2001, THROMB HAEMOSTASIS, V86, P985; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Engelberger RP, 2011, THROMB RES, V127, P535, DOI 10.1016/j.thromres.2011.02.008; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Green MJ, 2000, ARCH INTERN MED, V160, P2317, DOI 10.1001/archinte.160.15.2317; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kovacs MJ, 2007, J THROMB HAEMOST, V5, P1650, DOI 10.1111/j.1538-7836.2007.02613.x; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liew AYL, 2017, J THROMB THROMBOLYS, V43, P291, DOI 10.1007/s11239-016-1461-1; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Pernod G., 2002, REV MED SUISSE, V2376; Piazza G, 2007, CHEST, V132, P554, DOI 10.1378/chest.07-0430; Piazza G, 2009, THROMB HAEMOSTASIS, V102, P505, DOI 10.1160/TH09-03-0150; Raskob GE, 2014, J THROMB HAEMOST, V12, P1580, DOI 10.1111/jth.12698; Sartori M, 2019, INTERN EMERG MED, V14, P941, DOI 10.1007/s11739-019-02066-8; Silveira PC, 2015, JAMA INTERN MED, V175, P1112, DOI 10.1001/jamainternmed.2015.1687; Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944; vanBeek EJR, 1996, BRIT J HAEMATOL, V92, P725, DOI 10.1046/j.1365-2141.1996.375911.x; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1999, THROMB HAEMOSTASIS, V81, P493; Wells PS, 1998, J INTERN MED, V243, P15; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	35	0	0	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					288	296	1358863X21994672	10.1177/1358863X21994672		MAR 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000631603500001	33749393				2022-04-28	
J	Finkelstein, M; Cedillo, MA; Kestenbaum, DC; Shoaib, OS; Fischman, AM; Lookstein, RA				Finkelstein, Mark; Cedillo, Mario A.; Kestenbaum, David C.; Shoaib, Obaib S.; Fischman, Aaron M.; Lookstein, Robert A.			Relationship of hospital volume on outcomes in patients with acute pulmonary embolism: Analysis of a 70,000 patient database	VASCULAR MEDICINE			English	Article						epidemiology; population health; pulmonary embolism (PE)	SURGEON VOLUME; UNITED-STATES; MORTALITY; CARE; CENTRALIZATION; ASSOCIATION; EXPERIENCE; CRITIQUE; IMPACT	Positive relationships between volume and outcome have been seen in several surgical and medical conditions, resulting in more centralized and specialized care structures. Currently, there is a scarcity of literature involving the volume-outcome relationship in pulmonary embolism (PE). Using a state-wide dataset that encapsulates all non-federal admissions in New York State, we performed a retrospective cohort study on admitted patients with a diagnosis of PE. A total of 70,443 cases were separated into volume groups stratified by hospital quartile. Continuous and categorical variables were compared between cohorts. Multivariable regression analysis was conducted to assess predictors of 1-year mortality, 30-day all-cause readmission, 30-day PE-related readmission, length of stay, and total charges. Of the 205 facilities that were included, 128 (62%) were labeled low volume, 39 (19%) medium volume, 23 (11%) high volume, and 15 (7%) very high volume. Multivariable analysis showed that very high volume was associated with decreased 30-day PE-related readmission (OR 0.64; 95% CI, 0.55 to 0.73), decreased 30-day all-cause readmission (OR 0.84; 95% CI, 0.79 to 0.89), decreased 1-year mortality (OR 0.85; 95% CI, 0.80 to 0.91), decreased total charges (OR 0.96; 95% CI, 0.94 to 0.98), and decreased length of stay (OR 0.94; 95% CI, 0.92 to 0.96). In summary, facilities with higher volumes of acute PE were found to have less 30-day PE-related readmissions, less all-cause readmissions, shorter length of stay, decreased 1-year mortality, and decreased total charges.	[Finkelstein, Mark; Cedillo, Mario A.; Kestenbaum, David C.; Shoaib, Obaib S.; Fischman, Aaron M.; Lookstein, Robert A.] Icahn Sch Med Mt Sinai, Dept Diagnost Mol & Intervent Radiol, One Gustave Levy Pl, New York, NY 10029 USA		Finkelstein, M (通讯作者)，Icahn Sch Med Mt Sinai, Dept Diagnost Mol & Intervent Radiol, One Gustave Levy Pl, New York, NY 10029 USA.	Mark.Finkelstein@mountsinai.org					Alibhai SMH, 2008, J UROLOGY, V180, P155, DOI 10.1016/j.juro.2008.03.040; Alotaibi GS, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.01.041; Aquina CT, 2016, SURGERY, V159, P736, DOI 10.1016/j.surg.2015.09.021; Aujesky D, 2008, CAN MED ASSOC J, V178, P27, DOI 10.1503/cmaj.070743; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Chauvaud S, 2001, CIRCULATION, V104, pI12; de Cruppe W, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-165; de Cruppe W, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0944-7; Eastham JA, 2009, UROL ONCOL-SEMIN ORI, V27, P417, DOI 10.1016/j.urolonc.2009.01.010; Finkelstein M, 2015, STUD HEALTH TECHNOL, V210, P681, DOI 10.3233/978-1-61499-512-8-681; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hodgson DC, 2003, J NATL CANCER I, V95, P708, DOI 10.1093/jnci/95.10.708; Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Jimenez D, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4416; Jimenez D, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00445-2018; Joudi Fadi N, 2004, Support Cancer Ther, V2, P42, DOI 10.3816/SCT.2004.n.021; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Kabrhel C, 2016, CHEST, V150, P384, DOI 10.1016/j.chest.2016.03.011; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; Ng ACC, 2013, RESPIRATION, V85, P408, DOI 10.1159/000342024; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Nuttall M, 2004, J UROLOGY, V172, P2145, DOI 10.1097/01.ju.0000140257.05714.45; Petitti D., 2001, INT VOL OUTC REL CON; Prandoni P, 2016, NEW ENGL J MED, V375, P1524, DOI 10.1056/NEJMoa1602172; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saposnik G, 2007, NEUROLOGY, V69, P1142, DOI 10.1212/01.wnl.0000268485.93349.58; Stitzenberg KB, 2012, CANCER-AM CANCER SOC, V118, P54, DOI 10.1002/cncr.26274; The Leapfrog Group, SAF NUMB HOSP PERF L; Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668; Wang Jun-Sing, 2009, Diabetes Res Clin Pract, V84, pe27, DOI 10.1016/j.diabres.2009.02.010; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Wilt TJ, 2008, J UROLOGY, V180, P820, DOI 10.1016/j.juro.2008.05.010	33	2	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					38	46	1358863X20970263	10.1177/1358863X20970263		DEC 2020	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000609101000001	33332237				2022-04-28	
J	Henkin, S; Rothstein, ES; Young, MN				Henkin, Stanislav; Rothstein, Eric S.; Young, Michael N.			Images in Vascular Medicine: Trapped thrombus underneath a recently placed inferior vena cava filter	VASCULAR MEDICINE			English	Editorial Material									[Henkin, Stanislav; Rothstein, Eric S.; Young, Michael N.] Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA		Henkin, S (通讯作者)，Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	stanislav.henkin@hitchcock.org		Henkin, Stanislav/0000-0001-5968-1216			Caplin DM, 2011, J VASC INTERV RADIOL, V22, P1499, DOI 10.1016/j.jvir.2011.07.012; Duffett L, 2017, J THROMB HAEMOST, V15, P3, DOI 10.1111/jth.13564; Grewal S, 2016, CARDIOVASC DIAGN THE, V6, P632, DOI 10.21037/cdt.2016.09.08; Rogers FB, 1998, ARCH SURG-CHICAGO, V133, P406, DOI 10.1001/archsurg.133.4.406; Zhou DY, 2012, J VASC INTERV RADIOL, V23, P1557, DOI 10.1016/j.jvir.2012.08.016	5	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					346	347	1358863X20967432	10.1177/1358863X20967432		NOV 2020	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000608768400001	33175670	Bronze			2022-04-28	
J	Lewandowski, A; Ouma, G; Hornacek, D				Lewandowski, Ashley; Ouma, Geoffrey; Hornacek, Deborah			Tumor thrombosis of the internal jugular vein in a patient with follicular thyroid carcinoma	VASCULAR MEDICINE			English	Meeting Abstract									[Lewandowski, Ashley; Ouma, Geoffrey; Hornacek, Deborah] Cleveland Clin, Cleveland, OH 44106 USA				Ouma, Geoffrey/ABD-8521-2021					0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1427	NP35	NP35					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100077					2022-04-28	
J	Bukina, OV; Sinitsyn, AA; Pelevin, AV				Bukina, Oksana Vasilyevna; Sinitsyn, Aleksander Aleksandrovich; Pelevin, Andrey Viktorovich			Sclerotherapy of telangiectasias: A prospective, randomized, comparative clinical trial of hypertonic glucose versus sodium tetradecyl sulfate	VASCULAR MEDICINE			English	Article						hypertonic glucose; sclerotherapy; sodium tetradecyl sulfate; telangiectasias		To compare the disappearance of the telangiectasias after sclerotherapy with 75% glucose (HG) versus 0.2% sodium tetradecyl sulfate (STS). This prospective, randomized clinical trial compared the results of sclerotherapy of the telangiectasias with HG and STS. The primary efficacy end point was telangiectasia disappearance within 14, 28, 42, and 56 days following treatment. The clearing of the vessels was assessed using a six-point scale (from 0 to 5). A total of 159 women were treated (81 in the STS group; 78 in the HG group). The median score of the vessels clearing (IQR) was significantly lower in the STS group than in the HG group: 3 (2-4) versus 4 (3-5) after 56 days, p < 0.001. Pigmentation was frequently observed in the STS group (38.3% vs 2.6%; p < 0.001). In conclusion, throughout the entire follow-up period, sclerotherapy of telangiectasias with glucose was significantly superior to that with STS. Moreover, pigmentation and intravascular clots frequently occurred with STS treatment. Registered at the Russian Registry of Treatment of Chronic Venous Diseases (RRT CVD); ID: VRCVD 1.005.	[Bukina, Oksana Vasilyevna] Derzhavin Tambov State Univ, Cardiovasc Dept, Doctor Profi, Tambov, Russia; [Sinitsyn, Aleksander Aleksandrovich] Mir Zdorovja, Cardiovasc Dept, Kursk, Russia; [Pelevin, Andrey Viktorovich] Clin Hosp 4, Cardiovasc Dept, Ivanovo, Russia		Bukina, OV (通讯作者)，Derzhavin Tambov State Univ, Proezd N Ostrovskogo 20-78, Tambov 392014, Russia.	ovsafonova@yandex.ru		Bukina, Oksana/0000-0002-7408-6973			Baccaglini U, 1996, DERMATOL SURG, V22, P883, DOI 10.1111/j.1524-4725.1996.tb00592.x_1; Bertanha M, 2017, JAMA DERMATOL, V153, P1249, DOI 10.1001/jamadermatol.2017.3426; [Букина О.В. Bukina O.V.], 2019, [Флебология, Flebologiya], V13, P314; Bush R, 2017, PHLEBOLOGY, V32, P496, DOI 10.1177/0268355516673768; Goldman MP, 2002, DERMATOL SURG, V28, P52, DOI 10.1046/j.1524-4725.2002.01190.x; Munia MA, 2012, DERMATOL SURG, V38, P635, DOI 10.1111/j.1524-4725.2011.02226.x; Nootheti PK, 2009, DERMATOL SURG, V35, P53, DOI 10.1111/j.1524-4725.2008.34382.x; Parlar B, 2015, J EUR ACAD DERMATOL, V29, P549, DOI 10.1111/jdv.12627; Peterson JD, 2012, DERMATOL SURG, V38, P1322, DOI 10.1111/j.1524-4725.2012.02422.x; Rabe E, 2014, PHLEBOLOGY, V29, P338, DOI 10.1177/0268355513483280; Rabe E, 2010, PHLEBOLOGY, V25, P124, DOI 10.1258/phleb.2009.009043; Stemmer, 1969, PHLEBOLOGIE, V22, P143	12	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					297	301	1358863X21992853	10.1177/1358863X21992853		MAR 2021	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000630572300001	33733965				2022-04-28	
J	Ziegler, L; Lundqvist, J; Dreij, K; Wallen, H; de Faire, U; Paulsson-Berne, G; Hedin, U; Matic, L; Gigante, B				Ziegler, Louise; Lundqvist, Jasmin; Dreij, Kristian; Wallen, Hakan; de Faire, Ulf; Paulsson-Berne, Gabrielle; Hedin, Ulf; Matic, Ljubica; Gigante, Bruna			Expression of Interleukin 6 signaling receptors in carotid atherosclerosis	VASCULAR MEDICINE			English	Article						atherosclerosis; carotid artery disease; cerebrovascular disease; inflammation; interleukin 6 (IL6)		Interleukin (IL) 6 contributes to atherosclerotic plaque development through IL6 membrane-bound (IL6R and gp130) and soluble (sIL6R and sgp130) receptors. We investigated IL6 receptor expression in carotid plaques and its correlation with circulating IL6 and soluble receptor levels. Plasma samples and carotid plaques were obtained from 78 patients in the Biobank of Karolinska Endarterectomies study. IL6, sIL6R, and sgp130 were measured in plasma and IL6, IL6R, sIL6R, GP130, and sGP130-RAPS (sGP130) gene expression assessed in carotid plaques. Correlations between plaque IL6 signaling gene expression and plasma levels were determined by Spearman's correlation. Differences in plasma and gene expression levels between patients with (n = 53) and without (n = 25) a history of a cerebral event and statin-treated (n = 65) and non-treated (n = 11), were estimated by Kruskal-Wallis. IL6 and its receptors were all expressed in carotid plaques. There was a positive, borderline significant, moderate correlation between plasma IL6 and sIL6R and the respective gene expression levels (rho 0.23 and 0.22, both p = 0.05). IL6R expression was higher in patients with a history of a cerebrovascular event compared to those without (p = 0.007). Statin-treated had higher IL6R, sIL6R, and sGP130 expression levels and plasma sIL6R compared to non-treated patients (all p < 0.05). In conclusion, all components of the IL6 signaling pathways are expressed in carotid artery plaques and IL6 and sIL6R plasma levels correlate moderately with IL6 and sIL6R. Our data suggest that IL6 signaling in the circulation might mirror the system activity in the plaque, thus adding novel perspectives to the role of IL6 signaling in atherosclerosis.	[Ziegler, Louise; Wallen, Hakan] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18257 Stockholm, Sweden; [Ziegler, Louise] Danderyd Hosp, Dept Med, Stockholm, Sweden; [Lundqvist, Jasmin; Paulsson-Berne, Gabrielle; Gigante, Bruna] Karolinska Inst, Dept Med, Cardiovasc Med Unit, Stockholm, Sweden; [Dreij, Kristian] Karolinska Inst, Inst Environm Med, Unit Biochem Toxicol, Stockholm, Sweden; [Wallen, Hakan; Gigante, Bruna] Danderyd Hosp, Dept Cardiol, Stockholm, Sweden; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, Unit Cardiovasc & Nutr Epidemiol, Stockholm, Sweden; [de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Hedin, Ulf] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden; [Hedin, Ulf; Matic, Ljubica] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden		Ziegler, L (通讯作者)，Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18257 Stockholm, Sweden.	louise.dencker-ziegler@sll.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Heart and Lung FoundationSwedish Heart-Lung Foundation; Strategic Cardiovascular Programs of Karolinska Institutet; Stockholm County Council (ALF)Stockholm County Council; Swedish Society for Medical Research; Karolinska Institutet Foundations, SwedenKarolinska Institutet; Danderyd Hospital Fond, Stockholm, Sweden [176]; Stockholm County CouncilStockholm County Council	The BiKE study was funded by research grants from the Swedish Research Council, the Swedish Heart and Lung Foundation, the Strategic Cardiovascular Programs of Karolinska Institutet and Stockholm County Council, the Stockholm County Council (ALF). Ljubica Matic is the recipient of fellowships from the Swedish Society for Medical Research and the Swedish Heart and Lung Foundation, and acknowledges research funding from Swen and Ebba Hagberg, Tore Nilsson, Magnus Bergvall, the Swedish Research Council and Karolinska Institutet Foundations, Sweden. Louise Ziegler received the 2016 grant from the Danderyd Hospital Fond 176, Stockholm, Sweden.	Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Debing E, 2008, VASC ENDOVASC SURG, V42, P122, DOI 10.1177/1538574407307406; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Kanda T, 2000, CARDIOLOGY, V93, P191, DOI 10.1159/000007025; Klouche M, 1999, J IMMUNOL, V163, P4583; Koutouzis M, 2009, ACTA NEUROL SCAND, V119, P119, DOI 10.1111/j.1600-0404.2008.01068.x; Loppnow H, 2011, J CELL MOL MED, V15, P994, DOI 10.1111/j.1582-4934.2010.01036.x; Matic LP, 2018, JACC-BASIC TRANSL SC, V3, P464, DOI 10.1016/j.jacbts.2018.04.001; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Nilsonne G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165799; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Perisic L, 2016, J INTERN MED, V279, P293, DOI 10.1111/joim.12448; Persson J, 2012, ATHEROSCLEROSIS, V225, P491, DOI 10.1016/j.atherosclerosis.2012.09.036; Puz P, 2017, ATHEROSCLEROSIS, V263, P97, DOI 10.1016/j.atherosclerosis.2017.06.008; Puz P, 2013, ARCH MED SCI, V9, P254, DOI 10.5114/aoms.2013.34533; Razuvaev A, 2011, EUR J VASC ENDOVASC, V42, P722, DOI 10.1016/j.ejvs.2011.05.023; Reeh H, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0356-0; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Sommer J, 2014, J BIOL CHEM, V289, P22140, DOI 10.1074/jbc.M114.560938; Tanaka M, 2000, J CLIN INVEST, V106, P137, DOI 10.1172/JCI7479; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Wolf J, 2016, J BIOL CHEM, V291, P16186, DOI 10.1074/jbc.M116.718551; Yamagami H, 2004, STROKE, V35, P677, DOI 10.1161/01.STR.0000116876.96334.82; Zegeye MM, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0268-4; Ziegler L, 2020, EUR J PREV CARDIOL, V27, P122, DOI 10.1177/2047487319869694; Ziegler L, 2019, CARDIOVASC RES, V115, P213, DOI 10.1093/cvr/cvy191	31	4	4	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					3	10	1358863X20977662	10.1177/1358863X20977662		DEC 2020	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000609109000001	33350884	hybrid, Green Published			2022-04-28	
J	Stabile, E; Piccolo, R; Franzese, M; Accarino, G; Bracale, UM; Cappello, E; Cioffi, G; Cioppa, A; Crinisio, A; Flora, L; Landino, P; Martelli, E; Mancusi, R; Niola, R; Petrosino, F; Razzano, D; Ruotolo, C; Salemme, L; Sangiuolo, P; Santini, G; Soreca, E; Vigliotti, G; Villari, B; Amabile, G; Ammollo, RP; Barbarisi, D; Corbisiero, AM; D'angelo, A; Cangiano, G; De Gregorio, C; De Laurentis, M; Laurenzano, E; Ficarelli, I; Luongo, A; Molino, C; Sarti, G; Viola, D; Esposito, G				Stabile, Eugenio; Piccolo, Raffaele; Franzese, Michele; Accarino, Giancarlo; Bracale, Umberto Marcello; Cappello, Enrico; Cioffi, Giovanni; Cioppa, Angelo; Crinisio, Adolfo; Flora, Loris; Landino, Pietro; Martelli, Eugenio; Mancusi, Rosario; Niola, Raffaella; Petrosino, Fernando; Razzano, Davide; Ruotolo, Carlo; Salemme, Luigi; Sangiuolo, Paolo; Santini, Gianpaolo; Soreca, Emilio; Vigliotti, Gennaro; Villari, Bruno; Amabile, Giampaolo; Ammollo, Raffaele Pio; Barbarisi, Danilo; Corbisiero, Alfonsina M.; D'angelo, Antonio; Cangiano, Gianluca; De Gregorio, Claudia; De Laurentis, Mario; Laurenzano, Eugenio; Ficarelli, Ilaria; Luongo, Alessandro; Molino, Claudio; Sarti, Giuseppe; Viola, Daniela; Esposito, Giovanni			A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy	VASCULAR MEDICINE			English	Article						chronic limb-threatening ischemia (CLTI); COVID-19; peripheral artery disease (PAD)		The expansion of coronavirus disease 2019 (COVID-19) prompted measures of disease containment by the Italian government with a national lockdown on March 9, 2020. The purpose of this study is to evaluate the rate of hospitalization and mode of in-hospital treatment of patients with chronic limb-threatening ischemia (CLTI) before and during lockdown in the Campania region of Italy. The study population includes all patients with CLTI hospitalized in Campania over a 10-week period: 5 weeks before and 5 weeks during lockdown (n = 453). Patients were treated medically and/or underwent urgent revascularization and/or major amputation of the lower extremities. Mean age was 69.2 +/- 10.6 years and 27.6% of the patients were women. During hospitalization, 21.9% of patients were treated medically, 78.1% underwent revascularization, and 17.4% required amputations. In the weeks during the lockdown, a reduced rate of hospitalization for CLTI was observed compared with the weeks before lockdown (25 vs 74/100,000 inhabitants/year; incidence rate ratio: 0.34, 95% CI 0.32-0.37). This effect persisted to the end of the study period. An increased amputation rate in the weeks during lockdown was observed (29.3% vs 13.4%; p < 0.001). This study reports a reduced rate of CLTI-related hospitalization and an increased in-hospital amputation rate during lockdown in Campania. Ensuring appropriate treatment for patients with CLTI should be prioritized, even during disease containment measures due to the COVID-19 pandemic or other similar conditions.	[Stabile, Eugenio; Piccolo, Raffaele; Franzese, Michele; Esposito, Giovanni] Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Via S Pansini 5, I-80138 Naples, Italy; [Accarino, Giancarlo; D'angelo, Antonio] AOU San Giovanni di Dio & Ruggi dAragona, Dept Vasc & Endovasc Surg, Salerno, Italy; [Bracale, Umberto Marcello; Ammollo, Raffaele Pio] Univ Naples Federico II, Dept Publ Hlth, Div Vasc Surg, Naples, Italy; [Cappello, Enrico] Mediterranea Ctr Cuore, Div Vasc & Endovasc Surg, Naples, Italy; [Cioffi, Giovanni] Osped Pellegrini, Div Vasc Surg, Naples, Italy; [Cioppa, Angelo; Salemme, Luigi] Clin Montevergine, Div Invas Cardiol, Mercogliano, Italy; [Crinisio, Adolfo; Molino, Claudio] Clin Salus, Div Vasc & Endovasc Surg, Battipaglia, Italy; [Flora, Loris; Barbarisi, Danilo] AORN San Giuseppe Moscati, Div Vasc Surg, Avellino, Italy; [Landino, Pietro; Corbisiero, Alfonsina M.] Casa Cura S Michele, Dept Cardiol & Cardiac Surg, Maddaloni, Italy; [Martelli, Eugenio] AORN St Anna & San Sebastiano, Div Vasc & Endovasc Surg, Caserta, Italy; [Mancusi, Rosario; De Gregorio, Claudia] Villa dei Fiori Hosp, Div Vasc & Endovasc Surg, Acerra, Italy; [Niola, Raffaella; Amabile, Giampaolo; Cangiano, Gianluca] AORN Cardarelli, Div Vasc & Intervent Radiol, Naples, Italy; [Petrosino, Fernando; Luongo, Alessandro] Presidio Osped San Luca, Div Vasc Surg, Vallo Della Lucania, Italy; [Razzano, Davide] AO San Pio, Div Vasc Surg, Benevento, Italy; [Ruotolo, Carlo; Ficarelli, Ilaria] AORN Cardarelli, Div Vasc Surg, Naples, Italy; [Sangiuolo, Paolo; De Laurentis, Mario] Monaldi Hosp, AORN Osped Colli, Div Vasc Surg, Naples, Italy; [Santini, Gianpaolo; Sarti, Giuseppe] Osped Mare, Dept Radiol, Naples, Italy; [Soreca, Emilio] AO San Pio, Dept Radiol, Benevento, Italy; [Vigliotti, Gennaro; Viola, Daniela] Osped Mare, Div Vasc Surg, Naples, Italy; [Villari, Bruno; Laurenzano, Eugenio] Osped Sacro Cuore Gesu, Div Cardiol, Benevento, Italy		Stabile, E (通讯作者)，Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Via S Pansini 5, I-80138 Naples, Italy.	eugenio.stabile@unina.it	BRACALE, Umberto Marcello/AAH-8291-2021; Piccolo, Raffaele/AAA-7871-2019; ESPOSITO, Giovanni/F-2880-2010	BRACALE, Umberto Marcello/0000-0001-9507-9791; Piccolo, Raffaele/0000-0002-3124-9912; CIOPPA, ANGELO/0000-0003-4324-4227; ESPOSITO, Giovanni/0000-0003-0565-7127			Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Ardati AK, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006661; Benson RA, 2020, GLOBAL IMPACT 1 CORO, DOI [10.1101/2020.07.16.20153593, DOI 10.1101/2020.07.16.20153593]; Capaldo B, 2020, DIABETES CARE, V43, pE88, DOI 10.2337/dc20-1127; Cummings, 2019, ANAL INCIDENCE RATES; Duff S, 2019, VASC HEALTH RISK MAN, V15, P187, DOI 10.2147/VHRM.S209241; Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011; Rodriguez-Leor O, 2020, REC INTERV CARDIOL, V2, P82, DOI [DOI 10.24875/RECICE.M20000123, DOI 10.24875/RECIC.M20000120, 10.24875/RECIC.M20000120]; Sena G, 2020, J VASC SURG, V72, P758, DOI 10.1016/j.jvs.2020.04.489; Shishehbor MH, 2016, J AM COLL CARDIOL, V68, P2002, DOI 10.1016/j.jacc.2016.04.071; Tam CCF, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006631	11	6	6	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		174	179	1358863X20977678	10.1177/1358863X20977678		DEC 2020	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000608765100001	33332228	hybrid, Green Published			2022-04-28	
J	Stimach, I; Sharma, A; Southerland, AM; Gornik, HL				Stimach, Ivka; Sharma, Aditya; Southerland, Andrew M.; Gornik, Heather L.			Vascular Disease Patient Information Page: Cervical artery dissection (CeAD)	VASCULAR MEDICINE			English	Article						arterial dissection; cervical artery dissection; stroke; fibromuscular dysplasia (FMD)	ASSOCIATION; STROKE		[Stimach, Ivka; Gornik, Heather L.] Case Western Reserve Univ, Univ Hosp, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Sharma, Aditya; Southerland, Andrew M.] Univ Virginia, Heart & Vasc Ctr, Charlottesville, VA USA		Gornik, HL (通讯作者)，Univ Hosp, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA.	heather.gornik@uhhospitals.org		Sharma, Aditya/0000-0003-1756-2504			Biller J, 2014, STROKE, V45, P3155, DOI 10.1161/STR.0000000000000016; Debette S, 2011, Neurology, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Debette S, 2011, CIRCULATION, V123, P1537, DOI 10.1161/CIRCULATIONAHA.110.000125; Gornik HL, 2019, J HYPERTENS, V37, P229, DOI 10.1097/HJH.0000000000002019; Kloss M, 2018, NEUROLOGY, V90, pE1372, DOI 10.1212/WNL.0000000000005324; Markus HS, 2019, JAMA NEUROL, V76, P657, DOI 10.1001/jamaneurol.2019.0072; Talarowska P, 2019, VASC MED, V24, P112, DOI 10.1177/1358863X18811596; Vazquez SR, 2020, VASC MED, V25, P196, DOI 10.1177/1358863X19898262; Weinreich M, 2017, VASC MED, V22, P73, DOI 10.1177/1358863X16681666	10	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					674	677	1358863X211051427	10.1177/1358863X211051427		OCT 2021	4	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000711129600001	34674593				2022-04-28	
J	Goldhaber, SZ; Magnuson, EA; Chinnakondepalli, KM; Cohen, DJ; Vedantham, S				Goldhaber, Samuel Z.; Magnuson, Elizabeth A.; Chinnakondepalli, Khaja M.; Cohen, David J.; Vedantham, Suresh			Catheter-directed thrombolysis for deep vein thrombosis: 2021 update	VASCULAR MEDICINE			English	Review						deep vein thrombosis (DVT); post-thrombotic syndrome; quality of life; thrombolysis; venous thromboembolism (VTE)	CLINICAL-PRACTICE GUIDELINES; QUALITY-OF-LIFE; POSTTHROMBOTIC SYNDROME; VENOUS THROMBOSIS; PHARMACOMECHANICAL THROMBOLYSIS; ANTICOAGULATION; DETERMINANTS; ULTRASOUND; THERAPY; SOCIETY	Catheter-directed thrombolysis (CDT) has been utilized as an adjunct to anticoagulant therapy in selected patients with deep vein thrombosis (DVT) for approximately 30 years. CDT used to be limited to patients with DVT causing acute limb threat and those exhibiting failure of initial anticoagulation, but has expanded over time. Randomized trials evaluating the first-line use of CDT for proximal DVT have demonstrated that CDT does not produce a major reduction in the occurrence of post-thrombotic syndrome (PTS) and that it is poorly suited for elderly patients and those with limited thrombus extent or major risk factors for bleeding. However, CDT does offer selected patients with acute iliofemoral DVT improvement in reducing early DVT symptoms, in achieving reduction in PTS severity, and in producing an improvement in health-related quality of life (QOL). Clinical practice guidelines from medical and surgical societies are now largely aligned with the randomized trial results. This review offers the reader an update on the results of recently completed clinical trials, and additional guidance on appropriate selection of patients with DVT for catheter-directed thrombolytic therapy.	[Goldhaber, Samuel Z.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Goldhaber, Samuel Z.] Harvard Med Sch, Boston, MA 02115 USA; [Magnuson, Elizabeth A.; Chinnakondepalli, Khaja M.] St Lukes Mid Amer Heart Inst, Hlth Econ Technol Assessment Grp, Kansas City, MO USA; [Cohen, David J.] St Francis Hosp, Roslyn, NY USA; [Cohen, David J.] Cardiovasc Res Fdn, New York, NY USA; [Vedantham, Suresh] Washington Univ St Louis, Mallinckrodt Inst Radiol, St Louis, MO USA		Vedantham, S (通讯作者)，Washington Univ, Sch Med, Mallinckrodt Inst Radiol, 510 S Kingshighway Blvd,Box 8131, St Louis, MO 63110 USA.	vedanthams@wustl.edu		Vedantham, Suresh/0000-0002-5734-7553	National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01-HL088476, UH3-HL138325]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1-TR002345]	Dr. Vedantham's work is supported by grants from the National Heart Lung and Blood Institute (U01-HL088476, UH3-HL138325) and National Center for Advancing Translational Sciences (UL1-TR002345).	Anderson JL, 2014, CIRCULATION, V129, P2329, DOI 10.1161/CIR.0000000000000042; Bashir R, 2014, JAMA INTERN MED, V174, P1494, DOI 10.1001/jamainternmed.2014.3415; Comerota AJ, 2019, CIRCULATION, V139, P1162, DOI 10.1161/CIRCULATIONAHA.118.037425; Enden T, 2013, J THROMB HAEMOST, V11, P1032, DOI 10.1111/jth.12184; Enden T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002984; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Engelberger RP, 2017, J THROMB HAEMOST, V15, P1351, DOI 10.1111/jth.13709; Engelberger RP, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002027; Gagne PJ, 2017, J VASC SURG-VENOUS L, V5, P678, DOI 10.1016/j.jvsv.2017.04.007; Haig Y, 2014, J VASC SURG-VENOUS L, V2, P123, DOI 10.1016/j.jvsv.2013.10.054; Haig Y, 2016, LANCET HAEMATOL, V3, pE64, DOI 10.1016/S2352-3026(15)00248-3; Huang W, 2014, AM J MED, V127, P829, DOI 10.1016/j.amjmed.2014.03.041; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kahn SR, 2020, J VASC SURG-VENOUS L, V8, P8, DOI 10.1016/j.jvsv.2019.03.023; Kakkos SK, 2021, EUR J VASC ENDOVASC, V61, P9, DOI 10.1016/j.ejvs.2020.09.023; Kaufman JA, 2020, J VASC INTERV RADIOL, V31, P1529, DOI 10.1016/j.jvir.2020.06.014; Kearon C, 2019, THROMB HAEMOSTASIS, V119, P633, DOI 10.1055/s-0039-1677795; Kollias A, 2021, VASC MED, V26, P415, DOI 10.1177/1358863X21995566; Li RH, 2020, THROMB RES, V196, P340, DOI 10.1016/j.thromres.2020.09.014; Li WZ, 2021, CIRCULATION, V143, P1224, DOI 10.1161/CIRCULATIONAHA.120.049096; Magnuson EA, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005659; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Milling TJ, 2020, AM J EMERG MED, V38, P1890, DOI 10.1016/j.ajem.2020.05.086; Moriarty JM, 2021, J VASC INTERV RADIOL, V32, P549, DOI 10.1016/j.jvir.2020.09.012; National Institute for Health and Care Excellence, 2019, NICE GUID; Notten P, 2020, LANCET HAEMATOL, V7, pE40, DOI 10.1016/S2352-3026(19)30209-1; Ortel TL, 2020, BLOOD ADV, V4, P4693, DOI 10.1182/bloodadvances.2020001830; Razavi MK, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002772; Razavi MK, 2020, J VASC INTERV RADIOL, V31, P1517, DOI 10.1016/j.jvir.2020.07.010; SEMBA CP, 1994, RADIOLOGY, V191, P487, DOI 10.1148/radiology.191.2.8153327; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Vedantham S, 2004, J VASC INTERV RADIOL, V15, P565, DOI 10.1097/01.RVI.0000127894.00553.02; Vedantham S, 2016, J THROMB THROMBOLYS, V41, P68, DOI 10.1007/s11239-015-1318-z; Vedantham S, 2014, J VASC INTERV RADIOL, V25, P1317, DOI 10.1016/j.jvir.2014.04.019; Weinberg I, 2019, VASC MED, V24, P442, DOI 10.1177/1358863X19862043	36	0	0	3	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					662	669	1358863X211042930	10.1177/1358863X211042930		OCT 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000705349000001	34606385				2022-04-28	
J	D'Oria, M; Gunnarsson, K; Wanhainen, A; Mani, K				D'Oria, Mario; Gunnarsson, Kim; Wanhainen, Anders; Mani, Kevin			Long-term survival after repair of ruptured abdominal aortic aneurysms is improving over time - Nationwide analysis during twenty-four years in Sweden (1994-2017)	VASCULAR MEDICINE			English	Meeting Abstract									[D'Oria, Mario; Gunnarsson, Kim; Wanhainen, Anders; Mani, Kevin] Uppsala Univ, Uppsala, Sweden									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1337	NP13	NP13					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100036					2022-04-28	
J	Enriquez, K; Chitale, R; Moslehi, J; Kim, ESH				Enriquez, Kyle; Chitale, Rohan; Moslehi, Javid; Kim, Esther S. H.			Flying blind in a turkey shoot: a case of bow hunter's syndrome	VASCULAR MEDICINE			English	Meeting Abstract									[Enriquez, Kyle] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Chitale, Rohan] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Moslehi, Javid; Kim, Esther S. H.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1412	NP33	NP33					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100073					2022-04-28	
J	Scheidemental, A; Luli, J; Johnson, E; Bittar, S				Scheidemental, Andrew; Luli, Jordan; Johnson, Elston; Bittar, Samih			Biopsy-proven diagnosis and treatment of non-uremic calciphylaxis	VASCULAR MEDICINE			English	Meeting Abstract									[Scheidemental, Andrew; Luli, Jordan; Johnson, Elston] OhioHlth Doctors Hosp, Columbus, OH USA; [Bittar, Samih] OhioHlth Riverside Methodist Hosp, Columbus, OH USA									0	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1429	NP36	NP36					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100078					2022-04-28	
J	Tyagi, S; Friedland, DR; Rein, L; Tarima, SS; Mueller, C; Benjamin, EJ; Vasan, RS; Hamburg, NM; Widlansky, ME				Tyagi, Sudhi; Friedland, David R.; Rein, Lisa; Tarima, Sergey S.; Mueller, Christopher; Benjamin, Emelia J.; Vasan, Ramachandran S.; Hamburg, Naomi M.; Widlansky, Michael E.			Abnormal hearing patterns are not associated with endothelium-dependent vasodilation and carotid intima-media thickness: The Framingham Heart Study	VASCULAR MEDICINE			English	Article						aging; atherosclerosis; cardiovascular disease prevention; flow-mediated dilation	CARDIOVASCULAR RISK-FACTORS; DISEASE; ADULTS	Introduction: Prior data suggest associations between hearing loss, cardiovascular (CV) risk factors, and CV disease. Whether specific hearing loss patterns, including a strial pattern associated with inner ear vascular disease, are associated with systemic endothelial dysfunction and carotid intima-media thickness (IMT) remains unclear. Methods: We evaluated participants without prevalent CVD in the Framingham Offspring Study who underwent formal audiogram testing and brachial and carotid artery ultrasounds. Audiograms were categorized as normal or as belonging to one of four abnormal patterns: cochlear-conductive, low-sloping, sensorineural, or strial. Endothelial function as measured by brachial artery flow-mediated dilation (FMDmm and FMD%). Internal and common intima-media thicknesses (icIMT and ccIMT, respectively) were compared between audiogram patterns. Results: We studied 1672 participants (mean age 59 years, 57.6% women). The prevalence of each hearing pattern was as follows: 43.7% normal; 20.3% cochlear-conductive; 20.3% sensorineural; 7.7% low-sloping; and 8.0% strial. Strial pattern hearing loss was nearly twice as prevalent (p = 0.001) in those in the highest quartile of ccIMT and nearly 50% higher in those in the highest icIMT quartile (p = 0.04). There were no statistically significant differences between the prevalence of the strial pattern comparing the lowest quartiles of FMDmm and FMD% with the upper three quartiles. Age- and sex-adjusted linear regression models did not show significant associations between the vascular measures and hearing patterns. Conclusion: Abnormal hearing patterns were not significantly associated with impaired brachial FMD and increased carotid IMT after adjusting for age and sex effects, which may reflect age and sex-related distributional differences based on hearing loss pattern.	[Tyagi, Sudhi; Mueller, Christopher; Widlansky, Michael E.] Med Coll Wisconsin, Dept Med, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [Friedland, David R.] Med Coll Wisconsin, Dept Otolaryngol, Milwaukee, WI 53226 USA; [Rein, Lisa; Tarima, Sergey S.] Med Coll Wisconsin, Dept Biostat, Milwaukee, WI 53226 USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Framingham, MA USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] NHLBIs Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.; Hamburg, Naomi M.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Ctr Comp & Data Sci, Boston, MA 02118 USA; [Hamburg, Naomi M.] Boston Univ, Whitaker Cardiovasc Inst, Sch Med, Boston, MA 02118 USA; [Widlansky, Michael E.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA		Widlansky, ME (通讯作者)，Med Coll Wisconsin, Hub Collaborat Med, 5th Floor A5743,8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	mwidlans@mcw.edu	Benjamin, Emelia/E-7103-2011	Benjamin, Emelia/0000-0003-4076-2336; Widlansky, Michael/0000-0002-1461-9707	National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HC-25195, HHSN268201500001I, 75N92019D00031]; American Heart AssociationAmerican Heart Association [18SFRN34110082]; AHA Strategically Focused Research Network grant [HL007224]; Evans Medical Foundation; Department of Medicine, Boston University School of Medicine;  [T32GM089586];  [HL092577];  [HL141434];  [AG066010];  [2U54HL120163];  [HL125409];  [HL128240];  [HL144098];  [R38HL143561];  [R61AT010680];  [1R01 HL60040]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contracts No. N01-HC-25195, HHSN268201500001I, and 75N92019D00031). Dr Tyagi received support from T32GM089586. Dr Benjamin is supported by HL092577, HL141434, AG066010, and 2U54HL120163; American Heart Association 18SFRN34110082; brachial measurements were supported by 1R01 HL60040. Dr Hamburg is supported by an AHA Strategically Focused Research Network grant focused on cardiometabolic health and HL007224. Dr Vasan is supported by the Evans Medical Foundation and the Jay and Louis Coffman Endowment from the Department of Medicine, Boston University School of Medicine. Dr Widlansky is supported by HL125409, HL128240, HL144098, R38HL143561, and R61AT010680.	Balletshofer BM, 2005, THER APHER DIAL, V9, P385, DOI 10.1111/j.1744-9987.2005.00316.x; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Ciccone MM, 2012, ATHEROSCLEROSIS, V225, P511, DOI 10.1016/j.atherosclerosis.2012.10.024; Engdahl B, 2015, INT J AUDIOL, V54, P958, DOI 10.3109/14992027.2015.1090631; Fischer ME, 2015, ATHEROSCLEROSIS, V238, P344, DOI 10.1016/j.atherosclerosis.2014.12.031; Friedland DR, 2009, LARYNGOSCOPE, V119, P473, DOI 10.1002/lary.20130; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Helzner EP, 2011, J AM GERIATR SOC, V59, P972, DOI 10.1111/j.1532-5415.2011.03444.x; John U, 2007, Atherosclerosis, V195, pe144, DOI 10.1016/j.atherosclerosis.2007.04.007; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lohi V, 2015, INT J AUDIOL, V54, P265, DOI 10.3109/14992027.2014.974112; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; SALT AN, 1987, LARYNGOSCOPE, V97, P984; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X	15	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					595	601	1358863X211025087	10.1177/1358863X211025087		JUL 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000677008500001	34286655				2022-04-28	
J	Ribeiro, FRCD; Ribeiro, CHMA; Tavoni, TM; Sarges, ED; Freitas, FR; Stolf, NAG; Kalil, R; Maranhao, RC				de Macedo Ribeiro, Flavio Roberto Cavalleiro; Ribeiro, Carolina Heitmann Mares Azevedo; Tavoni, Thauany Martins; dos Santos Sarges, Erica; Freitas, Fatima Rodrigues; Stolf, Noedir Antonio Groppo; Kalil Filho, Roberto; Maranhao, Raul Cavalcante			Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus	VASCULAR MEDICINE			English	Article						cholesteryl ester transfer protein (CETP); diabetes; dyslipidemia; lipid nanoparticles; peripheral artery disease (PAD); high-density lipoprotein (HDL); unesterified cholesterol	LIPID TRANSFERS; RISK-FACTORS	Introduction: Low high-density lipoprotein (HDL)-cholesterol is frequent in patients with peripheral artery disease (PAD) and also in type 2 diabetes mellitus (T2DM), the major risk factor for PAD. The transfer of cholesterol from the other lipoproteins to HDL is an important aspect of HDL metabolism and function, and may contribute to atherogenic mechanisms that lead to PAD development. Objective: The aim of this study was to investigate the status of cholesterol transfers in patients with PAD without or with T2DM. Methods: Patients with PAD (n = 19), with PAD and T2DM (PAD + DM, n = 19), and healthy controls (n = 20), all paired for age, gender, and BMI were studied. Transfer of both forms of cholesterol, unesterified (UC) and esterified (EC), was performed by incubating plasma with a donor nanoemulsion containing radioactive UC and EC, followed by chemical precipitation and HDL radioactive counting. Results: Low-density lipoprotein (LDL)-cholesterol and triglycerides were similar in the three groups. Compared to controls, HDL-C was lower in PAD + DM (p < 0.05), but not in PAD. Transfer of UC was lower in PAD + DM than in PAD and controls (4.18 +/- 1.17%, 5.13 +/- 1.44%, 6.59 +/- 1.25%, respectively, p < 0.001). EC transfer tended to be lower in PAD + DM than in controls (2.96 +/- 0.60 vs 4.12 +/- 0.89%, p = 0.05). Concentrations of cholesteryl ester transfer protein (CETP) and lecithin-cholesterol acyltransferase (LCAT), both involved in HDL metabolism, were not different among the three groups. Conclusion: Deficient cholesterol transfer to HDL may play a role in PAD pathogenesis. Since UC transfer to HDL was lower in PAD + DM compared to PAD alone, it is possible that defective HDL metabolism may contribute to the higher PAD incidence in patients with T2DM.Keywords	[de Macedo Ribeiro, Flavio Roberto Cavalleiro; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues; Stolf, Noedir Antonio Groppo; Kalil Filho, Roberto; Maranhao, Raul Cavalcante] Univ Sao Paulo, Inst Coracao InCor, Hosp Clin HCFMUSP, Fac Med, Sao Paulo, Brazil; [Ribeiro, Carolina Heitmann Mares Azevedo; dos Santos Sarges, Erica] Univ Fed Para, Inst Ciencias Saude, Dept Ciencias Farmaceut, Belem, Para, Brazil; [Tavoni, Thauany Martins; Maranhao, Raul Cavalcante] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil		Maranhao, RC (通讯作者)，Hosp Clin USP InCor HCFMUSP, Inst Coracao, Lab Metabolismo & Lipides, Av Dr Eneas de Carvalho Aguiar 44, BR-05403900 Sao Paulo, Brazil.	ramarans@usp.br	Maranhão, Raul C/I-5996-2012; Tavoni, Thauany/ABG-5834-2021	Maranhão, Raul C/0000-0003-1520-4914; 	Sao Paulo Research Foundation (FAPESP) (Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/03742-0]; National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [431290/2016-4]; National Institute of Science and Technology Complex Fluids (INCT-FCx, Brazil); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	This work was supported by the Sao Paulo Research Foundation (FAPESP, grant 2014/03742-0, Brazil), National Council for Scientific and Technological Development (CNPq, grant 431290/2016-4, Brasilia, Brazil), and the National Institute of Science and Technology Complex Fluids (INCT-FCx, Brazil). Dr Maranhao has an A-1 Research Carrier Award from CNPq.	[Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc19-SINT01, 10.2337/dc19-Sint01]; Dua A, 2016, TECH VASC INTERV RAD, V19, P91, DOI 10.1053/j.tvir.2016.04.001; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Kunnen S, 2012, J LIPID RES, V53, P1783, DOI 10.1194/jlr.R024513; Lo Prete AC, 2009, LIPIDS, V44, P917, DOI 10.1007/s11745-009-3342-2; Makdisse Marcia, 2008, Arq. Bras. Cardiol., V91, P402, DOI 10.1590/S0066-782X2008001800008; Maranhao RC, 2014, ADV CLIN CHEM, V65, P1, DOI 10.1016/B978-0-12-800141-7.00001-2; Maranhao RC, 2012, CLIN CHIM ACTA, V413, P502, DOI 10.1016/j.cca.2011.11.011; MARANHAO RC, 1993, LIPIDS, V28, P691, DOI 10.1007/BF02535988; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Rye KA, 2014, CIRC RES, V114, P143, DOI 10.1161/CIRCRESAHA.114.300632; Sprandel MCO, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0270-8; Stoekenbroek RM, 2016, EUR HEART J, V37, P880, DOI 10.1093/eurheartj/ehv630; Taskinen MR, 2015, ATHEROSCLEROSIS, V239, P483, DOI 10.1016/j.atherosclerosis.2015.01.039; van den Berg MJ, 2016, AM J CARDIOL, V118, P804, DOI 10.1016/j.amjcard.2016.06.048; Xiang AS, 2019, LANCET DIABETES ENDO, V7, P575, DOI 10.1016/S2213-8587(19)30003-8; Zannis VI, 2015, HANDB EXP PHARMACOL, V224, P53, DOI 10.1007/978-3-319-09665-0_2	19	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					602	607	1358863X211021142	10.1177/1358863X211021142		JUN 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000665255500001	34137646				2022-04-28	
J	Rana, MN; Neeland, IJ				Rana, Mariam N.; Neeland, Ian J.			Taking a 'stand' against cardiovascular disease in the era of COVID-19	VASCULAR MEDICINE			English	Editorial Material						sedentary behavior; COVID-19; occupational health; standing desk	SEDENTARY TIME; ASSOCIATION; RISK		[Rana, Mariam N.; Neeland, Ian J.] Univ Hosp, Dept Med, Cleveland, OH USA; [Rana, Mariam N.; Neeland, Ian J.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Neeland, Ian J.] Univ Hosp, Harrington Heart & Vasc Inst, 11100 Euclid Ave, Cleveland, OH 44106 USA		Neeland, IJ (通讯作者)，Univ Hosp, Harrington Heart & Vasc Inst, 11100 Euclid Ave, Cleveland, OH 44106 USA.	ian.neeland@uhhospitals.org					Bodker A, 2021, VASC MED, V26, P374, DOI 10.1177/1358863X211001934; Buckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618; Coffeng JK, 2017, AM HEART J, V184, DOI 10.1016/j.ahj.2016.11.002; Garrett G, 2016, IISE T OCCUP ERG HUM, V4, P188, DOI 10.1080/21577323.2016.1183534; Gibbs BB, 2018, OCCUP ENVIRON MED, V75, P321, DOI 10.1136/oemed-2017-104732; Kramer A, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103442; Kulinski JP, 2014, MAYO CLIN PROC, V89, P1063, DOI 10.1016/j.mayocp.2014.04.019; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Pandey A, 2016, JAMA CARDIOL, V1, P575, DOI 10.1001/jamacardio.2016.1567; Rossi R, 2008, J AM COLL CARDIOL, V51, P997, DOI 10.1016/j.jacc.2007.11.044; Rudecki J, 2019, J PHYS ACT HEALTH, V16, P375, DOI 10.1123/jpah.2018-0575	11	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					383	385	1358863X211012750	10.1177/1358863X211012750		MAY 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000652223500001	33985391	Bronze			2022-04-28	
J	Bodker, A; Visotcky, A; Gutterman, D; Widlansky, ME; Kulinski, J				Bodker, Ariel; Visotcky, Alexis; Gutterman, David; Widlansky, Michael E.; Kulinski, Jacquelyn			The impact of standing desks on cardiometabolic and vascular health	VASCULAR MEDICINE			English	Article						flow-mediated (FMD) vasodilation; insulin resistance; obesity; sedentary lifestyle		Sedentary behavior is associated with cardiovascular disease (CVD) and mortality, independent of physical activity. The biological mechanisms underlying these associations are largely unknown. We hypothesized that obese subjects with sedentary desk jobs, when assigned a sit-stand desk, will reduce daily sedentary time, and show improvement in arterial flow-mediated dilation (FMD), an early indicator of CVD. Overweight and obese subjects without known CVD were recruited at our institution and given an adjustable sit-stand desk at work. Activities were quantified with an accelerometer for 7 days at baseline and during the intervention. FMD of the brachial and superficial femoral arteries, fasting lipids, insulin and glucose labs, and anthropometrics were measured at baseline, and 12 and 24 weeks. Repeated one-way ANOVA tests were used to compare measurements over time. Fifteen participants were enrolled (93% female, mean age 40 +/- 5 years, mean body mass index [BMI] 33 +/- 5). Mean daily sedentary time at work decreased by 90 minutes from baseline (385 +/- 49 minutes) to 12 weeks (297 +/- 80 minutes, p = 0.002) and 24 weeks (295 +/- 127 minutes, p = 0.015). Femoral FMD increased from baseline (4.9 +/- 1.7%) to 12 weeks (6.4 +/- 2.3%, p = 0.043) and further to 24 weeks (8.1 +/- 3.2%, p = 0.009). Significant improvement in fasting triglycerides and insulin resistance occurred. There was no change in brachial FMD, exercise activity, step counts, weight, or BMI. A significant reduction in sedentary time during working hours was identified with utilization of a sit-stand desk and sustained over 24 weeks. Improvements in FMD, triglycerides, and insulin resistance provide insight into mechanisms of adverse health risks associated with sedentary behavior.	[Bodker, Ariel; Gutterman, David; Widlansky, Michael E.; Kulinski, Jacquelyn] Med Coll Wisconsin, Dept Med, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [Visotcky, Alexis] Med Coll Wisconsin, Inst Hlth & Equ, Milwaukee, WI 53226 USA		Kulinski, J (通讯作者)，Med Coll Wisconsin, Div Cardiovasc Med, 8701 W Watertown Plank Rd,HUB,5th Floor, Milwaukee, WI 53226 USA.	jakulinski@mcw.edu		Kulinski, Jacquelyn/0000-0002-1517-7197; Widlansky, Michael/0000-0002-1461-9707	Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; Clinical and Translational Science Award (CTSA) program of the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436, KL2TR001438]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); Michael H Keelan Jr Research Foundation; Sally Bentley Endowment	This award is funded (in part or wholly) by the Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. This award is supported by grant numbers UL1TR001436 and KL2TR001438 from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources and the National Center for Advancing Translational Sciences. The content of this article is solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Additional support provided by the Michael H Keelan Jr Research Foundation grant and the Sally Bentley Endowment.	Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Biddle SJH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143398; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Bray GA, 2015, OBESITY, V23, P2, DOI 10.1002/oby.20964; Broadney MM, 2018, DIABETES CARE, V41, P2220, DOI 10.2337/dc18-0774; Carter S, 2017, EXERC SPORT SCI REV, V45, P80, DOI 10.1249/JES.0000000000000106; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dempsey PC, 2016, DIABETES CARE, V39, P964, DOI 10.2337/dc15-2336; Diaz KM, 2017, CIRCULATION, V136, P1362, DOI 10.1161/CIRCULATIONAHA.116.026858; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Garrett G, 2016, IISE T OCCUP ERG HUM, V4, P188, DOI 10.1080/21577323.2016.1183534; Gokce N, 2002, AM J CARDIOL, V90, P124, DOI 10.1016/S0002-9149(02)02433-5; Graves LEF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2469-8; Grunseit AC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-365; Hall G, 2021, PROG CARDIOVASC DIS, V64, P108, DOI 10.1016/j.pcad.2020.04.005; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Kulinski JP, 2016, JACC-CARDIOVASC IMAG, V9, P1470, DOI 10.1016/j.jcmg.2016.01.013; Kulinski JP, 2015, VASC MED, V20, P332, DOI 10.1177/1358863X15573837; Kulinski JP, 2014, MAYO CLIN PROC, V89, P1063, DOI 10.1016/j.mayocp.2014.04.019; Larsen RN, 2015, CLIN SCI, V129, P117, DOI 10.1042/CS20140790; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lind L, 2011, CIRCULATION, V123, P1545, DOI 10.1161/CIRCULATIONAHA.110.984047; Lyden K, 2017, MED SCI SPORT EXER, V49, P1022, DOI 10.1249/MSS.0000000000001177; Matsuzawa Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002270; Matthews CE, 2015, MED SCI SPORT EXER, V47, P1833, DOI 10.1249/MSS.0000000000000621; Neuhaus M, 2014, AM J PREV MED, V46, P30, DOI 10.1016/j.amepre.2013.09.009; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Pronk NP, 2012, PREV CHRONIC DIS, V9, DOI [10.5888.pcd9.110323, 10.5888/pcd9.110323]; Restaino RM, 2015, EXP PHYSIOL, V100, P829, DOI 10.1113/EP085238; Rudecki J, 2019, J PHYS ACT HEALTH, V16, P375, DOI 10.1123/jpah.2018-0575; Son Y, 2017, INT J VASC MED, V2017, DOI 10.1155/2017/7532702; Stamatakis E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0280-7; Thijssen DHJ, 2019, EUR HEART J, V40, P2534, DOI 10.1093/eurheartj/ehz350; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thijssen DHJ, 2009, MED SCI SPORT EXER, V41, P1072, DOI 10.1249/MSS.0b013e3181923957; Thosar SS, 2015, MED SCI SPORT EXER, V47, P843, DOI 10.1249/MSS.0000000000000479; Thosar SS, 2012, MED SCI MONITOR, V18, pRA173, DOI 10.12659/MSM.883589; Vogeser M, 2007, CLIN BIOCHEM, V40, P964, DOI 10.1016/j.clinbiochem.2007.05.009; WARNICK GR, 1990, CLIN CHEM, V36, P15; Watts K, 2004, J AM COLL CARDIOL, V43, P1823, DOI 10.1016/j.jacc.2004.01.032; Weatherson KA, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102951; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	49	4	4	1	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					374	382	1358863X211001934	10.1177/1358863X211001934		APR 2021	9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000637135900001	33813968				2022-04-28	
J	Armstrong, EJ				Armstrong, Ehrin J.			Intensifying our focus on critical limb ischemia	VASCULAR MEDICINE			English	Editorial Material						critical limb ischemia (CLI); peripheral artery disease (PAD)			[Armstrong, Ehrin J.] Univ Colorado, Rocky Mt Reg VA Med Ctr, Div Cardiol, Denver, CO USA		Armstrong, EJ (通讯作者)，Univ Colorado, Rocky Mt Reg VA Med Ctr, Div Cardiol, 1700 Wheeling St, Aurora, CO 80045 USA.	Ehrin.armstrong@gmail.com					Armstrong EJ, 2019, J ENDOVASC THER, V26, P199, DOI 10.1177/1526602819826593; Benedetto F, 2021, VASC MED, V26, P187, DOI 10.1177/1358863X20978468; Elbadawi A, 2021, VASC MED, V26, P155, DOI 10.1177/1358863X20951270; Huizing E, 2021, VASC MED, V26, P195, DOI 10.1177/1358863X20977907; Hurst JE, 2021, VASC MED, V26, P147, DOI 10.1177/1358863X20981132; Lee DO, 2021, VASC MED, V26, P139, DOI 10.1177/1358863X20984525; Losurdo F, 2021, VASC MED, V26, P164, DOI 10.1177/1358863X20979738; Mustapha JA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009724; Rodriguez MC, 2021, VASC MED, V26, P200, DOI 10.1177/1358863X20987896; Shishehbor MH, 2016, J AM COLL CARDIOL, V68, P2002, DOI 10.1016/j.jacc.2016.04.071; Stabile E, 2021, VASC MED, V26, P174, DOI 10.1177/1358863X20977678; Stavroulakis K, 2018, J ENDOVASC THER, V25, P320, DOI 10.1177/1526602818771383; Zettervall SL, 2018, J VASC SURG, V67, P507, DOI 10.1016/j.jvs.2017.06.086	13	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		121	122		10.1177/1358863X211000425			2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000638263600001	33825576	Bronze			2022-04-28	
J	Lefferts, EC; Rosenberg, AJ; Grigoriadis, G; Wee, SO; Kerber, S; Fent, KW; Horn, GP; Smith, DL; Fernhall, B				Lefferts, Elizabeth C.; Rosenberg, Alexander J.; Grigoriadis, Georgios; Wee, Sang Ouk; Kerber, Stephen; Fent, Kenneth W.; Horn, Gavin P.; Smith, Denise L.; Fernhall, Bo			Firefighter hemodynamic responses to different fire training environments	VASCULAR MEDICINE			English	Article						arterial stiffness; blood pressure; firefighter safety; occupational vascular disorders; pulse wave velocity		Firefighting is associated with an increased risk for a cardiovascular (CV) event, likely due to increased CV strain. The increase in CV strain during firefighting can be attributed to the interaction of several factors such as the strenuous physical demand, sympathetic nervous system activation, increased thermal burden, and the environmental exposure to smoke pollutants. Characterizing the impact of varying thermal burden and pollutant exposure on hemodynamics may help understand the CV burden experienced during firefighting. The purpose of this study was to examine the hemodynamic response of firefighters to training environments created by pallets and straw; oriented strand board (OSB); or simulated fire/smoke (fog). Twenty-three firefighters had brachial blood pressure measured and central blood pressure and hemodynamics estimated from the pressure waveform at baseline, and immediately and 30 minutes after each scenario. The training environment did not influence the hemodynamic response over time (interaction, p > 0.05); however, OSB scenarios resulted in higher pulse wave velocity and blood pressure (environment, p < 0.05). In conclusion, conducting OSB training scenarios appears to create the largest arterial burden in firefighters compared to other scenarios in this study. Environmental thermal burden in combination with the strenuous exercise, and psychological and environmental stress placed on firefighters should be considered when designing fire training scenarios and evaluating CV risk.	[Lefferts, Elizabeth C.; Rosenberg, Alexander J.; Grigoriadis, Georgios; Fernhall, Bo] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60608 USA; [Wee, Sang Ouk] Calif State Univ San Bernardino, Dept Kinesiol, San Bernardino, CA USA; [Kerber, Stephen; Horn, Gavin P.] UL Firefighter Safety Res Inst, Columbia, MD USA; [Fent, Kenneth W.] Natl Inst Occupat Safety & Hlth, Cincinnati, OH 45226 USA; [Horn, Gavin P.; Smith, Denise L.] Univ Illinois, Fire Serv Inst, Urbana, IL 61801 USA; [Smith, Denise L.] Skidmore Coll, Dept Hlth & Human Physiol Sci, Saratoga Springs, NY 12866 USA		Lefferts, EC (通讯作者)，Univ Illinois, Dept Kinesiol & Nutr, Integrat Physiol Lab, 1640 W Roosevelt Rd,MC 529, Chicago, IL 60608 USA.	eschro7@uic.edu	Rosenberg, Alexander/AAN-8652-2021	Horn, Gavin/0000-0002-4364-9673; Kerber, Stephen/0000-0002-4951-6927	Department of Homeland Security Fire Prevention and Safety Grant programUnited States Department of Homeland Security (DHS) [EMW-2014-FP-00590, EMW-2016-FP-00379]	This work was supported by the Department of Homeland Security Fire Prevention and Safety Grant program under Grants EMW-2014-FP-00590 and EMW-2016-FP-00379.	Collier SR, 2010, J STRENGTH COND RES, V24, P2846, DOI 10.1519/JSC.0b013e3181e840e0; Fahs CA, 2011, VASC MED, V16, P113, DOI 10.1177/1358863X11404940; Fahy RF., 2020, FIREFIGHTER FATALITI; Feistritzer HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116862; Fent KW, 2019, J OCCUP ENVIRON HYG, V16, P532, DOI 10.1080/15459624.2019.1617870; Fernhall B, 2012, EUR J APPL PHYSIOL, V112, P735, DOI 10.1007/s00421-011-2033-x; Hametner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141656; Hametner B, 2013, BLOOD PRESS MONIT, V18, P173, DOI 10.1097/MBP.0b013e3283614168; Heffernan KS, 2007, INT J SPORTS MED, V28, P197, DOI 10.1055/s-2006-924290; Horn GP, 2019, SAFETY SCI, V116, P287, DOI 10.1016/j.ssci.2019.03.017; Horn GP, 2018, ERGONOMICS, V61, P404, DOI 10.1080/00140139.2017.1355072; Horn GP, 2013, ERGONOMICS, V56, P1465, DOI 10.1080/00140139.2013.818719; Horn GP, 2011, PREHOSP EMERG CARE, V15, P214, DOI 10.3109/10903127.2010.545474; Hunter AL, 2017, CIRCULATION, V135, P1284, DOI 10.1161/CIRCULATIONAHA.116.025711; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Lefferts WK, 2015, VASC MED, V20, P222, DOI 10.1177/1358863X14566430; Pierce DR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01468; Poston WSC, 2011, J OCCUP ENVIRON MED, V53, P266, DOI 10.1097/JOM.0b013e31820af362; Smith DL, 2019, AM J CARDIOL, V123, P736, DOI 10.1016/j.amjcard.2018.11.049; Smith DL, 2016, EXERC SPORT SCI REV, V44, P90, DOI 10.1249/JES.0000000000000081; Smith DL, 2015, EUR J APPL PHYSIOL, V115, P2223, DOI 10.1007/s00421-015-3203-z; Smith DL, 1997, ERGONOMICS, V40, P500, DOI 10.1080/001401397188125; Smith DL, 2001, ERGONOMICS, V44, P244, DOI 10.1080/00140130010000910; Wassertheurer S, 2010, J HUM HYPERTENS, V24, P498, DOI 10.1038/jhh.2010.27; Wassertheurer S, 2008, SIMUL MODEL PRACT TH, V16, P988, DOI 10.1016/j.simpat.2008.04.016; Weiss W, 2012, BLOOD PRESS MONIT, V17, P128, DOI 10.1097/MBP.0b013e328353ff63; Yan HM, 2012, EUR J APPL PHYSIOL, V112, P2385, DOI 10.1007/s00421-011-2188-5	28	0	0	3	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					240	246	1358863X20987608	10.1177/1358863X20987608		FEB 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000620755700001	33606968	hybrid, Green Published			2022-04-28	
J	Harwood, AE; Pugh, CJA; Steward, CJ; Menzies, C; Thake, CD; Cullen, T				Harwood, Amy E.; Pugh, Christopher J. A.; Steward, Charles J.; Menzies, Campbell; Thake, C. Doug; Cullen, Tom			A systematic review of the role of heat therapy for patients with intermittent claudication due to peripheral artery disease	VASCULAR MEDICINE			English	Review						heat therapy; intermittent claudication; peripheral artery disease (PAD)	BLOOD-PRESSURE; EXERCISE; RISK; TREADMILL	Intermittent claudication (IC) is associated with impairments in quality of life and walking ability. Heat therapy is an emerging cardiovascular therapy, which may improve walking in patients with IC. We undertook a systematic review to establish current evidence for heat therapy for patients with IC. We searched five databases (Ovid Medline / PubMed, Embase, Scopus / Web of Science, Cochrane Library and Health Technology Assessment Databases). A total of 6751 records were screened with 76 full-text articles assessed for eligibility. We included three randomised control trials and three acute interventions. For chronic interventions, three different heat therapy interventions were used. The 6-minute walk distance significantly improved following whole-body immersion (p = 0.03; ES 0.94, 95% CI: 0.06-1.82), but not after Waon therapy or a water-perfused garment. Ankle-brachial pressure indices were significantly improved following whole-body immersion (p = 0.01; ES 1.10, 95% CI: 0.20-1.99) but not after other therapies. No form of heat therapy demonstrated statistical improvements in quality of life or brachial blood pressure. Acute interventions were characterised by large increases in limb blood flow and core temperature, and transient reductions in blood pressure post-heating. At present there are only three randomised controlled trials assessing heat therapy for patients with IC. Moreover, each of those randomised controlled trials utilised different heat therapies. There is also very limited study of the acute physiological responses to different heat therapy interventions in these populations. Future research should establish appropriate heat therapy protocols and implement more randomised trials to understand its effectiveness. PROSPERO: CRD42020187941	[Harwood, Amy E.; Steward, Charles J.; Menzies, Campbell; Thake, C. Doug; Cullen, Tom] Coventry Univ, Fac Hlth & Life Sci, Ctr Sport Exercise & Life Sci, Sci & Hlth Bldg,Whitefriars St, Coventry CV1 2DS, W Midlands, England; [Pugh, Christopher J. A.] Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cardiff, Wales		Harwood, AE (通讯作者)，Coventry Univ, Fac Hlth & Life Sci, Ctr Sport Exercise & Life Sci, Sci & Hlth Bldg,Whitefriars St, Coventry CV1 2DS, W Midlands, England.	amy.harwood@coventry.ac.uk	Cullen, Tom/AAY-6162-2021	Cullen, Tom/0000-0002-9058-6716; Steward, Charles/0000-0002-5405-4608; Harwood, Amy Elizabeth/0000-0002-5745-2564; Menzies, Campbell/0000-0002-2546-1618; Thake, C. Douglas/0000-0002-0632-2137			Abaraogu U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201095; Akerman AP, 2019, AM J PHYSIOL-HEART C, V316, pH1495, DOI 10.1152/ajpheart.00151.2019; Brunt VE, 2016, J PHYSIOL-LONDON, V594, P5329, DOI 10.1113/JP272453; Cullen T, 2020, J APPL PHYSIOL, V129, P1304, DOI 10.1152/japplphysiol.00608.2020; Dua A, 2020, J VASC SURG, V71, P1702, DOI 10.1016/j.jvs.2019.08.238; Ely BR, 2019, AM J PHYSIOL-REG I, V317, pR630, DOI 10.1152/ajpregu.00078.2019; Gardner AW, 2018, VASC MED, V23, P349, DOI 10.1177/1358863X18762599; Gill AW., 1927, LANCET, V210, P912; Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286; Harwood AE., 2017, B ROY COLL SURG ENGL, V99, P207; Harwood AE, 2017, J VASC SURG, V66, P1241, DOI 10.1016/j.jvs.2017.05.106; Harwood AE, 2016, ANN VASC SURG, V34, P280, DOI 10.1016/j.avsg.2016.02.009; Harwood AE, 2016, ANN VASC SURG, V30, P312, DOI 10.1016/j.avsg.2015.05.043; Hiatt WR, 2014, CIRCULATION, V130, P69, DOI 10.1161/CIRCULATIONAHA.113.007003; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Lane R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub4; Laukkanen T, 2015, JAMA INTERN MED, V175, P542, DOI 10.1001/jamainternmed.2014.8187; Mockford KA, 2011, ANN VASC SURG, V25, P182, DOI 10.1016/j.avsg.2010.07.021; Monroe JC, 2020, J APPL PHYSIOL, V129, P1279, DOI 10.1152/japplphysiol.00277.2020; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Motaganahalli R, 2020, LEG THERMOTHERAPY IN; National Institute for Health and Care Excellence (NICE), 2012, PERIPHERAL ARTERIAL; Neff D, 2016, AM J PHYSIOL-REG I, V311, pR392, DOI 10.1152/ajpregu.00147.2016; Nicolai SPA, 2009, J VASC SURG, V50, P322, DOI 10.1016/j.jvs.2009.01.042; Novakovic M, 2017, VASCULAR, V25, P412, DOI 10.1177/1708538116678752; Parmenter BJ, 2010, SPORTS MED, V40, P433, DOI 10.2165/11531330-000000000-00000; Pellinger TK, 2019, J CARDIOVASC NURS, V34, P130, DOI 10.1097/JCN.0000000000000510; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Shinsato T, 2010, J CARDIOL, V56, P361, DOI 10.1016/j.jjcc.2010.08.004; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Tei C, 2007, J AM COLL CARDIOL, V50, P2169, DOI 10.1016/j.jacc.2007.08.025; Thomas KN, 2017, AM J PHYSIOL-REG I, V312, pR281, DOI 10.1152/ajpregu.00404.2016; Treat-Jacobson D, 2019, CIRCULATION, V139, pE10, DOI 10.1161/CIR.0000000000000623; Ukai T, 2020, HEART, V106, P732, DOI 10.1136/heartjnl-2019-315752; Ye WNN, 2020, ARTIF ORGANS, V44, P680, DOI 10.1111/aor.13659	36	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					440	447	1358863X20983475	10.1177/1358863X20983475		FEB 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000621156800001	33587690	Green Published, hybrid			2022-04-28	
J	Behrooz, L; Hamburg, N				Behrooz, Leili; Hamburg, Naomi			Osteophytic iliac venous compression: A rare case of bony May-Thurner syndrome	VASCULAR MEDICINE			English	Meeting Abstract									[Behrooz, Leili; Hamburg, Naomi] Boston Med Ctr, Boston, MA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1231	NP23	NP24					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100055					2022-04-28	
J	Bender, M; Mix, D; Godwin, M; Aggarwal, A; Tefera, L; Campbell, J; Haddadin, I; Cameron, S				Bender, Matthew; Mix, Doran; Godwin, Matthew; Aggarwal, Anu; Tefera, Leben; Campbell, Joseph; Haddadin, Ihab; Cameron, Scott			It's Alive: Biologically Active Thrombus and Implications for Vascular Remodeling	VASCULAR MEDICINE			English	Meeting Abstract									[Bender, Matthew; Mix, Doran] Univ Rochester, Rochester, NY USA; [Godwin, Matthew; Aggarwal, Anu; Tefera, Leben; Campbell, Joseph; Haddadin, Ihab; Cameron, Scott] Cleveland Clin, Cleveland, OH 44106 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1426	NP34	NP35					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100076					2022-04-28	
J	Salces, NW; Arellano, R				Salces, Neil Wayne; Arellano, Rosella			Mean platelet volume and mean platelet volume/platelet count ratio as predictor of major limb amputation and in-hospital mortality in patients with critical limb ischemia	VASCULAR MEDICINE			English	Meeting Abstract									[Salces, Neil Wayne; Arellano, Rosella] Philippine Heart Ctr, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1343	NP13	NP13					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100037					2022-04-28	
J	Slysz, J; McDermott, MM; Tian, L; Zhao, LH				Slysz, Joshua; McDermott, Mary M.; Tian, Lu; Zhao, Lihiu			Exercise characteristics associated with improved walking performance in peripheral artery disease: the lite randomized clinical trial	VASCULAR MEDICINE			English	Meeting Abstract									[Slysz, Joshua; McDermott, Mary M.; Zhao, Lihiu] Northwestern Univ, Chicago, IL 60611 USA; [Tian, Lu] Stanford Univ, Palo Alto, CA 94304 USA					tian, lu/0000-0002-5893-0169				0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1278	NP7	NP7					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100026					2022-04-28	
J	Sy, D; Bernardo, JM				Sy, Darleen; Bernardo, Jasmin Melissa			Outcomes of complete decongestive therapy in patients with lymphedema enrolled in the vascular and lymphedema center of the Makati Medical Center, Philippines	VASCULAR MEDICINE			English	Meeting Abstract									[Sy, Darleen; Bernardo, Jasmin Melissa] Makati Med Ctr, Makati, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1317	NP10	NP10					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100030					2022-04-28	
J	Pasqualini, L; Bagaglia, F; Ministrini, S; Frangione, MR; Leli, C; Siepi, D; Lombardini, R; Marini, E; Kararoudi, MN; Piratinskiy, A; Pirro, M				Pasqualini, Leonella; Bagaglia, Francesco; Ministrini, Stefano; Frangione, Maria Rosaria; Leli, Christian; Siepi, Donatella; Lombardini, Rita; Marini, Ettore; Naeimi Kararoudi, Meisam; Piratinskiy, Alexander; Pirro, Matteo			Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication	VASCULAR MEDICINE			English	Article						endothelial progenitor cells; flow-mediated vasodilation; peripheral artery disease (PAD); physical activity	FLOW-MEDIATED DILATION; PHYSICAL-ACTIVITY; VASCULAR FUNCTION; MICROPARTICLES; MOBILIZATION; DYSFUNCTION; ACTIVATION; REACTIVITY; MARKER; IMPACT	Introduction: Exercise training improves walking capacity in patients with intermittent claudication (IC). Endothelial progenitor cells (EPCs), endothelial microparticles (EMPs), and endothelial dysfunction could play a role in this process. Methods: We measured EPCs and EMPs in a group of 60 patients with IC, and in a control group of 20 individuals without IC, before a treadmill test and 2, 24, and 48 hours after the test. Thirty patients with IC were randomly assigned to perform a 12-week home-based exercise training program. The EPC count, flow-mediated dilation (FMD) of the brachial artery, pain-free walking time (PFWT), and maximum walking time (MWT) were measured at the baseline and after the exercise training program. Results: In patients with IC, EMPs significantly increased 2 hours after the treadmill test, whereas EPCs significantly increased after 24 hours. Among the subjects assigned to complete the training program, we observed a significant increase in the number of EPCs after 12 weeks, as well as an improvement in FMD, PFWT, and MWT. A significant correlation between the variation of EPCs, FMD, and MWT was found. The increase of EPCs and FMD were independent determinants of the walking capacity improvement, without significant interaction. Conclusion: Our results suggest that EPCs mobilization contributes to the improvement of walking capacity in patients with IC undergoing structured physical training. A number of different, partly independent, mechanisms are involved in this process, and our results highlight the potential role of EMPs release and endothelial function improvement. ClinicalTrials.gov Identifier: NCT04302571	[Pasqualini, Leonella; Bagaglia, Francesco; Ministrini, Stefano; Frangione, Maria Rosaria; Siepi, Donatella; Lombardini, Rita; Marini, Ettore; Pirro, Matteo] Univ Perugia, Dept Med & Surg, Unit Internal Med Angiol & Atherosclerosis, Piazzale Gambuli 1, I-06132 Perugia, PG, Italy; [Leli, Christian] Azienda Osped Santi Antonio & Biagio & Cesare Arr, Microbiol Lab, Alessandria, Italy; [Naeimi Kararoudi, Meisam] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Piratinskiy, Alexander] Ural Fed Univ UrFU, Ekaterinburg, Russia		Ministrini, S (通讯作者)，Univ Perugia, Dept Med & Surg, Unit Internal Med Angiol & Atherosclerosis, Piazzale Gambuli 1, I-06132 Perugia, PG, Italy.	stefano.ministrini@studenti.unipg.it	Leli, Christian/AAP-9337-2020; Pirro, Matteo/AAC-2318-2022; Naeimi, Meisam/ABA-1979-2021; LOMBARDINI, Rita/U-4841-2017	Leli, Christian/0000-0002-8689-7028; LOMBARDINI, Rita/0000-0001-7682-9817; Ministrini, Stefano/0000-0003-4358-6411	'Fondo per la Ricerca di Base 2018' of Universita degli Studi di Perugia	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by `Fondo per la Ricerca di Base 2018' of Universita degli Studi di Perugia. The funder did not have any role in the design/conduct of the study.	Aboyans V, 2017, KARDIOL POL, V75, P1065, DOI 10.5603/KP.2017.0216; Agnoletti L, 1999, CIRCULATION, V100, P1983, DOI 10.1161/01.CIR.100.19.1983; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Augustine D, 2014, CIRC RES, V114, P109, DOI 10.1161/CIRCRESAHA.114.301904; Behrendt CA, 2020, EUR J VASC ENDOVASC, V60, P873, DOI 10.1016/j.ejvs.2020.08.027; Bitterli L, 2016, VASC MED, V21, P3, DOI 10.1177/1358863X15611225; Boyle LJ, 2013, J APPL PHYSIOL, V115, P1519, DOI 10.1152/japplphysiol.00837.2013; Bueno-Beti C, 2019, CARDIOVASC RES, V115, P409, DOI 10.1093/cvr/cvy189; Cornelis N, 2018, VASA, V47, P109, DOI 10.1024/0301-1526/a000654; Crawford JR, 2016, J CARDIOVASC TRANSL, V9, P184, DOI 10.1007/s12265-016-9678-0; De Biase C, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00414; Delaney CL, 2015, VASCULAR, V23, P561, DOI 10.1177/1708538114558329; Deng F, 2017, J CELL MOL MED, V21, P1698, DOI 10.1111/jcmm.13125; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Hageman D, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub4; HARRIS LM, 1995, AM J CARDIOL, V76, P207, DOI 10.1016/S0002-9149(99)80066-6; Highton Patrick J, 2018, Exerc Immunol Rev, V24, P46; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hodgkiss-Harlow KD, 2013, SEMIN VASC SURG, V26, P95, DOI 10.1053/j.semvascsurg.2013.11.002; Hoyer FF, 2010, J CELL MOL MED, V14, P2250, DOI 10.1111/j.1582-4934.2010.01114.x; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Karakoyun R, 2014, EUR J VASC ENDOVASC, V47, P172, DOI 10.1016/j.ejvs.2013.11.001; Mika P, 2013, INT J CARDIOL, V168, P838, DOI 10.1016/j.ijcard.2012.10.003; Pasqualini L, 2005, ATHEROSCLEROSIS, V183, P349, DOI 10.1016/j.atherosclerosis.2005.03.030; Pasqualini L, 2003, VASA-J VASCULAR DIS, V32, P139, DOI 10.1024/0301-1526.32.3.139; Pirro M, 2007, J HYPERTENS, V25, P2093, DOI 10.1097/HJH.0b013e32828e506d; Pirro M, 2006, ARTERIOSCL THROM VAS, V26, P2530, DOI 10.1161/01.ATV.0000243941.72375.15; Pirro M, 2009, J CARDIOVASC PHARM T, V14, P14, DOI 10.1177/1074248408331021; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Sandri M, 2005, CIRCULATION, V111, P3391, DOI 10.1161/CIRCULATIONAHA.104.527135; Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019; Serviente C, 2019, J APPL PHYSIOL, V126, P102, DOI 10.1152/japplphysiol.00420.2018; Stewart KJ, 2002, NEW ENGL J MED, V347, P1941, DOI 10.1056/NEJMra021135; STRANDNESS DE, 1970, J CARDIOVASC SURG, V11, P192; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Treat-Jacobson D, 2019, CIRCULATION, V139, pE10, DOI 10.1161/CIR.0000000000000623; Wils J, 2017, PHARMACOL THERAPEUT, V170, P98, DOI 10.1016/j.pharmthera.2016.10.014; Yataco AR, 1999, AM J CARDIOL, V83, P754, DOI 10.1016/S0002-9149(98)00984-9	41	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					633	640	1358863X211020822	10.1177/1358863X211020822		JUN 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000665228800001	34151646				2022-04-28	
J	Migliacci, R; Guglielmini, G; Busti, C; Falcinelli, E; Minuz, P; Gresele, P				Migliacci, Rino; Guglielmini, Giuseppe; Busti, Chiara; Falcinelli, Emanuela; Minuz, Pietro; Gresele, Paolo			Walking-induced endothelial dysfunction predicts ischemic cardiovascular events in patients with intermittent claudication	VASCULAR MEDICINE			English	Article						endothelial function; ischemia; reperfusion injury; nitric oxide; NO; peripheral artery disease (PAD); soluble P-selectin		Endothelial dysfunction, evaluated by flow-mediated dilatation (FMD), predicts adverse cardiovascular events in patients with intermittent claudication (IC). IC is an example of repeated ischemia/reperfusion injury that may contribute to the progression of vascular disease by worsening endothelial function, a trigger for acute cardiovascular events. The predictive value of effort-induced endothelial dysfunction for cardiovascular events in patients with IC has not been studied previously. The objective of this study was to assess whether exercise-induced endothelial dysfunction is predictive of adverse cardiovascular outcome in IC. In 44 patients with IC, we measured brachial artery FMD by B-mode ultrasonography at rest and 10 minutes after a maximal treadmill exercise. Treadmill exercise halved the FMD (from 3.5 +/- 0.6% to 1.45 +/- 0.46%, p < 0.05). After a follow-up period of 85 (72-98) months, a total of 20 major cardiovascular events occurred. In a multivariate analysis, a post-exercise reduction of brachial FMD > 1.3% was predictive for cardiovascular events. Maximal exercise-induced endothelial dysfunction is predictive of cardiovascular events in patients with IC.	[Migliacci, Rino] Osped Valdichiana S Margherita, Div Internal Med, Cortona, Italy; [Guglielmini, Giuseppe; Falcinelli, Emanuela; Gresele, Paolo] Univ Perugia, Sect Internal & Cardiovasc Med, Dept Med & Surg, Perugia, Italy; [Busti, Chiara] San Giovanni Battista Hosp, Dept Emergency Med, Foligno, Italy; [Minuz, Pietro] Univ Verona, Dept Med, Unit Gen Med Study & Treatment Hypertens Dis, Policlin GB Rossi, Verona, Italy		Gresele, P (通讯作者)，Univ Perugia, Sect Internal & Cardiovasc Med, Dept Med & Surg, Ctr Didatt, Edificio B Piano 1,Str Vicinale Via Corse, I-06132 Perugia, Italy.	paolo.gresele@unipg.it	Minuz, Pietro/K-7067-2016; Gresele, Paolo/F-6775-2013	Gresele, Paolo/0000-0001-5365-8445	MIURFIRBMinistry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB) [RBFR12W5V5_004]; Regione Umbria (Progetto Ricerca Finalizzata Regione Umbria)	This work was supported in part by a grant to PG from MIURFIRB (Protocol #RBFR12W5V5_004) and by Regione Umbria (Progetto Ricerca Finalizzata Regione Umbria 2013).	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Alhejily W, 2014, CLIN HEMORHEOL MICRO, V56, P265, DOI 10.3233/CH-131741; Anderson JD, 2009, J AM COLL CARDIOL, V54, P628, DOI 10.1016/j.jacc.2009.01.080; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010, 10.1016/j.jacc.2019.03.009]; Bailey TG, 2018, AM J PHYSIOL-HEART C, V314, pH19, DOI 10.1152/ajpheart.00344.2017; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Brevetti G, 2003, CIRCULATION, V108, P2093, DOI 10.1161/01.CIR.0000095273.92468.D9; Brevetti G, 2008, ATHEROSCLEROSIS, V197, P1, DOI 10.1016/j.atherosclerosis.2007.11.002; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Busti C, 2009, ATHEROSCLEROSIS, V203, P38, DOI 10.1016/j.atherosclerosis.2008.06.023; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Dormandy J, 1999, Semin Vasc Surg, V12, P123; Falcinelli E, 2019, THROMB RES, V175, P1, DOI 10.1016/j.thromres.2019.01.005; Falcinelli E, 2013, THROMB HAEMOSTASIS, V110, P349, DOI 10.1160/TH12-07-0504; FORMAN MB, 1989, J AM COLL CARDIOL, V13, P450, DOI 10.1016/0735-1097(89)90526-3; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Grenon SM, 2014, J VASC SURG, V59, P1025, DOI 10.1016/j.jvs.2013.10.084; Gresele P, 2009, THROMB RES, V123, P444, DOI 10.1016/j.thromres.2008.05.015; Gresele P, 2007, THROMB HAEMOSTASIS, V97, P444, DOI 10.1160/TH06-10-0555; Gresele P, 2018, J CARDIOVASC MED, V19, pE72, DOI 10.2459/JCM.0000000000000557; Gresele P, 2006, CARDIOVASC DRUG REV, V24, P148, DOI 10.1111/j.1527-3466.2006.00148.x; Gresele P, 2012, J VASC SURG, V56, P1622, DOI 10.1016/j.jvs.2012.05.064; Gresele P, 2009, EUR HEART J, V30, P131, DOI 10.1093/eurheartj/ehn565; Hackl G, 2016, EUR J VASC ENDOVASC, V52, P211, DOI 10.1016/j.ejvs.2016.05.011; Hafner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093357; Hausenloy DJ, 2019, CARDIOVASC RES, V115, P1143, DOI 10.1093/cvr/cvy286; Hiatt WR, 2015, CIRC RES, V116, P1527, DOI 10.1161/CIRCRESAHA.116.303566; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Januszek R, 2016, INT J CARDIOL, V222, P813, DOI 10.1016/j.ijcard.2016.07.274; Januszek R, 2014, J CARDIOL, V64, P145, DOI 10.1016/j.jjcc.2013.12.002; KIOWSKI W, 1994, CIRCULATION, V90, P27, DOI 10.1161/01.CIR.90.1.27; Komura N, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003202; Lenti M, 2014, THROMB HAEMOSTASIS, V111, P1089, DOI 10.1160/TH13-07-0588; Matsuzawa Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000426; McVeigh GE, 1996, AM J CARDIOL, V78, P668, DOI 10.1016/S0002-9149(96)00391-8; Migliacci R, 1996, NEW ENGL J MED, V334, P1674, DOI 10.1056/NEJM199606203342515; Migliacci R, 2008, FAM PRACT, V25, P228, DOI 10.1093/fampra/cmn035; Migliacci R, 2007, HAEMATOLOGICA, V92, P812, DOI 10.3324/haematol.10872; Minuz P, 2012, CLIN SCI, V122, P289, DOI 10.1042/CS20110199; Momi S, 2005, THROMB HAEMOSTASIS, V93, P535, DOI 10.1160/TH04-07-0464; Nenci GG, 2001, THROMB HAEMOSTASIS, V86, P1181; Newby DE, 1999, CIRCULATION, V99, P1411, DOI 10.1161/01.CIR.99.11.1411; Oakley C, 2008, EUR J VASC ENDOVASC, V36, P689, DOI 10.1016/j.ejvs.2008.06.036; Pasini AMF, 2018, J ATHEROSCLER THROMB, V25, P808, DOI 10.5551/jat.42432; Pizzimenti M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122125; Rahimi K, 2009, HEART, V95, P1937, DOI 10.1136/hrt.2009.173302; Seal JB, 2005, ANN VASC SURG, V19, P572, DOI 10.1007/s10016-005-4616-7; Silvestro A, 2002, ATHEROSCLEROSIS, V165, P277, DOI 10.1016/S0021-9150(02)00235-6; van Schaardenburgh M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1232-6; Vita JA, 2010, CAN J CARDIOL, V26, p45A, DOI 10.1016/S0828-282X(10)71062-X; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weiss DJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-230	55	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					394	400	1358863X211001927	10.1177/1358863X211001927		APR 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000641910400001	33845700				2022-04-28	
J	Klein, AJ; Hawkins, BM				Klein, Andrew J.; Hawkins, Beau M.			Addressing disparities in chronic limb-threatening ischemia care: What are we waiting for?	VASCULAR MEDICINE			English	Editorial Material						amputation; critical limb-threatening ischemia (CLTI); disparities; peripheral artery disease (PAD)			[Klein, Andrew J.] Piedmont Heart & Vasc Inst, Atlanta, GA USA; [Hawkins, Beau M.] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Cardiovasc Sect, Oklahoma City, OK USA		Klein, AJ (通讯作者)，Piedmont Heart & Vasc Inst, Intervent Cardiol Vasc & Endovasc Med, Atlanta, GA 30309 USA.	Andrew.Klein@piedmont.org					Armstrong EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000697; Arya S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007425; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hurst JE, 2021, VASC MED, V26, P147, DOI 10.1177/1358863X20981132; Jones WS, 2012, J AM COLL CARDIOL, V60, P2230, DOI 10.1016/j.jacc.2012.08.983; Lefebvre KM, 2015, VASC MED, V20, P51, DOI 10.1177/1358863X14565373; Mastenbroek MH, 2012, EUR J VASC ENDOVASC, V43, P433, DOI 10.1016/j.ejvs.2011.12.022; McBride CL, 2018, VASC MED, V23, P232, DOI 10.1177/1358863X18758914; Mentias A, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.120.009459; Roijers JJP, 2020, ANN VASC SURG, V66, P486, DOI 10.1016/j.avsg.2019.10.087; Saxon JT, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.012541; Schramm K, 2018, SEMIN INTERVENT RAD, V35, P9, DOI 10.1055/s-0038-1636515; Sprengers RW, 2010, J VASC SURG, V52, P843, DOI 10.1016/j.jvs.2010.04.057; Zayed M, 2014, ANN VASC SURG, V28, P1157, DOI 10.1016/j.avsg.2013.11.008	16	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		123	125	1358863X21992432	10.1177/1358863X21992432		FEB 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000620745800001	33606966	Bronze			2022-04-28	
J	Rodriguez, MC; Mark, JR; Gosdin, M; Humphries, MD				Rodriguez, Maria Ceja; Mark, John R.; Gosdin, Melissa; Humphries, Misty D.			Perceptions of patients with wounds due to chronic limb-threatening ischemia	VASCULAR MEDICINE			English	Article						amputation; critical limb-threatening ischemia (CLTI); patient-centered; patient education; peripheral artery disease (PAD); quality of life; wound care		Patients with chronic limb-threatening ischemia (CLTI) face numerous barriers to caring for lower extremity wounds. We explored the perceptions of CLTI patients to their wound/management and sought to determine attitudes towards their vascular provider as well as willingness for management through telemedicine. Patients admitted to hospital for treatment of Rutherford Grade 5 and 6 CLTI were asked complete a wound evaluation survey and took part in a semi-structured interview. Semi-structured interviews were recorded, transcribed, and analyzed using an inductive coding strategy. Codes were grouped for thematic analysis and aggregated into assertions. Eleven patients with a mean age of 60 years (35-79 years) were interviewed. All patients had peripheral artery disease (PAD) and eight patients had diabetes as well. Three overarching themes were identified. First, patients appear to have limited coping mechanisms and are overwhelmed by the care of their wounds. Second, in this cohort of patients, many had become passive observers of their care as demonstrated by a limited understanding of their disease processes and detachment from wound management. The third theme was how strong the desire to do everything to prevent limb loss was, but patients acknowledged this is hard to translate into real life with limited resources. Patients with CLTI have concerns that vascular providers must recognize and address to build strong patient-provider relationships and increase activation for management of their wounds and other medical conditions. Patients who have access to technology and with guidance may be able to understand getting care through remote medicine.	[Rodriguez, Maria Ceja; Mark, John R.; Humphries, Misty D.] Univ Calif Davis Hlth, Dept Surg, Sacramento, CA USA; [Gosdin, Melissa] Univ Calif Davis Hlth, Ctr Hlth Policy, Sacramento, CA USA		Humphries, MD (通讯作者)，Univ Calif Davis, Dept Surg, Div Vasc Surg, Med Ctr, 2335 Stockton Blvd,NAOB 5001, Sacramento, CA 95817 USA.	mdhumphries@ucdavis.edu		Humphries, Misty/0000-0001-7362-3303	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL143178]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this work is supported by the National Heart, Lung, and Blood Institute grant K23HL143178.	Benbassat J, 1998, BEHAV MED, V24, P81, DOI 10.1080/08964289809596384; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Biondi-Zoccai G, 2013, MINERVA CARDIOANGIOL, V61, P367; Chung J, 2015, J VASC SURG, V61, P162, DOI 10.1016/j.jvs.2014.05.101; Chung J, 2013, J VASC SURG, V58, P972, DOI 10.1016/j.jvs.2013.03.050; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DiLosa, 2018, 46 ANN S SOC CLIN VA; Eikelboom RH, 2005, J TELEMED TELECARE, V11, P22, DOI 10.1258/135763305775124920; Holst, NUMB SMARTPH US US 2; LADD R E, 1985, Journal of Emergency Medicine, V3, P149, DOI 10.1016/0736-4679(85)90048-4; Lin CW, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000795; Lin JH, 2020, J VASC SURG, V72, P268, DOI 10.1016/j.jvs.2019.10.063; Minc SD, 2020, J VASC SURG, V72, P1011, DOI 10.1016/j.jvs.2019.10.090; Nehler MR, 2014, J VASC SURG, V60, P686, DOI 10.1016/j.jvs.2014.03.290; Rodriguez-Osorio CA, 2008, CURR OPIN CRIT CARE, V14, P708, DOI 10.1097/MCC.0b013e328315a611; Santema TBK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013272; Schanzer A, 2008, J VASC SURG, V47, P774, DOI 10.1016/j.jvs.2007.11.056; Skrepnek GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134914; Suckow BD, 2015, ANN VASC SURG, V29, P722, DOI 10.1016/j.avsg.2014.12.005; Weinstein RS, 2014, AM J MED, V127, P183, DOI 10.1016/j.amjmed.2013.09.032; Zahner GJ, 2020, VASC MED, V25, P25, DOI 10.1177/1358863X19880277	21	2	2	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		200	206	1358863X20987896	10.1177/1358863X20987896		FEB 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000620743100001	33606967	Green Accepted			2022-04-28	
J	Merli, GJ; Kraft, WK; Eraso, LH; Galanis, T; Thomson, LJ; Ouma, GO; Viscusi, E; Gong, JZ; Lam, E				Merli, Geno J.; Kraft, Walter K.; Eraso, Luis H.; Galanis, Taki; Thomson, Lynda J.; Ouma, Geoffrey O.; Viscusi, Eugene; Gong, Jerald Z.; Lam, Edwin			Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS): A prospective cohort study	VASCULAR MEDICINE			English	Article; Early Access						anticoagulation; apixaban; peri-operative; pharmacokinetics	DIRECT ORAL ANTICOAGULANTS; RIVAROXABAN; DABIGATRAN; MANAGEMENT	Background: Apixaban pharmacokinetic properties and some clinical reports suggest cessation 48 hours prior to surgery is safe, but this has not been demonstrated in a naturalistic setting. We sought to measure the residual apixaban exposure in patients who had apixaban held as part of standard of care perioperative management. Methods: This was a prospective, observational study of patients in whom apixaban plasma concentration and anti-Xa activity were measured while at steady state apixaban dosing and again immediately prior to surgery. Clinical management of cessation and resumption of apixaban was at the discretion of the treating physician. Results: Paired blood samples were provided by 111 patients. Ninety-four percent (104/111) of patients had measured apixaban concentrations of <= 30 ng/mL. Only one patient had a value > 50 ng/mL. The median time between the self-reported last dose and presurgery blood sampling was 76 hours (range 32-158) for those who achieved concentrations <= 30 ng/mL and 59 hours (range 49-86) for those > 30 ng/mL. Measured anti-Xa activity correlated well with apixaban exposure. Clinically significant nonmajor bleeding was reported in one patient at 1 week postsurgery. There was one venous thromboembolic event and one stroke in the perioperative period. Conclusion: In a naturalistic setting with a heterogeneous patient population, apixaban discontinuation for at least 48 hours before a procedure resulted in a clinically insignificant degree of anticoagulation prior to a surgical procedure. ClinicalTrials.gov Identifier: NCT02935751	[Merli, Geno J.; Kraft, Walter K.; Eraso, Luis H.; Galanis, Taki] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Merli, Geno J.; Kraft, Walter K.; Eraso, Luis H.; Galanis, Taki] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [Kraft, Walter K.; Lam, Edwin] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Thomson, Lynda J.] Thomas Jefferson Univ, Dept Pharm, Philadelphia, PA 19107 USA; [Ouma, Geoffrey O.] Cleveland Clin, Dept Cardiovasc Med, Sect Vasc Med, Vasc & Thorac Inst, Cleveland, OH 44106 USA; [Viscusi, Eugene] Thomas Jefferson Univ, Dept Anesthesiol, Philadelphia, PA 19107 USA; [Gong, Jerald Z.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Lam, Edwin] NIH, Dept Pharm, Clin Pharmacokinet Res Unit, Bldg 10, Bethesda, MD 20892 USA		Merli, GJ (通讯作者)，Thomas Jefferson Univ, Pharmacol & Expt Therapeut, 111 S 10th St,6270 Gibbon Bldg, Philadelphia, PA 19107 USA.	geno.merli@jefferson.edu		Kraft, Walter/0000-0002-5074-0141	Bristol Myers SquibbBristol-Myers Squibb; Pfizer, as part of the American Thrombosis Investigator Initiated Research Program (ARISTA-USA); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32GM008562-24]	This research was funded by an investigator-initiated research award from Bristol Myers Squibb and Pfizer, as part of the American Thrombosis Investigator Initiated Research Program (ARISTA-USA). Edwin Lam was supported by a National Institutes of Health institutional training grant T32GM008562-24. Study design, research conduct, analysis, and manuscript preparation were conducted by the Thomas Jefferson University investigators, who had final editorial control over the published content.	Bristol-Myers Squibb Company/Pfizer Inc, 2019, ELIQUIS PRODUCT INSE; Byon W, 2019, CLIN PHARMACOKINET, V58, P1265, DOI 10.1007/s40262-019-00775-z; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; Douketis JD, 2019, JAMA INTERN MED, V179, P1469, DOI 10.1001/jamainternmed.2019.2431; Godier A, 2020, ANAESTH CRIT CARE PA, V39, P121, DOI 10.1016/j.accpm.2019.04.004; Godier A, 2017, EUR HEART J, V38, P2431, DOI 10.1093/eurheartj/ehx403; Godier A, 2015, THROMB RES, V136, P763, DOI 10.1016/j.thromres.2015.08.006; Korn W., 2016, CLIN CHEM, V62; Leil T, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.34; Levy JH, 2016, J THROMB HAEMOST, V14, P623, DOI 10.1111/jth.13227; Pernod G, 2013, ARCH CARDIOVASC DIS, V106, P382, DOI 10.1016/j.acvd.2013.04.009; Schmitz EMH, 2014, J THROMB HAEMOST, V12, P1636, DOI 10.1111/jth.12702; Skeppholm M, 2015, THROMB RES, V136, P148, DOI 10.1016/j.thromres.2015.04.030	13	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.											1358863X211047270	10.1177/1358863X211047270		NOV 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XH8QO	WOS:000725692600001	34809507	Green Submitted			2022-04-28	
J	Bradel, L; Kashyap, K; Jabbour, F; Bajona, P; Farah, V; Nguyen, V				Bradel, Laura; Kashyap, Kartikeya; Jabbour, Fouad; Bajona, Pietro; Farah, Victor; Nguyen, Vinh			The infectious tale of Aerococcal aortic endocarditis: cardiac pacing in acute aortic insufficiency with complete heart block as a bridge to aortic valve replacement	VASCULAR MEDICINE			English	Meeting Abstract									[Bradel, Laura; Kashyap, Kartikeya] Arnot Ogden Med Ctr, Elmira, NY USA; [Jabbour, Fouad; Bajona, Pietro; Farah, Victor; Nguyen, Vinh] Allegheny Hlth Network, Pittsburgh, PA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1356	NP30	NP31					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100068					2022-04-28	
J	Raza, S; Pellerito, J				Raza, Sarah; Pellerito, John			Novel approach in imaging and quantifying microperfusion in non-healing ulcers using contrast enhanced ultrasound: initial case report	VASCULAR MEDICINE			English	Meeting Abstract									[Raza, Sarah; Pellerito, John] Donald & Barbara Zucker Sch Med Hofstra Northwell, Manhasset, NY USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1321	NP27	NP27					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100062					2022-04-28	
J	Sebastian, T; Barco, S; Lichtenberg, M; Stahlhoff, S; Schlager, O; Jalaie, H; de Graaf, R; Erbel, C; Massmann, A; Schindewolf, M; Kucher, N				Sebastian, Tim; Barco, Stefano; Lichtenberg, Michael; Stahlhoff, Stefan; Schlager, Oliver; Jalaie, Houman; de Graaf, Rick; Erbel, Christian; Massmann, Alexander; Schindewolf, Marc; Kucher, Nils			Twelve-month clinical outcomes of a hybrid oblique self-expanding nitinol stent used for the treatment of post-thrombotic syndrome with common iliac vein compression: The TOPOS study	VASCULAR MEDICINE			English	Letter						angioplasty; deep vein thrombosis (DVT); post-thrombotic syndrome; stent; May-Thurner syndrome	VENOUS THROMBOSIS		[Sebastian, Tim; Barco, Stefano; Kucher, Nils] Univ Hosp Zurich, Clin Angiol, Raemistr 100, CH-8091 Zurich, Switzerland; [Barco, Stefano] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Lichtenberg, Michael; Stahlhoff, Stefan] Arnsberg Med Ctr, Dept Angiol, Arnsberg, Germany; [Schlager, Oliver] Med Univ Vienna, Div Angiol, Dept Med 2, Vienna, Austria; [Jalaie, Houman] Univ Hosp RWTH Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany; [de Graaf, Rick] Clin Friedrichshafen, Dept Radiol Intervent Radiol & Nucl Med, Friedrichshafen, Germany; [Erbel, Christian] Heidelberg Univ Hosp, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany; [Massmann, Alexander] Saarland Univ, Med Ctr, Clin Diagnost & Intervent Radiol, Homburg, Saar, Germany; [Schindewolf, Marc] Bern Univ Hosp, Inselspital, Swiss Cardiovasc Ctr, Div Angiol, Bern, Switzerland		Kucher, N (通讯作者)，Univ Hosp Zurich, Clin Angiol, Raemistr 100, CH-8091 Zurich, Switzerland.	nils.kucher@usz.ch	Barco, Stefano/V-4901-2017	Barco, Stefano/0000-0002-2618-347X	Optimed Medizinische Instrumente GmbH	This investigator-initiated study was funded by Optimed Medizinische Instrumente GmbH. Optimed had no involvement in the collection, analysis or interpretation of data.	Fraser DGW, 2004, J VASC SURG, V40, P612, DOI 10.1016/j.jvs.2004.05.029; Launois R, 1996, QUAL LIFE RES, V5, P539, DOI 10.1007/BF00439228; Marston WA, 2013, J VASC SURG-VENOUS L, V1, P219, DOI 10.1016/j.jvsv.2012.10.059; Murphy EH, 2017, J VASC SURG-VENOUS L, V5, P8, DOI 10.1016/j.jvsv.2016.09.002; Sebastian T, 2020, CIRC-CARDIOVASC INTE, V13, P366, DOI 10.1161/CIRCINTERVENTIONS.120.009673; Sebastian T, 2020, VASA, V49, P301, DOI 10.1024/0301-1526/a000857; Stoner MC, 2016, J VASC SURG, V64, pE1, DOI 10.1016/j.jvs.2016.03.420; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Villalta S, 1994, HAEMOSTASIS, V24	9	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					569	571	1358863X211017658	10.1177/1358863X211017658		JUN 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000665212600001	34130569				2022-04-28	
J	Moshref, AJ; Moussallem, E; Gray, BH				Moshref, Arian J.; Moussallem, Elie; Gray, Bruce H.			Images in Vascular Medicine: KILT syndrome - deep venous thrombosis, inferior vena caval agenesis, and kidney dysgenesis	VASCULAR MEDICINE			English	Editorial Material									[Moshref, Arian J.; Moussallem, Elie] Prisma Hlth Upstate, 200 Patewood Dr,Suite B260, Greenville, SC 29605 USA; [Gray, Bruce H.] Prisma Hlth, Greenville, SC USA		Moshref, AJ (通讯作者)，Prisma Hlth Upstate, 200 Patewood Dr,Suite B260, Greenville, SC 29605 USA.	arian.moshref@gmail.com		Moshref, Arian/0000-0001-5417-4741			Lauener S, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1567-7; Pomeranz CB, 2018, PEDIATR RADIOL, V48, P1521, DOI 10.1007/s00247-018-4155-3; Sagban TA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0223-4	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					574	575	1358863X211014581	10.1177/1358863X211014581		MAY 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000652880500001	34016007				2022-04-28	
J	Shirasu, T; Takagi, H; Yasuhara, J; Kuno, T; Kent, KC; Clouse, WD				Shirasu, Takuro; Takagi, Hisato; Yasuhara, Jun; Kuno, Toshiki; Kent, K. Craig; Clouse, W. Darrin			Smaller size is more suitable for pharmacotherapy among undersized abdominal aortic aneurysm: a systematic review and meta-analysis	VASCULAR MEDICINE			English	Review; Early Access						abdominal aortic aneurysm (AAA); doxycycline; meta-analysis; pharmacotherapy; randomized controlled trials	DOUBLE-BLIND; CONTROLLED TRIAL; GROWTH-RATE; DOXYCYCLINE; ROXITHROMYCIN	Background: Pharmacotherapy for undersized abdominal aortic aneurysm (AAA) is a clinical unmet need. Randomized controlled trials (RCTs) have failed to show effectiveness despite countless promising data in preclinical studies. We aimed to identify the population with undersized AAAs (30-54 mm) who potentially benefit from pharmacotherapy. Methods: In accordance with the PRISMA statement, we conducted a systematic review and meta-analysis of placebo-controlled RCTs. The primary outcome was mean difference (MD) in annual growth rate (< 0 favors pharmacotherapy), and the secondary outcome was aneurysm-related events (diameters > 55 mm, ruptures, or referral to surgery). Results: Our search strategy identified eight RCTs (six trials on antibiotics [ABx], two on renin-angiotensin system inhibitors [RAS-I]) with a total of 1325 patients. The mean of baseline diameters ranged from 33.1 mm to 43.1 mm. Neither ABx nor RAS-I showed significant differences in MD. Multivariable random-effects restricted maximum likelihood meta-regression revealed a statistically significant linear relationship between baseline diameter and MD (coefficient 0.15 [95% CI 0.0011, 0.30], p = 0.049) but not for the follow-up period (p = 0.28) and duration of treatment (p = 0.11). In line with this result, ABx with baseline diameter < 40 mm significantly reduced MD (-1.03 mm/year [95% CI -1.64, -0.42], p = 0.001) and a borderline significant difference in aneurysm-related events (HR 0.53 [95% CI 0.28, 1.00], p = 0.05), whereas the other groups > 40 mm never demonstrated effectiveness. Fixed-effect models did not change the results. No evidence of publication bias was detected. Conclusion: Undersized AAAs < 40 mm can potentially benefit from pharmacotherapy. Future RCTs should consider preferentially including undersized AAA with smaller diameters.	[Shirasu, Takuro; Kent, K. Craig; Clouse, W. Darrin] Univ Virginia Hlth Syst, Div Vasc & Endovasc Surg, 409 Lane Rd MR4, Charlottesville, VA 22903 USA; [Takagi, Hisato] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka, Japan; [Yasuhara, Jun] Nationwide Childrens Hosp, Ctr Cardiovasc Res, Abigail Wexner Res Inst, Columbus, OH USA; [Yasuhara, Jun] Nationwide Childrens Hosp, Heart Ctr, Columbus, OH USA; [Kuno, Toshiki] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiol, New York, NY USA		Shirasu, T (通讯作者)，Univ Virginia Hlth Syst, Div Vasc & Endovasc Surg, 409 Lane Rd MR4, Charlottesville, VA 22903 USA.	shirasu-tky@umin.ac.jp		Yasuhara, Jun/0000-0002-7937-3699			Baxter BT, 2020, JAMA-J AM MED ASSOC, V323, P2029, DOI 10.1001/jama.2020.5230; Bicknell CD, 2016, EUR HEART J, V37, P3213, DOI 10.1093/eurheartj/ehw257; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Chun KC, 2020, J VASC SURG, V71, P1913, DOI 10.1016/j.jvs.2019.08.252; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freiberg MS, 2008, CIRCULATION, V117, P1010, DOI 10.1161/CIRCULATIONAHA.107.720219; Geissbuhler M, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01310-0; Golledge J, 2020, JAMA CARDIOL, V5, P1374, DOI 10.1001/jamacardio.2020.3524; Golledge J, 2019, NAT REV CARDIOL, V16, P225, DOI 10.1038/s41569-018-0114-9; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hogh A, 2009, VASC ENDOVASC SURG, V43, P452, DOI 10.1177/1538574409335037; Iida Y, 2018, CURR DRUG TARGETS, V19, P1297, DOI 10.2174/1389450119666171227225008; Karlsson L, 2009, J VASC SURG, V50, P23, DOI 10.1016/j.jvs.2008.12.048; Kent KC, 2014, NEW ENGL J MED, V371, P2101, DOI 10.1056/NEJMcp1401430; Liberati A, 2009, ANN INTERN MED, V151; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Olson SL, 2021, JAMA SURG, V156, P363, DOI 10.1001/jamasurg.2020.7190; Rughani G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009536.pub2; Shirasu T, 2022, J VASC SURG, V75, P348, DOI 10.1016/j.jvs.2021.07.240; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thompson SG, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17410; Vammen S, 2001, BRIT J SURG, V88, P1066, DOI 10.1046/j.0007-1323.2001.01845.x; Weininger G, 2021, EXPERT REV CARDIOVAS, V19, P619, DOI 10.1080/14779072.2021.1940958	26	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.											1358863X211061603	10.1177/1358863X211061603		DEC 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XX9GZ	WOS:000736595900001	34930052				2022-04-28	
J	Acosta, KR; Caballero, TA; Beltran, J				Acosta, Katherine Rose; Caballero, Trifon Antonio; Beltran, Jenny			Clinical profile of patients with peripheral artery disease treated with high-pressure intermittent pneumatic compression in St. Luke's Medical Center-Quezon City: a 6-year retrospective cohort study	VASCULAR MEDICINE			English	Meeting Abstract									[Acosta, Katherine Rose; Caballero, Trifon Antonio; Beltran, Jenny] St Lukes Med Ctr Quezon City, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1430	NP21	NP21					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100049					2022-04-28	
J	Henkin, S; YoungD, M; Ramkumar, N; Vasaiwala, S; Ouellette, M; Lahoud, R; Lee, PV; Magnus, P; Malenka, D				Henkin, Stan; YoungD, Michael; Ramkumar, Niveditta; Vasaiwala, Samip; Ouellette, Michelle; Lahoud, Rony; Lee, Peter Ver; Magnus, Patrick; Malenka, David			Association of polyvascular disease with adverse outcomes after percutaneous coronary intervention	VASCULAR MEDICINE			English	Meeting Abstract									[Henkin, Stan; YoungD, Michael; Ramkumar, Niveditta; Malenka, David] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Vasaiwala, Samip] Maine Med Ctr, Portland, ME 04102 USA; [Ouellette, Michelle] Catholic Med Ctr, Manchester, NH USA; [Lahoud, Rony] Univ Vermont, Med Ctr, Burlington, VT USA; [Lee, Peter Ver] Eastern Maine Med Ctr, Bangor, ME USA; [Magnus, Patrick] Concord Hosp, Concord, NH USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1296	NP7	NP8					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100027					2022-04-28	
J	Mangulabnan, JL; Bernardo, JM				Mangulabnan, Jenny Lyn; Bernardo, Jasmine M.			Recurrent acute limb ischemia in a patient with known allergy to contrast material: a case report	VASCULAR MEDICINE			English	Meeting Abstract									[Mangulabnan, Jenny Lyn; Bernardo, Jasmine M.] Makati Med Ctr, Makati, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1285	NP26	NP26					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100059					2022-04-28	
J	Schmaier, A; Hurtado, GP; Manickas-Hill, Z; Sack, K; Chen, SY; Parikh, S				Schmaier, Alec; Hurtado, Gabriel Pajares; Manickas-Hill, Zachary; Sack, Kelsey; Chen, Siyu; Parikh, Samir			Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19	VASCULAR MEDICINE			English	Meeting Abstract									[Schmaier, Alec; Hurtado, Gabriel Pajares; Sack, Kelsey; Chen, Siyu; Parikh, Samir] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Manickas-Hill, Zachary] Ragon Inst MGH MIT & Harvard, Boston, MA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				YIA 1293	NP3	NP4					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100021					2022-04-28	
J	Sindiong, MKR; Porciuncula, LA; Estanislao, C; Igualada, V; Susanto, A				Sindiong, Monica Kristine Reyes; Porciuncula, Lea Arceli; Estanislao, Conrad; Igualada, Vivaldi; Susanto, Alwyn			Case Series: Internal jugular (IJ) vein catheter-related thrombosis in patients with severe COVID-19	VASCULAR MEDICINE			English	Meeting Abstract									[Sindiong, Monica Kristine Reyes; Porciuncula, Lea Arceli; Estanislao, Conrad; Igualada, Vivaldi; Susanto, Alwyn] St Lukes Med Ctr Quezon City, Quezon City, Philippines									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1284	NP25	NP26					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100058					2022-04-28	
J	von Bismarck, A; Weinberger, T; Steffen, J				von Bismarck, Amanda; Weinberger, Tobias; Steffen, Julius			Images in Vascular Medicine: Vena cava syndrome mimicking caput medusae	VASCULAR MEDICINE			English	Article									[von Bismarck, Amanda] Univ Hosp Munich, Dept Internal Med, Munich, Germany; [Weinberger, Tobias; Steffen, Julius] Univ Hosp Munich, Dept Cardiol, Munich, Germany		von Bismarck, A (通讯作者)，Univ Hosp Munich, Dept Internal Med 4, Ziemssenstr 1, D-80336 Munich, Germany.	amanda.von_bismarck@med.uni-muenchen.de					Castonguay M, 2008, CAN RESPIR J, V15, P444, DOI 10.1155/2008/279786; Cheng S, 2009, CARDIOL REV, V17, P16, DOI 10.1097/CRD.0b013e318188033c; Klein-Weigel PF, 2020, VASA, V49, P437, DOI 10.1024/0301-1526/a000908	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					672	673	1358863X211028296	10.1177/1358863X211028296		JUL 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000675641000001	34269155				2022-04-28	
J	Kollias, A; Kyriakoulis, KG; Lagou, S; Kontopantelis, E; Stergiou, GS; Syrigos, K				Kollias, Anastasios; Kyriakoulis, Konstantinos G.; Lagou, Styliani; Kontopantelis, Evangelos; Stergiou, George S.; Syrigos, Konstantinos			Venous thromboembolism in COVID-19: A systematic review and meta-analysis	VASCULAR MEDICINE			English	Review						deep vein thrombosis (DVT); prevalence; pulmonary embolism (PE); SARS-CoV-2	DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; PNEUMONIA; HETEROGENEITY	Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous thromboembolism events (VTE). This study performed a systematic review in PubMed/EMBASE of studies reporting the prevalence of VTE in patients with COVID-19 who were totally screened/assessed for deep vein thrombosis (DVT) and/or for pulmonary embolism (PE). Among 47 candidate studies (n = 6459; 33 in Europe), 17 studies (n = 3973; weighted age 63.0 years, males 60%, intensive care unit (ICU) 16%) reported the prevalence of PE with a pooled estimate of 32% (95% CI: 25, 40%), and 32 studies (n = 2552; weighted age 62.6 years, males 57%, ICU 49%) reported the prevalence of DVT with a pooled estimate of 27% (95% CI: 21, 34%). A total of 36 studies reported the use of at least prophylactic antithrombotic treatment in the majority of their patients. Meta-regression analysis showed that the prevalence of VTE was higher across studies with a higher percentage of ICU patients and higher study population mean D-dimer values, and lower in studies with mixed dosing of anticoagulation in > 50% of the population compared to studies with standard prophylactic dosing of anticoagulation in < 50% of the population. The pooled odds ratio for death in patients with COVID-19 and VTE versus those without VTE (17 studies, n = 2882) was 2.1 (95% CI: 1.2, 3.6). Hospitalized patients with severe COVID-19 are at high VTE risk despite prophylactic anticoagulation. Further research should investigate the individualized VTE risk of patients with COVID-19 and the optimal preventive antithrombotic therapy. PROSPERO Registration No.: CRD42020185543.	[Kollias, Anastasios; Kyriakoulis, Konstantinos G.; Lagou, Styliani; Stergiou, George S.; Syrigos, Konstantinos] Natl & Kapodistrian Univ Athens, Sch Med, Sotiria Hosp, Dept Med 3, 152 Mesogion Ave, Athens 11527, Greece; [Kontopantelis, Evangelos] Univ Manchester, Div Informat Imaging & Data Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Natl Inst Hlth Res, Sch Primary Care Res, Manchester, Lancs, England		Kollias, A (通讯作者)，Natl & Kapodistrian Univ Athens, Sch Med, Sotiria Hosp, Dept Med 3, 152 Mesogion Ave, Athens 11527, Greece.	taskollias@gmail.com	Kollias, Anastasios/AAB-9790-2019	Kollias, Anastasios/0000-0002-2098-1665; Kontopantelis, Evangelos/0000-0001-6450-5815; Kyriakoulis, Konstantinos/0000-0001-8986-2704			Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Alharthy A, 2021, J ULTRAS MED, V40, P443, DOI 10.1002/jum.15417; Alonso-Fernandez A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238216; [Anonymous], 2021, FREE STAT CALCULATOR; [Anonymous], 2020, STATSTODO COMB MEANS; [Anonymous], 2021, COVID 19 VTE ANT FRE; Artifoni M, 2020, J THROMB THROMBOLYS, V50, P211, DOI 10.1007/s11239-020-02146-z; Avruscio G, 2020, CTS-CLIN TRANSL SCI, V13, P1108, DOI 10.1111/cts.12907; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bavaro DF, 2020, INT J INFECT DIS, V98, P225, DOI 10.1016/j.ijid.2020.06.066; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bompard F, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01365-2020; Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097; Chen JP, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620936772; Chen SJ, 2021, J THROMB THROMBOLYS, V51, P33, DOI 10.1007/s11239-020-02181-w; Cho ES, 2021, J VASC SURG-VENOUS L, V9, P47, DOI 10.1016/j.jvsv.2020.07.009; Criel M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01201-2020; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254; Demelo-Rodriguez P, 2020, THROMB RES, V192, P23, DOI 10.1016/j.thromres.2020.05.018; Di Minno A, 2020, SEMIN THROMB HEMOST, V46, P763, DOI 10.1055/s-0040-1715456; Dujardin RWG, 2020, THROMB RES, V196, P308, DOI 10.1016/j.thromres.2020.09.017; Espallargas I, 2021, EUR RADIOL, V31, P1915, DOI 10.1007/s00330-020-07300-y; Fauvel C, 2020, EUR HEART J, V41, P3058, DOI 10.1093/eurheartj/ehaa500; Freund Y, 2020, ACAD EMERG MED, V27, P811, DOI 10.1111/acem.14096; Gerotziafas GT, 2020, THROMB HAEMOSTASIS, V120, P1597, DOI 10.1055/s-0040-1715798; Gervaise A, 2020, EUR RADIOL, V30, P6170, DOI 10.1007/s00330-020-06977-5; Giorgi-Pierfranceschi M, 2020, INTERN EMERG MED, V15, P1425, DOI 10.1007/s11739-020-02472-3; Grandmaison Gael, 2020, TH Open, V4, pe113, DOI 10.1055/s-0040-1713167; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ierardi AM, 2021, J ULTRASOUND, V24, P165, DOI 10.1007/s40477-020-00515-1; Jimenez-Guiu X, 2021, J VASC SURG-VENOUS L, V9, P592, DOI 10.1016/j.jvsv.2020.08.028; Joanna Briggs Institute, 2017, CRIT APPR TOOLS US J; Joly BS, 2020, INTENS CARE MED, V46, P1603, DOI 10.1007/s00134-020-06088-1; Koleilat I, 2021, J VASC SURG-VENOUS L, V9, P36, DOI 10.1016/j.jvsv.2020.06.012; Kollias A, 2020, BRIT J HAEMATOL, V190, P529, DOI 10.1111/bjh.16993; Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2010, STATA J, V10, P395, DOI 10.1177/1536867X1001000307; Kunutsor SK, 2020, THROMB RES, V196, P27, DOI 10.1016/j.thromres.2020.08.022; Larsen K, 2020, AM J TROP MED HYG, V103, P844, DOI 10.4269/ajtmh.20-0597; Le Jeune S, 2021, J THROMB THROMBOLYS, V51, P637, DOI 10.1007/s11239-020-02246-w; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Longchamp A, 2020, RES PRACT THROMB HAE, V4, P842, DOI 10.1002/rth2.12376; Longhitano Y, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9100310; Lu YF, 2020, INT J INFECT DIS, V100, P34, DOI 10.1016/j.ijid.2020.08.023; Marone Enrico M, 2020, Ann Vasc Surg, V68, P83, DOI 10.1016/j.avsg.2020.07.007; Mazzaccaro D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061781; Minet C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1003-9; Monfardini L, 2020, BRIT J RADIOL, V93, DOI 10.1259/bjr.20200407; Mouhat B, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01811-2020; Mueller-Peltzer K, 2020, RESP MED, V172, DOI 10.1016/j.rmed.2020.106135; Nadkarni GN, 2020, J AM COLL CARDIOL, V76, P1815, DOI 10.1016/j.jacc.2020.08.041; Nahum J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10478; Oudkerk M, 2020, RADIOLOGY, V297, pE216, DOI 10.1148/radiol.2020201629; Pavoni V, 2020, THROMB RES, V196, P313, DOI 10.1016/j.thromres.2020.09.013; Petropoulou M, 2017, STAT MED, V36, P4266, DOI 10.1002/sim.7431; Pizzolo F, 2020, THROMB RES, V194, P216, DOI 10.1016/j.thromres.2020.08.008; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; Porfidia A, 2020, THROMB RES, V196, P67, DOI 10.1016/j.thromres.2020.08.020; Poyiadji N, 2020, RADIOLOGY, V297, pE335, DOI 10.1148/radiol.2020201955; Ramadan L, 2021, AM J EMERG MED, V46, P786, DOI 10.1016/j.ajem.2020.08.096; Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407; Roncon L, 2020, EUR J INTERN MED, V82, P29, DOI 10.1016/j.ejim.2020.09.006; Santoliquido A, 2020, J THROMB HAEMOST, V18, P2358, DOI 10.1111/jth.14992; Shi L, 2020, INTENS CARE MED, V46, P2089, DOI 10.1007/s00134-020-06235-8; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Thachil J, 2020, J THROMB HAEMOST, V18, P1023, DOI 10.1111/jth.14810; Torres-Machorro A, 2020, THROMB RES, V196, P268, DOI 10.1016/j.thromres.2020.08.043; Trigonis RA, 2020, CRIT CARE MED, V48, pE805, DOI 10.1097/CCM.0000000000004472; Ventura-Diaz S, 2020, EMERG RADIOL, V27, P679, DOI 10.1007/s10140-020-01859-1; Voicu S, 2020, J AM COLL CARDIOL, V76, P480, DOI 10.1016/j.jacc.2020.05.053; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Whyte MB, 2020, THROMB RES, V195, P95, DOI 10.1016/j.thromres.2020.07.025; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Yu Y, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620953217; Zhang L, 2020, CIRCULATION, V142, P114, DOI 10.1161/CIRCULATIONAHA.120.046702	78	18	18	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					415	425	1358863X21995566	10.1177/1358863X21995566		APR 2021	11	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000637117400001	33818197	Green Published, hybrid			2022-04-28	
J	Nawata, T; Ariyoshi, T; Okuda, S; Wada, Y; Kubo, M; Yano, M				Nawata, Takashi; Ariyoshi, Toru; Okuda, Shinichi; Wada, Yasuaki; Kubo, Makoto; Yano, Masafumi			Images in Vascular Medicine: Usefulness of carotid ultrasonography for diagnosis and management of polymyalgia rheumatica-associated large-vessel vasculitis	VASCULAR MEDICINE			English	Editorial Material									[Nawata, Takashi; Okuda, Shinichi; Kubo, Makoto; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Ariyoshi, Toru] Yamaguchi Univ, Dept Clin Lab Sci, Ultrasound Examinat Ctr, Ube, Yamaguchi, Japan; [Wada, Yasuaki] Yamaguchi Univ, Div Clin Lab, Ube, Yamaguchi, Japan		Nawata, T (通讯作者)，Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	tnawata@yamaguchi-u.ac.jp	Okuda, Shinichi/AAG-8968-2020; Nawata, Takashi/AAQ-8245-2021	Okuda, Shinichi/0000-0003-2639-5373; Nawata, Takashi/0000-0003-0128-3463			Marvisi C, 2020, PRESSE MED, V49, DOI 10.1016/j.lpm.2020.104018; Salvarani C, 2012, NAT REV RHEUMATOL, V8, P509, DOI 10.1038/nrrheum.2012.97; Wakura D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158509	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					459	461	1358863X21995582	10.1177/1358863X21995582		MAR 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000630553800001	33733964	Bronze			2022-04-28	
J	Nowakowski, P; Uchto, W; Hrycek, E; Kachel, M; Ludyga, T; Polczyk, F; Zurakowski, A; Kazmierczak, P; Granada, JF; Nowakowska, I; Kiesz, RS; Milewski, KP; Buszman, PE; Buszman, PP				Nowakowski, Przemyslaw; Uchto, Wojciech; Hrycek, Eugeniusz; Kachel, Mateusz; Ludyga, Tomasz; Polczyk, Filip; Zurakowski, Aleksander; Kazmierczak, Pawel; Granada, Juan F.; Nowakowska, Iwona; Kiesz, Radoslaw S.; Milewski, Krzysztof P.; Buszman, Pawel E.; Buszman, Piotr P.			Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: Three-year outcomes of the randomized BIOPAC trial	VASCULAR MEDICINE			English	Article						drug-eluting balloon; femoropopliteal disease; innovation		The aim of the BIOPAC trial was to determine long-term safety and efficacy of a novel microcrystalline paclitaxel-coated balloon (mcPCB) with a biocompatible polymer as an excipient in the treatment of occlusive femoropopliteal lesions. In this first-in-human prospective controlled randomized trial, 66 patients with femoropopliteal, symptomatic (Rutherford stages 2B to 5) occlusive arterial disease were randomized to either mcPCB (study group) or POBA (plain old balloon angioplasty) (control group) on a 1:1 basis. Late lumen loss (LLL) at 6 months was the primary endpoint of the study and serious adverse events (SAE: death, amputation, repeated revascularization) were considered a composite secondary endpoint. Routine angiography was scheduled for all study subjects at 6-month follow-up; outpatient appointments were scheduled at 12 and 36 months after intervention. At 6 months, the LLL was 63% lower in the mcPCB group compared to the POBA group (0.52 +/- 1.2 vs 1.39 +/- 1.1 mm; p(sup) < 0.01). Binary restenosis occurred in 23% vs 52% of patients (p = 0.02). At 3 years, the prevalence of SAE was significantly lower in the mcPCB group (33.3 vs 63.3%; p = 0.02), which mainly resulted from a twofold reduction in target vessel revascularization rate (28.6 vs 59.3%; p = 0.02). The difference in mortality was nonsignificant (7.4 vs 14.3%; p = 0.42). Patients with mcPCB were less symptomatic and less likely to adhere to secondary prevention measures. In this pivotal trial, a novel mcPCB proved superior to POBA concerning LLL at 6-month follow-up, and SAE at 12 months. This result was sustained up to 3 years. There was no difference between groups regarding mortality.	[Nowakowski, Przemyslaw; Uchto, Wojciech; Hrycek, Eugeniusz; Zurakowski, Aleksander] Lesser Poland Cardiovasc Ctr Amer Heart Poland, Chrzanow, Poland; [Nowakowski, Przemyslaw] Univ Technol, Katowice, Poland; [Zurakowski, Aleksander; Buszman, Piotr P.] Krakow Univ, Andrzej Frycz Modrzewski, Krakow, Poland; [Kachel, Mateusz; Kazmierczak, Pawel; Kiesz, Radoslaw S.; Milewski, Krzysztof P.; Buszman, Piotr P.] Amer Heart Poland, Ctr Cardiovasc Res & Dev, Katowice, Poland; [Ludyga, Tomasz; Polczyk, Filip] EuroMed Cardiovasc Ctr, Katowice, Poland; [Granada, Juan F.] Cardiovasc Res Fdn, Skirbal Ctr Innovat, Orangeburg, NY USA; [Nowakowska, Iwona] Med Univ Silesia, Sch Hlth Sci, Dept Balneoclimatol & Biol Regenerat, Chair Physiotherapy, Katowice, Poland; [Kiesz, Radoslaw S.] San Antonio Heart & Endovasc Inst, San Antonio, TX USA; [Buszman, Pawel E.] Med Univ Silesia, Dept Epidemiol, Katowice, Poland		Buszman, PP (通讯作者)，Andrzej Frycz Modrzewski Krakow Univ, Dept Cardiol, Armii Krajowej 101, Bielsko Biala, Poland.	pbuszman@gmail.com		Nowakowski, Przemyslaw/0000-0002-5359-0476; Buszman, Piotr/0000-0003-1158-1325; Zurakowski, Aleksander/0000-0002-5135-6598; Nowakowska, Iwona/0000-0002-0078-8024	Balton Company, Warsaw, Poland	This study was funded from the unrestricted grant provided by the Balton Company, Warsaw, Poland. Balton company did not have any role in the study execution, data analysis, or manuscript creation.	Aboyans V, 2017, KARDIOL POL, V75, P1065, DOI 10.5603/KP.2017.0216; Buszman PP, 2018, JACC-CARDIOVASC INTE, V11, P2436, DOI 10.1016/j.jcin.2018.07.029; Buszman PP, 2013, JACC-CARDIOVASC INTE, V6, P883, DOI 10.1016/j.jcin.2013.04.013; Cassese S, 2012, CIRC-CARDIOVASC INTE, V5, P582, DOI 10.1161/CIRCINTERVENTIONS.112.969972; Dick P, 2008, RADIOLOGY, V248, P297, DOI 10.1148/radiol.2481071159; Katsanos K, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.011245; Kolodgie FD, 2016, J VASC INTERV RADIOL, V27, P1676, DOI 10.1016/j.jvir.2016.06.036; Lin YT, 2015, J ENDOVASC THER, V22, P319, DOI 10.1177/1526602815580783; Mahoney EM, 2010, CIRC-CARDIOVASC QUAL, V3, P642, DOI 10.1161/CIRCOUTCOMES.109.930735; Posa A, 2010, CATHETER CARDIO INTE, V76, P395, DOI 10.1002/ccd.22468; Scheinert D, 2014, JACC-CARDIOVASC INTE, V7, P11, DOI 10.1016/j.jcin.2013.05.022; Schneider PA, 2019, J AM COLL CARDIOL, V73, P2550, DOI 10.1016/j.jacc.2019.01.013; Speck U, 2012, CIRC-CARDIOVASC INTE, V5, P392, DOI 10.1161/CIRCINTERVENTIONS.111.967794; Tepe G, 2008, NEW ENGL J MED, V358, P689, DOI 10.1056/NEJMoa0706356; Werk M, 2008, CIRCULATION, V118, P1358, DOI 10.1161/CIRCULATIONAHA.107.735985; Yazdani SK, 2014, CATHETER CARDIO INTE, V83, P132, DOI 10.1002/ccd.24995	16	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					401	408		10.1177/1358863X20988360		MAR 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000627092100001	33686879				2022-04-28	
J	Tsai, S; Liu, YL; Alaiti, MA; Gutierrez, JA; Brilakis, ES; Banerjee, S				Tsai, Shirling; Liu, Yulun; Alaiti, Mohamad Amer; Gutierrez, Jorge Antonio; Brilakis, Emmanouil S.; Banerjee, Subhash			No benefit of vorapaxar on walking performance in patients with intermittent claudication	VASCULAR MEDICINE			English	Article						claudication; peripheral artery disease (PAD); randomized controlled trial	PERIPHERAL ARTERY-DISEASE; DOUBLE-BLIND; MULTICENTER; PREVENTION; CILOSTAZOL; EXERCISE; OUTCOMES; ASPIRIN; TRIAL	Background: The effect of pharmacologic agents in improving walking and quality of life measures in patients with intermittent claudication (IC) is variable. The objective of this study was to investigate the effect of the novel antithrombotic vorapaxar on symptom status in patients with IC. Methods: The study was a multicenter, randomized, placebo-controlled trial wherein patients with IC were treated with either vorapaxar or placebo in addition to a home exercise program for 6 months. Walking performance and quality of life were assessed by graded treadmill test (GTT) and 12-Item Short-Form Survey (SF-12), respectively, at baseline and at 6 months. A total of 102 subjects were randomized across 12 centers. Results: Of the subjects randomized, 66 completed all study assessments and comprised the dataset that was analyzed. After 6 months, there was no significant difference between the vorapaxar and placebo groups in walking performance, as reflected by the GTT, or in quality of life, as reflected by the SF-12. There were no severe bleeding events in either group. Conclusion: This study found no benefit of vorapaxar in patients with IC and reiterates the need for future drug therapy studies that expand the benefits of supervised exercise therapy in patients with IC. ClinicalTrials.gov Identifier: NCT02660866	[Tsai, Shirling; Alaiti, Mohamad Amer; Banerjee, Subhash] North Texas VA Hlth Care Syst, Dallas, TX USA; [Tsai, Shirling] UT Southwestern Med Ctr, Div Vasc Surg, Dept Surg, Dallas, TX USA; [Liu, Yulun] UT Southwestern Med Ctr, Dept Populat & Data Sci, Dallas, TX USA; [Alaiti, Mohamad Amer; Banerjee, Subhash] UT Southwestern Med Ctr, Div Cardiol, Dept Med, Dallas, TX USA; [Gutierrez, Jorge Antonio] Durham VA Med Ctr, Durham, GA USA; [Gutierrez, Jorge Antonio] Duke Univ, Div Cardiol, Dept Med, Sch Med, Durham, GA USA; [Brilakis, Emmanouil S.] Minneapolis Heart Inst, Minneapolis, MN USA		Tsai, S (通讯作者)，VA North Texas Hlth Care Syst, 4500 South Lancaster Rd, Dallas, TX 75216 USA.	Shirling.Tsai@utsouthwestern.edu		Tsai, Shirling/0000-0003-0269-2605; Banerjee, Subhash/0000-0003-0863-7914	Merck Co., Inc.Merck & Company; Aralez Pharmaceuticals RD, Inc.	The authors disclosed receipt of the following financial support for research, authorship, and/or publication of this article: This work was supported by a research grant from Merck & Co., Inc. and Aralez Pharmaceuticals R&D, Inc. All data analysis and manuscript preparation was performed independently of the sponsors.	Abbott JD, 2012, CIRC-CARDIOVASC INTE, V5, P139, DOI 10.1161/CIRCINTERVENTIONS.112.969857; Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Berger JS, 2012, CIRCULATION, V126, P491, DOI 10.1161/CIRCULATIONAHA.111.033886; Bonaca MP, 2016, CIRCULATION, V133, P997, DOI 10.1161/CIRCULATIONAHA.115.019355; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Dawson DL, 2000, AM J MED, V109, P523, DOI 10.1016/S0002-9343(00)00569-6; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286; Hess CN, 2018, JAMA-J AM MED ASSOC, V319, P2329, DOI 10.1001/jama.2018.5422; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; Narula N, 2018, J AM COLL CARDIOL, V72, P2152, DOI 10.1016/j.jacc.2018.08.002; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Shahin Y, 2013, BRIT J SURG, V100, P1154, DOI 10.1002/bjs.9198; Singer E, 2012, J AM HEART ASSOC, V1, P51, DOI 10.1161/JAHA.111.000067; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Wang A, 2015, EXPERT OPIN PHARMACO, V16, P2509, DOI 10.1517/14656566.2015.1099629	22	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					33	38	1358863X211042082	10.1177/1358863X211042082		OCT 2021	6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000706045400001	34609939				2022-04-28	
J	Patel, T; Betz, Y; Sporkin, H; Schumann, C; Matthew, R; Meyer, C; Kramer, C				Patel, Toral; Betz, Yaqub; Sporkin, Helen; Schumann, Christopher; Matthew, Roshin; Meyer, Craig; Kramer, Christopher			Creatine chemical exchange saturation transfer MRI to evaluate calf muscle energetics in peripheral artery disease Toral Patel	VASCULAR MEDICINE			English	Meeting Abstract									[Patel, Toral; Betz, Yaqub; Sporkin, Helen; Meyer, Craig; Kramer, Christopher] Univ Virginia, Charlottesville, VA USA; [Schumann, Christopher] Cone Hlth Med Grp, Greensboro, NC USA; [Matthew, Roshin] Piedmont Healthcare, Atlanta, GA USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				YIA 1215	NP3	NP3					1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100020					2022-04-28	
J	Zuo, Y; Yalavarthi, S; Navaz, S; Hoy, C; Shi, H; Harbaugh, A; Gockman, K; Zuo, M; Madison, J; Knight, J; Kanthi, Y				Zuo, Yu (Ray); Yalavarthi, Srilakshmi; Navaz, Sherwin; Hoy, Claire; Shi, Hui; Harbaugh, Alyssa; Gockman, Kelsey; Zuo, Melanie; Madison, Jacqueline; Knight, Jason; Kanthi, Yogen			Autoantibodies stabilize neutrophil extracellular traps in COVID-19	VASCULAR MEDICINE			English	Meeting Abstract									[Zuo, Yu (Ray); Yalavarthi, Srilakshmi; Navaz, Sherwin; Hoy, Claire; Shi, Hui; Harbaugh, Alyssa; Gockman, Kelsey; Zuo, Melanie; Madison, Jacqueline; Knight, Jason] Univ Michigan, Ann Arbor, MI 48109 USA; [Kanthi, Yogen] NHLBI, Bldg 10, Bethesda, MD 20892 USA									0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5				1326	NP11	NP12					2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000704017100033					2022-04-28	
J	Rajendran, S; Sundaresan, L; Venkatachalam, G; Rajendran, K; Behera, J; Chatterjee, S				Rajendran, Saranya; Sundaresan, Lakshmikirupa; Venkatachalam, Geege; Rajendran, Krithika; Behera, Jyotirmaya; Chatterjee, Suvro			Temporal dynamics of nitric oxide wave in early vasculogenesis	VASCULAR MEDICINE			English	Article						chicken embryos; development; hypoxia; nitric oxide; nitrite reduction; vasculogenesis	KAPPA-B; ANGIOGENESIS; SYNTHASE; STEM; EXPRESSION; REDUCTASE	Endothelium-derived nitric oxide (NO) is a mediator of angiogenesis. However, NO-mediated regulation of vasculogenesis remains largely unknown. In the present study, we show that the inhibition of NO significantly attenuated endothelial migration, ring formation, and tube formation. The contribution of nitric oxide synthase (NOS) enzymes during early vasculogenesis was assessed by evaluating endothelial NOS (eNOS) and inducible NOS (iNOS) mRNA expression during HH10-HH13 stages of chick embryo development. iNOS but not eNOS was expressed at HH12 and HH13 stages. We hypothesized that vasculogenic events are controlled by NOS-independent reduction of nitrite to NO under hypoxia during the very early phases of development. Semi-quantitative polymerase chain reaction analysis of hypoxia-inducible factor-1 alpha (HIF-1 alpha) showed higher expression at HH10 stage, after which a decrease was observed. This observation was in correlation with the nitrite reductase (NR) activity at HH10 stage. We observed a sodium nitrite-induced increase in NO levels at HH10, reaching a gradual decrease at HH13. The possible involvement of a HIF/NF-kappa B/iNOS signaling pathway in the process of early vasculogenesis is suggested by the inverse relationship observed between nitrite reduction and NOS activation between HH10 and HH13 stages. Further, we detected that NR-mediated NO production was inhibited by several NR inhibitors at the HH10 stage, whereas the inhibitors eventually became less effective at later stages. These findings suggest that the temporal dynamics of the NO source switches from NR to NOS in the extraembryonic area vasculosa, where both nitrite reduction and NOS activity are defined by hypoxia.	[Rajendran, Saranya; Sundaresan, Lakshmikirupa; Venkatachalam, Geege; Rajendran, Krithika; Behera, Jyotirmaya; Chatterjee, Suvro] AU KBC Res Ctr, Vasc Biol Lab, MIT Campus Anna Univ, Chennai 600044, Tamil Nadu, India; [Sundaresan, Lakshmikirupa; Chatterjee, Suvro] Anna Univ, Dept Biotechnol, Chennai, Tamil Nadu, India		Chatterjee, S (通讯作者)，AU KBC Res Ctr, Vasc Biol Lab, MIT Campus Anna Univ, Chennai 600044, Tamil Nadu, India.	soovro@yahoo.ca		Rajendran, Saranya/0000-0001-5241-9645	University Grant Commission Faculty Recharge Programme (UGC-FRP), Government of India; KBC Research Foundation, India	This work was partially supported by a grant from the University Grant Commission Faculty Recharge Programme (UGC-FRP), Government of India and KBC Research Foundation, India to Suvro Chatterjee.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Gentile C, 2013, DEV BIOL, V373, P163, DOI 10.1016/j.ydbio.2012.10.020; Ghatpande S, 2002, BLOOD, V99, P2379, DOI 10.1182/blood.V99.7.2379; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kevil CG, 2011, CARDIOVASC RES, V89, P489, DOI 10.1093/cvr/cvq409; Krause BJ, 2011, PLACENTA, V32, P797, DOI 10.1016/j.placenta.2011.06.025; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Mujoo K, 2006, STEM CELLS DEV, V15, P779, DOI 10.1089/scd.2006.15.779; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Nath AK, 2004, DEVELOPMENT, V131, P2485, DOI 10.1242/dev.01131; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sinha S, 2011, EUR J CELL BIOL, V90, P58, DOI 10.1016/j.ejcb.2010.07.005; Teichert AM, 2008, CIRC RES, V103, P24, DOI 10.1161/CIRCRESAHA.107.168567; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Volti GL, 2005, ANTIOXID REDOX SIGN, V7, P704, DOI 10.1089/ars.2005.7.704; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8	24	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					3	12	1358863X211035445	10.1177/1358863X211035445		SEP 2021	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000703593000001	34570637				2022-04-28	
J	Gornik, HL; Persu, A; Adlam, D				Gornik, H. L.; Persu, A.; Adlam, D.			First International Consensus on the diagnosis and management of fibromuscular dysplasia (vol 24, pg 164, 2019)	VASCULAR MEDICINE			English	Correction; Early Access																	Gornik HL, 2019, VASC MED, V24, P164, DOI 10.1177/1358863X18821816	1	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.												10.1177/1358863X211035538		JUL 2021	1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TR7LE	WOS:000679141500001		Bronze			2022-04-28	
J	Hsia, J; Kavanagh, ST; Hopley, CW; Baumgartner, I; Berger, JS; Fowkes, GR; Jones, WS; Mahaffey, KW; Norgren, L; Patel, MR; Rockhold, F; Blomster, J; Katona, BG; Hiatt, WR; Bonaca, MP				Hsia, Judith; Kavanagh, Sarah T.; Hopley, Charles W.; Baumgartner, Iris; Berger, Jeffrey S.; Fowkes, Gerry R.; Jones, W. Schuyler; Mahaffey, Kenneth W.; Norgren, Lars; Patel, Manesh R.; Rockhold, Frank; Blomster, Juuso; Katona, Brian G.; Hiatt, William R.; Bonaca, Marc P.			Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y(12) inhibitors: Insights from the EUCLID trial	VASCULAR MEDICINE			English	Article						anemia therapy; antiplatelet therapy; chronic kidney disease (CKD); peripheral artery disease (PAD)	ANEMIA; CLOPIDOGREL; TICAGRELOR	Patients with chronic kidney disease may develop new or more severe anemia when treated with antiplatelet agents due to blood loss in conjunction with impaired erythropoiesis. Because anemia independently predicts limb amputation and mortality among patients with peripheral artery disease (PAD), we evaluated the relationship between estimated glomerular filtration rate (eGFR) and hemoglobin (Hb) levels in the EUCLID trial in which patients with symptomatic PAD were randomized to ticagrelor or clopidogrel. At baseline, 9025, 1870, and 1000 patients had eGFR > 60, 45-59, and < 45 mL/min/1.73 m(2), respectively. The mean fall in Hb during the trial was 0.46 +/- 1.68 g/dL and did not differ by baseline eGFR category, although Hb fall > 10% was more frequent among patients with lower eGFR (p for trend < 0.0001). On-study treatment with iron, erythropoiesis-stimulating agents, and/or red blood cell transfusion was reported for 479 (5.3%), 165 (8.8%), and 129 (12.9%) patients in the three eGFR categories, respectively (p for trend < 0.0001). After adjustment for baseline and post-randomization effects, those not receiving anemia treatment had a smaller reduction in Hb from baseline than those receiving anemia treatment (p < 0.0001). Other determinants of Hb reduction included absence of on-study myocardial infarction, coronary or peripheral revascularization, residence outside North America, male sex, and baseline eGFR. We conclude that among patients with PAD treated with P2Y(12) inhibitors, lower baseline eGFR was associated with a greater reduction in Hb. ClinicalTrials.gov Identifier: NCT01732822	[Hsia, Judith; Kavanagh, Sarah T.; Hiatt, William R.; Bonaca, Marc P.] CPC Clin Res, 2115 N Scranton St 2040, Aurora, CO 80045 USA; [Hsia, Judith; Hiatt, William R.; Bonaca, Marc P.] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Hopley, Charles W.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA; [Baumgartner, Iris] Inselspital Bern, Dept Angiol, Bern, Switzerland; [Berger, Jeffrey S.] NYU, Sch Med, Dept Med, New York, NY USA; [Berger, Jeffrey S.] NYU, Sch Med, Dept Surg, New York, NY USA; [Fowkes, Gerry R.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Jones, W. Schuyler; Patel, Manesh R.; Rockhold, Frank] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Mahaffey, Kenneth W.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Norgren, Lars] Orebro Univ Hosp, Fac Med & Hlth, Orebro, Sweden; [Blomster, Juuso; Katona, Brian G.] AstraZeneca LP, Gothenburg, Sweden		Hsia, J (通讯作者)，CPC Clin Res, 2115 N Scranton St 2040, Aurora, CO 80045 USA.	judith.hsia@cpcmed.org	Patel, Manesh/AAC-5385-2019	Norgren, Lars/0000-0003-2071-7132; Berger, Jeffrey/0000-0001-8216-4647; Hsia, Judith/0000-0002-3413-7836	AstraZenecaAstraZeneca	The EUCLID trial was sponsored by AstraZeneca. The authors received no financial support for the research, authorship, and/or publication of this article.	Aboyans V, 2017, KARDIOL POL, V75, P1065, DOI 10.5603/KP.2017.0216; [Anonymous], 2012, KIDNEY INT S, V2, P279, DOI DOI 10.1038/kisup.2012.37; Berger JS, 2016, AM HEART J, V175, P86, DOI 10.1016/j.ahj.2016.01.018; Desormais I, 2014, EUR J VASC ENDOVASC, V48, P202, DOI 10.1016/j.ejvs.2014.04.005; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Guerrero C, 2018, THROMB RES, V167, P142, DOI 10.1016/j.thromres.2018.05.024; Hayasaka M, 2013, VASC HEALTH RISK MAN, V9, P65, DOI 10.2147/VHRM.S39351; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Hopley CW, 2019, VASC MED, V24, P422, DOI 10.1177/1358863X19864172; Kansal A, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.119.008069; Kikkert WJ, 2016, EUR HEART J, V37, P1104, DOI 10.1093/eurheartj/ehv584; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Luders F, 2016, EUR J INTERN MED, V31, P62, DOI 10.1016/j.ejim.2016.03.002; McDermott MM, 2020, J VASC SURG, V71, P988, DOI 10.1016/j.jvs.2019.05.058; Ning SY, 2019, HEMATOL-AM SOC HEMAT, P315, DOI 10.1182/hematology.2019000034; Ward R, 2020, AM HEART J, V220, P51, DOI 10.1016/j.ahj.2019.11.007	16	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	DEC	2021	26	6					608	612	1358863X211017641	10.1177/1358863X211017641		JUN 2021	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XK6NF	WOS:000658463700001	34082620				2022-04-28	
J	Sartori, M; Favaretto, E; Cosmi, B				Sartori, Michelangelo; Favaretto, Elisabetta; Cosmi, Benilde			Relevance of immobility as a risk factor for symptomatic proximal and isolated distal deep vein thrombosis in acutely ill medical inpatients	VASCULAR MEDICINE			English	Article						deep vein thrombosis (DVT); immobility; immobilization; medical inpatients; risk factor; venous thromboembolism (VTE)		Immobility is a well-recognized risk factor for deep vein thrombosis (DVT) in surgical patients, whereas the level of DVT risk conferred by immobility is less defined in patients on medical wards. The aim of this study was to establish whether immobility and its duration are associated with the risk of DVT in acutely ill medical inpatients. We conducted a cohort study in acutely ill medical inpatients. Patients underwent whole leg ultrasound for suspected lower extremity DVT and were divided into two groups according to presence or absence of immobility, defined as total bed rest or sedentary without bathroom privileges. The endpoint was the detection of proximal DVT or isolated distal DVT (IDDVT). Among the 252 acutely ill medical inpatients with immobility (age 82.6 +/- 10.3 years, female 63.9%), ultrasound showed 36 (14.3%) proximal DVTs and 39 (15.5%) IDDVTs, while there were 11 (4.4%) proximal DVTs and 26 (10.5%) IDDVTs among the 248 inpatients without immobility (age 73.6 +/- 14.2 years, female 54.8%). The risk of proximal DVT was higher in immobile than in mobile patients (OR 3.59, 95% CI: 1.78-7.23, p = 0.0001), whereas the risk of IDDVT was similar between the two groups (OR 1.56, 95% CI: 0.92-2.66, p = 0.111). During the first 3 days of hospitalization, the frequency of all DVTs was similar in patients with and without immobility, but it was 0.26 +/- 0.03 vs 0.18 +/- 0.03, respectively, after 4 days. In conclusion, immobility for more than 3 days is a risk factor for proximal DVT in acutely ill medical inpatients.	[Sartori, Michelangelo; Favaretto, Elisabetta; Cosmi, Benilde] IRCCS Azienda Osped Univ Bologna, Div Angiol & Blood Coagulat, Via Albertoni 15, I-40138 Bologna, Italy		Sartori, M (通讯作者)，IRCCS Azienda Osped Univ Bologna, Div Angiol & Blood Coagulat, Via Albertoni 15, I-40138 Bologna, Italy.	michelangelo.sartori@aosp.bo.it		Sartori, Michelangelo/0000-0003-3466-4676			Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x; Bjori E, 2019, THROMB RES, V176, P115, DOI 10.1016/j.thromres.2019.02.024; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Engbers MJ, 2014, J THROMB HAEMOST, V12, P290, DOI 10.1111/jth.12480; Fleischer AE, 2015, J FOOT ANKLE SURG, V54, P497, DOI 10.1053/j.jfas.2015.02.022; Galanaud JP, 2009, J THROMB HAEMOST, V7, P2028, DOI 10.1111/j.1538-7836.2009.03629.x; Galanaud JP, 2009, THROMB HAEMOSTASIS, V102, P493, DOI 10.1160/TH09-01-0053; Goldhaber SZ, 2011, NEW ENGL J MED, V365, P2167, DOI 10.1056/NEJMoa1110899; Hull RD, 2013, CLIN APPL THROMB-HEM, V19, P268, DOI 10.1177/1076029612452781; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P438, DOI 10.1001/jama.2010.43; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Pottier P, 2002, REV MED INTERNE, V23, P910, DOI 10.1016/S0248-8663(02)00686-0; Pottier P, 2009, THROMB RES, V124, P468, DOI 10.1016/j.thromres.2009.05.006; Rosenberg D, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001152; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Sartori M, 2016, EUR J VASC ENDOVASC, V52, P658, DOI 10.1016/j.ejvs.2016.07.022; Sartori M, 2019, INTERN EMERG MED, V14, P941, DOI 10.1007/s11739-019-02066-8; Sevestre MA, 2010, AM J MED, V123, P158, DOI 10.1016/j.amjmed.2009.05.034; Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944; Spyropoulos AC, 2009, THROMB HAEMOSTASIS, V102, P951, DOI 10.1160/TH09-02-0073; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; Vardi M, 2013, J THROMB HAEMOST, V11, P467, DOI 10.1111/jth.12108; Weill-Engerer S, 2004, J AM GERIATR SOC, V52, P1299, DOI 10.1111/j.1532-5415.2004.52359.x; Ye F, 2018, CLIN APPL THROMB-HEM, V24, P13, DOI 10.1177/1076029616677802; Yusen RD, 2013, THROMB HAEMOSTASIS, V110, P1152, DOI 10.1160/TH13-02-0170; Zakai NA, 2004, J THROMB HAEMOST, V2, P2156, DOI 10.1111/j.1538-7836.2004.00991.x	27	1	1	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					542	548	1358863X21996825	10.1177/1358863X21996825		APR 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000637147600001	33813966				2022-04-28	
J	Kadian-Dodov, D; Creager, MA; Hamburg, NM; Aronow, H				Kadian-Dodov, Daniella; Creager, Mark A.; Hamburg, Naomi M.; Aronow, Herbert			SVM Communications: Interview with Writing Committee of Advanced Training Statement on Vascular Medicine and Talking Points from Paclitaxel Coalition	VASCULAR MEDICINE			English	Editorial Material							TASK-FORCE		[Kadian-Dodov, Daniella] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Kadian-Dodov, Daniella] Icahn Sch Med Mt Sinai, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; [Creager, Mark A.] Dartmouth Hitchcock Med Ctr, Heart & Vasc Ctr, Sect Cardiovasc Med, Lebanon, NH 03766 USA; [Hamburg, Naomi M.] Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Aronow, Herbert] Brown Univ, Warren Alpert Med Sch, Div Cardiol, Providence, RI 02912 USA; [Aronow, Herbert] Lifespan Cardiovasc Inst, Providence, RI USA		Kadian-Dodov, D (通讯作者)，Icahn Sch Med Mt Sinai, One Gustave L Levy Pl,Box 1033, New York, NY 10029 USA.	daniella.kadian-dodov@mountsinai.org		Creager, Mark/0000-0001-9758-6447			Creager MA, 2004, J AM COLL CARDIOL, V44, P941, DOI 10.1016/j.jacc.2003.10.012; Creager MA, 2021, CIRC-CARDIOVASC INTE, V14, DOI [10.1161/HCV.0000000000000079, 10.1016/j.jacc.2020.09.579, 10.1177/1358863X20987551]; Creager MA, 2015, J AM COLL CARDIOL, V65, P1832, DOI 10.1016/j.jacc.2015.03.025	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		232	233	1358863X21993906	10.1177/1358863X21993906		MAR 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000628958700001	33710941	Bronze			2022-04-28	
J	Hobaus, C; Ursli, M; Yussef, SM; Wrba, T; Koppensteiner, R; Schernthaner, GH				Hoebaus, Clemens; Ursli, Martin; Yussef, Sarah Mohammed; Wrba, Thomas; Koppensteiner, Renate; Schernthaner, Gerit-Holger			Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes	VASCULAR MEDICINE			English	Article						atherosclerosis; chronic kidney disease (CKD); mortality; peripheral artery disease (PAD); soluble urokinase-type plasminogen activator receptor (suPAR)	CHRONIC KIDNEY-DISEASE; SUPAR; RISK; BIOMARKERS	Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with chronic kidney disease (CKD) severity and peripheral artery disease (PAD). We hypothesize an association of PAD severity and suPAR in patients without advanced CKD and further risk stratification according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. For study purposes, suPAR was measured in 334 PAD patients (34% women, age 69 (62-78) years, eGFR 68 +/- 20 mL/min/1.72 m(2)) by commercial ELISA. Patients were followed for 10 years to assess long-term all-cause survival by Cox regression. Higher suPAR levels were associated with lower ankle-brachial index (R = -0.215, p = 0.001) in patients with PAD without media-sclerosis (n = 236). suPAR levels inversely correlated with decreased glomerular filtration rate (R = -0.476, p < 0.001) and directly correlated with urinary albumin-to-creatinine ratio (R = 0.207, p < 0.001). Furthermore, higher suPAR levels associated with a higher KDIGO risk score (p < 0.001). Baseline suPAR was significantly associated with all-cause mortality (HR 1.40 (95% CI 1.16-1.68), p < 0.001) over 10 years. suPAR remained associated with mortality (HR 1.29 (1.03-1.61), p = 0.026) after multivariable adjustment for age, sex, cardiovascular risk factors, and eGFR. Future research may define a standard role for suPAR assessment in PAD's work-up and treatment, especially in patients with CKD.	[Hoebaus, Clemens; Yussef, Sarah Mohammed; Koppensteiner, Renate; Schernthaner, Gerit-Holger] Med Univ Vienna, Div Angiol, Med 2, Vienna, Austria; [Ursli, Martin] Karl Landsteiner Univ Hlth Sci, Karl Landsteiner Inst Nephrol & Hematooncol, Univ Hosp St Poelten, Dept Internal Med 1, St Polten, Austria; [Wrba, Thomas] Med Univ Vienna, IT4Sci, IT Syst & Commun, Vienna, Austria		Hobaus, C (通讯作者)，Med Univ Vienna, Dept Internal Med 2, Div Angiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	clemens.hoebaus@meduniwien.ac.at		Hobaus, Clemens/0000-0002-9704-1452			[Anonymous], 2013, Kidney Int Suppl (2011), V3, P63; [Anonymous], 2000, JAMA, V284, P3043; Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Eapen DJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001118; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE, V26 26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; Guo SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138718; Guthoff M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40627; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hayek SS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008194; Hayek SS, 2017, KIDNEY INT REP, V2, P425, DOI 10.1016/j.ekir.2017.02.001; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Heraclides A, 2013, DIABETOLOGIA, V56, P1542, DOI 10.1007/s00125-013-2914-0; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hodges G, 2020, SCAND CARDIOVASC J, V54, P339, DOI 10.1080/14017431.2020.1762917; Hodges GW, 2015, CAN J CARDIOL, V31, P1293, DOI 10.1016/j.cjca.2015.03.023; Hobaus C, 2017, ANN MED, V49, P291, DOI 10.1080/07853890.2016.1241428; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lv L, 2020, NEPHROL DIAL TRANSPL, V35, P465, DOI 10.1093/ndt/gfy265; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Matsushita K, 2017, LANCET DIABETES ENDO, V5, P718, DOI 10.1016/S2213-8587(17)30183-3; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Outinen TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071335; Rasmussen LJH, 2017, INT J CANCER, V141, P191, DOI 10.1002/ijc.30732; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Sehestedt T, 2011, ATHEROSCLEROSIS, V216, P237, DOI 10.1016/j.atherosclerosis.2011.01.049; Slot O, 1999, ANN RHEUM DIS, V58, P488, DOI 10.1136/ard.58.8.488; Smilowitz NR, 2020, ATHEROSCLEROSIS, V297, P149, DOI 10.1016/j.atherosclerosis.2019.12.016; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Tahhan AS, 2017, ATHEROSCLEROSIS, V264, P108, DOI 10.1016/j.atherosclerosis.2017.06.019; Theilade S, 2015, J INTERN MED, V277, P362, DOI 10.1111/joim.12269; Torino C, 2018, KIDNEY INT REP, V3, P1100, DOI 10.1016/j.ekir.2018.05.004; Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Zhao YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132869	40	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					11	17		10.1177/1358863X20982077		JAN 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000618399500001	33448911	Green Published			2022-04-28	
J	Mitchell, C; Korcarz, CE; Zagzebski, JA; Stein, JH				Mitchell, Carol; Korcarz, Claudia E.; Zagzebski, James A.; Stein, James H.			Effects of ultrasound technology advances on measurement of carotid intima-media thickness: A review	VASCULAR MEDICINE			English	Review						atherosclerosis; cardiovascular disease; carotid intima-media thickness (IMT)		In this review, we describe how technological advances in ultrasound imaging related to transducer construction and image processing fundamentally alter generation of ultrasound images to produce better quality images with higher resolution. However, carotid intima-media thickness (IMT) measurements made from images acquired on modern ultrasound systems are not comparable to historical population nomograms that were used to determine wall thickness thresholds that inform atherosclerotic cardiovascular disease risk. Because it is nearly impossible to replicate instrumentation settings that were used to create the reference carotid IMT nomograms and to place an individual's carotid IMT value in or above a clinically relevant percentile, carotid IMT measurements have a very limited role in clinical medicine, but remain a useful research tool when instrumentation, presets, image acquisition, and measurements can be standardized. In addition to new validation studies, it would be useful for the ultrasound imaging community to reach a consensus regarding technical aspects of ultrasound imaging acquisition, processing, and display for blood vessels so standard presets and imaging approaches could reliably yield the same measurements.	[Mitchell, Carol; Korcarz, Claudia E.; Stein, James H.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Cardiovasc Med, G7-341 CSC,600 Highland Ave,MC 3248, Madison, WI 53792 USA; [Zagzebski, James A.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA		Stein, JH (通讯作者)，Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Cardiovasc Med, G7-341 CSC,600 Highland Ave,MC 3248, Madison, WI 53792 USA.	jhs@medicine.wisc.edu	Korcarz, Claudia/A-5728-2018	Korcarz, Claudia/0000-0001-9691-9027; Stein, James/0000-0002-2770-8223			Ahman H, 2009, J DIAGN MED SONOG, V25, P145, DOI 10.1177/8756479309334354; Anvari A, 2015, RADIOGRAPHICS, V35, P1956, DOI 10.1148/rg.2015140338; Bhagirath KM, 2012, ECHOCARDIOGR-J CARD, V29, P354, DOI 10.1111/j.1540-8175.2011.01557.x; Centurion Osmar Antonio, 2016, Crit Pathw Cardiol, V15, P152; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Daft C, 2005, ULTRASON, P467; del Sol AI, 2002, EUR HEART J, V23, P934, DOI 10.1053/euhj.2001.2965; Espeland MA, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-3; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; Greenland P, 2000, Circulation, V101, pE16; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrington, 2010, J VASC ULTRASOUND, V34, P185; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Johnsen SH, 2007, STROKE, V38, P2873, DOI 10.1161/STROKEAHA.107.487264; Kremkau, 2021, SONOGRAPHY PRINCIPLE; Kremkau FW, 2019, J DIAGN MED SONOG, V35, P439, DOI 10.1177/8756479319842078; Kremkau FW., 2017, NEW PARADIGM UNDERST; Kremkau FW., 2018, J VASC ULTRASOUND, V42, P198; Liu W, 2008, PHYS MED BIOL, V53, P4169, DOI 10.1088/0031-9155/53/15/011; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; McLaughlin, 2018, ZAGZ CARS DIST LECT; MIELE FR, 2006, ULTRASOUND PHYS INST; Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Otto CM., 2013, TXB CLIN ECHOCARDIOG, P1; Pasquini L, 2010, ULTRASOUND OBST GYN, V36, P423, DOI 10.1002/uog.7615; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Potter K, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-6; Roman MJ, 2006, J AM SOC ECHOCARDIOG, V19, P943, DOI 10.1016/j.echo.2006.04.020; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Steffel CN, 2019, J ULTRAS MED, V38, P307, DOI 10.1002/jum.14690; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tattersall MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204708; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Tole NM., 2005, BASIC PHYS ULTRASONO; WONG ML, 1993, ARTERIOSCLER THROMB, V13, P482, DOI 10.1161/01.ATV.13.4.482; Yen CL, 2009, EUR J RADIOL, V71, P11, DOI 10.1016/j.ejrad.2008.04.004; Yu YM, 2009, J MATERN-FETAL NEO M, V22, P616, DOI 10.1080/14767050902801793; Zagzebski JA., 2012, INTRO VASCULAR ULTRA, P20	43	1	1	1	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					81	85	1358863X20969826	10.1177/1358863X20969826		NOV 2020	5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000608755800001	33203316				2022-04-28	
J	Majmudar, K; Golemi, I; Tafur, AJ				Majmudar, K.; Golemi, I; Tafur, A. J.			Outcomes after venous thromboembolism in patients with gastric cancer: Analysis of the RIETE Registry (vol 17, pg 33, 2020)	VASCULAR MEDICINE			English	Correction																	Majmudar K, 2020, VASC MED, V25, P210, DOI 10.1177/1358863X19893432	1	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	APR	2021	26	2			SI		234	234	1358863X20931821	10.1177/1358863X20931821		JUN 2020	1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	RK4JL	WOS:000538475100001		Bronze			2022-04-28	
J	Ngetich, E; Lapolla, P; Chandrashekar, A; Handa, A; Lee, R				Ngetich, Elisha; Lapolla, Pierfrancesco; Chandrashekar, Anirudh; Handa, Ashok; Lee, Regent			The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: A systematic review	VASCULAR MEDICINE			English	Review						abdominal aortic aneurysm (AAA); attractin; dipeptidyl peptidase IV; pathogenesis	ENDOTHELIAL PROGENITOR CELLS; NLRP3 INFLAMMASOME; DIABETES-MELLITUS; BLOOD MONOCYTES; INHIBITOR; ATTRACTIN; OPPORTUNITIES; MACROPHAGES; PROGRESSION; SITAGLIPTIN	Abdominal aortic aneurysm (AAA) is an important vascular disease carrying significant mortality implications due to the risk of aneurysm rupture. Current management relies exclusively on surgical repair as there is no effective medical therapy. A key element of AAA pathogenesis is the chronic inflammation mediated by inflammatory cells releasing proteases, including the enzyme dipeptidyl peptidase IV (DPP-IV). This review sought to recapitulate available evidence on the involvement of DPP-IV in AAA development. Further, we assessed the experimental use of currently available DPP-IV inhibitors for AAA management in murine models. Embase, Medline, PubMed, and Web of Science databases were utilised to access the relevant studies. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). A narrative synthesis approach was used. Sixty-four studies were identified from the searched databases; a final 11 were included in the analysis. DPP-IV was reported to be significantly increased in both AAA tissue and plasma of patients and correlated with AAA growth. DPP-IV inhibitors (sitagliptin, vildagliptin, alogliptin, and teneligliptin) were all shown to attenuate AAA formation in murine models by reducing monocyte differentiation, the release of reactive oxygen species (ROS), and metalloproteinases (MMP-2 and MMP-9). DPP-IV seems to play a role in AAA pathogenesis by propagating the inflammatory microenvironment. This is supported by observations of decreased AAA formation and reduction in macrophage infiltration, ROS, matrix MMPs, and interleukins following the use of DPP-IV inhibitors in murine models. There is an existing translational gap from preclinical observations to clinical trials in this important and novel mechanism of AAA pathogenesis. This prior literature highlights the need for further research on molecular targets involved in AAA formation.	[Ngetich, Elisha; Lapolla, Pierfrancesco; Chandrashekar, Anirudh; Handa, Ashok; Lee, Regent] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Level 6,Headley Way, Oxford OX3 9DU, England		Lee, R (通讯作者)，Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Level 6,Headley Way, Oxford OX3 9DU, England.	regent.lee@nds.ox.ac.uk	Lapolla, Pierfrancesco/AAT-8407-2021	Lapolla, Pierfrancesco/0000-0002-3088-5263; Ngetich, Elisha/0000-0002-9563-6938	Rhodes scholarship; Foundation Blanceflor Boncompagni Ludovisi, nee Bildt scholarship; Sloane-Robinson/Clarendon scholarship	Elisha Ngetich is supported by the Rhodes scholarship. Pierfrancesco Lapolla is supported by The Foundation Blanceflor Boncompagni Ludovisi, nee Bildt scholarship. Anirudh Chandrashekar is supported by the Sloane-Robinson/Clarendon scholarship. The remaining authors have no disclosures.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Aroor AR, 2014, AM J PHYSIOL-HEART C, V307, pH477, DOI 10.1152/ajpheart.00209.2014; Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Bao W, 2014, J VASC SURG, V59, P1098, DOI 10.1016/j.jvs.2013.04.048; Birnbaum Y, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0743-0; Birnbaum Y, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000227; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Carr RD, 2010, J CLIN ENDOCR METAB, V95, P872, DOI 10.1210/jc.2009-2054; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Da Silva RR, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03313; Dai Y, 2014, CARDIOVASC DRUG THER, V28, P425, DOI 10.1007/s10557-014-6539-4; Dattani N, 2018, DIABETES VASC DIS RE, V15, P367, DOI 10.1177/1479164118780799; de Oliveira BC, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108733; Deacon CF, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00080; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; Dunaevsky YE, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129636; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Fan H, 2003, ADV EXP MED BIOL, V524, P165; Fisman EZ, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0294-0; Friedrich D, 2007, BIOL CHEM, V388, P155, DOI 10.1515/BC.2007.017; Fujimura N, 2016, J VASC SURG, V64, P46, DOI 10.1016/j.jvs.2016.02.020; Golledge J, 2020, J INTERN MED, V288, P6, DOI 10.1111/joim.12958; Golledge J, 2017, BRIT J SURG, V104, P1486, DOI 10.1002/bjs.10587; Golledge J, 2017, J VASC SURG, V65, P225, DOI 10.1016/j.jvs.2016.08.003; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; He JA, 2021, J VASC RES, V58, P148, DOI 10.1159/000513465; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Horowitz M, 2016, DIABETES, V65, P2124, DOI 10.2337/dbi16-0023; Hsu CY, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0447-9; Husain M., 2017, ARTERIOSCL THROM VAS, V37, pA101; Isoda K, 2018, INT J CARDIOL, V270, P221, DOI 10.1016/j.ijcard.2018.05.072; Itoga NK, 2019, J VASC SURG, V69, P710, DOI 10.1016/j.jvs.2018.06.194; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kahne T, 1999, INT J MOL MED, V4, P3; Kang YM, 2016, ENDOCRINOL METAB, V31, P258, DOI 10.3803/EnM.2016.31.2.258; Kim MJ, 2016, BMB REP, V49, P529, DOI 10.5483/BMBRep.2016.49.10.115; Kitamura K, 2017, EUR HEART J, V38, P808; Klemann C, 2016, CLIN EXP IMMUNOL, V185, P1, DOI 10.1111/cei.12781; Kohashi K, 2016, J ATHEROSCLER THROMB, V23, P441, DOI 10.5551/jat.31997; Kuhnl A, 2017, DTSCH ARZTEBL INT, V114, P391, DOI 10.3238/arztebl.2017.0391; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; Langley AK, 2007, PHARMACOTHERAPY, V27, P1163, DOI 10.1592/phco.27.8.1163; Laudes M, 2010, EXP CLIN ENDOCR DIAB, V118, P473, DOI 10.1055/s-0030-1249014; Lee Regent, 2020, Ann Surg, DOI 10.1097/SLA.0000000000004439; Lee R, 2017, INT J CARDIOL, V245, P253, DOI 10.1016/j.ijcard.2017.06.058; Liljeqvist ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227889; Lindeman JH, 2019, CIRC RES, V124, P631, DOI 10.1161/CIRCRESAHA.118.312439; Lindholt JS, 2006, EUR J VASC ENDOVASC, V31, P453, DOI 10.1016/j.ejvs.2005.10.030; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121077; Lu HY, 2017, J VASC SURG, V66, P1217, DOI 10.1016/j.jvs.2016.05.093; Mathur A, 2016, J TRANSL INTERN MED, V4, P35, DOI 10.1515/jtim-2016-0008; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; NICE, 2020, ABD AORT AN DIAGN MA; Noda Y, 2013, EUR HEART J, V34, P116; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Patel K, 2018, CARDIOLOGY, V141, P107, DOI 10.1159/000490373; Poulsen JL, 2016, EUR J VASC ENDOVASC, V52, P487, DOI 10.1016/j.ejvs.2016.07.004; Prakash SK, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000323; Radak D, 2016, CURR VASC PHARMACOL, V14, P196, DOI 10.2174/1570161113666150529125127; Ren PP, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014044; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V322, P1155, DOI 10.1001/jama.2019.13772; Salim HM, 2016, VASC PHARMACOL, V79, P16, DOI 10.1016/j.vph.2015.08.011; Scheen AJ, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2659; Sedo A, 2005, ARTHRITIS RES THER, V7, P253, DOI 10.1186/ar1852; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Shantikumar S, 2010, EUR J VASC ENDOVASC, V39, P200, DOI 10.1016/j.ejvs.2009.10.014; Shih CM, 2014, CURR MED CHEM, V21, P2012, DOI 10.2174/09298673113206660273; Singh Awadhesh Kumar, 2014, Indian J Endocrinol Metab, V18, P753, DOI 10.4103/2230-8210.141319; Sutton SS, 2020, J INVEST MED, V68, P1015, DOI 10.1136/jim-2019-001177; Takahara Y, 2018, J ATHEROSCLER THROMB, V25, P698, DOI 10.5551/jat.42481; Tang W, 2000, P NATL ACAD SCI USA, V97, P6025, DOI 10.1073/pnas.110139897; Tsai CL, 2015, DIABETES-METAB RES, V31, P190, DOI 10.1002/dmrr.2585; Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763; Valencia-Sanchez L, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55050148; van Poppel PCM, 2011, DIABETES CARE, V34, P2072, DOI 10.2337/dc10-2421; Wassef M, 2007, J VASC SURG, V45, P192, DOI 10.1016/j.jvs.2006.09.004; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wrenger S, 2006, J LEUKOCYTE BIOL, V80, P621, DOI 10.1189/jlb.1105678; Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648; Yang L, 2017, ONCOTARGET, V8, P92827, DOI 10.18632/oncotarget.21608; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yeo Giles S H, 2003, Biochem J, V376, pe7, DOI 10.1042/BJ20031675; Yu J., 2015, ARTERIOSCL THROM VAS, V35, pA671; Yu J, 2016, SURG TODAY, V46, P1099, DOI 10.1007/s00595-015-1287-z; Yu XY, 2019, HEART, V105, P1351, DOI 10.1136/heartjnl-2018-314639; Zhang JQ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01050	94	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2022	27	1					77	87	1358863X211034574	10.1177/1358863X211034574		AUG 2021	11	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YR0KU	WOS:000685845800001	34392748	Green Published, hybrid			2022-04-28	
J	Han, H; Barnes, GD				Han, Henry; Barnes, Geoffrey D.			PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19	VASCULAR MEDICINE			English	Editorial Material						COVID-19; venous thromboembolsim (VTE); pulmonary embolism (PE)			[Han, Henry; Barnes, Geoffrey D.] Univ Michigan, Frankel Cardiovasc Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA		Barnes, GD (通讯作者)，Univ Michigan, Frankel Cardiovasc Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	gbarnes@umich.edu		Han, Henry/0000-0003-4911-1070; Barnes, Geoffrey/0000-0002-6532-8440			Bonten MJM, 2016, RANDOMIZED EMBEDDED; Bryce C., 2020, PATHOPHYSIOLOGY SARS, DOI [DOI 10.1101/2020.05.18.20099960, 10.1101/2020.05.18.20099960, 10.1101/2020.05.18.20099960v1]; Colling ME, 2020, VASC MED, V25, P471, DOI 10.1177/1358863X20932640; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Finn MT, 2021, VASC MED, V26, P426, DOI 10.1177/1358863X21995896; Houston BL, 2020, CLIN TRIALS, V17, P491, DOI 10.1177/1740774520943846; Kollias A, 2021, VASC MED, V26, P415, DOI 10.1177/1358863X21995566; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Neal M., 2020, ANTITHROMBOTICS ADUL; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Spyropoulos AC, 2021, RES PRACT THROMB HAE, V5, P296, DOI 10.1002/rth2.12486; Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035; Tsaplin S, 2021, J VASC SURG-VENOUS L, V9, P1371, DOI 10.1016/j.jvsv.2021.02.018; Yusuf Hussain R., 2012, Morbidity and Mortality Weekly Report, V61, P401; Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618	17	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					434	436	1358863X211012776	10.1177/1358863X211012776		MAY 2021	3	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000652864500001	34014133	Bronze			2022-04-28	
J	Hoel, H; Pettersen, EM; Hoiseth, LO; Mathiesen, I; Seternes, A; Seljeflot, I; Hisdal, J				Hoel, Henrik; Pettersen, Erik Mulder; Hoiseth, Lars Oivind; Mathiesen, Iacob; Seternes, Arne; Seljeflot, Ingebjorg; Hisdal, Jonny			Effects of intermittent negative pressure treatment on circulating vascular biomarkers in patients with intermittent claudication	VASCULAR MEDICINE			English	Article						intermittent claudication; intermittent negative pressure treatment; peripheral artery disease (PAD); vascular endothelium; vascular medicine	VON-WILLEBRAND-FACTOR; CONSERVATIVE TREATMENT; SUCTION; EXERCISE; FLOW; ATHEROSCLEROSIS; MARKERS; BLOOD	The aim of this study was to investigate the effects of lower extremity intermittent negative pressure (INP) treatment for 1 hour twice daily for 12 weeks, on circulating vascular biomarkers in patients with intermittent claudication. Patients were randomized to treatment with -40 mmHg INP (treatment group), or -10 mmHg INP (sham control group). Venous blood samples were collected at baseline and after 12 weeks, and concentrations of vascular adhesion molecule-1 (VCAM-1), intracellular adhesion molecule-1 (ICAM-1), E-selectin, P-selectin, von Willebrand factor (vWF), l-arginine, asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA) were analyzed. A larger proportion of the patients in the treatment group (25/31) had a reduction in vWF levels after 12 weeks, compared to the sham control group (17/30) (p = 0.043). Within the treatment group there was a significant mean (SEM) reduction in the concentration of vWF of -11% (4) (p = 0.019), whereas there was no significant change in the levels of vWF in the sham control group (1% (6); p = 0.85). There were no significant differences in the change of any of the biomarker levels between the groups after 12 weeks of treatment. In conclusion, there were no differences in the change of the circulating levels of the measured biomarkers between the treatment group and the sham control group after 12 weeks of INP treatment. However, the observed changes in vWF might indicate a beneficial effect of INP treatment on endothelial activation and endothelial injury. Clinicaltrials.gov Identifier: NCT03640676	[Hoel, Henrik; Seljeflot, Ingebjorg; Hisdal, Jonny] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Hoel, Henrik; Hisdal, Jonny] Oslo Univ Hosp, Dept Vasc Surg, Trondheimsveien 235, N-0586 Oslo, Norway; [Hoel, Henrik; Mathiesen, Iacob] Otivio AS, Oslo, Norway; [Pettersen, Erik Mulder] Sorlandet Hosp, Dept Surg, Kristiansand, Norway; [Pettersen, Erik Mulder; Seternes, Arne] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway; [Hoiseth, Lars Oivind] Oslo Univ Hosp, Dept Anesthesiol, Oslo, Norway; [Seternes, Arne] St Olavs Hosp, Sect Vasc Surg, Dept Surg, Trondheim, Norway; [Seljeflot, Ingebjorg] Oslo Univ Hosp, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway		Hoel, H (通讯作者)，Oslo Univ Hosp, Dept Vasc Surg, Trondheimsveien 235, N-0586 Oslo, Norway.	ho-hen@online.no			Research Council of NorwayResearch Council of Norway [285758]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was part of a university-industry collaborative project funded in part by Otivio AS and The Research Council of Norway (grant no. 285758).	Aboyans V, 2017, KARDIOL POL, V75, P1065, DOI 10.5603/KP.2017.0216; Afzelius P, 2018, SCAND J CLIN LAB INV, V78, P456, DOI 10.1080/00365513.2018.1497803; COOKE JP, 1991, J CLIN INVEST, V88, P1663, DOI 10.1172/JCI115481; Felmeden DC, 2003, BLOOD COAGUL FIBRIN, V14, P425, DOI 10.1097/00001721-200307000-00001; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Hageman D, 2020, J VASC SURG, V71, P1692, DOI 10.1016/j.jvs.2019.08.239; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Herrmann LG, 1934, ANN SURG, V100, P750, DOI 10.1097/00000658-193410000-00016; Herrmann LG, 1935, J AMER MED ASSOC, V105, P1256, DOI 10.1001/jama.1935.02760420026007; HIMMELSTRUP H, 1991, CLIN PHYSIOL, V11, P263, DOI 10.1111/j.1475-097X.1991.tb00457.x; Hoel H, 2020, J VASC SURG, DOI [10.1016/j.jvs.2020.10.024, DOI 10.1016/J.JVS.2020.10.024.]; Hoel H, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14241; Holder SM, 2019, J APPL PHYSIOL, V126, P1687, DOI 10.1152/japplphysiol.00009.2019; Jud P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32607-8; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Landis EM, 1935, AM J MED SCI, V189, P305; LIP GYH, 1995, BRIT HEART J, V74, P580; Makris GC, 2012, EUR J VASC ENDOVASC, V44, P569, DOI 10.1016/j.ejvs.2012.09.009; MEHLSEN J, 1993, ANGIOLOGY, V44, P16, DOI 10.1177/000331979304400103; New York Heart Association Criteria Committee, 1994, NOMENCLATURE CRITERI, V9th, P253; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Oresanya L, 2018, J VASC SURG, V67, P620, DOI 10.1016/j.jvs.2017.11.044; Palmefors H, 2014, ATHEROSCLEROSIS, V235, P150, DOI 10.1016/j.atherosclerosis.2014.04.026; Peyvandi F, 2011, BLOOD TRANSFUS-ITALY, V9, pS3, DOI 10.2450/2011.002S; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saetre T, 2011, ANGIOLOGY, V62, P301, DOI 10.1177/0003319710385338; Sinkowitz SJ, 1917, J AMER MED ASSOC, V68, P961; SMITH FB, 1993, ATHEROSCLEROSIS, V102, P155, DOI 10.1016/0021-9150(93)90157-P; SMYTH CN, 1969, LANCET, V2, P657; Soeki T, 2016, INT HEART J, V57, P134, DOI 10.1536/ihj.15-346; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x	31	1	1	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	OCT	2021	26	5					489	496	1358863X211007933	10.1177/1358863X211007933		MAY 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	WC1IH	WOS:000652522900001	33985385	Green Published, hybrid			2022-04-28	
J	Aronow, HD				Aronow, Herbert D.		SVM Sci Program Comm	SVM Communications: Message from the Scientific Program Committee Chair	VASCULAR MEDICINE			English	Editorial Material									[Aronow, Herbert D.] Brown Univ, Alpert Med Sch, Lifespan Cardiovasc Inst, Providence, RI 02912 USA		Aronow, HD (通讯作者)，Brown Univ, Alpert Med Sch, Lifespan Cardiovasc Inst, Providence, RI 02912 USA.							0	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					356	356	1358863X211007200	10.1177/1358863X211007200		APR 2021	1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000638755900001	33823704	Bronze			2022-04-28	
J	Zheng, J; Li, R; Zayed, MA; Yan, Y; An, HY; Hastings, MK				Zheng, Jie; Li, Ran; Zayed, Mohamed A.; Yan, Yan; An, Hongyu; Hastings, Mary K.			Pilot study of contrast-free MRI reveals significantly impaired calf skeletal muscle perfusion in diabetes with incompressible peripheral arteries	VASCULAR MEDICINE			English	Article						ankle&#8211; brachial index (ABI); calcification; diabetes mellitus; noncompressible artery; perfusion		Patients with diabetes mellitus (DM) are more likely to have densely calcified lesions in the below-the-knee tibial arteries. However, the relationship between peripheral arterial calcification and local skeletal muscle perfusion has not been explored. Thirty subjects were prospectively recruited into three groups in this pilot study: (1) Non-DM: 10 people without DM; (2) DM, ABI < 1.3: 10 people with DM and normal ankle-brachial index (ABI) (0.9-1.3); and (3) DM, ABI > 1.3: 10 people with DM and ABI > 1.3. All subjects underwent calf perfusion measurements at rest and during an isometric plantarflexion contraction exercise within the magnetic resonance imaging (MRI) system. The noncontrast MRI techniques were applied to quantitatively assess skeletal muscle blood flow (SMBF) and oxygen extraction fraction (SMOEF) in medial gastrocnemius and soleus muscles. Both SMBF and SMOEF reserves were calculated as the ratio of the exercise value to the resting value. Exercise SMBF and SMOEF values in the medial gastrocnemius muscle were lower in the two DM groups than in the non-DM group (p < 0.05). The SMBF reserve in medial gastrocnemius was significantly lower in the DM, ABI > 1.3 group compared to the DM, ABI < 1.3 group (p < 0.05). This study demonstrates that people with DM and calcified arteries had lower perfusion in gastrocnemius muscle compared to those without DM and those with DM and a normal ABI.	[Zheng, Jie; Li, Ran; An, Hongyu] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, 4525 Scott Ave,Room 3114, St Louis, MO 63130 USA; [Zayed, Mohamed A.; Yan, Yan] Washington Univ, Dept Surg, Sect Vasc Surg, Sch Med, St Louis, MO 63130 USA; [Hastings, Mary K.] Washington Univ, Phys Therapy Program, Sch Med, St Louis, MO 63130 USA		Zheng, J (通讯作者)，Washington Univ, Mallinckrodt Inst Radiol, Sch Med, 4525 Scott Ave,Room 3114, St Louis, MO 63130 USA.	zhengj@mir.wustl.edu		Yan, Yan/0000-0002-5917-1475	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AR065672, R01DK105322, K08HL132060, R03EB028415]	This study was supported in part by research grants from the National Institutes of Health (R21AR065672, R01DK105322, K08HL132060, and R03EB028415).	ABBOTT RD, 1990, AM J MED, V88, P376, DOI 10.1016/0002-9343(90)90492-V; An H, 2003, MAGN RESON MED, V50, P708, DOI 10.1002/mrm.10576; An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Armstrong DG, 1998, ARCH INTERN MED, V158, P289, DOI 10.1001/archinte.158.3.289; BEKS PJ, 1995, DIABETOLOGIA, V38, P86, DOI 10.1007/s001250050257; Bittel DC, 2015, J DIABETES COMPLICAT, V29, P250, DOI 10.1016/j.jdiacomp.2014.11.003; Boss A, 2006, NMR BIOMED, V19, P125, DOI 10.1002/nbm.1013; Boyce A., 2020, ENDOTEXT; Chowdhury MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182952; Conte MS, 2019, EUR J VASC ENDOVASC, V58, pS1, DOI 10.1016/j.ejvs.2019.05.006; Davidson BP, 2019, J AM SOC ECHOCARDIOG, V32, P1086, DOI 10.1016/j.echo.2019.05.001; DIAMOND JE, 1989, PHYS THER, V69, P797, DOI 10.1093/ptj/69.10.797; Edmonds ME, 2000, Z KARDIOL, V89, P101; Faries PL, 2001, AM J SURG, V181, P251, DOI 10.1016/S0002-9610(01)00551-7; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Forsythe RO, 2016, DIABETES-METAB RES, V32, P232, DOI 10.1002/dmrr.2756; Gershater MA, 2009, DIABETOLOGIA, V52, P398, DOI 10.1007/s00125-008-1226-2; Hastings MK, 2016, CLIN BIOMECH, V32, P261, DOI 10.1016/j.clinbiomech.2015.11.001; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Huang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090201; Ingelsson E, 2007, DIABETES, V56, P1718, DOI 10.2337/db07-0078; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Kalliokoski KK, 2004, MICROVASC RES, V67, P125, DOI 10.1016/j.mvr.2003.11.004; Kang IS, 2016, J VASC SURG, V64, P1335, DOI 10.1016/j.jvs.2016.04.047; Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166; Maluf KS, 2003, CLIN BIOMECH, V18, P567, DOI 10.1016/S0268-0033(03)00118-9; McDermott MM, 2005, AM J EPIDEMIOL, V162, P33, DOI 10.1093/aje/kwi167; Meneses AL, 2018, AM J PHYSIOL-HEART C, V315, pH1425, DOI 10.1152/ajpheart.00232.2018; Mustapha JA, 2017, J CARDIOVASC SURG, V58, P383, DOI 10.23736/S0021-9509.17.09878-0; Ouwendijk R, 2006, RADIOLOGY, V241, P603, DOI 10.1148/radiol.2412050781; Potier L, 2011, EUR J VASC ENDOVASC, V41, P110, DOI 10.1016/j.ejvs.2010.09.020; Rac-Albu Marius, 2014, Maedica (Bucur), V9, P295; Shammas AN, 2017, J ENDOVASC THER, V24, P376, DOI 10.1177/1526602817705135; Shoji T, 2001, J AM SOC NEPHROL, V12, P2117, DOI 10.1681/ASN.V12102117; Smith CD, 2008, FOOT ANKLE INT, V29, P185, DOI 10.3113/FAI.2008.0185; Suzuki E, 2001, DIABETES CARE, V24, P2107, DOI 10.2337/diacare.24.12.2107; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Wang L, 2006, J AM COLL CARDIOL, V48, P1018, DOI 10.1016/j.jacc.2006.04.089; Wu WC, 2008, AM J PHYSIOL-HEART C, V294, pH2129, DOI 10.1152/ajpheart.01399.2007; Wu WC, 2009, J AM COLL CARDIOL, V53, P2372, DOI 10.1016/j.jacc.2009.03.033; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Zettervall SL, 2016, ARTERIOSCL THROM VAS, V36; Zettervall SL, 2018, J VASC SURG, V67, P507, DOI 10.1016/j.jvs.2017.06.086; Zheng J, 2014, J VASC SURG, V59, P419, DOI 10.1016/j.jvs.2013.07.115; Zheng J, 2014, MAGN RESON MED, V71, P318, DOI 10.1002/mrm.24669	45	0	0	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					367	373	1358863X21996465	10.1177/1358863X21996465		MAR 2021	7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000631603300001	33749394				2022-04-28	
J	Smolderen, KG; Pacheco, C; Provance, J; Stone, N; Fuss, C; Decker, C; Bunte, M; Jelani, QU; Safley, DM; Secemsky, E; Sepucha, KR; Spatz, ES; Mena-Hurtado, C; Spertus, JA				Smolderen, Kim G.; Pacheco, Christina; Provance, Jeremy; Stone, Nancy; Fuss, Christine; Decker, Carole; Bunte, Matthew; Jelani, Qurat-ul-ain; Safley, David M.; Secemsky, Eric; Sepucha, Karen R.; Spatz, Erica S.; Mena-Hurtado, Carlos; Spertus, John A.			Treatment decisions for patients with peripheral artery disease and symptoms of claudication: Development process and alpha testing of the SHOW-ME PAD decision aid	VASCULAR MEDICINE			English	Article						claudication; patient centered; patient education; shared decision-making; peripheral artery disease (PAD)		Patients with peripheral artery disease (PAD) face a range of treatment options to improve survival and quality of life. An evidence-based shared decision-making tool (brochure, website, and recorded patient vignettes) for patients with new or worsening claudication symptoms was created using mixed methods and following the International Patient Decision Aids Standards (IPDAS) criteria. We reviewed literature and collected qualitative input from patients (n = 28) and clinicians (n = 34) to identify decisional needs, barriers, outcomes, knowledge, and preferences related to claudication treatment, along with input on implementation logistics from 59 patients and 27 clinicians. A prototype decision aid was developed and tested through a survey administered to 20 patients with PAD and 23 clinicians. Patients identified invasive treatment options (endovascular or surgical revascularization), non-invasive treatments (supervised exercise therapy, claudication medications), and combinations of these as key decisions. A total of 65% of clinicians thought the brochure would be useful for medical decision-making, an additional 30% with suggested improvements. For patients, those percentages were 75% and 25%, respectively. For the website, 76.5% of clinicians and 85.7% of patients thought it would be useful; an additional 17.6% of clinicians and 14.3% of patients thought it would be useful, with improvements. Suggestions were incorporated in the final version. The first prototype was well-received among patients and clinicians. The next step is to implement the tool in a PAD specialty care setting to evaluate its impact on patient knowledge, engagement, and decisional quality. ClinicalTrials.gov Identifier: NCT03190382	[Smolderen, Kim G.; Jelani, Qurat-ul-ain; Mena-Hurtado, Carlos] Yale Univ, Dept Internal Med, Vasc Med Outcomes VAMOS Program, Cardiovasc Med Sect, New Haven, CT USA; [Pacheco, Christina; Stone, Nancy; Fuss, Christine; Decker, Carole; Bunte, Matthew; Safley, David M.; Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Pacheco, Christina; Provance, Jeremy; Decker, Carole; Safley, David M.; Spertus, John A.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Secemsky, Eric] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sepucha, Karen R.] Massachusetts Gen Hosp, Dana Farber Harvard Canc Ctr, Boston, MA 02114 USA; [Spatz, Erica S.] Yale Univ, Ctr Outcomes Res & Evaluat, Yale New Haven Hlth Hosp, Dept Internal Med,Cardiovasc Med Sect, New Haven, CT USA		Smolderen, KG (通讯作者)，Yale Univ, Sect Cardiovasc Med, Dept Internal Med, Dana Clin Bldg,Room 305,789 Howard Ave, New Haven, CT 06519 USA.	kim.smolderen@yale.edu	Spertus, John/ABD-3075-2021	Secemsky, Eric/0000-0003-3861-3163; Smolderen, Kim/0000-0001-6104-6254; Jelani, Qurat-ul-ain/0000-0003-3393-8348	Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [IP2 PI000753-01, CE-1304-6677]; Netherlands Organization for Scientific Research (VENI Grant)Netherlands Organization for Scientific Research (NWO) [916.11.179]; W. L. Gore & Associates, Inc. (Flagstaff, AZ); Merck & Company, Inc. (Kenilworth, NJ); NIH/NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL150290]	Research reported in this manuscript was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (IP2 PI000753-01; CE-1304-6677), The Netherlands Organization for Scientific Research (VENI Grant No. 916.11.179), unrestricted grants from W. L. Gore & Associates, Inc. (Flagstaff, AZ) and Merck & Company, Inc. (Kenilworth, NJ). Dr Eric Secemsky is funded in part by NIH/NHLBI K23HL150290.	Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; ClinicalTrials.gov, 2020, SHOWME PAD PER ART D; Coulter A., 2012, 2012 UPDATE INT PATI; de Graaff JC, 2002, ANN VASC SURG, V16, P495, DOI 10.1007/s10016-001-0121-9; Garvelink MM, 2013, J PSYCHOSOM OBST GYN, V34, P170, DOI 10.3109/0167482X.2013.851663; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471; Hahn C, 2008, DOING QUALITATIVE RE; Hallin A, 2002, EUR J VASC ENDOVASC, V24, P255, DOI 10.1053/ejvs.2002.1647; Harmsen MG, 2018, HEALTH EXPECT, V21, P659, DOI 10.1111/hex.12661; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Healthwise, 2016, PER ART DIS SHOULD I; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Ottawa Hospital Research Institute, 2020, PAT DEC AIDS SHOW ME; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Smolderen KG, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003860; Smolderen KG, 2009, J VASC SURG, V50, P1391, DOI 10.1016/j.jvs.2009.07.109; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026	22	1	1	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2021	26	3					273	280	1358863X20988780	10.1177/1358863X20988780		FEB 2021	8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SL5RP	WOS:000624246800001	33627058	Green Accepted			2022-04-28	
J	Shibata, T; Morishita, K; Shingaki, M; Ishikawa, K; Mawatari, T; Okawa, M; Kawaharada, N				Shibata, Tsuyoshi; Morishita, Kiyofumi; Shingaki, Masami; Ishikawa, Kazunori; Mawatari, Toru; Okawa, Miho; Kawaharada, Nobuyoshi			Images in Vascular Medicine: Heart-shaped saphenous vein graft pseudoaneurysm: Endovascular repair with covered stent	VASCULAR MEDICINE			English	Editorial Material									[Shibata, Tsuyoshi; Kawaharada, Nobuyoshi] Sapporo Med Univ Hosp, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan; [Morishita, Kiyofumi; Shingaki, Masami; Ishikawa, Kazunori; Mawatari, Toru; Okawa, Miho] Hakodate Municipal Hosp, Dept Cardiovasc Surg, Hakodate, Hokkaido, Japan		Shibata, T (通讯作者)，Sapporo Med Univ Hosp, Dept Cardiovasc Surg, Chuo Ku, 291,Minami 1 Jo Nishi 16 Chome, Sapporo, Hokkaido 0608543, Japan.	shibatatsuyoshi0827@yahoo.co.jp	Shibata, Tsuyoshi/AFU-7328-2022	Shibata, Tsuyoshi/0000-0002-4105-2937			Cenizo, 2020, CASE REP VASC MED, V2020; Fujimura N, 2020, CARDIOVASC INTER RAD, V43, P223, DOI 10.1007/s00270-019-02376-6; Yanagiuchi T, 2016, EJVES Short Rep, V30, P16, DOI 10.1016/j.ejvssr.2016.02.001	3	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	AUG	2021	26	4					462	463	1358863X21995573	10.1177/1358863X21995573		FEB 2021	2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	TY5MH	WOS:000620745100001	33576728	Bronze			2022-04-28	
J	Bunte, MC; Gosch, K; Elkaryoni, A; Noman, A; Johnson, E; Jones, P; Indaram, MB; Vupputuri, S				Bunte, Matthew C.; Gosch, Kensey; Elkaryoni, Ahmed; Noman, Anas; Johnson, Erin; Jones, Philip; Indaram, Mahathi B.; Vupputuri, Sravanthi			Bleeding, death, and costs of care during hospitalization for acute pulmonary embolism: Insights from the Saint Luke's Outcomes of Pulmonary Embolism (SLOPE) study	VASCULAR MEDICINE			English	Article						bleeding; mortality; pulmonary embolism (PE); readmission	CATHETER-DIRECTED THROMBOLYSIS; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; RESOURCE UTILIZATION; MULTICENTER TRIAL; SINGLE-ARM; RISK; PROGNOSTICATION; FIBRINOLYSIS; VALIDATION	Limited data exist that comprehensively describe the practical management, in-hospital outcomes, healthcare resource utilization, and rates of post-hospital readmission among patients with submassive and massive pulmonary embolism (PE). Consecutive discharges for acute PE were identified from a single health system over 3 years. Records were audited to confirm presence of acute PE, patient characteristics, disease severity, medical treatment, and PE-related invasive therapies. Rates of in-hospital major bleeding and death, hospital length of stay (LOS), direct costs, and hospital readmission are reported. From January 2016 to December 2018, 371 patients were hospitalized for acute massive or submassive PE. In-hospital major bleeding (12.1%) was common, despite low utilization of systemic thrombolysis (1.8%) or catheter-directed thrombolysis (3.0%). In-hospital death was 10-fold higher among massive PE compared to submassive PE (36.6% vs 3.3%, p < 0.001). Massive PE was more common during hospitalizations not primarily related to venous thromboembolism, including hospitalizations primarily for sepsis or infection (26.8% vs 8.2%, p = 0.001). Overall, the median LOS was 6.0 days (IQR, 3.0-11.0) and the median standardized direct cost of admissions was $10,032 (IQR, $4467-$20,330). Rates of all-cause readmission were relatively high throughout late follow-up but did not differ between PE subgroups. Despite low utilization of thrombolysis, in-hospital bleeding remains a common adverse event during hospitalizations for acute PE. Although massive PE is associated with high risk for in-hospital bleeding and death, those successfully discharged after a massive PE demonstrate similar rates of readmission compared to submassive PE into late follow-up.	[Bunte, Matthew C.; Gosch, Kensey; Jones, Philip] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Bunte, Matthew C.; Johnson, Erin; Vupputuri, Sravanthi] St Lukes Hlth Syst, Kansas City, MO USA; [Bunte, Matthew C.; Elkaryoni, Ahmed; Noman, Anas] Univ Missouri Kansas City, Dept Med, Kansas City, MO USA; [Indaram, Mahathi B.] Allegheny Gen Hosp, Pittsburgh, PA USA		Bunte, MC (通讯作者)，Univ Missouri Kansas City, St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	mbunte@saintlukeskc.org		Bunte, Matthew/0000-0002-8768-1376	Inari Medical, Inc.	Statistical analysis was supported through an investigator-initiated research grant from Inari Medical, Inc. However, the authors solely collected and retained the data and independently examined the data, and have submitted the manuscript for publication without data interpretation from the sponsor.	Albaghdadi MS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006841; [Anonymous], 2020, VIZIENT CLIN DATA BA, V2020; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bloomer TL, 2017, CATHETER CARDIO INTE, V89, P754, DOI 10.1002/ccd.26900; Chatterjee S, 2014, JAMA-J AM MED ASSOC, V311, P2414, DOI 10.1001/jama.2014.5990; Giri J, 2019, CIRCULATION, V140, pE774, DOI 10.1161/CIR.0000000000000707; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jimenez D, 2014, AM J RESP CRIT CARE, V189, P718, DOI 10.1164/rccm.201311-2040OC; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2014, CIRCULATION, V129, P479, DOI 10.1161/CIRCULATIONAHA.113.005544; Kuo WT, 2015, CHEST, V148, P667, DOI 10.1378/chest.15-0119; LaMori JC, 2015, CLIN THER, V37, P62, DOI 10.1016/j.clinthera.2014.10.024; Lin BW, 2012, AM J EMERG MED, V30, P1774, DOI 10.1016/j.ajem.2012.02.012; Lin J, 2014, J MANAGE CARE PHARM, V20, P174, DOI 10.18553/jmcp.2014.20.2.174; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Mostafa A, 2016, AM J CARDIOL, V117, P1014, DOI 10.1016/j.amjcard.2015.12.041; Park B, 2009, CHEST, V136, P983, DOI 10.1378/chest.08-2258; Patel N, 2015, CATHETER CARDIO INTE, V86, P1219, DOI 10.1002/ccd.26108; Piazza G, 2015, JACC-CARDIOVASC INTE, V8, P1382, DOI 10.1016/j.jcin.2015.04.020; R Development Core Team, 2019, R LANG ENV STAT COMP; Research Data Assistance Center, 2020, MEDPAR INP ADM TYP C; Secemsky E, 2018, AM J MED, V131, P1506, DOI 10.1016/j.amjmed.2018.07.035; Secemsky EA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009047; Sharifi M, 2019, VASC MED, V24, P103, DOI 10.1177/1358863X18824159; Sista AK, 2017, VASC MED, V22, P37, DOI 10.1177/1358863X16670250; Smith SB, 2016, CHEST, V150, P35, DOI 10.1016/j.chest.2016.02.638; Spyropoulos AC, 2007, J MANAGE CARE PHARM, V13, P475, DOI 10.18553/jmcp.2007.13.6.475; Tapson VF, 2018, JACC-CARDIOVASC INTE, V11, P1401, DOI 10.1016/j.jcin.2018.04.008; Todoran TM, 2018, J THROMB THROMBOLYS, V46, P39, DOI 10.1007/s11239-018-1659-5; Tu T, 2019, JACC-CARDIOVASC INTE, V12, P859, DOI 10.1016/j.jcin.2018.12.022; Wible BC, 2019, J VASC INTERV RADIOL, V30, P1370, DOI 10.1016/j.jvir.2019.05.024	36	0	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	FEB	2021	26	1					28	37	1358863X20967415	10.1177/1358863X20967415		NOV 2020	10	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	QF5WP	WOS:000608820100001	33227228				2022-04-28	
